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SECTION 1
Introduction
and
Introductory Review of Past Work
1,1 Introduction
'The immunological responses of an animal are put into effect
s'
by the activity of the fixed and circulating cells which in aggregate 
make up its lymphoid tissue,*
This statement which introduces a review of the immunological 
activities of lymphocytes by Gowans and McGregor (1965) puts 
forward concisely the reasons for interest in the lymphocytes. 
Lymphoid tissue in the body is thought to amount to one per cent of 
the body weight (Yoffey and Courtice, 1970) and although the bulk 
of this tissue is to be found in lymph nodes, spleen, bone marrow 
and other organs throughout the body a small fraction is readily 
accessible to investigation in the peripheral blood. The majority 
of the lymphocytes in peripheral blood are normally only transiently 
blood cells; about two thirds of the cells interchange with cells 
elsewhere in the lymphoid system while others are short lived cells 
(Everett, Caffrey and Reike, I964). Lymphocytes of the peripheral 
blood are therefore more representative of the tissue as a whole 
than might at first appear.
The blood lymphocyte population is heterogeneous both in 
morphology and function, and it has become clear that the two 
principal immune responses, antibody production and infiltration of 
tissues with sensitised cells, the cellular immune response, are 
attributable to distinct cell populations (Roitt, Greaves,
Torrigiani, Brostoff and Playfair, I969). It is now possible to 
distinguish these cell populations in peripheral blood lymphocytes 
by recognition of surface immunoglobulins which are found in 
substantial quantity only on cells of the antibody producing line 
(Papamichail, Brown and Holborow, 1971). Morphological assessment 
of the blood lymphocytes has remained unsatisfactory in that 
classifications of the lymphocytes depend on considerations of cell 
size and degree of basophilia in stained preparations, Histo- 
chemical measurements or electron microscopy might improve the 
classification, but there are practical difficulties in applying 
these techniques in quantity.
Lymphocytes in tissue culture will react to specific antigen 
stimuli in sensitized individuals and more generally to non-specific 
mitogens such as the kidney bean extract, phytohaemagglutinin 
(Eirschorn and Ripps, I965). The reaction known as the trans­
formation response involves cell enlargement nucleic acid synthesis 
and later cell division. Tests of lymphocyte function based on 
this transformation response have been applied in human disease and, 
when there is a known immunological derangement, have frequently 
shown up an impaired ability of the lymphocytes to respond to 
mitogens. Although alterations in the proportion of large'*’and 
small lymphocytes in the blood have been documented in human 
disease such changes are difficult to define and a simple and 
objective method of describing the nature of the blood lymphocyte 
population is not available. It is to this problem that the thesis
is directed.
The work described is the approach of a biochemist to the 
problem of assessment of the lymphocytes. Measurements of 
nucleic acids have been carried out on lymphocytes isolated from 
the peripheral blood using deoxyribose nucleic acid (DNA) to 
establish cell numbers and ribose nucleic acid (RNA) to determine 
the metabolic activity of the cells. The mean RNA/d NA ratio of 
isolated blood lymphocytes has been proposed as a suitable 
objective measurement of the cells and the ratio has been 
determined in a series of normal subjects and in diseases of 
special immunological interest.
Clarity of presentation has demanded that the thesis be 
written in sections. This introduction is followed by a short 
general review of past work on the role of the lymphocyte in immune 
processes, A second separate section deals with investigations of 
the methodology, and then in the third section a study of normal 
lymphocytes and the effect of diseases on blood lymphocyte nucleic 
acids is presented, A fourth section considers the lymphocyte 
nucleic acids in renal transplantation and includes measurements on 
human thoracic duct cells with observations on the nature of 
lymphocyte RNA, A short concluding discussion draws points from 
the preceding sections in a general review of the worko
1,2 Introductory review of past work
The lymphocytes are directly involved in the production of 
the immune response, a process so involved that a review of any 
aspect of these cells must begin with an outline of the events of 
antibody immunity and cell mediated immunity. Both of these 
reactions are triggered by the presence of antigen, and depending 
on the nature of the antigen as well as its presentation,humoral 
antibody is produced or sensitised lymphocytes appear as effectors 
of the cellular immune response (Gowans and McGregor, 1965)#
An appreciation that there are two mechanisms of immune 
response developed from the observation that in some instances 
(antibody immunity) a state of temporary immunity can be trans­
ferred from an immune animal to a non-immune animal by means of 
serum, while in other types of immune response transfer of immunity 
with serum does not occur. Cell mediated immunity was recognised 
when it proved possible to transfer cells from sensitized animals 
and thereby transfer reactions of the delayed hypersensitivity 
type such as skin contact sensitivity (Landsteiner and Chase, 1942), 
skin allograft immunity (Billingham, Brent, Medawar and Sparrow,
1954), and tuberculin hypersensitivity (Chase, 1945). lymphocytes 
were the important cells in the transfers (Billingham, Silvers and 
Wilson, 1962) and these cells are regarded as effectors in cell 
mediated reactions.
It is instructive to look closely at the part played by
lymphocytes in immune processes. In a revealing experiment 
Gowans (I962) transferred thoracic duct small lymphocytes from an 
inhred strain of rats into the El hybrid between the donor strain 
and an unrelated strain. He showed that the transferred small 
lymphocytes reacted against tissue antigens in the hybrid which 
were foreign to the transferred cells, that is antigens inherited 
from the unrelated parental strain. A graft versus host reaction 
ensued. This experiment identified the rat small lymphocyte as a 
cell capable of recognising antigen and possibly also an effector 
of tissue damage.
Important evidence of diversity in lymphocyte function has 
come from studies of mice which have been thymactomis;ed at birth 
(Miller and Osoba, I967). The tliymectomized animals are partially 
depleted of small lymphocytes and have a severely limited capacity 
to produce a cell mediated immune reaction, for example in allo­
graft rejection or in delayed hypersensitivity, Humoral antibody 
production in response to certain antigens in thymectomized 
animals is less markedly impaired (Miller and Mitchell, I969). 
Developments from this type of experiment led to the study of mice 
which have been exposed to whole body irradiation and these 
investigations have clarified our understanding of lymphocyte 
function. Restoration of radiation depleted animals by means of 
a thymic graft revealed that thymus derived cells would respond to 
antigen by mitosis, but they did not m:.ilce antibody in significant 
quantity (Davies, Leuchars, Wallis, Marchant and Elliot, I967).
6Hossal and his colleagues (Nossal, Cunningham, Mitchell and Miller,
1968), using chromosomal markers to identify the lymphocytes, were 
able to show that most antibody producing cells were bone marrow 
derived and it is now held that some form of co-operation between 
thymus derived lymphocytes and bone marrow derived lymphocytes is 
necessary for the processes of recognition of a variety of antigens 
and production of specific antibody (Claman and Chaperon, I969),
An earlier observation by Click introduces additional evidence 
of diversity of lymphocyte function. It was shown by Click and 
his co-workers (Click, Chang and Jaap, 1956) that a lymphoid organ 
present in birds, the bursa of Fabricius, was necessary for the 
proper development of anribody producing cells in chickens.
Although a single organ equivalent to the bursa has not been 
demonstrated in mammals its importance in birds is evidence in 
favour of the existence of a population of lymphocytes distinct 
from the thymus dependent cells. The present view, and this has 
gained wide acceptance, is that mammalian lymphocytes are derived 
ultimately from bone marrow as undifferentiated stem cells. Some 
of the stem cells come under the influence of the thymus and 
proliferate within its substance to become thymus dependent,
T™lymphocytes® These are the cells with capacity to recognise 
antigen and to proliferate out^with the thymus in a cellular immune 
response. Other lymphocytes, again derived from bone marrow stem 
cells, proliferate in areas of the lymph nodes, gut and spleen. 
These B-lyrnphocytes are of the antibody producing line and are best
considered as bone marrow derived thymus independent cells 
(Meuwissen, Stutman and Good, 1969? Davies, I969? Roitt, Greaves, 
Torrigiani, Brostoff and Playfair, I969). Anatomical parallel of 
the functional division of the lymphocytes is observed in the lymph 
nodes where certain regions known as the paracortical areas are 
populated almost completely by thymus dependent cells (parrott, 
de Sousa and East, I966), while tli^ nnus independent B-lymphocytes 
proliferate in the germinal centres.
The validity of these observations for human immune reactions 
has been accepted principally as a result of observations in 
pathology. Thus, the clearest demonstration of the presence of at 
least two distinct populations of lymphocytes in man has been the 
recognition of immunological diseases in which there may be 
independent failure of either one of the.two types of immunity.
In 1965 Di George described congenital absence of the thymus in a 
child and this defect was associated with failure of delayed hyper­
sensitivity reactions, i.e, cell mediated immunity. Such children 
have a relatively intact capacity to form immunoglobulins (Fulginiti, 
Hathaway, Pearlman, Blackburn, Reiquam, Githens, Claman and Kernpe, 
1966). On the other hand a form of sex linked hypogammaglobulin- 
aemia exists, first described by Bruton (1952), in which the tliymus 
gland is normal, circulating small lymphocytes appear normal, but 
there is a partial lymphocyte depletion from the thymus independent 
areas of the lymph nodes. Plasma cells are lacking and these 
infants fail to produce significant quantities of immunoglobulins
8(Meuwissen, Stutman and Good, 1959),
Further evidence of distinct populations of lymphocytes has 
been the detection of surface immunoglobulins on the cells by 
immunofluorescent technique. Both T-lymphocyte and B-lymphocytes 
have antigens fixed to their surface by means of specific membrane- 
bound immunoglobulins, but only in B-lymphocytes is this sufficient 
to be detected by fluorescein conjugated anti-immunoglobulin. In 
mice the cells shown to be carrying surface immunoglobulins by this 
method have been identified as B-lymphocytes (Raff, 1971) and a 
proportion of the blood lymphocytes in man, of the order of one in 
three, show detectable surface immunoglobulin typical of B- 
lymphocytes (Paparaichail, Brown and Holborow, 1971), It is now 
almost certain that in man the presence of surface immunoglobulin 
detectable by immunofluorescent technique identifies the B— 
lymphocytes, more especially since in the Bruton type agarnma- 
globulin none are found in peripheral blood (Froland, Natvig and 
Berdal, 1971),
It is likely that the life span of T-lymphocytes and B- 
lymphocytes is considerably different. There is undoubtedly a 
population of lymphocytes in the rat with a life span in excess of 
two hundred days. This is the interpretation of the persistence 
of unlabelled cells during a long period of continuous administration 
of initiated thymidine to these animals (Robinson, Breeder, Lourie 
and Haley, I965). A minority of rat lymphocytes have a life span 
of less than two weeks (Everett, Caffrey and Rieke, I964),
It has been possible to study the life span of the lymphocytes 
in man by investigation of the persistence of small lymphocytes 
damaged during therapeutic radiation. By this method it is 
reckoned that the average life span of the human long-lived small 
lymphocytes is between four and five years (Bucton, Court-Brown and 
Smith, 1967)* The long—lived cells recirculate between blood and 
lymph nodes either directly or by percolation through the tissues 
and thence by way of the efferent lymphatics and the thoracic duct 
reappear in blood (Gowans, 1959)* Long-lived and short-lived 
lymphocytes are to be found in varying proportion in different . 
lymphoid organs and regions of lymphoid organs (Ford and Gowans,
1969)? thoracic duct lymph showing a low percentage of the short­
lived cells and peripheral blood a greater proportion; about one 
third of the blood lymphocytes in the rat are these short-lived 
cells (Everett et al., 1964)* This is the proportion of immuno­
globulin bearing B-lymphocytes in the peripheral blood in man. 
Furthermore, it is long-lived lymphocytes which are depleted in 
thymectomized and therefore T-lymphocyte depleted rats (Rieke and 
Schwartz, I966). Definite proof is required however that short­
lived lymphocytes are B-lymphocytes and the long-lived variety are 
T-lympho cyt es,
Oort and Turk (1965) 'have made a detailed study of the changes 
which occur in regional lymph nodes of the guinea pig during the 
development of contact sensitivity to the chemical oxazolone, a 
cell mediated reaction. They observed enlargement of lymphocytes
10
in the paracortical areas of the local node to form pyroninophilic 
blast cells. The lymphoblasts reached their maximum concentration 
four days after contact with oxazolone, the day before the animal 
became sensitized to this chemical agent. Mitoses were apparent 
in the lymphoblasts after day four and from auto-radiographic 
studies it appeared very likely that the resulting daughter cells 
were small lymphocytes. Similar changes have been described in 
the days following- the application of a skin homograft in the 
rabbit (Scothorne and McGregor, 1955),
llhen the antigenic stimulus gives rise to an antibody response 
the changes in the lymph node are to be found in the medullary 
region. On the sixth day following intra-dermal injection of a 
purified pneumococcal antigen there is a marked increase in the 
number of plasma cells to be found in the areas known as the 
medullary cords (Oort and Turk, I965), Paracortical areas of the 
lymph nodes appear unchanged when this antigen is administered.
The expression of the immune response is influenced by the nature 
of the antigen as recent studies of the response to Salmonella 
flag^ellar protein have shown quite clearly (parish, 1971), 
Progressive chemical modification of the antigen resulted in a 
steady reduction of the ability of the antigen to induce antibody 
production and an enhancement of the cell mediated response. It 
is however likely that many antigens provoke a combined cell 
mediated and antibody mediated immune response (Turk, I967),
11
The in vivo response to antigen challenge has been examined in 
a different way by Hall and his colleagues (Hall, 1957? Hall, 
Morris, Moreno and Hessis, 1957). These authors developed the 
technique of cannulation of the efferent lymphatics of a lymph node 
draining the flank region in sheep. They then stimulated the 
region drained by the node with a suitable antigen and studied the 
changes in the cellular content of the lymph flowing from the node. 
It was clear from these experiments that large numbers of basophilic 
cells appeared in the lymph when the antigen was a skin allograft, 
and there was a similar response to injected human red blood cells. 
Although both reactions probably involve a mixed cell mediated and 
antibody response there were differences in the timing of the 
greatest outflow of basophilic cells. Unfortunately there are no 
studies of an uncomplicated cell mediated or antibody immune 
response using this technique.
An important advance in the study of lymphocyte function was 
the development of an in vivo model of the immune response. In 
i960 Nowell discovered that phytohaemagglutinin, a mucoprotein 
extracted from the red kidney bean, phaeseolus vulgaris, was able 
to stimulate cultured white blood cells to divide. It is small 
lymphocytes which have the capacity to react to non-specific 
mitogens such as phytohaemagglutinin or to specific antigens where 
there has been previous exposure of the cell donor to the antigen 
(llirschorn and Ripps, 1965). This so called transformation 
response which includes RNA, DNA and protein synthesis with
12
enlargement and division in some of the cells, is thought to 
parallel the in vivo response of the lymphocytes (Rubin, 1967),
The response to phytohaemagglutinin and other non-specific agents 
such as Pokeweed mitogen and Streptolysin-3 stimulate a high 
proportion of lymphocytes without prior sensitizing contact.
The extent of this in vitro reactivity of the lymphocytes relates 
to the immunological potential of the cells and is diminished when 
there is deficiency of thymus dependent cells (Davies, I969)* A 
similar but more specific reaction to bacterial or viral antigens 
in sensitized individuals is a more close parallel of the natural 
in vivo response but is of lesser degree (Meuwissen, Stutman and 
Good, 1969), Many reports of alteration in the lymphocyte trans­
formation response in human disease have appeared in the literature, 
some of which will be detailed later.
This thesis is mainly concerned with the blood lymphocytes.
The work of Hall and his colleagues on the cellular content of the 
lymph implied that changes are to be expected in the blood 
lymphocytes during an immune response. The large basophilic cells 
of the efferent lymphatics drain to the blood stream by way of the 
major lymphatic trunlcs, furthermore the electron microscopic 
appearances of these basophilic lymphoid cells in animals (Hall, 
Morris, Moreno and Bessis, 1957) are very similar to the cells 
described in the peripheral blood in man in association with an 
immunological response (Zuoker-Franklin, 1959). The striking 
feature of the cells, and this accounts for their basophilia on
13
stained preparations are the abundant clustered ribosomes in the 
cytoplasm which is usually lacking in a developed endoplasmic 
reticulum.
When a peripheral blood smear stained with Wright's stain is 
examined by light microscopy it is immediately obvious that the 
lymphocytes are heterogeneous. Wintrobe (196?) stales that the 
lymphocyte is generally small (ten microns in diameter) but larger 
forms are common (ten to thirty microns). Attempts to be more 
precise in a morphological classification of the cells have met 
with the difficulty of making arbitrary divisions where no natural 
morphological classes exist. Attention has been drawn to this 
problem by several reviewers (Gowans and McGregor, 1955? Sell and 
Asofsky, 1958),
Early classification of blood lymphocytes relied on the 
microscopic appearance of the cells on stained smears, in particular 
the size and degree of basophilia (Wiseman, 1931? Reich and Reich, 
1933? Pariser, Zucker and Meyer, 1952). With greater under­
standing of the immune response, interest in this type of measurement 
revived and because of the difficulty of making objective 
measurement of basophilia various means of assessing the lymphocytes 
have been devised, Hernberg made cell diameter measurements on 
stained smears of peripheral blood (Hernberg, 1954). besiewska 
(1957) adopted histochemical techniques to measure lymphocyte DNA 
and RNA content, and Crowther and his colleagues (Crowther, Fairley 
and Sewell, 1959) determined labelled Uridine and Thymidine uptake
14
of the lymphocytes in an assessment of the rates of RNA and DNA 
synthesis in the cells. A limited series of conditions have been 
investigated by these several authors, Hernberg's studies were of 
thyrotoxicosis, Lesiewska's measurements were in children with 
viral infections, and Crowther's group examined the effect of 
immunisation in normal subjects and in patients with Hodgkin's 
disease. Prom these studies it is evident that the blood 
lymphocyte population changes to include a greater proportion of 
the more basophilic, RNA containing, cells in response to a 
variety of stimuli.
Each of the methods used in the assessment of the lymphocytes 
has disadvantages. Cell diameter measurements are laborious and 
the cell size recorded depends on the techniques used. The 
histochemical approach requires individual measurements from a 
large number of cells and although the procedure of Crowther at al, 
is shorter it is difficult to obtain reproducible results when the 
uptake of nucleic acid precursors is measured in vitro (Parker and 
Lulces, 1969). Determination of RNA and DNA content of the 
lymphocytes may offer some advantages in reproducibility, but this 
has not been previously investigated.
Chemical measurements of DNA and RNA in blood leucocytes have 
been undertaken by Davidson, Leslie and White (1951) ^ud by Metals 
and Mandel (l950) but no chemical measurements of DNA and RNA in 
blood lymphocytes have been described except in patients with acute 
and chronic lymphatic leucaemia (Rigas, Duerst, Jump and Osgood,
15
1955). The opportunity therefore exists to make a study of the 
nucleic acid content of the blood lymphocytes by chemical analyses 
in a variety of conditions.
At the time of writing there is no clear evidence which links 
B-lymphocytes or T-lymphocytes with any particular morphological 
class of cell; both may be small lymphocytes. There is a 
suggestion based on measures of cell size and electrophoretic 
mobility that the 3-lymphocytes may be larger than T-lymphocytes 
(Davies, 1959) s-nd this is supported by independent observations, 
Metcalf (1957) compared the size of lymphocytes in suspension 
by Coulter counter and showed that lymph node cells and these from 
Beyer's patch were larger and more heterogeneous than thymus small 
lymphocytes. Heiniger, Riedwyl, Giger, Sordat and Cottier (1967) 
demonstrated by electron microscopy that small lymphocytes from the 
thymus of Swiss albino mice had a smaller nucleolar volume than 
small lymphocytes from the popliteal node in these animals; this 
was by a considerable margin, 0,11 }om^  as against 0,45 pm^.
Thymic small lymphocytes also had less cytoplasm. Furthermore,
thymic lymphocytes have been shown to be lacking in polyribosome 
structures (Clawson, Cooper and Good, 1955), From these 
observations it might be anticipated that T-lymphocytes, at'least 
during the intra-thymic phase of their life span, would have a 
lower RNA content than B-lymphocytes, Large lymphoid cells which 
appear in the blood during an immune response may be plasma cells
precursors (Birbeck and Hall, 1957) of the B~lymphocyte line, but
16
it is also possible that the large lymphocytes are T-lymphocytes 
which have undergone blastoid transformation. Techniques to 
differentiate these alternatives have hitherto been lacking as have 
effective methods of monitoring the changes in the circulating 
lymphocytes.
This review has only introduced topics from the vast literature 
on the lymphocytes but it has given justification for a study of 
the blood lymphocytes drawing attention to one of the problems, 
the difficulty of assessing these cells.
17
SECTION 2
Methods and their verification
18
2.1 Introductory review
Isolation of lymphocytes from peripheral blood.
The large number of published methods for the separation of 
leucocytes and lymphocytes from the peripheral blood is an 
indication that no technique is entirely satisfactory, for example 
Skoog and Beck (1958) have compared three methods and given data 
on yields and purity of the isolated cells, as well as information 
about the optimum conditions for cell separation. Two general 
principles have been used in methods for isolating the leucocytes 
from blood* In one type3, advantage is taken of the property of 
certain high molecular weight materials such as dextran or gelatin 
to accelerate red cell sedimentation. Separation of polymorpho­
nuclear leucocytes and lymphocytes takes place by differential 
adhesion of the cells either to the same added material, gelatin is 
effective (Coulson and Chalmers, 1964)9 or to additional adsorbents 
such as cotton wool (Cooper, 1967)9 or glass beads (Habinowitz, 
1964)* In another procedure the cells are separated by 
centrifugation through layers of different density; solutions of 
bovine serum albumin (Vallee, Hughes and Gibson, 1947) or silicone 
oil (Seal, 1959) have been used. In the present investigation 
methods depending on these two principles were tried and compared.
19
Measurement of RNA and DNA in human lymphocytes.
Reviewers of the problem of nucleic acid determination in 
tissues have agreed that the most generally useful method of RNA 
measurement, and one that is still reasonably convenient, is to 
apply ultra-violet absorptiometry to the R M  fraction separated by 
the Schmidt Thannhauser method (Hutchison and Munro, I96I). An 
important proviso made by these authors is that allowance must be 
made for the small amount of protein present in the separated RNA 
fraction and since the amount and nature of the protein is variable 
depending on the tissue analysed the factors employed in any 
correction technique must be worked out for the tissue concerned.
Analyses of the DNA fraction following the Schmidt Thannhauser 
separation engenders similar dangers of contamination with protein 
as are encountered with the RNA fraction (Hutchison and Munro, 
1961). Davidson (1957) recommended the extraction of the D M  with 
hot perchloric acid, 0.5 N at 80 C for ten minutes, however if 
ultra-violet absorptiometry is to be employed, correction for the 
presence of protein will still be necessary (Tsanev and Markov, 
i960). Much of this section is concerned therefore with an 
assessment of the validity of these analytical methods for human 
lymphocytes.
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2.2 The gelatin method for the isolation of blood lymphocytes
The gelatin sedimentation method of Coulson and Chalmers 
(1964) fo3? the separation of human lymphocytes from peripheral 
blood was modified in order to increase the purity of the 
lymphocyte yield and the convenience of sample collection, 
Ethylene-diamine—tetra acetic acid (EDTA) was used as the anti­
coagulant which avoided the need for immediate defibrination of 
the blood sample, a disadvantage of the original method. 
Defibrination was retained as a step in the separation however, 
since the fibrin clot selectively traps and removes polymorpho­
nuclear leucocytes; the procedure was used after the bulk of the 
red cells had been removed and the selection therefore more 
efficient. In the method, an aqueous solution of gelatin prepared 
from lime-processed hides was mixed with the blood to accelerate 
red cell sedimentation. This gelatin has a high content of 
calcium (8.0 tng per 100 g of the solid), so that an increase in the 
amount of EDTA anticoagulant was required for the modified method.
Materials
1 ) 'Repelcote*, a 2^ solution of dimethyldiohlorosilane in carbon
tetrachloride (Hopkin and Williams, Ltd.).
2) 0.11 M EDTA, 4 g of the disodium salt per 100 ml water brought
to pH 7.4 with 4 M potassium hydroxide to give a solution of
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40 mg EDTA per ml.
3) 0.10 M calcium chloride, 1.10 g anhydrous salt per 100 ml in
0.05 sodium chloride (4 .O mg calcium per ml),
4 ) Gelatin, a 3^ solution in O.I5 M sodium chloride. The gelatin
was number 277? number 309 or number 66OO3, obtained from the 
Gelatin and Glue Research Association, Warwick Street, 
Birmingham, 12. The solution was freshly prepared for each 
batch of analyses.
5 ) 0,15 M sodium chloride,
6) 0 .3 0 M sodium chloride.
Procedure
Venous blood, 20 ml, was collected in a polystyrene tube 
containing 1 ml of the EDTA solution. After mixing, 6.0 ml of 
the gelatin solution were added and the solution mixed again.
The diluted blood was then transferred to a siliconed tube and 
stood at a temperature of 37 0 for thirty minutes during which 
time the mixture separated into two visibly distinct layers. The 
whole of the upper layer, freed from the bulk of the red cells, 
was removed to a 50 ml conical flask fitted with a stirring rod 
suitable for defibrination (i.e. a glass rod with a wire paper-clip 
fixed on its end). Calcium chloride solution, 2 ml, were added 
and defibrination carried out by swirling. After about fifteen 
minutes, when defibrination was complete, 3 ml of the EDTA solution
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were added and the suspension removed to a centrifuge tube. The 
cells were then spun down by centrifugation at 350 gav (14OO rev/ 
min in a centrifuge head of 16 cm radius) for ten minutes. The 
lymphocytes sedimented as a small button tinged with red, there 
being some red cell contamination at this stage. It was 
convenient to make a smeer of the sediment by spreading a small 
sample on a glass slide; the fixed and stained preparation was 
then used to assess the contamination with white cells other than 
lymphocytes. The red cells were removed by a process of osmotic 
shock; 2 ml or 3 ml of ice cold distilled water were added to the 
cell button, the cells suspended and left for exactly fifteen 
seconds. Normal tonicity was then restored by the addition of an 
equal volume of ice cold 0,30 M sodium chloride solution and the 
cells maintained thereafter at 4 C. Centrifugation at 125 gav 
(900 rev/min in the centrifuge head of radius 16 cm) again gave a 
cellular button, this time grey-white in colour. The haemoglobin 
from the lysed red cells remained in solution and was removed by 
Pasteur pipette together with a thin layer of red cell ghosts 
overlying the compact button. The lymphocytes were then 
suspended in 2.5 ml of O.I5 M sodium chloride solution. Some 
clumping of the cells was occasionally observed and these cell 
aggregates were removed by allowing them to sediment to the bottom 
of the tube on standing for five minutes. The suspended cells 
were then collected by Pasteur pipette and a cell count was carried 
out.
23
Usually about 12 million cells were obtained from 20 ml of 
blood representing a yield of 25 per cent of the lymphocytes*
A minimum of three million cells were required for reliable 
estimation of nucleic acid so that 10 ml of peripheral blood would 
in most cases give a satisfactory yield of cells. Reduced 
volumes of blood were used on some occasions with appropriately 
adjusted reagent volumes but in general a 20 ml sample was used.
The few cell suspensions with less than 90 per cent of lymphocytes 
were regarded as unsuitable for chemical analysis and were discarded.
2.3 The gelatin and cotton wool method for the isolation 
of blood lymphocytes
At a later stage of the work, following a suggestion by 
H,L, Cooper (1967), an additional step in the separation was 
adopted which improved the purity of the final lymphocyte 
suspension, so that samples with excessive contamination with poly­
morphonuclear leucocytes were all but eliminated. The new step 
was to add cotton wool to the defibrinated suspended cells., 
sufficient to soak up free fluid (the cotton wool was pre-washed 
in distilled water and dried). After fifteen minutes at 37 G 
the purified cell suspension was expressed from the cotton wool by 
pressure and the cells centrifuged ready for osmotic shock as 
before. This modified method will be referred to as the gelatin
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and cotton wool method. The previous method, Section 2,2, is 
the gelatin method.
2.4 The silicone oil method for the isolation of blood lymphocytes
S.H. Seal (1959) has published a method intended for the 
isolation of cancer cells from the peripheral blood which allowed 
separation of lymphocytes from other cells by centrifugation 
through silicone oil of a particular specific gravity. The 
method described here has been modified from the published 
technique in an effort to maintain the viability of the lymphocytes 
by maintenance of a suitable osmolality and to eliminate possible 
difficulties with the technique due to fluctuations in room 
temperature.
Materials
1) Silicone Oil
MS 510 Hopkin and Williams, Ltd. (Relative density at 20 C 
with respect to water at 20 C 0.9956)#
MS 555 Hopkin and Williams, Ltd, (Relative density at 20 C 
with respect to water at 20 C 1,0715).
The two silicone oils (density measured by density bottle 
technique) were blended to give an oil of relative density 
at 20 C with respect to water at 20 C of 1.0695-1*0698;
25
the preparation being 2.5 ml 5IO to 97#5 ml 555; this was 
a modification from the original technique,
2) Polyvinyl Pyrrolidone (PVP)
35.0 g of PVP (British Drug Houses, Ltd.) was dissolved in 
500 ml of 0 .85$^ saline with 0,5 ml of WH 1339 polymer and
2.5 g of EDTA, The pH was adjusted to 7*4 (approximately 
5 ml of M KOH) and the volume made up to 1 litre. Water, 
100 ml, was then added to give a final osmolality of 290 m 
osrnole/kg,
3) Saponin. A 2 %  solution of Saponin in water.
Procedure
Ten ml of silicone oil blended to a relative density of 
1,0695 to 1,0698, was placed in a 50 ml siliconised centrifuge 
tube and overlaid with 20 ml of PVP solution and the whole 
cooled to 4 C, Then 8 ml to 12 ml of defibrinated blood was 
added to the PVP layer and the tubes spun at 500 gav (I65O rev/ 
min in a head of 16 cm radius) for thirty minutes at 4 G, This 
was the time required for the red blood cells to penetrate the 
surface of the oil, lymphocytes, with a few red cells, then 
remained at the PVP oil interface in a thin grey and red layer. 
The supernatant PVP solution was removed down to a level close 
to the oil surface and the cells washed off with 20 ml of fresh 
PVP solution using small aliquots and disturbing the oil as
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little as possible. Gross contamination with oil droplets was 
reduced by allowing -these to settle out from the washings. Red
blood cells were lysed by addition of 1 ml of 2^ saponin to
20 ml of PVP cell suspension. The lymphocytes were then 
centrifuged at 200 gav (1,100 rev/min in a centrifuge head of 
radius 16 cm) for thirty minutes at 4 G and washed in 10 ml of
PVP, It was convenient to suspend the cells in 3 ml of PVP for
counting and removal of aliquots.
2.5 Cytology
lymphocyte counts.
Counting of lymphocytes in suspension was carried out by 
adding 0.1 ml of the cell suspension to 1,0 ml of 1,5^ acetic acid 
solution, tinted with methyl violet, using accurate pipettes for 
the dilution. The cells were counted in an improved Weubauer 
counting chamber.
Whole blood white cell counts.
This was carried out by standard technique using the Coulter 
counter, model F, (Coulter Electronics Ltd., England).
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Differential counts on blood white cells by light microscopy.
One hundred cells were examined on each blood smear stained 
with Leishman's stain. The battlement technique (MacGregor, 
Richards and Loh, 1940) was used to ensure representative 
counting of the cells.
Cell diameter measurements.
Some measurements were carried out of lymphocyte diameters as 
measured on a fixed and stained blood smear. These measurements 
were made using the Watson image shearing eyepiece, previously 
calibrated by a ruled calibration slide. Measurements to 
were readily made with this technique.
Cell viability.
Estimation of viability of the isolated cells was carried out 
by the standard trypan blue method (Parker, 1961) which showed up 
dead or damaged cells, since only they are stained when the dye is 
added to a cell suspension. The procedure was as follows:- to 
1 ml of isolated lymphocytes suspended in 0.15 M sodium chloride, 
0.5 ml of a 0,5^ solution of trypan blue in water was added. The 
cells were examined by light microscopy after ten minutes and the 
percentage of stained cells recorded. Cells prepared by the 
gelatin method and the silicone oil procedure were shown to respond 
to mitogens in tissue culture but no systematic comparison of cell 
viability by this method was carried out.
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2,6 Phosphorus measurement
The method of Allen (l940) was used for measurement in the 
range 10 micrograms to 100 micrograms of phosphorus. Di­
potassium hydrogen phosphate, Analar grade, was the standard and 
was prepared by drying to constant weight at 100 C,
2,7 Protein measurement
Measurements in the range of 10 micrograms to 150 micrograms 
of protein were carried out by the method of Lowry, Rosebrough, 
Parr and Randall (l95l)* Bovine serum albumin fraction V 
(Armour Pharmaceutical Co., England) was the standard used.
Figure 1
The separation of R M  and D M  hy the modified Schmidt Thannhauser 
technique*
T H E  S E P A R A T I O N  O F  R N A  A N D  D N A
C e i l  s u s p e n s i o n  
D N A  ^
P r e c i p i t a t i o n  of R N A  i n O * 2 M  P e r c h l o r i c  a c i d  
P r o t e i n
p p t . w a s h e d  in 0 - 2 M  P e r c h l o r i c  a c i d  
t o  r e m o v e  n u c l e o t i d e s
1 h o u r  i n c u b a t i o n  w i t h  0  3 M  K O H  
a t  370c  h y d r o l y s e s  R N A
R e a c i d i f i c a t i o n  w i t h  p e r c h l o r i c  a c i d  
a n d  p pt. w a s h e d .
_  P ? ^ ^ n  a r e  r e p r e c i p i t a t e d
t n 6  R N A  f r a c t i o n  P e r c h l o r i c  s a l t s
T r e a t m e n t  w i t h  O ' S M  p e r c h l o r i c  a c i d  
a t 8 0 * C  f o r 1 0  m i n s  r e n d e r s  D N A  a c i d  s o l u b l e
C o o l e d  t o  4 " C
p p t .  is p r o t e i n  a n d  
A c i d  s o l u b l e  m a t e r i a l  is p e r c h l o r a t e  s a l t s
t h e ’D N A '  f r a c t i o n
The flow diagram for the method of separation of a cell suspension 
into R M  and DNA fractions is outlined. Details are in the text 
(Section 2.8 ).
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2,8 The measurement of R M  and DNA
The method used was that of Schmidt and Thannhauser (1945) 
as modified hy Fleck and Munro (1962), emitting extraction with 
lipid solvents (Hallinan, Fleck and Munro, I963), and using 
Schneider*s modification for extraction of DNA (Davidson, 1957)# 
Considerable reduction in scale from the standard procedures was 
required to give sufficient sensitivity for measurement of the 
small amounts of nucleic acid present in the samples of 
lymphocytes. The method makes use of the hydrolysis of RNA in 
dilute .alkali as a means of. rendering it acid soluble under 
conditions in which DNA and protein are stable. Reacidification 
allows separation of the acid soluble oligonucleotides derived 
from hydrolysis of the RNA from the insoluble residue of DNA and 
protein. The DNA protein fraction may then be treated with hot 
perchloric acid to extract the DNA, The flow diagram for the 
separation has been drawn up in Figure 1,
Range
The range for the method as described is from 0,4 micrograms 
to 5*0 micrograms RIU\ phosphorus and from 1 microgram to 25 
miorograms DNA phosphorus.
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Procedure
All manipulations were carried out at 4 G unless otherwise 
stated.
The sample, containing a known quantity of lymphocytes between 
2 X 20^ and 20 x 10^ cells, was pipetted into a 9 cm by 1 cm 
centrifuge tube usually in 2,0 ml of 0.15 M sodium chloride. To
this was added one half volume of 0,6 M PGA making the mixture 
0,2 M in PCA, The suspension was left for ten minutes then 
centrifuged for five minutes at 500 gav (I65O rev/min in a I6 cm 
radius centrifuge head). The supernatant was discarded and the 
pellet resuspended in 0,2 M PGA, Centrifugation as before, 
followed by resuspension and recentrifugation, gave a pellet 
washed twice in PGA, Excess of acid was carefully drained from 
the pellet which was then broken up by shaking, treated with 
0,5 ml of 0,3 M potassium hydroxide, and incubated at 37 G for 
exactly one hour.
At the end of the incubation period the solution was cooled 
to 4 C, and 0,25 ml of 1,2 M PGA added. After standing for ten 
minutes, centrifugation at 500 gav for five minutes was carried 
out and the supernatant transferred to a graduated tube. The 
precipitate was washed twice with 0.75 ml volumes of 0,2 M PGA, 
the washings being added to the graduated tube. The pooled 
supernatant and washings were made up to a volume of 2,5 ml or, 
in some experiments, 3*0 ml with 0.2 M PGA giving the RNA fraction
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in 0,2 M PCA. It was found to be necessary to ensure that the 
graduation on the tubes was accurate.
The washed precipitate which contained the DNA together with 
cellular protein was treated with 2,0 ml of 0*5 M PCA and 
incubated at 80 C for ten minutes then cooled to 4 C, allowed to 
stand for thirty minutes, and centrifuged for five minutes at 
500 gav. Supernatant 1.5 ml was removed and mixed with an equal 
volume of 0,5 M PCA to give the DNA fraction in 0,5 M PCA,
Measurement of RNA,
Measurement of the RNA content of the separated RNA fraction 
was carried out by ultra-violet absorptiometry.
A small amount of protein may be solubilised by the alkaline 
digestion procedure and this polypeptide will contribute to the 
optical density at 260 nm, A correction may be made for this 
error provided that the specific extinction of the contaminating 
material is known as well as its concentration. As an 
alternative to protein assay, a correction for protein 
contamination may be made by application of a two wavelength 
correction (Fleck and Munro, 1962). This necessitates the 
preparation of a sample of the tissue RNA to obtain values 'for 
the specific extinction coefficients at two selected wavelengths, 
together with knowledge of the specific extinction coefficients 
of the contaminating polypeptide at the selected wavelengths,
A sample of human lymphocyte RNA was obtained by the method of
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Digirolamo, Henshaw and Hiatt (1964)9 and the purified poly­
peptide prepared following the technique of Fleck and Munro (I962).
Correction by protein estimation.
lymphocytes were isolated in quantity from human blood 
discarded from the heart lung machine. The polypeptide prepared 
from them had a maximal absorption at 275 nm, and a minimum at 
255 nm. The extinction ^26o”^ nra ^ solution of the polypeptide
in 0,2 M PCA containing 1 pg protein per ml was 0,00075 optical 
density units. This factor was used to correct the extinction 
at 260 nm of the RNA fraction for its measured protein contamination.
Correction by two wavelength measurements.
Purified human lymphocyte RNA had, after alkaline digestion 
and solution in 0,2 M perchloric acid, a molar extinction 
coefficient with respect to phosphorus of 9200 at 260 nm with a 
1 cm light path. This solution had a maximum at 262 nm and a 
minimum at 235 The ratio of the extinction at 260 nm to the
extinction of 280 nm was 1.3. Unhydrolysed RNA had a similar 
spectrum except that the maximum was at 260 nm. There was no 
detectable protein contamination of this purified RNA but since 
some minor protein contamination was found in the fraction 
obtained by the modified Schmidt Thannhauser procedure described 
above, correction factors were calculated as follows.
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The corrected RNA concentration, cRNAP of a solution, is 
given by: cRNAP = A.E^ - B.Eg (Fleck and Munro, 1962), where
and are the optical density measurements of the solution 
made at two wavelengths ^ and X g *  and B are constants 
depending on the extinction coefficients of the pure RNA and of 
the contaminating protein. The selected wavelengths were -
260 nm and )\ ^  = 232 nm, A and B are derived as follows
A = ^ B = ^
P. Pn
" 2':^ ~
2 n
r^ and r^ are the specific extinction coefficients of the lymphocyte 
RNA at \  ^ and / these- values are 0,296 at 260 nm and 0,l82 at
232 nm for a solution in 0,2 M perchloric acid containing 1 |ig of 
RNA phosphorus per ml, ^l/P^ is the ratio of the extinction 
coefficients of the protein contaminant at \ ^ and g, A 
solution of the pure polypeptide in 0,2 M perchloric acid gave the 
value for ^l/Pg of 0,210,
Substitution gives the values of 3.876 for A, and 0,812 for B, 
Thus cRMP = (3.876 . ^  ™ A
phosphorus per ml.
A reagent blank obtained by ca,rrying a sample of saline 
through the procedure of the Schmidt Thannhauser separation gives 
small but significant extinction values at the two wavelengths 
used, and a reagent blank was therefore included with each batch 
of analyses and appropriate correction made.
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Measurement of DNA.
The modified Schmidt Thannhauser procedure described above
gave the DNA fraction in 0.5 M perchloric acid. Measurement of
the optical density at 265 nm was used to estimate the DNA
content (Davidson, 1957). The standard for these measurements
was highly polymerised calf thymus DNA (Sigma London Chemical Co.),
This had a molar extinction coefficient of 9500 with
265 Hm
respect to its phosphorus content, the measurement being again in
0.5 M PCA, a 1 ug P per ml solution of the DNA in 0.5 M PCA
having an extinction at 265 ^  of 0.308 after the usual acid and
alkali treatments of the separation procedure. The wavelength
used represents the maximum for both the standard and the
lymphocyte DNA. The separated DNA fraction was found to contain
a small amount of solubilized protein so that a protein correction
was again applied. This was carried out as described under the
measurement of RNA substituting the values applicable to the DNA
measurement (Tsanev and Markov, I960).
Calf thymus standard of concentration 1 ^ ug DNA phosphorus per
ml had an extinction of 0.308 = r_ and E^_%^ of 0.127 =
265 ^  1 232 nm
r^ in 0 ,5 M PCA.
P /Values used for the protein contaminant were l/Pg = 0,224. 
The corrected DNA concentration was given by:
cDNAP = (3.571 . ■■ (0.802 . D M  phosphorus
per ml. Again corrections to the extinction values for the 
reagent blank were made.
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In some experiments DNA was determined by the Ceriotti (1955) 
procedure using calf thymus DNA as standard.
In later experiments, when access to the Olivetti programma 101 
computer became available, a simple programme was used to calculate 
the RNAP content per 10^ cells, DNAP content per 10^ cells, and the 
RNAP/dNAP ratio, given the appropriate optical density values, 
sample volume measurements and the number of cells analysed.
The results have been expressed as DNA phosphorus (DNAP) and 
RNA phosphorus (RNAP) since values for the standards were arrived 
at by phosphorus determinations. Conversion from DNAP to DNA 
values and RNAP to RNA values depends on factors (approximately 
ten per cent of DNA and RNA is phosphorus) which are not 
necessarily the same in different tissues. Future determined 
results are therefore expressed as DNAP and RNAP which are 
preferable to the derived values for DNA and RNA,
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2.9 Statistical methods
The statistical methods used in this and later sections were 
standard procedures as described by Sneiecor and Cochran (I967) 
and by Armitage (1971)• In most instances statistical 
comparisons of mean values were by Student's t-test but where a 
preliminary F-test showed significant between-group variance 
Welsh's test for 'd' was employed (Armitage, I97I), referring to 
the tables of values of *d' (Pearson and Hartley, 1954) for values 
of statistical probability, p.
2,10 Results of comparison of yields, purity and viability of the 
cells in two methods of isolating lymphocytes from blood
In the initial stages of the work, two methods of lymphocyte 
separation were compared by measuring the yields of lymphocytes 
obtained and the purity of the isolated cells by differential 
counting of a stained preparation. The results of these 
measurements on samples of blood from normal individuals are 
listed in Table 1, The silicone oil method was superior to the 
gelatin separation only on the basis of the yield of lymphocytes 
obtained from blood. The average yield was 46 per cent of the 
theoretical possible lymphocyte yield in the silicone oil method, 
and 25 per cent in the gelatin method. There were only marginal 
differences in the purity of tte isolated cells in the two methods
Table 1
Comparison of yield, purity and cell viability in two techniques 
of isolating lymphocytes from blood, the silicone oil method and the 
gelatin method.
Percentage yield 
of lymphocytes
Percentage of 
lymphocytes in 
isolated cells
Percentage of 
viable cells
Silicone oil Gelatin
separation separation
studied 8 12
mean 46 25
range 14 to 68 11 to 62
mean 98 94
range 95 to 100 90 to 98
mean 60 96
range 30 to 75 90 to 99
percentage yield is the number of separated lymphocytes expressed 
as a percentage of the number of lymphocytes present in the whole blood; 
percentage of lymphocytes in isolated cells expresses the purity of the 
preparation measured on a stained film; percentage of viable cells is 
the percentage which do not take up the dye trypan blue in a standard 
technique described by Parker (I96I).
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but when cell viability was compared the silicone oil method was 
strikingly inferior. Sixty per cent of the lymphocytes on 
average were viable after silicone oil separation while an 
average of 96 per cent were viable after the gelatin procedure.
In normal individuals all the mononuclear cells examined which were 
isolated by the silicone oil method, the gelatin method or the 
gelatin and cotton wool method, had the appearance of large or 
small lymphocytes; contaminating cells, always less than ten per 
cent and usually less than five per cent, were polymorphonuclear 
leucocytes.
Experiments to establish mhe validity of the method of 
measurement of RNA and DNA.
Determination of the validity of the RNA and DNA analyses 
requires a consideration of specificity, accuracy, precision and 
sensitivity of the methods employed. For this assessment, 
specificity will be defined as the extent to which the method 
measures either RNA or DNA and not interfering substances; 
accuracy describes how much individual determinations deviate from 
the amounts actually present; precision is defined as the 
repeatability of the analyses, and sensitivity describes the 
amount of the analysed substance which can be distinguished from 
zero. In practice, this last parameter corresponds to the 
standard deviation in replicate measurements (Richterich, 1969),
38
2.11 The specificity of the RNAP measurements
Errors in the determination of RNA by the Schmidt Thannhauser 
procedure can arise from the ultra-violet absorbancy of protein 
present in the fraction. Correction for this lack of 
specificity, as has been indicated earlier in the section, was 
carried out by measurement at two wavelengths with application of 
a mathematical correction, as well as by direct measurement of 
the contaminating polypeptide.
Presented here are the results of a series of measurements 
to establish that the two wavelength corrections are appropriate. 
Figure 2 shows the correlation between RNAP determinations by 
ultra-violet absorptiometry using the two wavelength correction, 
and RNAP measurements on the same samples with correction by 
actual measurement of the contaminating protein. The 
correlation coefficient of 0.96 established that the two wave­
length method of correction would be satisfactory. It is also 
more convenient than the alternative method. More rigorous 
checking of the specificity has not been undertaken since the 
method is an established one and the recommended check procedures 
(Hutchison and Munro, I96I) have been carried out.
Figure 2
Measurement ot lymphocyte HjNA by ultra-violet absorptiometry; 
correlation of two methods of correction for protein error.
yUg R N A  Phosphorus/ml 
Correction by Protein Measurement
2-0-1
10 -
r = 0-96
y = 0*98 x + 0 ’01
10 2*0X
/ i g  R N A  Phosphorus/ml 
Correction by Two W avelength Procedure
The ordinate (y) gives measurement of RNA hy ultra-violet absorption 
in nineteen samples expressed as jug RNAP phosphorus per ml, corrected by 
measurement of protein contamination. The abscissa (x) shows the results 
of the analyses of the same samples using ultra-violet absorptiometry and 
the two wavelength correction. The regression line of y on x is drawn.
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2.12 The specificity of the DMA? measurements
The results obtained in the DNAP analyses of a series of 
samples of lymphocytes using the two wavelength procedure were 
compared with the M A P  analyses by an independent method of 
measurement, i.e. that of Geriotti (1955)» The correlation 
coefficient of 0.97 obtained in the comparison (Figure 3). 
The relationship between the two methods was such that one 
microgram PHA phosphorus by Geriotti was equivalent to 0.94 
micrograms of DNA phosphorus by the ultra-violet measurement 
plus 0.004. Thus the Geriotti reaction gave slightly lower but 
still well correlated results when compared with ultra-violet 
absorptiometry but since the measurements by the Geriotti 
technique .are of lower accuracy than these using ultra-violet 
absorptiometry (see over) the latter method is considered 
superior.
Figure 3
Measurement of DMA. A correlation of two methods.
1
fj^ g D N A  Phosphorus 
Estimated by the 
Geriotti Procedure
3 0 - 1
2*0 -
< = 0 - 9 7
y = 0 9 4  x  +  0  0 0 4
1*0 20
/Ug D N A  Phosphorus Estimated by U V  obsorbancy
3 0
Measurements of DNA by the Geriotti procedure as the ordinate (y) 
are compared with measurements of DNA by the two wavelength procedure 
in the abscissa ^x). The regression line of y on x is shown.
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2.13 Assessment of accuracy
Recovery experiments for the methods of nucleic acid analyses.
A solution was prepared containing DNA, RNA and protein in 
amounts similar to those encountered in analyses of lymphocyte 
preparations, i.e. 4.40 ug DNA phosphorus, 2 . 7 0 ^  RNA phosphorus, 
and 3 mg of protein per 1 ml aliquot. The materials used were 
highly polymerised calf thymus DNA (Sigma London Chemical Co.), 
yeast RNA (Papst Laboratories, Wisconsin), repurified hy the 
method of Zytko et al.(1958), and bovine serum albumin fraction V 
(Armour Pharmaceutical Co.,-England), The phosphorus content of 
the standard DNA and RNA solutions were determined in triplicate 
and the results compared with the results of multiple analyses by 
the modified Schmidt Thannhauser procedure measuring both DNAP and 
RNAP by ultra-violet absorbancy. DNA was also measured by the 
Ceriotti procedure* The results of replicate analyses are shown 
in Table 2. Adequate reproducibility is reflected in the low 
standard deviations of the recoveries. The Ceriotti method with 
the mean recovery of 82 per cent was less satisfactory than ultra­
violet absorbancy with 100 per cent recovery for measurement of 
DNA, Ultra-violet absorbancy of RNA gave an 86 per cent recovery,
Table 2
The assessment 
methods.
of accuracy. Recovery experiments with comparison
Method of Number of Percentage Observed range
analysis analyses recovery of recovery 
(per cent)
DNA by Geriotti 14
mean 82,0 
SD 9.4
65 to 98
DNA by UV 18 mean 100.4 93 to 111
absorbtiometry SD 4.7
RNA by UV 
absorbtiometry
19
mean 86.4 
1 SD 4.5
75 to 100
L. ......  . . ■
The results of multiple analyses of a standard solution of DNA, OTA and 
protein carried out to assess the recoveries obtainable by methods of 
nucleic acid measurement when compared with phosphorus estimations of 
the pure solutions taken as 100 per cent* Each aliquot contained 
4*40 }xg OTA phosphorus, 2.70 p.g OTA phosphorus and 3 mg bovine serum 
albumin.
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2.14 The precision of the lymphocyte analyses
The precision of the entire procedure of cell separation and 
nucleic acid analyses hy ultra-violet absorbancy was examined by 
comparing the lymphocyte DNAP per 10^ cells, RNAP per 10^ cells, 
and RN/iP/d n AP ratio values derived from duplicate samples of blood 
obtained from five individuals and separately carried through the 
stages of the analyses. Results for the gelatin method of 
separation are tabulated and the values of a similar series using 
silicone oil separation are included in a summarised form for 
comparison (Table 3). Using gelatin to separate the cells, the 
mean variation for DNAP measurements was - 6,0 per cent and for 
RNAP measurements was i 8,8 per cent. When the ratio ^^fp' 
calculated from these results, the mean variation fell to - 3.8 
per cent.
The values for the duplicate blood samples using silicone oil 
as a method of cell separation show variation of a similar order 
to the gelatin method. The failure of the RNAP/dNAP ratio to 
have the lowest variation in this series was brought about by one 
duplicate result of RNAP/DNAP ratio having a variation of - 24.0 
per cent. This was an isolated result; in general, the 
variation was within five per cent on either side of the mean for 
the two results.
Table 3
Analyses of duplicate blood samples. 
3A Gelatin cell separation method.
jig DNAP per 10^ cells pg EKAP per 10 cells
Duplicate
results ' Mean
Variation Duplicate
results
Mean Variation
0.822,0.763 (0.792) +3.7# 0.227,0.184 (0.205) +10.7#
0.713,0.836 (0.774) +7 . 9# 0.133,0.167 (0.150) +11.2#
0.879,0.705 (0.792) +11.0# 0,162,0.125 (0,143) +13.3#
0.740,0.911 (0.825) +10.4# 0.229,0.315 (0.272) +15.7#
0.898,0.844 (0.871) + 3.1# 0,233,0.224 (0,228) +1,7#
Average Variation + 6 .0# Average Variation = + 8 .8#
RNAP/DNAP ratio
Duplicate _ . ..
results Mean Variation
0.276,0.242 (0.259) +6.8^
0.187,0.199 (0.193) +3.15?
0.185,0.178 (0.182) +2.2#
0.310,0,346 (0,328) +5.5#
0.259,0.265 (0,262) +3.9#
Average Variation = +3.8#
Table 3 (cont'd) 
3B Silicone oil cell separation method.
pg DNAP per 10 cells pg RNAP per 10 cells
Duplicate
results
Mean Variation Duplicate
results Mean Variation
0 .694,0.780 (0 .737) 5.9# 0 .226,0.264 (0 .245) 7 .8#
0 .670,0.710 (0.690) 2 .9# 0 .180,0.163 (0 .171) 5.2#
0 .719,0.687 (0.703) 2.3# 0 ,169,0.208 (0.188) 10.0#
0 .746,0.757 (0.751) 0 .8# 0.298,0.295 (0 .297) 0 .5#
0 .854,0.926 (0.890) 4 .0# 0.242,0.249 (0 .245) 1 .2#
0 .935,1.020 (0 .977) 4 .3# 0 .265,0.295 (0.280) 5 .3#
Average Variation = +3 .3# Average Variation +5.0#
KUAp /m AP ratio
Duplicate
results Mean Varianci
0 .326,0.338 (0.332) 1.8#
0 .269,0.229 (0 ,249) 8 .0#
0.235,0.305 (0 .270) 24.0#
0 .400,0.397 (0 .398) 0.4#
0 .283,0.269 (0 .276) 2.5#
0 .284,0.290 (0.287) 1.0#
Average Variation = +6 .3#
Duplicate samples of blood from normal individuals were carried 
through the stages of the analyses for DNA. and HiA. The observed 
values for the nucleic acids are tabulated for each pair of results and 
shown also as percentage variation either side of the mean.
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2,15 The sensitivity of the method of the chemical analyses
A series of aliquots of a lymphocyte suspension obtained from 
one normal individual and containing a range of numbers of cells 
from 1.43 million to 14,3 million lymphocytes were analysed. The 
individual measurements of DNAP and RNAP gave linear results over 
this range and the plot of the number of estimated cells against 
their nucleic acid content passed through the origin (Figure 4 ), 
Satisfactory results for both DNAP and RNAP measurements by ultra­
violet absorbancy were obtained when from 3 x 10^ cells to 
14 X 10^ cells are analysed*
2,16 Storage of isolated lymphocytes prior to analyses
In certain experiments, after the lymphocytes have been 
separated from blood, the isolated cells were stored prior to 
analysis. The presence of active nucleases in lymphocytes 
(Barnes, 1940) necessitated rigorous storage conditions for the 
preservation of the cells. Satisfactory conditions were found 
to be storage in 0,05 M sodium acetate, acetic acid buffer, 
pH 5 ,2 , at a temperature below -4 0 C; solid carbon dioxide in 
a Dewar flask is a convenient method of maintaining the buffered 
cells below this temperature, A correction table for the
Assessment oi tne sensitivity of tne method of M A  and OTA analysis.
;jg DNA or RNA  
Phosphorus
12 D N A
10
8
6
4
R N A
2
14121086420
N umber  of C e l ls  x10®
Aliquots of a sample of lymphocytes containing different numbers 
of cells were analysed. The results plotted show the measured amounts 
of M A  ana RNA phosphorus in relation to the number of cells analysed.
Table k
The effect of storage of a lymphocyte suspension at “4 0 C in 0 . 0 5  M 
acetate buffer pH 5 @2 % on the results of nucleic acid analysis.
Measurement 1 No 
1 storage
j
1 day
storage
5  daya 
storage
27 days 
storage
ug I)NA phosphorus 9.12 1 0 . 0 0 9.75 8.04
per sample
9.49 10,05 9.28 9.10
9.50 9.80 9.00 8.06
9.50 9.40 8.61
Mean M A P 9.40 9.81 9.16 8.40
Percentage change 0 4 - 4 a 4
I
■"2 • 6 -11,7
p.g RNA phosphorus . 3.57 3,13 3.10 3.10
per sample
■ 3.42 - 3.44 3.13 3 . 1 0
: 3 . 3 4 3.45 3.41 2.93
3.35 3  < . 0 0 3.73 2.94
Mean RNAP 3,42 3 . 2 8 3 . 3 4 3.02
Percentage change 0 “4 , 9 -2.3 -1 1 . 8
mkV/mkV ratio 0 , 3 9 0 , 3 1 0.32 0.39
in sample
0.36 0 . 3 4 0.34 0.32
0 . 3 5  ^ 0,35 0.38 0,36
0,35 0 . 3 3
1
0 , 4 3
«
Moan ratio 0,365 : 0 . 3 3 4 0,366 0 . 3 5 7
Percentage change 0 ' -8.5 ! +0,2 - 2 . 2
Multiple samples of human thoracic duct lymphocytes containing 
13 % 1 0 ^ cells were analysed in batches of four by the standard 
procedure either immediately or after the stated poriod of storage at
-40c,
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possible small losses of nuoleio aoid which might occur in 
storage at - 4 0  C was prepared from the results of serial 
quadruplicate analyses of replicate samples of human thoracic 
duct lymphocytes analysed fresh, and after storage in the buffer 
for one day, five days and twenty-seven days at - 4 0  C. Details 
of the method of obtaining the cells appear in Section 4 . The 
results of the serial analyses of the cells appear in Table 4 , 
from which it can be seen that the losses in storage by this 
method are negligible if a five day storage is to be used. If 
the storage is longer a correction for losses of both DMA and RNA 
amounting to about ten per cent at twenty-seven days would be 
required,
Whole blood may be stored at room temperature for up to one 
and a half hours before starting the separation without alteration 
to the value obtained for the lymphocyte RNAP/DNA? ratio.
2 .17 Discussion
The gelatin sedimentation method of separating lymphocytes 
from the peripheral blood was preferredfor several reasons. The 
most important of these was the impaired viability of the cells 
in the alternative method. Viability is a requirement since 
RNA is a labile polymer readily attacked by cell nucleases which
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are likely to be released in damaged cells. The yield of cells 
by the gelatin method was adequate for chemical analyses provided 
2 0  ml of blood was taken and the need to discard samples because 
of impaired cell purity in the gelatin preparation was overcome 
by the addition of an incubation with washed cotton wool as has 
been described. The silicone oil method of cell separation was 
used for an experimental period only, and in view of its cumber­
someness as well as the impaired viability cells, it is not 
recommended. In the alternative method the choice of gelatin 
to be used is of interest. The critical properties of the 
material are not known though it is believed that the long 
gelatin molecule accelerates rouleaux formation of the 
erythrocytes, and therefore assist sedimentation, Chalmers (1967) 
and Johns (I97O) have some further comments on the nature of the 
process. The gelatin was of recent manufacture and similar to 
that used by Coulson and Chalmers in their published method (I964)# 
An important detail is the period of time allowed for the fibrin 
strands, and later the cotton wool, to trap polymorphonuclear 
leucocytes; fifteen minutes is the time recommended for each of 
these stages since prolongation of this results in poor cell 
yields. The rigorous conditions for cell lysis were satisfactory 
for chemical work but could require modification if cell culture 
was contemplated and here the work of Thomson, Bull and Robinson 
(1966) on the resistance of lymphocytes to osmotic shock was 
valuable in confirming the fifteen second exposure to distilled
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water as optimum for lysing red cells without destroying 
leucocytes.
The specificity of the chemical method is not in doubt since 
satisfactory answers have been given to the question of protein 
contamination of the separated DNA and RNA fractions in the 
validation of the chemical methodology. Accuracy has been 
determined by measuring solutions of known nucleic aoid content. 
The mean recovery for the DNA analyses by ultra-violet 
absorptiometry of 1 0 0 , 4  per cent needs no comment. Minor losses 
during acid precipitation steps or suboptimal hydrolysis of RNA 
by alkali are the most likely reasons for the incomplete ( 8 6  per 
cent) recovery of RNA but avoiding these possible losses is 
difficult. Alternative methods of analyses which rely on hot 
acid extraction of the tissue without precipitation stages 
(Schneider, 1 9 4 5 ) are less satisfactory for the DNA analysis 
(liutchison and Munro, 1 9 6 1 ) and prolongation of alkali digestion 
in the Schmidt Thannhauser procedure results in release of 
protein into the RNA fraction which makes ultra-violet 
absorptiometry even with protein corrections less accurate (Fleck 
and Munro, 1 9 6 2 ), Direct phosphorus determination of the RNA 
fraction has been used (Davidson, Leslie and White, 1 9 5 1 ) but 
there is evidence that this fraction contains organic phosphorus 
components other than ribonucleotides. This has not been 
examined in leucocytes, but in rat liver (Davidson and Smellie, 
1951) and rabbit spleen (Davidson, Fraser and Hutchison, 1 9 5 1 )
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the non-nucleotide phosphorus represents 2 0  per cent and 25 per 
cent respectively of the phosphorus present in the fraction.
The recovery of 8 6  per cent for the RNA measurements in the 
present method is therefore acceptable accuracy since this 
recovery is consistent.
In the experiments to measure precision, comparisons of 
determinations of DNAP content, RNAP content and RNAP/dNAP ratio 
in duplicate blood samples showed clearly that the ratio RNAP/
DNAP has the smallest between duplicate variation and showed 
adequate precision. This finding illustrates the technical 
advantage of using the measurement which does not depend on cell 
counting, the lymphocyte RNAP/DNAP ratio. It is clear from 
Table 3  that an individual estimate of lymphocyte DNAP or RNAP 
expressed per million cells lacks precision. Cell counting 
error is the principal source of variation and since this error 
is dependent on the square root of the number of cells counted 
it could be reduced by repeated counting. In the present study, 
time for cell counts was limited since it was considered 
important that the isolated cells should be treated with cold 
perchloric acid as soon as possible after their removal from the 
blood circulation, thereby limiting degradation of nucleic acid 
particularly the more labile RNA* Any nucleic acid degradation 
would give consistently low values for the mean cell content while 
the error of cell counting tends to be a random one.
The lower limit of sensitivity of the method has not been
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exactly determined but the method gives accurate results for the
more critical RNA measurements using I.4 x 1 0 ^ cells. This
limit might he variable depending on the protein content of the
specimen, so in practice the limit on the number of cells
required for reliable determination of nucleic acids has been
3 . 0  X 1 0  ^ cells. This limit has been observed in all the results
and is well above the theoretical limit set by the standard
deviation obtained in the determination of accuracy, i,e, 4 * 5  per
6
cent of 2,7 pg RNAP corresponding to 0 , 5  x 1 0  cells.
The investigations of the methodology may be summarised as 
follows:
1) The gelatin method as well as the gelatin and cotton wool 
method are satisfactory techniques for the preparation of 
lymphocyte suspensions from whole blood,
2) The modified Schmidt Thannhauser technique for the separation 
of RNA and DNA and subsequent ultra-violet absorptiometry of the 
separated fractions using two wavelength corrections for the 
presence of protein is the method of choice for human lymphocyte 
nucleic acid analyses. The method had adequate specificity, 
accuracy, precision and sensitivity.
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3 ) In the combined technique, applying nucleic acid measurements 
to lymphocytes isolated from blood, determination of cell DNA 
and RNA content lacked precision due to cell counting errors. 
Precision for the measurement of the lymphocyte RNA/DNA ratio 
was good, and satisfactory analyses may be carried out provided 
at least 3  x 1 0  ^ cells are analysed.
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SECTION 3
Lymphocyte Nucleic Acid
Measurements in Normal Individuals and in 
the Presence of Immunological Abnormality
50
3.1 Introduction and review of past work
There are no normal values for the blood lymphocyte DNA, RNA 
or RNA/DNA ratio in the literature so the first step in the 
recognition of changes in the lymphocyte nucleic acid content in 
pathology is to define these normal values. Three methods of 
isolating the lymphocytes have been described earlier and initial 
studies compare results by these methods. When the normal range 
has been established possible differences in the lymphocyte 
chemistry related to -age or sex will be considered, and the 
variation in lymphocyte DNA., RNA and RNA/DNA ratio on repeated 
analyses in an individual over a period of time investigated.
The blood lymphocyte count is a variable of possible 
importance in the study of the lymphocyte nucleic aoid content. 
Changes in the blood lymphocyte count dependent on age, sex and 
pathology are well known (Wintrobe, 1 9 6 7 ? Cruikshank and 
Alexander, 1 9 7 0 )-? and a valuable compilation of these has 
appeared recently (Uastham, 1 9 7 0 ). In infancy the lymphocyte 
count is high relative to young adult values and gradually 
declines with increasing age. The blood lymphocyte count is on 
average marginally higher in females than in males* The 
differences between individuals are however much greater than 
these age or sex differences and this is recognised in the 
normal range for the blood lymphocyte count which is usually
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reported as I5OO to 3 5 0 0  cells per mm^. The relationship between 
the blood lymphocyte count and the lymphocyte nucleic acid content 
is not known and will be included in the investigation. Blood 
lymphocyte counts were not determined in some studies,carried 
out before the importance of this measurement was appreciated.
Three conditions of known immunological abnormality have been 
examined in detail, namely rheumatoid arthritis, Sjpgren*s 
syndrome and thyrotoxicosis. Blood analyses from patients with 
systemic and discoid lupus erythematosus, infection and with 
neoplastic disease are in sufficient number to justify listing as 
three separate groups* In addition, small numbers of patients 
with a variety of conditions have had measurements of blood 
lymphocyte nucleic acids and these form a miscellaneous group.
The lymphocyte chemistry will be examined in each condition, 
starting with the DNA measurement since if the DNA content of the 
cell is constant, the lymphocyte RNA/DNA ratio is validated as an 
index of the cell RNA, The relationship between severity of the 
disease and the lymphocyte results will be considered as well as 
the influence of drug therapy where this is appropriate. In 
some conditions the relationship between the lymphocyte chemistry 
and the appearance of the cells on a peripheral blood film has 
been investigated.
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The lymphocytes in rheumatoid arthritis.
Rheumatoid arthritis is a common disease and immunological 
abnormalities are such a striking feature of the pathology that 
this condition was the first choice for the study of lymphocyte 
nucleic acids in disease. Abnormalities of the antibody and the 
cell mediated immunity systems are well documented in rheumatoid 
arthritis, for example rheumatoid factor is present in the sera of 
about 8 0  per cent of patients with the disease (Olynn, I965), It 
has the characteristics of an auto-antibody and can react with a 
patient's own IgG (Hannestad, I968). Other antibodies are found 
with abnormal frequency in the sera of patients with rheumatoid 
arthritis, including anti-nuclear factor (Alexander, Breraner and 
Duthie, i960) and thyroid auto-antibodies (Buchanan, Crooks, 
Alexander, Koutras, Wayne and Gray, I96I), The presence of 
rheumatoid factor in the serum is not restricted to patients with 
rheumatoid arthritis (Anderson, Buchanan and Goudie, I967) and the 
factor is unlikely to be the cause of the lesions, Harris and 
Vaughan (196I) having demonstrated that infusion of serum positive 
for rheumatoid factor into healthy volunteers did not produce 
disease in the recipients, although autologous rheumatoid factor 
injected locally into a joint can sustain joint inflammation 
(Restifo, Lussier, Rawson, Hookey and Hollander, I965). Attention 
has therefore been directed to cell mediated immunity in the disease 
process.
Cell mediated effects have proved more difficult to
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investigate. Skin hypersensitivity to the chemical agents 2 ,4 - 
dinitroohlorobenzene and para-nitro-sodimethyl analine is known 
to be cell mediated and this response has been tested in patients 
with rheumatoid arthritis. The ability to become sensitized to 
these materials is depressed compared with normal individuals 
(Epstein and Jessar, 1 9 5 9 )? however, these authors noticed no 
correlation of abnormal tests with a particular stage of the 
disease. The vitro response of the blood lymphocytes from 
patients with rheumatoid arthritis to the non-specific mitogen 
phytohaemagglutinin (PHA) and to streptolysin 0  has been examined 
by Leventhal, Waldorf and Talal (1 9 6 ?), Their results clearly 
demonstrated impaired lympnooyte responses to both these agents, 
confirming that depressed lymphocyte function is a feature of the 
disease. The skin hypersensitivity reaction and the phyto­
haemagglutinin response are thought to be mediated by thymus 
dependent lymphocytes (Davies, 1 9 & 9 ) so T-lymphocyte function is 
impaired in rheumatoid arthritis. Recently it has been shown 
that a greater than normal proportion of B~lymphocytes are present 
in the blood of patients with the disease (Papamichail, Brown and 
Holborovr, 1 9 7 1 ) so impaired T-lymphocyte function may be linked 
with a relative or absolute deficiency of these cells. ^
A relative but not necessarily an absolute lymphocytosis is 
a well-recognised feature of rheumatoid arthritis and there is 
unmistakable evidence of ectopic lymphocyte activity, recognisable 
by the classical histology of the lesions in the rheumatoid nodule,
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and by lymphocytic infiltration of the synovia in affected joints. 
Only two references to the morphology of the blood lymphocyte in 
rheumatoid arthritis have been found in the literature, thus 
Zucker“Franklin (I969) recorded the presence of atypical 
lymphocytes in the blood of patients with the disease, and in an 
earlier less sophisticated study Kristenson (1949) found increased 
numbers of large lymphocytes in the peripheral blood of a patient 
with arthritis. It may be possible to measure the extent of 
these changes by examining the lymphocyte chemistry.
The American Rheumatism Association have graded rheumatoid 
arthritis as probable or definite depending on the number of easily 
recognisable features of the disease present in a particular 
patient (Ropes, 1 9 5 9 )# In an initial analysis results from 
patients with probable and definite rheumatoid arthritis are 
combined but later the results of the lymphocyte analysés are 
listed according to the two American Rheumatism Association 
categories. Any relation between severity of the disease and the 
lymphocyte abnormality should then be apparent. It may also be 
possible to relate measurable features of the disease, e.g. the 
E.S.R, or the rheumatoid factor titre to the lymphocyte RNAP/DNAP 
ratio in a series of patients. Certain features of rheumatoid 
arthritis are associated with a poor prognosis. Duthie, Brown, 
Truelove, Barger and Lavrrie (I964) have found a tendency to 
progressive disease in patients with a high rheumatoid factor titre, 
and in those with subcutaneous nodules, A study of these points
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will be made to establish the relationship between disease activity 
and the lymphocyte chemistry.
The steroid therapy commonly used in rheumatoid arthritis 
could be a factor in influencing the cell chemistry since cortico­
steroids are known to have a lympholytic action (Dougherty and 
Frank, 1953). This will require to be tested.
The demonstration of abnormality of the lymphocytes both by 
chemistry and by morphology would be more convincing than either 
alone. Studies will be included which make this comparison of 
lymphocyte nucleic acid content and measurements of the cells as 
they appear on a stained blood film.
The lymphocytes in sicca and Sjogren's syndrome.
The study of Sjçfgren's syndrome contributes to knowledge of 
lymphocyte nucleic acid content in immunologic disease since the 
syndrome includes two conditions with similar frequencies of 
abnormal circulating antibodies and yet differing degrees of tissue 
involvement.
Sjdgren's syndrome consists of kerato-conjunctivitis sicca 
(dry eye), xerostomia (dry mouth) and rheumatoid arthritis or other 
connective tissue diseases. The first two, when present by them­
selves, constitutes the sicca syndrome (Block, Buchanan, Kohl and 
Bunim, I965). About half of the patients with Sjbgren’s syndrome
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have rheumatoid arthritis as the associated disorder. These 
individuals frequently have multiple antibodies in their serum 
and there are widespread chronic inflammatory changes with 
lymphocyte infiltration in a variety of tissues. In sicca 
syndrome multiple antibodies are present, perhaps in greater 
frequency than in the complete Sjogren's syndrome, and although 
chronic inflammatory changes may be present in a variety of 
tissues, notably the lacrimal and salivary glands, there is no 
connective tissue disease.
In parallel with their studies on rheumatoid arthritis , 
Leventhal,Waldorf and Talal (1967) have produced evidence of 
functional abnormalities of lymphocytes in Sjogren's syndrome.
They found in a significant number of patients with Sjdgren's 
syndrome that the lymphocytes failed to produce a normal in vitro 
transformation response to the mitogens, phytohaemagglutinin and 
streptolysin 0 , There was a similar frequency of abnormalities 
in the response of patients to the contact allergen 2 ,4 -dinitro- 
chlorobenzene, failure to become sensitised to the chemical is 
evidence of an impaired delayed hypersensitivity response. The 
patients with the combination kerato-conjunctivitis, xerostomia 
and rheumatoid arthritis, i.e. the full Sjogren's syndrome," showed 
a greater proportion of abnormal responses than the group with 
sicca syndrome alone. In Sjogren's syndrome a leuoopenia with a 
relative increase in a proportion of lymphocytes has been reported 
(Bloch et al,, I965) but otherwise information on the nature of the
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blood lymphocytes in the disease is lacking* In the nucleic acid 
measurements on the blood lymphocytes which follow,answers are 
sought for two questions, firstly, is there biochemical evidence 
V that the lymphocytes are abnormal in the sicca syndrome or in 
Sjdgren's syndrome, and secondly, is there a difference in degree 
of abnormality between sicca syndrome and the complete Sjogren's 
syndrome *
The lymphocytes in thyrotoxicosis.
A general discussion of the aetiology of thyrotoxicosis would 
be out of place in this introduction, but it is clear from a 
recent review (Havard, 1 9 6 9 ) that immunological factors or, more 
precisely, the circulating immunoglobulin 'long acting thyroid 
stimulator' (LATS) is involved in the over-stimulation of the 
thyroid gland in most patients with thyrotoxicosis. Excepted 
from this are the rare occasions when an autonomous toxic adenoma 
is present* The existence of LATS became apparent when Adams and 
Purves (1956) observed that material in the blood of thyrotoxic 
patients which was thyroid stimulating was not pituitary thyroid 
stimulating hormone. This was a protein material later identified 
as an immunoglobulin (Kriss, Pleshakov and Chien, I964?
Dorrington and Munro, I965), and is of the class IgG * Depending 
on the assay technique used and whether sera are concentrated
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before analysis, LATS can be demonstrated in up to 8 0  per cent of 
patients with thyrotoxicosis (Carneiro, Dorrington and Munro,
1966). When sera are analysed without prior concentration the 
LATS assay is positive in about 3 0  per cent of patients (Sellers, 
Awad and Schonbaum, 1 9 7 0 ). The most convincing evidence that LATS 
can produce thyrotoxicosis is derived from the study of thyro­
toxicosis in pregnancy. Mothers who have a high titre for LATS 
pass the immunoglobulin via the placenta to the foetus and thyro­
toxicosis is produced in the infant, a condition which resolves 
as the LATS activity disappears (McKenzie, 1 9 6 4 ). Attempts to 
produce LATS experimentally by injecting thyroid antigens into 
animals have been only partially successful (Burke, I968) but 
natural auto-antibodies do occur frequently in the sera of 
patients with thyrotoxicosis; as many as 85 per cent of patients 
showing abnormalities (Anderson, Buchanan and Goudie, I967).
There is sufficient evidence therefore to regard thyrotoxicosis 
as an auto-immune disease although an unusual one since the 
affected organ is stimulated rather than depressed.
The presence of an abnormality in cell mediated immunity in 
thyrotoxicosis is less well established. A variable degree of 
thyroiditis with infiltration of lymphocytes into the gland tissue 
is a feature of the pathology of thyrotoxicosis (Buchanan, 
Alexander, Crooks., Koutras, Wayne, Anderson and Goudie, I96I), and 
lymphocytes have been observed invading the thyroid vesicles in 
the disease (Irvine and Muir, I963). Patients with thyrotoxicosis
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may show a relative lymphocytosis in the peripheral blood 
(Williams, I965). A single author, Hernberg (1 9 5 4 ), has 
published data on the nature of the lymphocytes in thyrotoxicosis. 
Hernberg measured the size of the lymphocytes in fixed and 
stained blood films, and found that the mean lymphocyte 
diameter was at the upper limit of normal or above normal in 
thyrotoxicosis, and returned to normal when the patients were 
euthyroid after partial thyroidectomy. Despite this finding.
De Groot and Jaksina failed to show a significant functional 
abnormality in thyrotoxic lymphocytes in the courses of studies 
of the phytohaemagglutinin response of these cells. The near 
normality of the phytohaemagglutinin response and the absence of 
massive infiltration of lymphocytes in the tissues suggests that 
the immunological abnormality of thyrotoxicosis may be slight and 
related to activity of B»lymphocytes, cells of the antibody 
producing line. Measurements of lymphocyte RHAP/dHAP ratio 
would not of course specifically identify this abnormality but 
the chemical determinations may confirm Hernberg's data, 
Furthermore, it is now possible to compare lymphocyte from blood 
positive in the LATS bio-assay with blood negative in the LATS 
assay. Carneiro et al,(l9 6 6 ) have shown a correlation between 
the iodine turnover per unit weight of the gland and the LATS 
activity, and although the severity of thyrotoxicosis is difficult 
to measure it is possible to test for a correlation between the 
1 ^^^ uptake of the gland and chemical abnormalities of the 
lymphocytes.
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The lymphocytes in systemic lupus erythematosus.
Changes in the lymphocytes are not a striking feature of the 
pathology of systemic lupus erythematosus although there is often 
a leucopenia and lymphopenia. The important histological features 
are widespread fibrinoid degeneration and necrosis in the walls 
of small blood vessels associated with areas of collagenous 
fibrosis and hyalinisation. A perivascular cellular infiltrate, 
mainly of lymphocytes, is also seen. The tissues which may be 
involved include skin, myocardium, pericardium a,nd endocardium, 
kidney and spleen. When there is clinical evidence of skin 
involvement alone the lesion is referred to as discoid lupus 
erythematosus•
A variety of antibodies are found in the sera of patients with 
the disease; the list includes antibodies to nucleohistone complex, 
DNA, hi stone and other nuclear and nucleolar proteins. Antibodies 
to cytoplasmic constituents may also be present (Anderson, 1 9 6 3 )* 
Some understanding of the immunopathology of the vascular lesions 
in systemic lupus erythematosus has come from study of the 
analogous spontaneous disease in hybrid mice, the offspring of the 
cross between WZB and WZW strains. It has been shown in these 
animals (Lambert and Dixon, I969) that there is a close relation­
ship in time between the appearance of antinuclear antibodies and 
the development of kidney damage. It is probable that the kidney
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lesions result from glomerular localisation of antigen-antibody 
complexes (Seegel, Accinni, Andres, Christian, Erlanger and Hsu, 
1969). Antigen-antibody complexes are thought to be important in 
the human disease and cell mediated reactions less so. However, 
the present views on the importance of thymic dependent lymphocytes 
in control of the antibody as well as cell mediated response make 
investigation of the blood lymphocytes in lupus erythematosus of 
interest. The number of patients in the present study is small 
and includes patients with discoid as well as systemic lupus 
erythematosus (Haserick, I965). Within this limitation, 
measurement of the DHA and RHA content of the blood lymphocytes 
should give an indication of abnormality in these cells.
The lymphocytes in infection,
Hyperbasophilic medium sized lymphocytes, plasma cells and 
primative lymphoid cells appear in the blood after immunisation 
and infection and, from the evidence outlined in the introduction, 
it is likely that these are derived from lymphoid tissue in 
response to immune stimuli. Detailed investigation of the 
response to immunisation in man has been studied by two groups, 
Pariser, Zucker and Meyer (1 9 5 2 ) and Crowther, Fairley and Sewell, 
(1969). The earlier study was of the secondary response to 
diptheria toxoid while both primary and secondary responses were 
examined by Crowther and his group. From these studies it is
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clear that following both primary and secondary immunisation 
large lymphoid cells appear in the peripheral blood with the 
maximum response on the fourth to sixth day following 
immunisation. Although there is considerable individual 
variation in the response, in no case were there more than six. 
per cent of atypical lymphoid cells present in the peripheral 
blood.
Lesiewska (1967) has investigated the blood lymphocytes 
following bacterial and viral infection and shown that only minor 
changes in the proportion of large basophilic lymphocytes take 
place following bacterial infection in children. Much more 
marked changes occurred following virus infection. In a study 
of chicken-pox and measles the absolute number and percentage of 
large lymphoid cells increased more than two-fold. Lesiewska 
confirmed this data with histochemical determinations of 
lymphocyte ERA content. The virus-induced changes in the 
lymphocytes may well be produced by blastoid transformation as 
has been demonstrated in leucocytes from patients with a previous 
history of infectious mononucleosis, exposed in culture to EB 
virus (Diehl, Henle, Henle and Kohn, I968).
A group of patients with bacterial and viral infections are 
included in the present study to assess the degree of change which 
might occur in the lymphocyte RNA and DBA content during an 
infection, allowing that only a proportion of the samples were 
taken at the optimum time of four to six days after exposure to
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the viral or bacterial antigens.
The lymphocytes in neoplastic disease.
In a review of immunological factors affecting tumour growth, 
Klein (1 9 7 0 ) maintains that the immune response against tumours 
resembles a homograft reaction and that cellular immunity plays 
the major part in this response. Failure of the mechanisms of 
immunological surveillance have been proposed as important in the 
proliferation of neoplastic cells (Keast, 1 9 7 0 ). There is 
undoubtedly an association between immunological disorders and 
cancers of the reticulo-endothelial system, but this need not be 
cause and effect, and the concept of impaired immunological 
surveillance and the development of cancer in man remains as a 
hypothesis at present (Doll and Kinlin, 1 9 7 0 ),
There are functional abnormalities of cellular immunity in 
the presence of established neoplasm. The tuberculin response 
shows a marked depression in cancer patients (Hughes and Mackay, 
1965). The in vitro phytohaemagglutinin response of blood 
lymphocytes from patients with carcinoma is impaired (iwao, I968) 
and this impairment is attributable to abnormalities of the cells, 
not the plasma (Golob, Israsena, Quatrale and Becker, 1 9 6 9 ).
A study of the morphology of the blood lymphocytes in a series 
of patients with breast cancinoma was made by Smetana, Janele and
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Malinsky (I966), They recorded the average number of nucleoli per 
lymphocyte nucleus and made the interesting observation that the 
number of cells with multiple nucleoli is increased in malignancy. 
Since the nucleoli are concerned with RNA bio-synthesis, chemical 
measurements of DBA and particularly RNA content may show changes 
from normal in the presence of neoplasm. Lymphopenia is a 
feature of established malignancy and is recorded in the two 
papers cited (iwao, I968, and Smetana et al., I966),
The lymphocyte in a miscellany of conditions,
A detailed study of the lymphocyte chemistry in a wide range 
of conditions is beyond the scope of this thesis but inclusion of 
results from small numbers of patients with a variety of 
conditions does broaden the knowledge of the lymphocyte in 
disease processes. The conditions represented in the miscellaneous 
group show a spectrum of involvement of the immunity system in the 
disease process.
The conditions with a recognisable abnormality of immunity 
will be considered first, Macroglobulinaemia is a disease 
characterised by a proliferation of lymphoid cells usually 
recognisable by lymphadenopathy, splenomegaly and infiltration of 
the bone marrow by atypical lymphoid cells. The serum shows an 
excessive quantity of an immunoglobulin of the class IgM.
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Atypical lymphocytes are recognised in the peripheral hlood and it 
appears that these plasmacytoid lymphocytes are the source of the 
excessive immunoglobulin (Zucker-Praiiklin, Franklin and Cooper, 
1962).
Neoplastic overproliferation of plasma cells may occur in the 
bone marrow and elsewhere in the distinct condition of myelomatosis. 
A patient with light-chain myeloma is included in this study and 
here the plasma cells are producing excessively the shorter so 
called light amino-acid chains of an immunoglobulin. Abnormal 
cells in the peripheral blood are not usually a feature of this 
disease. The presence of non oaseating granulomatae in a variety 
of tissues is the principal feature of sarcoidosis. It is 
considered to be a disease of hypersensitivity (Epstein, 196?) and 
it is recognised that there is a deficiency of some forms of 
delayed hypersensitivity reactions (Good, Kelly, Hotstein and Varoo, 
1962) while the lymphocyte response to phytohaemagglutinin is also 
impaired (Topilsky, Siltzbach, Williams and Glade, 1972),
Functional abnormality of the blood lymphocyte in sarcoidosis is 
therefore established.
In other conditions represented in the miscellaneous section 
the presence of a cellular immune abnormality is less certain. 
Crohn's disease may affect any level of the gastro-intestinal 
tract from stomach to colon, but most commonly involves the 
terminal ileum. The diseased areas show ulceration and 
destruction of the mucosa, marked submucosal fibrosis with chronic
66
inflammation and infiltration with neutrophils, lymphocytes, 
histiocytes and plasma cells. Aggregation of lymphocytes into 
follicles may occur in suhserosal and submucosal zones and these 
areas may show sarcoid-like granulomas (Robbins, 1 9 6 ?)• The 
presence of aggregates of lymphocytes has suggested that an 
immunological reaction is a feature of the disease, however there 
is no consistent change in the levels of serum immunoglobulins, 
and tests for organ specific cellular hypersensitivity to 
intestinal mucosal components by the leucocyte migration test 
proved negative (Weeke and Bendixen, I969)*
Broberger and Perlman (1959) have pointed out features of the 
immunopathology of ulcerative colitis. Anti-colonic antibodies 
are found in the sera of a proportion of patients with established 
disease, and more recently it has been shown that some patients 
with the disease have elevated levels of serum IgG, furthermore 
leococytes from the majority of patients show sensitization to 
pooled foetal colonic or jejunoileal mucosal antigens in the 
leucocyte migration test (Weeke and Bendixen, I969)#
These abnormalities of both cellular and antibody immunity may 
be reflected in changes in the blood lymphocytes although they may 
just as readily be secondary features of the disease as of primary 
importance in the pathogenesis.
Although pemphigus and pemphigoid are regarded as auto­
immune diseases it is the presence of circulating antibodies to 
intercellular material in pemphigus and to the basement zone of
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skin in pemphigoid which are important. The primary lesions can 
occur without local infiltration with chronic inflammatory cells 
so the typical changes associated with a cell hound immune 
reaction are absent (Beutner, Jordon and Chorzelski, I968),
There has been considerable speculation on the cause of 
Whipple's disease since the original description in I907 (Whipple, 
1907). Recently Maxwell, Ferguson, McKay, Irvine and Watson di'ew 
attention to the sparcity of the lymphocyte and plasma cell response 
in the gut lesions and showed a functional impairment of the 
lymphocyte responses to phytohaemagglutinin in patients with this 
disease. Colonic histiocytosis, although affecting a more distal 
part of the gut, is histologically similar to Whipple's disease 
and both these conditions have been included in the study of 
patients from the miscellaneous group as conditions with possible 
abnormality of immunity.
The conditions which are unlikely to be associated with an 
abnormality of immunity include patients with salicylate over­
dosage, acne, osteoporosis and nutritional osteomalacia.
Three patients with leucaemia have been studied and their 
results included in the miscellaneous group. Measurements of the 
lymphocyte DITA and RNA content in leucaemia have been reported by 
Rigas et ah, (1956), and the opportunity is taken to compare the 
findings in a limited series here with nucleic acid measurements 
reported in the literature.
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mTERIALS AND MSTHODS
3 . 2  Clinical material
Normal individuals.
Three groups of normal individuals were studied in initial 
measurements to Investigate possible effects of the cell isolation 
technique on the normal range.
Normal group 1 .
There were seven individuals in this group, all hospital staff, 
five were males. Their mean age was twenty-seven years with a 
range of from twenty-two years to thirty-one years. Fifteen 
analyses using the silicone oil method of cell separation were 
carried out on this group.
Normal group 2 ,
The gelatin method of cell separation was used for the 
separation of lymphocytes from blood in a study of the thirty-nine 
normal individuals in group 2 , All but three were hospital staff. 
Their mean age was thirty-five years with a range of from eighteen 
years to seventy-seven years; nineteen of the group were males.
Some details of these individuals are listed in Appendix 1 . Six
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individuals were members of both group 1  and group 2 ,
Normal group 3 .
Eleven males and nine females, all but one hospital staff, 
made up this group* Their mean age was thirty years with a range 
of from eighteen years to sixty-three years. Only one individual
was common to another of the normal groups. Details of the
individuals in group 3  appear in Appendix 2 ,
Rheumatoid arthritis.
Thirty-five patients with rheumatoid arthritis were studied. 
Twenty-four had definite rheumatoid arthritis by the American 
Rheumatism Association criteria (Ropes, 1 9 5 9 ); twenty-one of this 
group were female, and their mean age was fifty-five years with a 
range of from twenty-five ÿeare to seventy-eight years. The 
remaining eleven patients, eleven of whom were female, had probable 
rheumatoid arthritis. Their mean age was forty-seven years with 
a range of from twenty-five years to seventy years. Details of 
the patients are listed in Appendix 3 .
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Sicca syndrome and Sjbgren's syndrome.
Two groups of patients were studied, patients with the sicca 
syndrome and a second group with Sjpgren's syndrome.
The diagnostic criteria for the sicca syndrome were the 
presence of kerato~conjunctivitis sicca and xerostomia as recognised 
hy dry mouth and an abnormal sialogram. All eight of the patients 
were females and the average age was sixty-four years with the 
range from fifty-five years to seventy-six years. Eight patients 
with Sjdgren's syndrome had the features of the sicca syndrome with, 
in addition,definite rheumatoid arthritis by the American 
Rheumatism Association criteria (Ropes, 1959)• One of the eight 
patients was male and the age range for the group was fifty-one 
years to seventy-eight years with an average age of sixty-six 
years.
Details of the patients with sicca syndrome and Sjbgren's 
syndrome are listed in Appendix 4#
Thyrotoxicosis.
Thirty-four patients with thyrotoxicosis, initially untreated, 
were the subjects of a study* There were thirty women and four 
men with an age range of from twenty-two years to seventy years 
and a mean Bge of forty-nine years. The clinical thyrotoxicosis 
was confirmed by radio-iodine uptake studies, serum protein bound
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iodine determinations and serum tri-iodothyronine resin sponge 
tests. The results of a selection of these measurements are
included in Appendix 5*
The initial studies of untreated thyrotoxicosis were followed 
hy lymphocyte nucleic acid determination on patients euthyroid as 
a result of treatment. Ten patients received Carbimazole and the 
lymphocyte RNA and DNA measurements were carried out after control 
of the thyrotoxicosis and while a maintenance dose of 15 mg or 
20 mg of Garbimazole was continued. This was an average of four
months (range two to six months) after starting drugs. Twenty-
one patients were treated with radioactive iodine and the nucleic 
acid measurements were carried out on the lymphocytes after control 
of the thyrotoxicosis, again four months (ra,nge two to six months) 
from the date of the dose. Of the remaining five patients, three 
patients had a partial thyroidectomy and two patients did not 
return.
Lupus erythematosus.
Eight patients with lupus erythematosus comprised the first of 
the minor studies. All but one were females. The age range was 
eighteen years to sixty-five years. Details of these patients, 
including the degree of systemic involvement according to Haserick'© 
classification (I964), have been recorded, A single patient had
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skin manifestations only (group l). Four patients (Haserick 
group 2) showed evidence of LE cells in the hlood as well as skin 
lesions and three patients had unequivocal systemic disease (group 
3), Details of these patients are listed in Appendix 6,
Infection.
Eight patients with bacterial infection and two patients with 
viral infection were the subjects of a study. Six of the group 
were males. The age range of the group was seventeen years to 
sixty-three years with a mean age of thirty-one years. Details 
of the individual patients and the nature and duration of their 
infections are drawn up in Appendix 7,
Neoplasm,
Six patients with histologically confirmed malignant neoplasms 
were studied, all were females. Their age ra.nge was fifty-eight 
years to seventy—five years. Details of these patients are 
listed in Appendix 8, Four had invasive spread with métastasés 
and two had local neoplasm only.
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Miscellaneous*
This group comprised twenty-two patients and fifteen different 
conditions are represented. No advantage is to he gained from 
analysing these patients as a group and their individual data 
appear in Appendix 9*
3*3 Methods
Three different methods of isolation of lymphocytes from hlood, 
the gelatin method (Section 2*2), the gelatin and cotton wool 
method (Section 2.3), and the silicone oil method (Section 2.4), 
have been used in lymphocytes from normal individuals. In the 
patients with rheumatoid arthritis, Sjpgren's syndrome, lupus 
erythematosus and infection, the gelatin method was used. For all 
the remaining patient groups the gelatin and cotton wool technique 
was used.
Chemical analysis of the lymphocytes in all the studies of 
nucleic acid content was hy the method described in Section 2,8
Special techniques.
Certain specialised methods have been referred to and results
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recorded in succeeding sections. These techniques were not all 
part of the work of the thesis hut contribute information to it. 
References for these methods are included here - Erythrocyte 
sedimentation rate was measured by the method of Restergren; 
rheumatoid factor measi^irements followed the sensitised sheep red 
cell agglutination technique of Ziff, Brown, Lospalluto, Baden and 
McEwan (1956); bioassay for long acting thyroid stimulator (LATS), 
the technique used was that of Kriss, Pleshakov and Chien (I964).
The LATS activity was measured using 0,5 ml of test serum injected 
intraperitoneally into white male Swiss mice whose thyroid iodine
131was labelled with I , The thyroid stimulation was monitored by 
measuring the increase in blood radio-activity at twenty-four hours; 
the net increase in blood radio-activity is expressed as counts per 
minute per 0,1 ml of blood and the results are recorded as 
percentage increase, A blood radio-activity of 150 per cent of 
that before administration of serum was taken as a LATS positive 
response. These measurements were carried out by Dr, J.P.B. Smith,
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RESULTS
3.4 The normal range for lymphocyte DNA rhosphorus and RNA phosphorus 
content and the ratio RNAP/PNAP, and the effect of differing 
cell separation techniques
The results for the analyses of the lymphocyte nucleic acid 
content in normal individuals hy three methods of cell separation 
are set out in Table 5 which shows DNAP per 10^ cells, RNAP per 10^ 
cells, and the RNAP/DNAP ratio for each of the methods, giving the 
mean result, the standard deviation and the observed range in each 
case. The method for chemical measui‘ement of the isolated cells 
was the same throughout. There were differences in variance 
between the methods as shown in Table 5A. The most important of 
these for future work is the observation that the gelatin and 
cotton wool method has a significantly lower variance than either 
of the other two methods, Where a significant difference in 
variance was found the d-test was used in the comparison of mean 
values (see Section 2,9). Analyses of the results by Student's 
t—test and where appropriate, the d-test, appear in Table 5^*
The only significant difference found in the mean value for normal 
individuals between methods was in the comparison of the RNAP/DNAP 
ratio for the gelatin method and the gelatin plus cotton wool 
method. The mean for the latter method was significantly lower
Table 5
Lymphocyte nucleic acid analyses in normal individuals; three cell 
separation techniques compared.
ly S o c y - te  g lio sph o ru .
separation cells
Silicone
oil
Jig R m  phosphorus ratio
per 10 cells
Melatin
Gelatin 
plus 
cotton wool
All methods 
combined
Range 0*66 to 0 .92 Range 0.16 to 0,30 Range 0,18 to 0.40
Mean 0.752 Mean 0.223 Mean 0.299
SD 0.085 SD 0.048 SD 0.064
Range 0.55 to 1.15 Range 0.12 to 0.36 Range 0.16 to 0.37
Mean 0.744 Mean 0.203 Mean 0.274
3D 0.142 SD 0.061 SD 0.055
Range 0.59 to 1.01 Range 0.16 to 0.29 Range 0,21 to 0.35
Mean 0.732 Mean 0.215 Mean 0.295
3D 0.114 SD 0,041 SD 0.036
Range 0.55 to 1.15 Range 0.12 to 0.36 Range 0.16 to 0.40
Me an 0.742 Mean 0.210 Mean 0.284
SD 0.124 SD 0.054 SD 0.055
The nucleic acid analyses were obtained from fifteen estimations from 
seven individuals (silicone oil method), thirty-nine estimations from 
thirty-nine individuals (gelatin method), twenty estimations from twenty 
Individuals (gelatin plus cotton wool) and the combined results seventy- 
four estimations from sixty individuals.
Table 3A
Analysis of the variance of the results in Table 5 by the 
F-test•
Comparison
Degrees
of
freedom
Silicone oil v gelatin method 14 + 38
DNAP
RNAP
EWP/DFAP ratio
Silicone oil v gelatin and 
cotton wool method
DNAP
RNAP
RNAP/MAP ratio
Gelatin v gelatin and cotton 
wool method
DNAP
RNAP
RNAp/dM P  ratio
14 + 19
38 + 19
F Probability
2.79
1.62
1.35
1.80
1.37
3.17
1.55
2.21
2.34
< 0.01
N.S.
N.3.
N.S.
N.S,
:0.05
N.S
<0.05
<0.05
Mean values are compared in Table 5B overleaf.
Table 53
Statistical analysis of mean values in Table 5*
Where variance between the groups is significant, Welsh's test 
for *d' has been used to calculate the probability.
Comparison
Silicone oil v gelatin method
DNAP
RNAP
RFAP/DHAP ratio
Silicone oil v gelatin and 
cotton wool method
DNAP
RNAP
RNAP/DNAP ratio
Gelatin v gelatin and cotton 
wool method
DNAP
RNAP
RRAP/DNAP ratio
* *
0.19 0.25,0.5 
1.15
1.47
0.97
0.57
0.25 0.22,0.8
0.33
0,78 0 .54,0.5  
1.55 1.8 4,0.5
Probability
N.S.
< 0.3 2^ 0.2 
<0.2 ;>*0.1
< 0.4 > 0.3
< 0 .6 > 0.5
N.S.
<0.8>0.7
N.S.
< 0.05
*
Degrees of freedom as for Table 5A.
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at the five per cent level.
Since the cell separation technique showed only a minor effect 
on the results of the lymphocyte analyses the results for the three 
methods of cell separation in normal individuals were combined.
The range of normal for an analysis, usually calculated as two 
standard deviations either side of the mean value, applies when the 
distribution of results about the mean is of the gaussian type.
The distribution of the present results was therefore examined.
The values obtained in seventy-four determinations from sixty 
normal individuals are shown in frequency histogram form in 
Figure 5*
6
DNA phosphorus per 10 cells.
The class interval for the histogram was 0.03 jug DNAP per 10^ 
cells. The distribution is skewed with a tail on the side of 
high levels of DNA phosphorus. The mode is at 0*69 jug to 0.71 yug 
DNAP per 10^ cells. The coefficient of skewness (Snedecor and 
Cochrane, 1967) was +1.29 indicating positive skew with a »p* value 
of less than 0*01.
RNA phosphorus per 10^ cells*
The class interval here was 0,02 jug RNAP per 10^ cells. The
Figure 5
The distribution of the results of nucleic acid analyses from 
normal lymphocytes.
F r e q u e n c y
I 5 i
0 50 0 60 0 70 0 80 0-90 1 00 j i g  DNAP per 10® c e l l s
0-10 0 15 0-20 25 0-30 0 35 j i g  RNAP p e n o ®  c e l l s
0 15 0 20 0 25 0 30 0 •35 0 40 R N A P / d NAP  r a t i o
The three histograms show the frequency with which the various 
levels of DNA phosphorus, RNA phosphorus and the calculated KNAP/DNAR 
ratio were found in seventy estimations of the lymphocyte nucleic acids 
in sixty normal individuals.
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distribution shows a skew similar to that observed for the DNA 
analyses with a bias towards the higher levels of RNAP content.
The coefficient of skewness was +1.00 showing positive skew with a 
'p' value of less than 0.01.
The ratio RUAP/b NAP.
The class interval for the ratio is 0.02. The distribution 
of results does not show skew (the coefficient of skew was zero) and 
there is no significant kurtosis, i.e. flatness or peaked deviation 
from the normal distribution (Snedecor and Cochrane, 1967)* The 
mode is not well defined around 0.24 to 0.25 for these results but 
by the available tests these results are normally distributed.
Since the analyses of both DNA phosphorus and RNA phosphorus
content of the lymphocytes in the sixty normal individuals show a
significant skew towards positive values the normal range for these
measurements is best defined as the observed range. For DNA
phosphorus the range was 0.55 p-g to 1.15 jug DNAP per 10^ cells with
6a mean value of 0.742 jug DNAP per 10 cells. The normal range for 
RNA content was 0.12 jug to 0.36 jag RNAP per 10^ cells with a mean 
value of 0.210 jug RNAP per 10^ cells. The normal distribution of 
the values for the ratio RNAP/dNAP permits the use of a normal range
calculated as two standard deviations on either side of the mean.
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The mean value was 0.284 and the normal range therefore 0.174 to 
0.394*
The majority of the measurements which follow were carried 
out hy the more satisfactory gelatin and cotton wool method.
This method has a lower coefficient of variation for the RNAp/dNAP 
ratio than the other two methods, i.e. 12 per cent as against 
21 per cent and 20 per cent. The normal range for the gelatin 
and cotton wool method is re-stated with values rounded off for 
convenience.
BÏÏAP 0.60 - 1.00 /ug DNAP per 10 oelli.s
RNAP 0.16 - 0.30 jag RNAP per 10 cells
RNAP/DNAP O . P2-0.37 
ratio
3*5 The demonstration that sex of the donor has no effect on the 
results of lymphocyte nucleic acid analyses
The results for the comparison of the lymphocyte analyses 
from thirty-one normal male and twenty-nine normal female 
Individuals are shown in Table 6. These were again the results of 
the combined normal group first referred to in Section 3*4#•
There were no significant differences between males and females 
in the observed values for DNA phosphorus content, RNA phosphorus 
content or the RNAP/DNAP ratio of the lymphocytes when analysed by 
the t-test.
Table ^
Comparison of lymphocyte analyses in males and females
pg DHAP per 10 
lympnocytes
ykg K M P  per 10 
lymphocytes
6
Mean 0.737 Mean 0.204 Mean 0.260
Male
SD 0.095 SD 0.050 SD 0.065
Female
Mean 0.738 Mean 0,209 Mean 0.286
SD 0.125 SD 0.058 SD 0.051
Comparison oi the results of lymphocyte analyses from thirty-one 
normal males ana twenty-nine normal females® There were a total of
seventy-four analyses* forty from the males.
Statistical analysis by t-test
Comparison
Degrees
of
freedom
DWAP Males v Females
RNAP Males v Females 72
RMP/PNAP Males v Females 72
t ; Probability
0.04 ; >0.9
0.3W <0.9 >0.8
0.46 < 0 .8 >0.7
There are no significant sex differences in the nucleic acid analyses^ 
either by mean value or variance. The values of P for the comparisons of 
variance- in DMP,RNAP and PTTAp/pRûp are 1,73, 1.34 and 1.62 respectively.
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3.6 The effect of circadian rhythm on the results of the analyses
The possible effect of circadian rhythm on the results has 
not been studied but it can be discounted in the study of blood 
lymphocytes which follow, since all the blood samples were taken in 
the period O83O hours to 1130 hours. The study of human thoracic 
duct lymphocytes reported in Section 4 was the only study in which 
samples were taken at other times throughout the day.
3.7 The effect of the age of the individual on the lymphocyte nucleic 
acid analyses
When the results from the sixty normal individuals were 
analysed by age in decades, no age effect on the DNA analyses 
could be detected. The advantages in precision of using RWAp/ 
DNAP ratio as a measure of the R M P  content of the cell has been 
established so the RWAP/DNAP ratios of the lymphocytes in normal 
individuals have been tabulated according to the age of the donor. 
These RNA/DNA results appear in Table 7. The data is insufficient 
to make a complete assessment of the effect of age on the results. 
Although a significant difference has been shown between the mean 
results for age group thirty to thirty-nine, and the mean result 
for age group twenty to twenty-nine (p = <0,05 by Student's t-
Table 7
Age group and the lymphocyte HNAP/DMP ratio
 ^ 20 to 29 30 to 39 40 to 49,50 to 59
Number in group 4 41 ! 10 4 | b 3
Mean RIIAP/BNAP of 0 .2 9 8 O.29O 0.323 0.203 ‘ 0.259 0.270
lymphocytes 1 \
^0 f"thI*RMAP/imAp" 0-02* 0-054 0.044 0 .0 1 0 ' U.O58 0.034
The results of 70 estimations of the lymphocyte RNAP/DNAP in 
60 normal individuals are grouped by age in decades*
Analyses by t-test shows differences at the 5?5 level of significance 
between the mean values for age group 30 to 39 hnd both the 20 to 29 
group and the 50 to 59 age group. The t values were 2,13 and 2.71 
respectively. However, since 15 intercomparisons have been made it is 
not established that a real difference exists between the age groups.
So
test) and a similar statistically significant difference is present 
between age group thirty to thirty-nine and age group fifty to 
fifty-nine, i.e. the mean RNAP/dNAP ratio of the lymphocytes 
appears to be slightly higher for individuals in their fourth 
decade than at other periods, these findings must be interpreted 
with caution. There is unlikely to have been a methodological 
influence on the finding since six of the results for the age 
group thirty to thirty-nine were obtained by the standard gelatin 
method, and four by the cotton wool modification, A more 
important point is that fifteen intercomparisons have been made, 
two of which showed a significant difference with a probability 
of one in twenty. The data are therefore insufficient evidence 
of a real difference in lymphocyte RNAP/bNAP ratio between age 
groups.
3,8 The variation in the lymphocyte nucleic acid content in two 
individuals studied serially
The peripheral blood lymphocytes were analysed over a period 
of one year in one individual, a male of twenty-nine years, using 
the gelatin cell separation method. The serial analyses are 
presented in Figure 6. During this period, measurement of the 
DNAP content of the lymphocytes varied from I-O5 jug to 0,62 jjg per
i^ 'igure 6
Serial determinations of lymphocyte nucleic acids in one individual
LYMPHOCYTE RNA A N D  DNA IN ONE INDIVIDUAL
yUg P h o sp h o ru s  
p e r  m illio n  ceils
1 0
8
6
D N A
4
2
R N A
0
3
RNAP
DNAP
6 8 
Time in Months
10 12 14
Serial analyses of D M  phosphorus per 10 cells, RÎTA phosphorus 
per 10^ cells and theRNAP/DMP ratio of the blood lymphocytes are 
plotted for one individual, and measured at intervals over one year* 
Average normal values and the normal range are indicated*
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10^ cells, and the RNAP content per 10^ cells from 0,27 to 0,13 /ig. 
The variation in the DNAP and RNAP tended to be coincidental while 
the calculated ratio RI’TAP/DNAP of the lymphocytes showed less 
variation (0,20 to 0,30) than the individual RNAP and DNAP values, 
particularly when the estimations were repeated after an interval 
of a few days. In a second individual, a female aged twenty-three 
years, the lymphocytes were analysed five times over a period of 
nine months. Again the RNAP/DNAP ratio of the blood lymphocytes 
showed a lower variability than either the DNA phosphorus or the 
RNA phosphorus results. The observed range of the RNAP/dNAP ratio 
was from 0.21 to 0,33 in the nine month period.
3,9 The blood lymphocyte nucleic acid content in rheumatoid arthritis 
DNA analyses.
The results of the blood lymphocyte DNA analyses are summarised 
in Table 8 which shows normal values for comparison. The mean 
DNAP content of the lymphocytes in rheumatoid arthritis is 0.736 p g  
DNAP per lO^cells. There is a high probability that the small 
difference between this result and that found in the normal group, 
0,744 p g  DNAP per ]0^ cells, is a chance finding (p = > 0.7)»
There is no significant difference in variance between the two 
groups.
Table 8
The nucleic acid content of the lymphocytes in rheumatoid arthritis
Group
Rheumatoid
Arthritis
Normal
Numoer of DNAP ^ RNAP ^ RNAP/DNAP
analyses pg per 10 cells pg per 10 cells ratio
35
39
Mean 0*736 
SD 0.133
Mean 0.744 
SD 0.142
Mean 0.294 
SD 0.069
Mean 0.203 
SD 0.06l
Mean 0.346 
SD 0.062
Mean 0.274 
SD 0.055
The comparison of the lymphocyte nucleic acid determinations in 
patients with rheumatoid arthritis and the results in normal individuals 
by the same method.
Statistical analysis cy t-test 
Comparison Degrees of 
freedom
Rheumatoid Arthritis DNAP
V  RNAP
Normal RNAP/DNAP
72
72
72
0.26
3.45
5.41
Probability
< 0.8 > 0.7
< 0.01>t)o00l 
*
< 0.001
*These differences are significant.
There are no significant differences in variance; the P values for 
the comparisons of DNAP, RNAP and RNAP/DNAP ratio are I.I9, 1.27 and 1.27 
respectively.
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RNA analyses.
The results for these analyses are listed in Table 8. The 
mean value for the RNA content of the lymphocytes from patients 
with rheumatoid arthritis is 0.254 p g  RNAP per 10^ cells and the 
corresponding value in the normal group is 0.203 pg RNAP per 10^ 
cells. There is no significant difference in variance but the 
difference between mean values is significant (p = < 0 .0l).
The RNAP/dNAP ratio.
The values for the RNAP/dNAP ratio calculated from the 
measurements of RNA and DNÆ content in the cells are listed in 
Table 8 which shows mean values and standard deviations in the 
patient and normal groups. In rheumatoid arthritis patients the 
mean value is 0.346 and in the normal group 0.254* Differences 
in variance are not significant but the mean RNAP/dNAP ratio is 
significantly greater than normal in rheumatoid arthritis
(p = <0 .001).
It was possible to match for age and sex, ten patients with 
definite rheumatoid arthritis and ten controls. Pairings were 
carried out by random selection where more than one match was 
available. The lymphocyte RNAP/dNAP was again different in the 
matched groups; the mean ratio for the rheumatoid arthritis 
patients was 0,37? standard deviation 0.04, and for the normal
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subjects 0,265 standard deviation 0,03 (p = < 0 ,001),
3.10 The relationship between the severity of rheumatoid arthritis 
and the lymphocyte chemistry
The American Rheumatism Association classification of 
rheumatoid arthritis was applied to the patients studied and the 
results of lymphocyte chemistry re-analysed in two groups, 
definite rheumatoid arthritis and probable rheumatoid arthritis.
DNA analyses.
There is no significant difference in blood lymphocyte DNA 
content between definite rheumatoid arthritis, probable rheumatoid 
arthritis and the normal group. The mean values were 0,73j^'
DNAP per 10^ cells, 0.76^ug per 10^ cells and O.R^^ug per 10^ 
cells respectively. These results are recorded in Table 9#
Table 9
Lymphocyte nucleic acid content in probable and definite 
rheumatoid arthritis and the comparison with normal*
Group
Definite
rheumatoid
arthritis
Probable
rheumatoid
arthritis
24
Number of ' M A P  g RNAP g RN-\p/DrrAP
individuals per 10 cells pg per 10 cells ratio
i
Mean 0*367 
SD 0*054
Mean 0.299 
SD 0.053
11
Mean 0*726 
SD 0.121
Mean 0.756 
SD 0.159
Mean 0*267 
SD 0.064
Mean 0. 225 
SD 0.074
Normal 3 9
Mean 0*744 
SD 0.142
Mean 0.203 
SD 0.061
Mean 0*274 
SD 0.055
Mean values and standard deviations are shown for blood lymphocyte 
DNA phosphorus and ENA phosphorus content and the RNAP/DNAP ratio.
There are no significant differences in variance (F-test) in the 
comparisons listed for analysis by t-test.
Table 9 (oont'd)
Statistical analysis by t-test
!
’ Degrees
Comparison of
freedom
t Probability P
DNAP No significant differences — — - N.s.
RNAP Definite RA V normal
t
61 3.97 <0.001 1.10
probable RA V
I
normal 48 1*04 ^0 .40?O,30 1.47
Definite RA V probable RA 33 1,73 <0 .10>0.05 1.34
RNAp /dNAP Definite RA V normal 61 6 .70 *<0.001 1.04
Probable RA V normal 48 1.09 <0*30>0.20 1.08
Definite RA V probable RA 33 3,51 <0*01>0.001 1.04
*
These differences are significant
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RNA analyses*
The RNA content of the blood lymphocytes in definite rheumatoid 
arthritis was 0*27 p g  RNAP per 10^ cells. The mean RNA content of 
the lymphocytes from the patients with probable rheumatoid arthritis 
was. 0.23 p g  RNAP per 10^ cells* Intercomparisons of the groups, 
definite rheumatoid arthritis, probable rheumatoid arthritis and 
normal, revealed a significant difference in the comparison of the 
group with definite rheumatoid arthritis and the normal results
(p = C. 0.001),
RNAP/dNAP ratio results.
The results of the lymphocyte RNAP/PNAP ratio for the three 
groups, definite rheumatoid arthritis, probable rheumatoid 
arthritis and normal individuals, are summarised in Table 9 and 
the individual results displayed in Figure 7.
Statistical analysis of the results reveals a significant 
difference between the mean RNAP/DNAP ratio result in definite 
rheumatoid arthritis^0,37 and the mean ratio in the normal group 
0,27 (p = < 0 ,001), A further significant difference was-'* 
demonstrable between the RNAp/DNAP ratio in probable rheumatoid 
arthritis 0.30 and the ratio in definite rheumatoid arthritis
(p = < 0 .01),
Results presented in Section 3*5 and Section 3*7 support the
Figure 7
The RNAP/DNAP of the blood lymphocytes in patients with rheumatoid 
arthritis#
RNAP
DNAP
0-5
0-4
0-3
0-2
0 1
I:
Normal Probable RA Definite RA
The patients with rheumatoid arthritis were grouped according to 
the American Rheumatism Association criteria for probable and definite 
rheumatoid arthritis and the blood lymphocyte RNAP/bMP ratio results 
for these groups separately plotted,# A series of normal values are also 
shown.
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belief that age and sex differences between control and patient 
groups would not themselves produce the results shown.
3.11 The relationship between the lymphocyte RNAP/PNAP ratio and 
measurable features of the disease (probable and definite 
rheumatoid arthritis)
Figure 8 shows the relationship between the blood lymphocyte
RNAp/DNAP ratio and the ESP (Westergren) in mm per hour. The
correlation coefficient is .0.50 (t = 3.34, n = 37, P = <0.01)
indicating that some correlation is present but the correlation of
E3R and ratio is not a close one.
A similar degree of correlation exists between the plasma
level of rheumatoid factor, as measured by the sheep red cell
agglutination titre, and the lymphocyte RNAP/DNAP ratio* The
results of the sheep cell agglutination were expressed as the log
of the reciprocal of the titre and an arbitrary value of 0.5 on
the log scale was given to negative titres, i.e. those less than
/l6* The linear correlation coefficient for the comparison
calculated at 0.56 (t = 3.76, n = 33, P = 0,001),
A comparison was made in patients with rheumatoid arthritis,
either probable or definite, between individuals with a high
1rheumatoid factor titre, i.e. /256 or greater and those with a
Fifflire 8
Studies on probable and definite rheumatoid arthritis; the 
correlation of the blood lymphocyte RNAP/DNAP ratio and the erythrocyte 
sedimentation rate.
RHEUMATOID ARTHRITIS  
Comparison of ESR and Lymphocyta RNA/DNA
/O O "
80-
60 -
00
20 -
0-1 OS
LYMPHOCYTE RNA!DNA
Individual values of the erythrocyte sedimentation rate by the 
Westergren method are correlated with the results of the lymphocyte 
RWAP/bWAP ratio in patients with rheumatoid arthritis. The 
coefficient of linear correlation was 0.50.
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lower or negative titre. The mean value of the RNAF/DNAP ratio 
of the blood lymphocytes in the high titre group was 0,39 and in 
the low titre group 0.29; the means were significantly different 
(p = <-0,00l). When this study was extended in a comparison of 
serO“positive rheumatoid arthritis, i.e, all patients with a titre 
greater then ^/l6 and sero-negative rheumatoid arthritis, titre 
less than ^/l6, the mean values for the lymphocyte HMP/PNAP ratio 
were: sero-positive 0,36; sero-negative 0.29. These mean
values were still significantly different (p = <0,0l).
i
The comparison of eight patients with subcutaneous nodules 
and twenty-seven patients not showing this sign, again revealed a 
significant difference when the lymphocyte RNAP/DNaP ratio was 
compared. The means for the groups were; with nodules 0.39; 
no nodules 0.33, (p - < 0 ,05).
3.12 The influence of drug treatment of the HWAP/M.AP ratio of the 
lymphocyte in rheumatoid arthritic
The possibility that ' treatment could have affected the 
lymphocyte HWAP/DNAP in the present study was tested by grouping 
the results of thirty-five patients with probable or definite 
rheumatoid arthritis according to the drug therapy they were 
receiving at the time of the analysis. The four groups were: 
patients on salicylates and steroids, salicylates alone, steroids
Table 10
Drug treatment and the lymphocyte RKAP/DMP ratio in rheumatoid 
arthritis*
Group and therapy Number Mean SD
RA, salicylates and 
steroids
11 0.344 0.065
RA, salicylates only 15 0.364 0.066
RA, steroids only 3 0.293 0.032
RA, no therapy 6 0.330 0.042
Normal, no therapy 39 0.269 0.050
Lymphocyte RNAP/DNAP Comparison with untreate
normal results p value
p = < 0.001
p « < 0.001 
Not significant 
p « < 0.05
The results of lymphocyte RNAP/DNAP ratio in thirty-five patients 
with rheumatoid arthritis classified by drug treatment regime and the 
comparison by t-test with normal individuals. There was a significant 
difference in variance between the group on steroids only and the normal 
group (P " 3*28, p « < 0 .05), otherwise there were no differences in variances 
and the remaining comparisons by t-test are valid.
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alone, and no therapy. The mean values of the lymphocyte RTLlp/ 
M A P  ratios for the patients in each group appear in Table 10,
The lymphocyte RNA content as measured by the RNAP/MAP ratio was 
still elevated in patients on no therapy (mean value = 0,33) 
compared with 0.27 in normal individuals (p = <0,05). However 
more striking differences from normal were found in the treated 
groups except in the case of steroid treatment alone where the 
group was too small for satisfactory statistical analysis.
Two patients with probable rheumatoid arthritis were studied 
at the time steroid therapy was started. The blood lymphocyte 
RNAP/dNAP ratios for the patients before treatment were 0.19 and 
0,26. After twenty-four hours on prednisone 5 mg p.i.d,, the 
lymphocyte RNAP/MAP ratios were 0.20 and 0.22 respectively, and in 
the second patient, after one week of treatment, the ratio had 
risen marginally from the initial 0.26 to 0.29.
3.13 The nature of the blood lymphocyte in rheumatoid arthritis
The measurements on the lymphocytes in rheumatoid arthritis 
and in some of the studies which follow were carried out at an 
early stage of the work when the importance of the blood lymphocyte 
count was not yet appreciated. Differential white cell counts on 
a stained blood film were not carried out in all patients with 
rheumatoid arthritis, but films from five patients with definite
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rheumatoid, arthritis were closely examined. Strikingly abnormal 
cells were rare, less then one per cent of the lymphocytes, 
although an increased number of deeply basophilic medium sized 
and large lymphocytes were seen,
A comparison was made between the lymphocyte diameter measured 
on a blood film stained with a standard technique^and the chemical 
analysis of the lymphocytes separated from blood d.rawn at the same 
time. One hundred cell diameters from each blood film were 
measured to obtain a value of the mean lymphocyte diameter in 
microns (pm). Blood films from five normal individuals and from 
five patients with definite rheumatoid arthritis were examined in 
this way. To avoid observer bias, the slides were coded and all 
the cell diameter measurements were made without knowledge of the 
diagnosis or the chemical analysis. The relationship between the 
mean lymphocyte diameter and the RNAP/DNAP ratio of the cells, 
illustrated in Figure 9? shows that an increase in the average 
lymphocyte diameter occurs as their RNAP/MAP increases. The 
coefficient of linear correlation of the ten results was 0,76  
(t “ 3,23, p = <0.02), The possibility that the square of the 
lymphocyte diameter might give a better correlation with the chemical 
analysis was not found in practice. The mean lymphocyte diameter 
averaged for five normal individuals was 8,98 microns and the mean 
of the measurements in five patients with definite rheumatoid 
arthritis was 10,27 microns. The normal group and the patients did 
not differ significantly by cell diameter measurements (p = 0.05
ji'igure 9
Correlation of tjie lympnocyte RNAP/DNAP ratio and the mean 
lymphocyte diameter.
Ratio 
RNAP 
DNAP 
0-5 n
0*4
0 3-
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R N A P /d NAP r a t i o  and CELL SIZE
T = 0 • 76 
P = 0 02
O
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MEAN LYMHOCYTE DIAMETER MICRONS
Values for the lymphocyte RNAP/DNAP ratio in five normal individuals 
and five patients with rheumatoid arthritis are correlated with the mean 
lymphocyte diameter measured on a fixed and stained blood smear. The
lymphocyte diameters are mean values of one hundred cells for each 
patient. The coefficient of linear correlation was 0.76.
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< 0,10) although hy chemical analysis the difference w a s  highly 
significant (p = < 0,001),
3,14 The relationship between the blood lymphocyte count and the 
lymphocyte RI’:A/D1JA ratio
The blood lymphocyte count (cells per mm^) and the lymphocyte 
RNAP/d NAP ratio were simultaneously determined in fourteen normal 
individuals and twelve patients with rheumatoid arthritis. The 
results, plotted in Figure 10, show different symbols for the 
normal and patients* results. The blood lymphocyte count and the 
RNAP/dMP ratio are essentially independent variables. The 
coefficient of linear correlation calculated at 0*11 (t - 0,38, 
n = 14, p = 0,6) for the normal results and 0.37 (t = 1,38,
n = 12, p = '..*0,1) for the results in rheumatoid arthritis. The 
correlation coefficient for the combined results was 0,19 (t = 1,85, 
n ” 26, p - > 0,05), In no case was there a significant 
correlation between the lymphocyte count and the RNAP/DNAP ratio.
Fif?ure 10
The relationship between lymphocyte RNAP/DNAP ratio and the diood 
lymphocyte count*
Bl ood l y m p h o c y t e  Count  
Ce l l s  per  cu . mm.
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The blood lymphocyte count in cells per mm derived from a leucocyte 
count and a diiierential count on one hundred cells is compared with the 
RNAP/dNAP ratio of the lymphocytes measured in the same individuals* 
Results from normal subjects solid circles) and patients with rheumatoid 
arthritis (solid triangles) are shown. The coefficient of linear 
correlation was 0.19*
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3*15 The blood lymphocyte nucleic acid content in sicca syndrome and 
in S.jpi^ren^s syndrome
DNA analyses.
The mean lymphocyte DNA content is very similar in the two 
groups of normal individuals, in patients with sicca syndrome and 
in Sjdgren's syndrome, as may he seen from the results recorded in 
Table 11. The mean lymphocyte DNA content in sicca syndrome and 
in Sjpgren's syndrome was 0.74 p g  and 0.77 p g  DNAP per 10^ cells 
respectively. The corresponding results for the groups of normal 
individuals were 0.74 and 0.73 yUg DNAP per 10^ cells. No 
statistically significant differences either of variance or of 
mean values were found between normal and patient groups.
RNA analyses.
The results of the RNA analyses summarised in Table 11 were 
used to calculate the lymphocyte RNAp/DNAP ratio results for the 
groups listed above.
Lymphocyte RNAP/dNAP ratio results.
Evidence that the average lymphocyte DNA content is not a
Table 11
Lymphocyte nucleic acid content in sicca syndrome and Sjogren's 
syndrome with comparison with two groups of normal individuals.
Group Number 
Sicca syndrome 8
Sjdgren's 
syndrome
Normal (gelatin 
and cotton wool 
method)
Normal (gelatin 
method)
8
20
39
DNAP ^ KNAP ^ RNAP/DNAP
jug per 10 cells pg per 10 cells ratio
Mean 0.735 Mean 0.239 Mean 0.330
SD 0.122 SD 0.057 SD 0 .098
Mean 0.755 ■Mean 0.276 Me an Ü .366
SD 0 .106 SD 0.053 SD 0 .0 6 0
Mean 0.732 Mean 0.215 Mean 0 .2 9 5
SD 0*114 SD 0.041 SD 0 .0 3 6
Mean 0.744 Mean 0.203 'Mean 0 .274
SD 0.142 SD 0.061 SD 0 .0 5 5
In this comparison, two normal groups are included since the cell 
separation technique used in the study of sicca syndrome was the gelatin 
and cotton wool method and that used in the Sjogren's syndrome study was 
the gelatin method.
Table 11 (cont'd.) 
Analysis of the results of Table 11 by t-test
Comparison Degrees of 
freedom t Probability
P
M A P Sicca syndrome V no rmal 26 O.o6 >0.9 1.14
Sjogren's
syndrome V normal 45
0.18 <0.9 >0.8 1.79
RNAP Sicca syndrome V normal 26 1.27 <0.3 >0.2 1.93
Sjôgren* s
syndrome V normal 45 2.93 <0.01 y 0.001 1.33
KNAP/ Sicca syndrome 
r a S o  S36gren-s
V
V
normal
normal
26
45
1.38
4.27
< 0.2 >0.1 
<0.001
7.44
1.19
*
These differences are significant.
Consideration of the values of F, the ratio of the variances in 
these comparisons validated the use of the t-test to compare mean values. 
The exception was the comparison of the RNAP/DNAP ratio in Sicca syndrome 
and the normal group. Here F calculated at 7.44, significant with 
p = <0.01. The d-test, d - 0.99, 0.9 showed no significant difference* 
in mean values for this particular comparison.
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significant variable in patients with sicca syndrome and Sjdgren's 
syndrome allows legitimate use of the RI'JAP/dNAP ratio in 
considering changes in the average cell RITA.
The results of the analyses of lymphocyte RRAP/PNAP in sicca 
syndrome and Sjogren's syndrome as well as the two normal groups 
are summarised in Table 11, and the distribution of the results is 
illustrated in Figure 11. When comparisons are made between the 
patients* results and their appropriate control group, two 
observations may be made. Firstly, the lymphocytes in the eight 
patients with sicca syndrome have a mean RNAP/PRAP ratio of 0.33? 
not statistically different from the normal control subjects who 
have a mean ratio of 0.30. Secondly, the blood lymphocytes in 
Sjogren*s syndrome were significantly abnormal; their mean RIIAP/ 
DNAP ratio wa,s 0.37# The corresponding control value was 0.27 
(p " <i0,00l). Consideration of differences in variance did not 
alter these conclusions.
On the evidence presented in Section 3*5 and Section 3,7? the 
age and sex differences between patients and control would not 
influence the findings.
Figure 11
Lymphocyte RKAP/DMP ratio in sicca syndrome and S^àgren's syndrome
0  6
0  4
I -
<
0:
0 2
• i l
î ï t .
t S
I
LYMPHOCYTE  
R N A /D N A  RATIO
N O R M A L
- t .
#
X
SICCA
SYNDROME
SJOGRENS
SYNDROME
individual results of the lymphocyte RRAP/PNAP ratio are plotted 
for patients with sicca syndrome and Sjogren’s syndrome. Normal 
results, using two methods of isolating the lymphocytes from hlood, the 
gelatin method and the gelatin plus cotton wool method, are included 
for comparison. The broken lines indicate mean values.
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3.16 The relationship of the severity of the disease and the lymphocyte 
HI'JAP/dNAP ratio, A comparison of sicca syndrome end S.jdgren's 
syndrome
Although it has been demonstrated that the blood lymphocytes 
in Sjogren*s syndrome, a disease with widespread tissue 
manifestations, are significantly different from normal while the 
lymphocytes in the less severe sicca syndrome do not show this 
degree of abnormality, direct comparison of the lymphocyte RNAP/
DNAP ratios, 0.37 in Sjogren's syndrome and 0,33 in sicca syndrome, 
fails to show a significant'difference (p - >0.3). Inspection of 
Figure 11 shows that there was only one result in the sicca syndrome 
which could be considered abnormal, while in Sjogren's syndrome 
there were four lymphocyte EPAP/DNAP ratio results at the abnormal 
level of 0,40 or greater.
3.17 The effect of drug treatment on the RNAp/pNAP ratio of the 
lymphocytes in sicca syndrome and Sjdgren's syndrome
Sicca syndrome.
Six of the patients studied were receiving no therapy, one was 
taking indornethacin and one was having mefenamic acid both in a
Sable 12
The results of the hlood lymphocyte RKAP/DHAP ratio aeterminatxon
in Sjogren's syndrome listed oy treatment regimes.
Therapy
Wot on treatment
Salicylate and 
steroid
Salicylate alone
Steroid alone
Lymphocyte RNAP/DWAF ratio
0,46,0.34 Mean = 0.40
0.40
0.41,0.40,0.31
Mean 0.37
0.33,0.28
Mean ® U.3I
Blood lymphocyte analyses from eight patients with Sjpgren's 
syndrome were grouped according to therapy at the time oî‘ the analysis. 
The group mean values for the RNAP/BNAP ratio are recorded where this 
is appropriate.
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standard therapeutic dose. The lymphocyte RNAP/d NAP ratio of 
these last two patients were within the normal range while the one 
patient with abnormal lymphocyte chemistry was having no drug 
treatment at the time of the measurement.
Sjogren's syndrome.
The majority of patients with Sjogren's syndrome were on drug 
treatment and this is most simply shown by a table (Table 12), 
Although the numbers of patients are small there is no evidence 
that drug treatment effects' are an explanation of the finding of 
an abnormal lymphocyte RRAP/dNAP ratio in Sjogren's syndrome.
3.18 The blood lymphocyte nucleic acid content in thyrotoxicosis 
DMA results.
Table 13 shows the summarised results of the DNA analyses of 
the lymphocytes from the patients with untreated thyrotoxicosis and 
the results in normal individuals for comparison. The mean DNAP 
content of the lymphocytes was almost identical in patients and 
the normal group.
The nucleic acid analyses of the lymphocytes from patients with 
untreated thyrotoxicosis, with results in norroal individuals analysed 
by the same method.
— . . u . „ n .
Mean u*737 Mean 0,22% Mean O .316
Thyrotoxicosis 20 gg 0 .II9 SD 0.039 SB O.O6O
Mean 0.732 Mean 0.215 Mean 0.295
Normal 34 gg 0 .II4 1 SB 0.041 SB 0.036
Mean values and standard deviations are shown for measurements of 
lymphocyte D M  phosphorus? H M  phosphorus and R M p/dM P  ratio.
Analysis by t-test
Comparison Degrees of ' freedom t ■ Probability F
Thyrotoxicosis v normal DNAP
RNAP
RNAP/DMP ratio
h'2
52
52
0,21
1.26
1.41
j
' < 0 .9 > 0.8  
< 0.2 > 0 .1  
<  0 .2 > 0 .1
1.09
1.11
2.79
Comparison of variance between test and control group showed a 
significant difference for the RNAP/DNAP ratio only (P = 2.79, P = <0.0l),
Analysis of the means by d-test (d = 1.45, 0.86 M.S.) confirmed the t-test 
result.
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ENA results.
These results also appear in Table 13. The mean ENA content 
of the lymphocytes in patients with untreated thyrotoxicosis was 
0.23 }ig RNAP per 10^ cells? slightly greater than the mean value 
in the normal group, but the difference is not statistically 
significant,
RNAP/d NAP ratio results.
The mean of the result for the lymphocyte ENAP/dNAP ratio in 
patients with untreated thyrotoxicosis was found to be 0.32 
although greater than that found in the normal control group 0.30; 
the difference was not statistically significant (p = >0.10).
A difference in variance between test and control group did not 
alter this finding.
3.19 The blood RITAP/PNAP ratio in relation to measurable features . 
of thyrotoxicosis
The lymphocyte RNAP/PNAP ratio in LATS positive and LATS negative 
patients.
Figure 12 shows the results of the blood lymphocyte RiîAp/PNAP
Figure 12
Lymphocyte RNAP/DÎÎAP ratio in thyrotoxicosis. A comparison
of results from patients with sera positive and negative for LATS.
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Individual results for the lymphocyte RRAP/DNAP ratio in 
patients with thyrotoxicosis are grouped according to the results 
of the LATS hio-assay. Normal results are shown and the result of 
the t-test compax'ison^patient and normal results indicated.
Broken lines denote mean values.
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ratio measurements from twelve thyrotoxic patients whose sera 
were positive in the LATS bio-assay and compares the lymphocyte 
results with those from twenty-two patients negative in the LATS 
assay. The lymphocyte chemistry and the LATS assays were 
determined prior to treatment of the hyperthyroidism, lymphocyte 
RNAP/dMP ratio data from twenty normal individuals are included 
for comparison. The mean RNAP/MAP ratio of the lymphocytes 
from thyrotoxic patients with LATS positive sera was 0.326 
(S.D. 0 .044)? and from those with LATS negative sera it was 0.302 
(S.D, 0 ,046), Intercomparisons were made and it was found that 
the mean lymphocyte RNAP/DMP ratio was significantly higher in 
the LATS positive thyrotoxic group than in normal individuals 
(p = <0,0.09 ). The difference in the direct comparison of LATS 
positive and LATS negative individuals did not reach statistical 
significance (p = >  O.IO).
The lymphocyte RNAP/PNAP ratio and the 24—hour uptake of the
gland.
No attempt was made to correlate directly lymphocyte chemistry
and thyroid radio-iodine uptake. By the technique used, 15 to
40 per cent of an administered test dose of is normally
131retained by the gland. A high uptake of I ‘ was arbitrarily 
defined as 60 per cent or greater of the test dose, and the
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lymphocyte RNAP/DNAP ratio from patients with a high uptake
compared with the ratio in patients with a 24-hour uptake less
than 60 per cent. There was no significant difference in the
lymphocyte chemistry between the high and low uptake groups,
indeed the mean ratio was marginally greater in patients with a 
131lower I uptake, 0*32 as against 0*31,
3.20 The effect of treatment of thyrotoxicosis on the lymphocyte 
nucleic acid content
Treatment of the thyrotoxicosis did not produce a consistent 
change in the DNA values. In patients rendered euthyroid by the 
various forms of treatment the mean DNA content of the lymphocyte 
was 0.666 /Ug DNA phosphorus per 10^ cells with a standard deviation 
of 0 ,159. Although lower than the levels found in normal 
individuals the difference was not significant by 't'— test (p =
9- 0.10).
When the post treatment results for the DNA values were 
separated by treatment regimes the following results were obtained? 
in Carbimazole treated patients the mean lymphocyte DNA content 
was 0,675 pg DNA phosphorus per 10^ cells, in radio-iodine treated 
patients the mean DNA content of the lymphocytes was 0.645 J"ag DNA 
phosphorus per 10^ cells, and in patients treated by surgery the
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mean post-treatment lymphocyte DNA content was 0,778 pg DNA 
phosphorus per 10^ cells. Only in the case of radio-iodine 
treated patients was the difference significantly different from 
normal (p = <-0,02).
Table 14 shows the RNAP/DNAP ratios of the lymphocytes from 
thyrotoxic patients before and after treatment with Carbimazole, 
radio-active iodine or partial thyroidectomy? and the data are 
compared to results from twenty normal individuals. The mean 
lymphocyte RNAp/DNAP ratio following therapy with Carbimazole in 
ten patients was 0.365? higher than in the normal control group 
with a mean ratio of 0.295 (p = <0.02). A statistically 
significant difference wa^ again found when the mean ratio? after 
treatment? was compared to pre-treatment results for these 
Carbimazole treated patients. When the lymphocyte RNAP/DNAP 
ratio data from patients treated with radio-iodine therapy was 
examined there was a difference between the mean ratio after 
therapy and the mean ratio found in normal people. The details 
are tabulated and it may be noted that the mean post-radio-iodine 
treatment RNAp/DNAP ratio was 0.352? significantly greater than the 
value in normal individuals. There was not however a significant 
difference between the mean lymphocyte RNAP/DNAP before and after 
therapy in the radio-iodine*treated patients.
The results in the three patients after treatment by partial 
thyroidectomy are also tabulated. The mean post-treatment RNAP/ 
DNAP ratio of the lymphocytes 0.432 is substantially higher than
Table 14
The errect o f  treatment of thyrotoxicosis on the hlood lymphocyte 
RNAP/DNAP ratio.
Numbers 
Treatment in
groups
Carbimazole 10«10
Pre-treatment Post-treatment
131
Partial
thyroia-
ectomy
Normal
untreated
individuals
21,19
3,3
20
^thyrotoxic) ^euthyroid)
Mean 0.308
*
Mean 0.365
SD 0.053 . SD 0.050
Mean 0.323 Mean 0.352
SD 0.068 SD 0.048
Mean 0.336 : Mean 0.432
SD 0.054 ; SD 0.057
Mean 0.295
*
Mean values
SD 0 .03b significant 
results in
Comparison of pro and 
post treatment mean vaii 
t
2.55
1.60
Probability 
<.0.02 > 0.01
<0.20 >0.10
<0.10 >0.05
control subjects.
The results of comparison of the lympnocyue RNAP/dNAp ratio in pre- 
treatment thyrotoxic ana post-treatment euthyroia patients are tabulated? 
showing the mean values and the standard deviation with the number of 
individuals in each group* The results of the t-test of this comparison 
are listed. There were no significant differences in variance between 
the groups compared? and t-test results are therefore valid.
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either the pre-treatment value or the results in normal individuals? 
hut the small sample prevents adequate statistical analysis.
3.21 Blood lymphocyte count results in thyrotoxicosis
The mean leucocyte count in the peripheral hlood of twenty-
three patients with thyrotoxicosis prior to treatment was 7140 
3
cells per mm ? and the mean lymphocyte count for the nineteen of 
these patients in which it was determined was 2350 cells per mm^ 
with a standard deviation of 960 cells per ram^ . The observed 
range of the lymphocyte count was from 1060 cells to 46OO cells
,per mm 3^ Two patients had a leucopenia with a total white cell
count of less than 4OOO cells per mm^ and in these patients there
was a relative lymphocytosis, The correlation between the blood
lymphocyte count and the MAP/DBAP ratio is not significant? 
r = 0 .30 (t = 0.99? n = 12? p = >0.3).
Data following treatment is incomplete? but for five Carbi­
mazole treated patients the mean blood lymphocyte count was 267O 
before therapy? and after treatment in three the mean was 217O 
cells per ram^ . In patients treated with radio-iodine the mean 
lymphocyte count before treatment was 2100 cells per mm^? and in 
seven patients after therapy with radio-iodine the mean blood 
lymphocyte count was I9OO cells per mm^. Statistical significance
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was not established for these results but the trend is for the 
blood lymphocyte count to fall following Carbimazole therapy and 
to be unchanged when radio-iodine is the treatment.
3.22 The blood lymphocyte nucleic acid content in lupus erythematosus
The results of the blood lymphocyte nucleic acid analyses in 
lupus erythematosus appear in Table 15.
DNA results.
The mean lymphocyte DNAP content in the eight patients with 
lupus erythematosus was 0,744 )^g DNAP per 10^ cells, identical 
with the average value found in normal individuals.
RNA results,
The mean lymphocyte RNA content in the patients with lupus 
erythematosus was 0.276 jug RNAP per 10^ cells, significantly 
greater than the normal value (p = <0,0l).
Table 15
#11 I I I .  I W M * — " . I  ' #  i > n r t i i |
Lymphocyte nucleic acicL analyses in lupus erythematosus*
Group : mrnoer _  HBAP/BMP
)Jtg per lu cells pg per 10 cells ratio
LUPUS erythematosus 8 ^ea» 0.744 Mean 0.276 Mean 0.3/6
SD 0.113 ‘ SD 0.080 SD 0.102
Normal 3 9 Mean 0.744 Mean U.203 Mean 0.274
SD Ü.142 SD 0.061 SD 0.102
The nucleic acia analyses of the lymphocytes rrom patients with 
lupus erythematosus with results of normal individuals? analysed by the 
same methods, for comparison. Mean values and standard deviations for 
lymphocyte DNA phosphoms, RNA phosphorus, RNAP/DNAP ratio in patient 
and control groups are shown.
Analysis by t-test 
Comparison ^freedora”^ ■  ^ I Probability P
DNAP Normal v lupus erythematosus: 45 0.01 ! >0.0% I .58
*
RNAP Normal v lupus erythematosus 4 5  2.92 <0.01 >0.001 1.72
V lupus erythematosus 4*09 <0.001 I .06
Ur'iAir
Differences are significant.
There were no significant differences in variance in these comparisons 
and the t-test results are valid.
loo
RBAP/dBAP ratio results.
The mean lymphocyte RBAP/d HAP ratio is significantly increased 
in the group of patients with lupus erythematosus when compared 
with the normal control group. The mean ratio of the eight 
patients was 0,376 compared with the control value. This is a 
significant difference (p - < 0,001),
Data on the hlood lymphocyte count was not obtained in these 
patients.
The relationship of the lymphocyte nucleic acid analyses to the 
disease process.
There were eight patients in this study of lupus erythematosus, 
one had the skin manifestations only, four had skin lesions with 
LK cells present in the blood, and three had the systemic form of 
the disease. The lymphocyte RN^.P/DNAP ratio in four patients was 
above the upper limit of normal of 0.40* Of these, three had 
general systemic manifestations of the disease and one had skin 
lesions with L5 cells in the blood,
loi
Treatment of lupus erythematosus and the lymphocyte RNAP/DNAP 
results.
Steroid therapy was being administered to two of the four 
patients with an elevated lymphocyte RNAp/dNAP ratio. One 
patient on no therapy had a lymphocyte RNAp/dNAP ratio of 0,41? 
one patient with a lymphocyte RNAP/DNAP ratio of 0,43 was 
receiving salicylate therapy only. The patient with the highest 
lymphocyte RNAP/dNAP ratio, a value of 0,57? was on steroid 
therapy? but also had undergone thymectomy two years prior to the 
measurement,
3,23 The blood lymphocyte nucleic acid content in infection
The results of the analyses in patients with infection are 
summarised in Table 16,
DNA results.
The mean lymphocyte DNA content for nine patients with 
infection was 0,728 jag DNA phosphorus per 10^ cells? not 
significantly different from normal.
Table 16
Lymphocyte nucleic acicL analyses in viral or bacterial infection*
Group
Infection
Normal
Number
9
3 9
DNAP g i RNAP ^
Jig per 10 cells jxg per 10 ceils,
Mean 0*728 
SD 0*102
Mean 0*744 
SD 0.142
Mean 0,226 
SD 0*050
Mean 0.203 
SD 0.061
RNAP/DNAP
ratio
Mean 0.313 
SD 0.047
Mean 0.274 
SD 0*055
Mean values and standard deviations of the results of lymphocyte 
nucleic acid analyses from patients with infection, either viral or 
bacterial, are listed*
Comparison
Analysis by t-test
Degrees of 
freedom
DNAP Infection v normal 
RNAP Infection v normal 
RNAP/
DNAP infection v normal 
ratio
4 6
46
46
t , Probability
0.32 <0*8 >0*7 
1*02 <0*4 >0*3
2,07 < 0*05 > 0*01
This difference is significant*
There were no significant differences in variance in these
comparisons, validating the t-test*
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RBA results.
The mean lymphocyte RNA content in these patients was 0,266 p g  
RNA phosphorus per 10^ cells, slightly greater than the average 
normal value by this method of 0.203 jug RNAP per 10^ cells but not 
significantly different.
RNAp/DNAP ratio results.
The mean RNAP/DNAP ratio of the patients with infection was 
0.313, significantly greater than the normal mean for the gelatin 
method of 0.274 (p = < 0 ,05), but not significantly different from 
normal when compared with the normal group by all methods,
A comparison of the lymphocyte chemistry between the seven 
patients with bacterial infection and three patients with viral 
infection is hardly justified and mean values for the lymphocyte 
RNAP/dNAP? 0,31 and 0.32 respectively, were similar.
3.24 The blood lymphocyte nucleic acid content and the lymphocyte 
count in neoplasm
The results of the analyses in patients with neoplastic disease 
are summarised in Table 17 which shows values and standard
Table 17
The nucleic acid analyses of blood lymphocytes from patients with 
neoplasm histologically confirmed, with results from normal 
individuals analysed by the same methods for comparison.
Group
Neoplasm
Normal
Number
6
20
DNAP g RNAP g RNAP/DNAP
p.g per 10 cells jag per 10 cells ratio
Mean 0.710 Mean O .298 Mean 0.417
SD 0.113 3D 0.090 SD 0.105
Mean 0.732 
SD 0.114
Mean 0.215 
SD 0.041
Mean 0.295 
SD 0.036
Mean values and standard deviations for the results of lymphocyte 
DNA phosphorus, RNA phosphorus and RNAP/DNA? ratio are shown.
Group
Neoplasm v normal 
DNAP
Analysis by F-test
Degrees of 
freedom
RNAP
ENAP/DNAP ratio
5, 19 
5, 19 
5, 19
P
1.02
4.82
8.54
Probability
N.S.
< 0.01
< 0.001
There are significant differences in variance in some comparisons, 
so the d-test and t-test are required in analysis of the mean values.
Table 1?A
Statistical analysis of results from Table 17
Group Degrees of freedom Probability
Neoplasm v normal
DNAP 5? 19
RNAP 5? 19
RNAP/DNAP ratio 5, 19
0*41 —
3.27 2.19,0*9
4*49 2.80,1.0
■cO.7 >0.6 
*
<0.05
*
< 0.05
*
Significant differences by d-test. The probabilities 
are greater when the less valid t-test is used.
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deviations of the patients and normal results.
DNA results.
The mean DNA content of the lymphocytes in the patients with 
neoplastic disease O.7IO pg DNAP per 10^ cells was slightly lower 
than the value found in normal lymphocytes, but the mean values 
were not significantly different by t-test.
RNA results*
The mean RNA content of the blood lymphocytes in these patients 
was 0.298 p g  RNAP per 10^ cells. There was greater variance in 
the patients' results than the control results and comparison of 
the mean values by the d-test showed the value of O .298 p g  RNAP 
per 10^ cells to be significantly elevated (p = <0,0l).
RN/'P/DNAP results.
Ï.
The mean value for the lymphocyte RNAP/DNAP ratio in the 
patients with neoplastic disease was 0.417 compared with 0.295 in 
the normal group, a significant difference (p - <0,05). This 
value was obtained by the d-test which allows for the difference
lo4
in variance between control and test groups.
The lymphocyte chemistry and the nature of the disease.
In a small group of patients it is not justifiable to 
classify the results by tissue of origin although this information 
is noted for each patient in Appendix 8, It is striking however 
that all four patients with metastatic spread of carcinoma had 
blood lymphocyte RNAP/dNAP ratios above 0,45 a,nd the ratios in the 
two patients with local neoplasm were normal, i.e. 0,26 and 0.31,
The blood lymphocyte count in patients with neoplastic disease.
All but two of the blood lymphocyte counts in the patients 
with neoplastic disease were in the normal range 1500 to 3500 cells 
per mm^. One abnormal count was 1034 cells per mm^ in a patient 
with extensive secondary neoplasm from breast carcinoma. The 
blood lymphocyte RNAP/PNAP ratio in this patient was 0,47. The 
other was 1452 cells per mm^, just at the borderline of normal, in 
a patient with liver secondary neoplasm from carcinoma of colon, 
and associated with a lymphocyte RRAP/MAP ratio of 0,46. The 
mean blood lymphocyte of the group was 2060 cells per mm^.
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3.25 The blood lymphocyte nucleic acid content in miscellaneous 
conditions
The suiiimary of the results of the lymphocyte analyses in 
twenty-two patients divided into fifteen different disease 
categories is listed in Table 18. The individual results are 
drawn up in Appendix 9. The mean DNA content of the lymphocytes 
for the entire group was 0.700 p g  DNAP per 10^ cells, not 
significantly different from the value in normal individuals. 
Analysis of this heterogeneous group would be unprofitable, but 
there are several points of- interest in the results listed in 
Table 13. The highest lymphocyte ENAP/dNAP ratio of the group 
was a value of O.4O in the only patient with acute leucaemia.
This was almost certainly due to the presence of blast cells since 
a very high yield of cells was obtained from this patient's blood. 
Allowing that the analyses were made on groups of one, two, or 
sometimes three patients, it is of interest that high normal 
values for the lymphocyte PNAP/DNAP ratio were found in ulcerative 
colitis and macroglobulinaemia. Normal or low normal ratios were 
recorded in pemphigus, colonic histiocytosis, following typhoid- 
paratyphoid immunisation, acne, osteoporosis, osteomalacia, light 
chain myeloma, and chronic lymphatic leucaemia. Intermediate 
between these, that is with RNAP/DNAP ratios within the normal 
range but slightly above the mean for normal individuals, were the
Table 18
The blood lymphocyte nucleic acid content in a miccellanoous 
series of conditions.
Group
Number
in
group
Mean^DNAP 
per 10 cello
(m s )
MeangHNAP 
per 10 cells
(pg)
Mean EHAP/DNAP
ratio per 
10^ cells
Acute leucaemia 1 0.66 0.26 0.40
Ulcerative colitis 2 0.64 0.23 0.36
Macroglobulinaemia, 1 0.65 0.23 0.36
Crohn's disease 2 0.53 0 .1 9 0.34
Sarcoidosis 1 0.98 0 .32 0.33
Salicylate poisoning 1 0,98 0.28 0.33
Whipple's disease 2 0.58 0 .17 0 .31
Pemphigoid 1 0.74 0.22 0.30
Colonic histio­
cytosis 2 0.57 0.17 0 .29
Acne 1 0 .80 0.23 0 .2 9
Post-TAB
immunisation 3 0.83 0.23 0.2b
Osteoporosis 1 0.71 0 .1 9 0.27
Osteomalacia 1 0.43 0.10 0.24
Light chain myeloma 1 0,57 0.13 0.22
Chronic lymphatic 
leucaemia 3 0,95 0.22 0.22
Mean values for the lymphocyte DNA phosphorus? KNA phosphorus and 
RNA 1/DNAP ratio are shown where there is more than one patient with the 
same condition*
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lymphocytes from patients with Crohn's disease, sarcoidosis, 
salicylate poisoning and Whipple's disease»
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3,26 Discussion
Results obtained in normal individuals*
DNA results#
The value of 0*74 yg DRA phosphorus per million lymphocytes 
found in normal individuals, the mean value obtained by combining 
the results of three cell separation techniques (Table 5)> is 
close to that found by Davidson, Leslie and White (l95l) 0*70 jig 
DRA phosphorus per million cells, and Metais and Mandell (1950)
0*69 DRA phosphorus pe"^  million cells, in their measurements 
on preparations of mixed leucocytes* Although the measurements 
of Davidson et alo (1991) and those described here were carried 
out by different methods it appears that the lymphocyte and the 
polymorphonuclear leucocyte of peripheral blood contain similar 
amounts of DNA* This conclusion is supported by Hale and Wilson 
(1961) who used microdensitometry analyses of blood cells and 
found that the amount of Feulgen stained material (dRA) in the 
mature polymorph is the same as in the small lymphocyte and that 
the leucocyte of the peripheral blood is practically exclusively 
diploid (Hale and Wilson, 1959)• In a later paper Hale (I963) 
found that certain polymorphonuclear leucocytes apparently 
contained less DHA than other human cells, a finding of interest 
in view of the small discrepancy between the results in lymphocytes
108
reported here and previous work on mixed leucocyte preparations.
The important point is that provided the DÎJA content of the 
lymphocyte is constant, variation in the RNA content of the cell 
may he assessed by measuring the RRAP/dRAP ratio of the cell 
preparation thus eliminating cell counting error.
Recently Sakai (1971) determined the mean DNA content of 
normal human lymphocytes by the chemical method described in this 
thesis and published elsewhere (Glen, I967). Although his cell 
separation technique was slightly different, he obtained a value 
of 0,71 /Ag per 10^ cells for the mean DNAP content of the 
lymphocytes.
The DNA content observed in the lymphocytes is a]so in accord 
with the values in the literature for the mean DNA content in 
other human cells (Leslie, 1955). For cells regarded as 
predominately diploid, e,g. brain and kidney cells, the values are
0.68 jag and 0,83 pg DNAP per 10^ cells respectively* A 
proportion of liver cells are polyploid and in this tissue the mean 
cell DNA content is slightly higher, 1,00 ^  DNAP per 10^ cells.
In the light of these values and the mean DNAP content found in 
the lymphocytes, 0,74 pg DNAP per 10^ cells, it is reasonable to 
accept that the majority of normal blood lymphocytes are diploid 
cells.
When lymphocytes are separated from blood by methods differing 
in principle, gelatin sedimentation methods and the silicone oil 
technique, the mean values for the DNA content and RNA content and
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the calculated RNAP/dNAP ratio of the lymphocytes obtained from 
normal blood are similar in each case (Table 5)» Ideally, the 
same blood sample should have been analysed by all three methods, 
but practical difficulties of running the methods simultaneously 
prevented this. The similarity of the chemical analyses of 
lymphocytes by the three methods is evidence that the cells 
isolated from blood are representative of the circulating 
lymphocytes. This point has to be considered since the yields of 
cells obtained in the separation are low (Table l). In the 
gelatin and cotton wool method, the method adopted for most of 
the work presented, losses of lymphocytes occur when red cells are 
removed by sedimentation and some lymphocytes are trapped in the 
cotton wool. It is possible that differential losses of either 
large or small lymphocytes could occur during lymphocyte isolation 
in pathological conditions, but the results reported in Section 3.13 
would counter this belief since there is an acceptable correlation 
between the RNAP/DNAP ratio of the isolated cells measured 
chemically and the mean diameter of the lymphocytes measured on a 
peripheral blood smear. There is evidence that thymus independent 
lymphocytes may be relatively more adherent to glass, and 
presumably cotton wool, than thymus dependent cells (Davies, 1969)* 
Somewhat surprisingly, the mean lymphocyte RNAP/dNAP ratio of 
normal lymphocytes is marginally but significantly greater when 
the cells are isolated in the presence rather than the absence of 
cotton wool, A probable explanation for this is the removal of
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residual polymorphonuclear leucocytes (which have a low RNA content) 
by the exposure to cotton wool.
Although no important differences between methods for the 
lymphocyte nucleic acid measurements have been shown, the ranges 
observed in normal individuals differ slightly and it has been the 
practice to compare results in pathology with a normal series 
appropriate to the method of cell separation.
RNA results and the RNAP/DNAP ratio results in normal individuals.
The mean value for the-RNA phosphorus per 10^ cells in the 
series of normal results was 0.210 jig with a standard deviation of
0.054 for sixty individuals studied. These were the combined 
results obtained by the three methods of cell separation reported 
individually and in combined form in Table 5*
The calculated mean RNAP/DNAP ratio for the sixty normal 
individuals was O .284 with a standard deviation of 0.055. These 
values are lower than these obtained by Davidson et al.(l95l) who 
found a mean RNA phosphorus of 0.24 pg per million cells which 
gave a value for the RNAP/dNAP ratio of 0.35 ” O.I6 . Although
A
the measurements of Davidson et al, were carried out on cell 
preparations containing both lymphocytes and polymorphs and could 
be expected to give different results, the analytical methods used 
are also important. Davidson et al* (1951) estimated RNA by
Ill
measuring the total phosphorus content of the Schmidt Thannhauser 
RNA fraction. There is evidence that this fraction contains 
significant amounts of organic phosphorus compounds other than 
ribonucleotides. Davidson and Smellie (1932) investigated this 
point, although not specifically in leucocytes, and found that 
20 to 23 per cent of the phosphorus in the fraction from rat liver 
was other than ribonucleotide phosphorus while in rabbit spleen 
(Davidson, Fraser and Hutchison, 1951) the figure was 10 to I5 per 
cent. In order to arrive at absolute values and to compare the 
results in lymphocytes reported here with the leucocyte 
measurements of Davidson, Leslie and White (l95l)> it should be 
noted that the method described here for the analysis of RNA gives 
an 86 per cent recovery. If an allowance is made for the less 
than one hundred per cent recovery in the present ultra-violet 
measurements (add I4 per cent), and the error due to the likely 
presence of non-ribonuc^eotide phosphorus in the measurements of 
Davidson et al, (subtract 12 per cent), the content of RNA 
phosphorus is similar in normal lymphocytes and leucocytes, being 
close to 0.24 jag per million cells for the present measurements 
and 0,21 for these of Davidson et al,. When the corrections are 
applied to the RNA values and the RNAP/dNAP ratio calculated from 
them, the results are 0,32 and 0.31 for the present observation 
and those of Davidson et al, respectively. These are low values 
for the RNAP/dNAP ratio when compared with other tissues, e.g. 
liver with an HNAP/dNAP of 2,48 (Leslie, 1955)? similarly low
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values have been reported from leucocytes, thymus and lymphoid 
tissues in animals (Leslie, 1955).
In the determinations of lymphocyte nucleic acid, no advantage 
is to be had from making the small corrections arising from the less 
than one hundred per cent recovery and no such corrections were 
made.
Individual differences in the lymphocyte RMAP/dNAP ratio 
observed in the normal subjects are unexplained although each was 
questioned about recent illnesses, allergies and immunisations.
Some of this data is included in Appendices 1 and 2,
The inconclusive findings in relation to age effect in the 
result of the R M P / dITA'P dcGerminations in lymphocytes from normal 
individuals requires little further comment. Although the data 
pointed to the possibility that the lymphocyte RNAP/dNAP in age 
group thirty years to thirty-nine years was higher than in the 
preceding decade or in the decade fifty years to fifty-nine years, 
for the reasons stated in Section 3*7 this is uncertain.
Functional differences in the lymphocytes which appear to be age 
related have been reported, Pisciotta, Westring, Deprey and 
Walsh (1967) observed that the in vitro response to phytohaem- 
agglutinin in lymphocytes decreased as the age of donor of the calls 
increased. Curiously, their data show an impoverished response 
of the blood lymphocytes to the mitogen when the donor of the 
cells was in the age group thirty years to forty years.
Serial measurements of the lymphocytes in two individuals
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(Section 3.8) illustrate the advantage to be had from measuring 
the lymphocyte RNAP/DNAP ratio rather than relating the nucleic 
acid measurement to a cell count. The coefficient of variation 
of twelve results from one individual over a period of fourteen 
months were as follows: for DNAP per 10^ cells, 18 per cent ;
for RNAP per 10^ cells, 24 par cent; for the RNAP/dNAP ratio,
16 per cent. The coefficient of variation of the RNAP/dNAP ratio 
results of this individual (l6 per cent) was less than coefficient 
of variation of single analyses from forty normal individuals by 
the same method (20 per cent).
The frequency distributions of the measurements, DNA phosphorus
6 6 
per 10 cells and RNAP per 10 cells, are demonstrably skewed with
an excess of individuals in whom the calculated DNAP content and
RNAP content of the lymphocytes is higher than the mode (Figurée 5 ),
These findings are thought to be evidence that the error of cell
counting has not been a completely random one probably because cell
clumping has occurred during the isolation procedure resulting in
8,n underestimate of the number of lymphocytes in the suspension.
The contrasting normal distribution of the RNAP/dNAP ratios,
calculated from the same results, has confirmed that the likely
cause of the skewed distribution is cell counting error. Other
authors (Rigas, Duerst, Jump and Osgood, 1958) have found a normal
distribution of the results of DNA phosphorus and RNA phosphorus
per'10^ cells in analyses of cells from patients with chronic
lymphatic leucaemia.
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From the evidence presented in Section 3,8 it is apparent 
that the lymphocyte RNAP/dNAP ratio changes only gradually over 
periods of some days, at least in normal individuals. Considerable 
day to day variation in apparent DNAP and RNAP content of the 
lymphocytes can therefore be attributed to the cell counting 
errors and would confirm the value of the RNAP/dNAP ratio in 
assessing the circulating lymphocytes.
Similar results for the lymphocyte nucleic acid content have 
been recorded in males and females so the theoretical sex difference 
in the DNA content of the lymphocytes resulting from the different 
sex chromosome has not been observed.
Results in Pathology,
DNA. results.
Table 19 provides a list of the values found for the mean
lymphocyte DNA content in the pathological conditions studied in
this section as well as the values found in normal individuals,
131With the single exception of I treated patients none of the 
mean values in the pathological conditions is significantly 
different from the normal, indeed the mean values are remarkably 
similar. This observation is a notable one since even in 
conditions where there is increased immunological activity there 
is no significant change in the average DNA content of the blood
Table 19
The mean D M  content of the blood lymphocytes summarised from a
series of studies on patient and normal groups.
Group
Number
in
group
Mean lymphocyte DNAP 
/ig per lu^ cells
S .1 pgren ' s syndrome 8 0,76
Rheumatoid arthritis 39 0.74
Lupus erythematosus 8 0.74
Normal, combined 
results
60 0,74
Thyrotoxicosis 34 0,74
Sicca syndrome 8 0,74
Infection 9 0,73
Neoplasm 6 0,71
The mean values of the lymphocyte D M  phosphorus are corrected to
two significant figures. None is significantly different from normal.
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lymphocytes. It is possible that a more sensitive procedure 
might show such a change since a small proportion, less than one 
per cent, of large lymphocytes from human peripheral blood will 
incorporate tritiated thymidine into their nuclei (Bond, Cronkite, 
Fliedner and Schork, 1958). Small lymphocytes do not incorporate 
labelled DNA precursors, and these cells appear to become labelled 
only as a result of division of already tagged cells. Cooper and 
Firkin (1965) were able to demonstrate DNA synthesis in peripheral 
blood mononuclear cells of three patients with rheumatoid arthritis, 
but once again the percentage of mononuclear cells actively 
synthesising DNA was low, less than 0,25 per cent had measurable 
tritiated thymidine uptake by auto-radiography.
Present understanding of the DNA synthesis cycle in mammalian 
cells indicates that dividing cells are in a hyperdiploid state 
during the period of DNA synthesis and for the period thereafter 
known as the phase. Measurements for example by Lajtha,
Oliver a,nd Ellis (1954) in mouse L cells revealed that these two 
periods can make up half of the generation time. Where the 
proportion of lymphocytes in the blood that are actively dividing, 
is sufficiently great it may be possible to detect an increase in 
the mean cell DNA content, Lesiewska (I967) was able to show a 
small increase in the DNA content of the blood lymphocytes in some 
children with virus infections and the evidence was that this was 
due to the presence of a proportion of hyperdiploid cells. The 
present restricted study of virus and bacterial infection did not
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however reveal an alteration in the blood lymphocyte DNA content. 
In the next section it will be shown that the lymphocytes 
from patients with a renal allograft on therapy with azathioprine 
and prednisolone have a mean lymphocyte DNA phosphorus content 
slightly but significantly greater than normal. These patients 
are of course subject to considerable immunological stimuli and 
it is possible that active DNA synthesis has contributed to the 
increase in mean lymphocyte DNA content. The only other group 
which shows a significant increase in the lymphocyte DNAP content 
is the group of patients rendered euthyroid by radio-iodine 
therapy. No definite explanation can be given for this last 
finding although a tentative one might be the direct effect of 
radiation damage on the lymphocytes. Tissue culture experiments 
with mouse L cells (Whitmore, Stunners, Till and Gulyas, 1981) 
have shown that substantial irradiation (2000 r) allows 
continued DNA synthesis without division so that the average DNA 
content per cell reaches three or four times the diploid value. 
This effect might be operative at a much lower radiation level 
in radio-sensitive lymphocytes.
The possibility that failure of the system of immunological 
surveillance occurred in advanced neoplastic disease has been 
introduced. In this context the observation that in patients 
with neoplastic disease the mean lymphocyte DNA content is low 
although not significantly less than normal, may be relevant and 
could point to a reduced DNA turnover in these cells. This is
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of course the converse of the argument which suggests that an 
elevated DNA content points to an increase in the proportion of 
cells which are synthesising DNA, If the two other conditions in 
which there may he immunologic deficiency are considered together,
i.e. Whipple's disease and colonic histiocytosis, the mean 
lymphocyte DNA content for the four patients is 0*572 Jig DNAP per 
10^ cells. This value is significantly lower than control values 
at the five per cent level. Because of this low mean value and 
repeated low values found in one patient with Whipple's disease 
who attended regularly for routine clinical surveillance, 
chromosome analysis of the lymphocytes was carried out. Normal 
male karyotype was found with no evidence of a hypodiploid line; 
however, one member of the D- group chromosomes had a deleted short 
arm. Expert opinion (Ferguson-Smith, 1970) was that this was a 
possible rare normal variant. To date it has not been possible 
to test for this abnormality in other patients with Whipple's 
disease.
RNA and RNA/dNA ratio results
Rheumatoid arthritis.
The data on the RNAP content lymphocytes, supported by the 
calculated ratio RNAP/DNAP of the cells, is regarded as
Table 20
mean RN^P/DNAP ratio of the blood lymphocytes
of studies In patient and normal groups.
Condition Number in 
group
!
Mean
RKAp/dHAP
Neoplasm 6
*
0,42
Lupus erythematosus 8 0,38
Sjogren’s syndrome 8
*
0.37
Rheumatoid arrhritis 39 0,35
Sicca syndrome 8 0.33
Thyrotoxicosis 34 0.32
Infection 9 0.31
Normal 60 0.27
The mean values for the ratio of lymphocyte RNA phosphorus to 
DNA phosphorus are corrected to two significant figures# The values 
marked with an asterisk are mean values significantly greater than the 
normal.
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unequivocal evidence that the average RNA content of the blood 
lymphocytes in patients with rheumatoid arthritis is increased. 
Although twenty-three out of thirty-five patients had lymphocyte 
RNAp/dNAP levels within the two standard deviation normal range, 
in only one patient (a patient with sero-negative probable 
rheumatoid arthritis) was the mean lymphocyte RNAP/mAP ratio 
below 0 ,27, the mean for normal individuals. Backing for the 
reality of these changes comes from the correlation of the RBAP/ 
DNAP ratio and cell diameter measurements in Section 3»13. This 
is evidence that there are alterations to the peripheral blood and 
that an artefact of the cell separation procedure has not produced 
the abnormal ratios.
The work of Leventhal, Waldorf and Talal (I967) has suggested 
that depressed lymphocyte function is a feature of rheumatoid 
arthritis. More specifically, these authors, in their study of 
classical rheumatoid arthritis, found that the lymphocytes from 
eight out of seventeen patients (47 pci' cent) gave an abnormal 
in vitro transformation response to either phytohaemagglutinin or 
streptolysin 0, In the present results, eleven out of twenty- 
four patients with definite rheumatoid arthritis (46 per cent) 
had lymphocytes with an abnormal mean RNAP/dNAP ratio. It' is not 
of course legitimate to link the functional and chemical 
abnormalities in two independent series of patients but their 
frequencies are remarkably in accord.
It is difficult to be certain that drug treatment has not
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influenced the result of the analyses. Patients on no therapy 
are the group with the lowest average lymphocyte RNAP/dNAP in 
Table 10 where different therapeutic regimes are compared.
However, the untreated group tend to have less active disease than 
those on salicylates or steroids, but even so the patients not on 
treatment have a mean RNAP/DHAP ratio significantly greater than 
normal. Also convincing is the high level of the lymphocyte 
RNAP/dNAP in patients on salicylate therapy alone. Salicylates 
are not known to have any direct action on the lymphocyte nucleic 
acids although the site of action may be interference with the 
supply of ATP to the cell. The anti-inflammatory action of the 
drug is not understood (Smith, 1959)# An immunosuppressive 
action is only apparent at very high dosages (jager and Nickerson, 
1947) and it is worth recording that nucleic acid measurements 
carried out on a patient with salicylate overdosage were within 
normal limits. Steroids might be expected to raise the average 
RNAP/DNAP of the lymphocytes initially by virtue of their cytolytic 
action on the smaller cells and data to be presented in the study 
of renal transplantation confirms this, at least for the high 
dose levels of prednisone which are necessary for initiation of 
immunosuppression. Evidence that lymphocytolysis continues on 
the more usual maintenance dosages is lacking. In the small 
study reported in Section 3.12 no changes occurred in the blood 
lymphocyte RNAP/dNAP ratio as therapy with 20 mg per day of 
prednisone was started.
120
The action of steroids on human lymphocyte nucleic acid 
metabolism is a dose related inhibition of DNA and RNA synthesis 
(Tormey et al. I967), and since active DNA synthesis is very 
limited in blood lymphocytes, a fall in the RNAP/dNAP ratio could 
therefore result in long-term therapy. For three reasons then, 
the abnormalities in untreated patients, the absence of an effect 
on the lymphocytes of high salicylate dosage, and the observed 
as well as the theoretical effects of moderate levels of steroid 
dosage, it is considered unlikely that the abnormalities 
demonstrated in the lymphocyte RNA/DNA ratio are the result of 
drugs alone.
It is concluded that the average RNAP/DNAP ratio of the 
lymphocytes is increased in rheumatoid arthritis as part of the 
disease process or the reaction to it, and this implies that there 
is an increase, either absolute or relative, in the number of the 
larger lymphocytes circulating in the blood in these patients.
The observations of Papamichail, Brown and Holborow (I971) referred 
to earlier, that the percentage of IgG bearing lymphocytes in the 
peripheral blood, regarded as B-lymphocytes, is twice the normal 
in patients with definite active rheumatoid arthritis, are relevant. 
B-lymphocytes may carry more RNA than T-lymphooytes; an increase 
in the proportion of the fo'rmer could account for the impaired 
phytohaemagglutinin response of the blood lymphocytes and the 
altered RNAP/DNAP ratio. Atypical mononuclear cells of the type 
described by Crowther et al*(I969) may be contributing to the
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elevated M A P / dNAP ratio, and could be of the B-lymphocyte line.
No correlation has been found between the lymphocyte count and the 
RNAP/dNAP ratio of the cells and it has not been possible to 
distinguish between an absolute or relative increase in the number 
of larger cells.
Sicca syndrome and Sjogren's syndrome.
Knowledge of the mean lymphocyte DNA content in sicca syndrome 
and Sjdgren's syndrome allows use of the lymphocyte RNAP/DNAP ratio 
of the cells as a measure of their RNA content.
A positive answer has been obtained to the first of the two 
questions posed in the introduction; abnormalities of the 
lymphocytes have been demonstrated in Sjdgren's syndrome but are 
only rarely present in patients with sicca syndrome. Tt appears 
unlikely that this difference has resulted from drug therapy.
Information on the second question, that of a difference of 
degree of abnormality between sicca syndrome and Sjogren's syndrome, 
is contained in the statistical comparison of each condition with 
control values (Table 11). Sjôgren's syndrome shows a 
significantly elevated lymphocyte RNAP/DNAP ratio while sicca 
syndrome does not. Comparison between two conditions, one showing 
marked abnormality in circulating antibodies and the other 
combining abnormal circulating antibodies with the presence of a
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collagen disease, is of theoretical interest and a. table has been 
prepared (Table 21) which compares data of the present study with 
that from a similar group of patients in the U.S.A.
Three disease categories are included in the table, sicca 
syndrome, sicca syndrome with rheumatoid arthritis (SjOgren's 
syndrome), and rheumatoid arthritis without sicca syndrome. The 
present results on the mean blood lymphocyte RNAP/DNAP ratio are 
compared with the published data of Leventhal, Waldorf and Talal 
(1967) on the vitro response of the blood lymphocytes to 
phytohaemagglutinin as well as streptolysin 0 measured by per cent 
transformation. Also tabulated are the results by these authors 
of the skin hypersensitivity response to dinitrochlorobenzene 
(DNCB), failure of the patient to become sensitized to the chemical 
after skin application is recorded as an abnormal response. The 
disease categories in the study by Leventhal and her group were 
defined in the same way as has been followed in the study of 
lymphocyte nucleic acids, except that classical rheumatoid 
arthritis is required for inclusion in the rheumatoid arthritis 
group in the American study. Patients with probable and definite 
rheumatoid arthritis were included in the group studied by 
lymphocyte nucleic acid determination. Patients in this last 
group numbered twenty-three and were drawn from the previous study 
on rheumatoid arthritis.
All of the tests show uneven distribution of abnormality 
between the three patient groups. Abnormalities are most frequent
' Table 21
The frequency of abnormal findings in sicca syndrome, Sjogren's 
syndrome and uncomplicated rheumatoid arthritis, comparing lymphocyte 
nucleic acid analyses with published results for in vitro transformation 
studies and skin sensitivity tests (Leventhal et ah, 1907),
Test
Lymphocyte
m :a p/bh a p
PHA response
Streptolysin ü 
response
Sicca Sjogren's Rheumatoid 1 Normal
syndrome syndrome arthritis Individuali
Number of tests 8 8 "23 ! 59
Number abnormal 2 4 6 ! 0
per cent abnormal 25 50 26 0
Number of tests 13 12 IT 20
Number abnormal 4 9 4 ' Ü
Per cent abnormal 31 75 24 L. « .
Number of tests 13 12 17
!
1 20
Number abnormal 4 8 8 i 2
Per cent abnormal 31 67 47 ! ^ 0
Number of tests 9 9 15 ! 17
Number abnormal 4 Ü 5 : 1
Per cent abnormal 45 09 33 ; 6
BNGB skin 
sensitivity
The frequency of abnormal tests in the present lymphocyte analyses 
is compared with the frequency with which the in vitro response to tho 
two mitogens phytohaemagglutinin and Streptolysin 0 are abnormal and the 
frequency of failure to become sensitised to skin application of dinitro- 
chlo ro benzene•
#This group is limited, to patients without any of the features which 
suggest sicca syndrome or Sjogren's syndrome.
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in patients with Sjogren's syndrome and are at a lower frequency 
in both sicoa syndrome and uncomplicated rheumatoid arthritis.
This observation held for the results obtained in the present 
series of patients, so in addition to the functional abnormality 
of the lymphocyte pointed out by the American study, there would 
appear to be a greater proportion of lymphocytes with a high RNA 
content in Sjbgren's syndrome than in uncomplicated rheumatoid 
arthritis or sicca syndrome. This was not statistically
significant however by the test nor were the mean values
significantly different on intercomparisons by t-test. Some 
tests show more abnormalities than others, thus the failure of 
DNCB to sensitise skin was the most frequent of the abnormalities, 
although it should be noted that some control individuals responded 
abnormally to the test. The mean lymphocyte RMP/jJNAP ratio of 
the blood lymphocytes was the test with the lowest frequency of 
abnormal results, but a direct comparison cannot be made with the 
other tests since different patients were studied. None the less, 
when account is taken of the percentage of abnormalities in the 
control group^ the freouencies of abnormal responses to streptolysin 0 
and to PHA are of the same order as the percentage abnormalities of 
lymphocyte chemistry.
Some authors consider that the vitro transformation response 
measures the potential effectiveness of both cellular and antibody 
response (Benezra, Grey and Davies, 1989) and the conventional 
view now is that the ability of lymphocytes to respond to the non­
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specific stimuli of PHA and perhaps to streptolysin 0 relates to 
the functional capacity of the T-lymphocytes. Leventhal's group 
found a poor correlation between a failure of DITCB to sensitize 
the skin and an abnormal in vitro response of the patients* 
lymphocytes to the mitogens. Their suggestion that the two 
tests might be measuring different parameters of lymphocyte 
function is not in line with the conventional view. However, 
other investigators have found a good correlation between failure 
of skin sensitization and an impaired PHA transformation response 
in other diseases, for example primary biliary cirrhosis (Fox, 
James, Scheur, Sharma and Sherlock, I969). On the present 
information it is reasonable to accept normal skin sensitization 
specifically and a normal lymphocyte phytohaemagglutinin response 
less specifically, as measures of the integrity of the delayed 
hypersensitivity response.
To the acknowledged presence of impaired lymphocyte function 
in Sjogren's syndrome, the present contribution has been to 
demonstrate that there is an abnormal lymphocyte constitution in 
this disease. Once again it is not possible to decide whether an 
excess of large lymphocytes, possible B-lymphocyte or a relative 
or absolute deficiency of T-lymphocytes, are directly related to 
the abnormal mean lymphocyte RNAP/DHAP ratio in the disease.
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Thyrotoxicosis.
The finding that thyrotoxic patients whose sera were positive 
in the LATS hio-assay had statistically significant chemical 
abnormality in their blood lymphocytes, is confirmation of 
Hernberg's observation (1954) of morphological abnormality of the 
lymphocytes in thyrotoxicosis. That the difference was not 
significant when all the untreated thyrotoxic patients were 
Included in the comparison with normal control subjects is an 
indication that the changes in the lymphocytes are small. In the 
present measurements, including all the thyrotoxic patients, the 
mean lymphocyte RNAP/DNAP ratio was increased by an average of 
7.5 per cent over normal control values. The results recorded 
by Hernberg for the mean cell diameter of normal lymphocytes 
(11 ,70 microns) and for the mean cell diameter of thyrotoxic 
lymphocytes (12,42 microns) differ by 6,2 per cent. Hernberg's 
data was presented graphically and a statistical analysis was not 
carried out. Geometric consideration might suggest that the cube 
or square of the cell diameter would be the important value, but 
the similarity of the magnitude of abnormality between the cell 
diameter measurements and the chemical analysis is in accord with 
the correlation between lymphocyte diameter measurements and the 
mean cell RN/p/dNAP ratio established in the section on rheumatoid 
arthritis (Section 3,13), That the absolute values for blood 
lymphocyte diameters recorded in Section 3.13 are lower than
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Hernberg's observations is of little consequence since the actual 
diameter depends on the method of preparation and staining of the 
blood film.
Close examination of the data from De Groot and Jaksina (1969), 
that is their comparison of the phytohaemagglutinin response of 
lymphocytes from thyrotoxic patients and normal lymphocytes, shows 
a trend towards an increased radioactive thymidine uptake by 
lymphocytes from patients with thyrotoxicosis on exposure of the 
cells to mitogen. Once again the differences between patients' 
values and control values were small; the average percentage 
uptake of label was 1.38 for control lymphocytes and 2,07 for 
lymphocytes from thyrotoxic patients, and this difference of the 
means did not reach statistical significance.
The possibility of an abnormality in the lymphocytes in some 
patients with thyrotoxicosis is an expected finding since, as was 
outlined in the introduction, there is evidence of immunological 
abnormality in the disease. The total lymphocyte counts observed 
in the untreated thyrotoxic patients in the present study are in 
the middle of the accepted range for blood lymphocyte numbers,
i.e. 1500 to 3500 cells per cubic mm, and once again the likely 
explanation of the elevated RHAP/DHAP ratio found in the lymphocytes 
from thyrotoxic patients is'an increased proportion of the larger 
cells in the blood. Perhaps here there is only a small increased 
proportion of circulating B~lymphocytes, a possibility which is 
supported by the finding of De Groot and Jaksina and by the present
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observations on patients with sera positive in the bio-assay for
the immunoglobulin LATS,
The data presented in Table I4 and in Section 3.20 suggests
that the abnormality of the lymphocytes is intensified following
radio-iodine therapy; the mean lymphocyte RlTAP/ûNAP ratio tends
to increase although not significantly over the pre-treatment
value, while the lymphocyte count is unchanged. Release of
antigen by the radiation damaged thyroid gland could be the
explanation of an intensified immunological reaction following
radio-iodine therapy. Thus, Sinhorn, Fagraeus and Johnsson (I965)
showed that antibodies to cytoplasmic antigens but not to thyro-
globulin were more frequently found in patients afne^ treatment
131for liyperthyroidism with I than before treatment. This rise
in the number of patients with antibody was temporary and most
marked in the first year following treatment. It is established
that the likely cause of post-irradiation hypothyroidism following 
131I therapy in thyrotoxicosis is damage to thyroid cell nuclei 
which renders the cell incapable of division so that cell 
replacement is halted and the number of active cells decreases 
(Greig, 1966), It also remains possible in view of the antibody 
studies and the present results, that the immunological disease 
may continue after the hoi’monal disorder has been corrected.
The data following surgical treatment is limited in the 
present study, but once again there appears to be evidence of 
greater abnormality of the lymphocytes after therapy than before
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it. Of interest here are the observations that the tendency for 
patients thus treated to become myxoedematous is correlated with 
the degree of lymphocytic infiltration of the gland (Whitesell and 
Black, 1949) and with the presence of thyroid antibodies in the 
serum (Buchanan, Koutras, Crooks, Alexander, Brass, Anderson,
Goudie and Gray, I962),
The possible effect of the antithyroid drug Carbimazole 
requires consideration in view of the results in Table 14» Once 
again the lymphocytes in drug treated patients show an elevated 
RNAP/dNAP ratio. In this case there may be an associated 
reduction in lymphocyte count (Section 3.2l) although the point 
is uncertain in view of the very limited data. An extra-thyroidal 
action of thiouracil drugs has been postulated previously. Borell 
and Holmgren (1948) demonstrated a decrease of oxygen uptake of 
thyroidectomised rat tissues on exposure to met^iylthiouracil, but 
this was not confirmed in rat kidney slices (Braverman and Ingbar, 
1962). It is of considerable interest that a study of the thymus 
in thyroid disease carried out in 1967 (Michie, Beck, Mahaffy, 
Honein and Fowler) revealed that tlpymic atrophy occurred following 
treatment of patients with thyrotoxicosis with antithyroid drugs. 
The implied repression of thymic dependent lymphocytes offers an 
explanation for the significant elevation of the lymphocyte RHAP/ 
BNAP in patients on this form of therapy.
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Lupus erythematosus.
It is clear from the introductory review of the pathogenesis 
of lupus erythematosus that circulating antibody and resultant 
immune complex formation are of paramount importance in the disease 
process. The significant elevation of the blood lymphocyte RITAP/ 
BHAP ratio recorded in Section 3.22 indicates that the circulating 
lymphocytes may be distinctly abnormal, four of the eight patients 
had a ratio above the normal range. Since the principal 
immunological abnormality is of antibody formation, once again the 
possibility of an increased proportion of circulating B-lymphocytes 
has to be considered. It is possible that these are present as 
atypical mononuclear cells or, less likely, plasma cells in the 
peripheral blood. The possibility has not been tested in the 
present study, but descriptions of the disease do not include 
reference to this type of abnormal cell in the blood,
A single report of the response of the lymphocytes to 
phytohaemagglutinin has appeared in the literature, a study of 
fourteen patients with systemic lupus erythematosus (patrucco, 
Rothfield and Hirschhorn, 1967). The measurements of the blast 
cell response to the mitogen were not significantly different from 
normal although the mean response wa,s slightly impaired and there 
was a blast response to native BNA, This evidence might suggest 
that the tliymic dependent cell function is normal in systemic 
lupus erythematosus. The method of assessment of lymphocyte
13o
transformation used by these authors was measurement of percentage 
transformed cells and their data less conclusive since their 
measurements on lymphocytes from patients with rheumatoid 
arthritis were also within the range of normal.
Infection,
The mean MAP/hhAP ratio of the blood lymphocytes recorded 
for the patients with infection is less markedly elevated than 
that observed in conditions such as neoplasm, systemic lupus 
erythematosus, Sjogren's syndrome and rheumatoid arthritis 
(Table 20) although the ratio is just significantly greater in 
patients with infection than in normal individuals. The data 
support observations of altered morphology of the lymphocytes in 
infection which have been outlined in the introduction. The 
group of patients with infection show a relatively minor 
abnormality of their lymphocytes, of interest since in uncomplicated 
and acute infection the response of the host is mainly directed 
to antibody formation, Germinal centre formation and the 
appearance of plasma cells at cortico-medullary junction and 
medullary cords of the lymph nodes are the specific features of 
humoral antibody formation (Turk, 196?) the development of which 
(although not the initiation) is a function of the thymus 
independent B-lymphocytes. The demonstration of atypical mono­
131
nuclear cells in the blood detailed earlier is a well recognised 
feature of this response. The present results have shown that 
the measurement of lymphocyte RhAP/bNAP ratio is sufficiently 
sensitive to show up alterations to the blood lymphocytes in 
patients with infection although the timing of the blood sampling 
has not been optimum.
Neoplasm.
The group of patients with neoplasm heads the list of patient 
groups drawn up in Table ’RO-, as the condition with the most marked 
chemical abnormality of the lymphocytes. Inspection of the 
individual results in Appendix 8 shows that the RNAP/bNAP ratio 
results recorded in patients with carcinoma associated with 
secondary spread, up to 0,5 1? are the highest values recorded in 
the entire study. The only comparable values were found during 
rejection of renal allografts and will be reported in Section 4*
In their review of tumour immunology, Meuwissen, Stutman and Good 
(1969) are strongly of the belief that tumour destruction is a 
cell mediated immune reaction. Their evidence is extensive, 
based mainly on experimental tumour transplantation work although 
backed by the circumstantial evidence of the association of 
immunological deficiency, either natural or iatrogenic, with an 
increased incidence of malignancy in man.
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Meuwissen et al.(I969) have drawn attention to oases in which 
a tumour was accidently transplanted in man during allograft trans­
plantation to become widely disseminated during immunosuppressive 
therapy, only to regress again when immunosuppressive therapy was 
withdrawn (Wilson, Hagar, Hampers, Corson, Merril and Murray, I968), 
The observation that the only two patients with localised carcinoma 
in the study had near normal lymphocyte chemistry raises the 
question whether the abnormality of the lymphocytes arises as a 
result of the tumour or whether a deficiency of immunocompetent 
T-lymphocytes is the prelude to metastatic tumour spread. The 
small study of the lymphocytes in malignancy presented here was not 
intended to answer this question, however, within the limits set 
by the measurement of average cell nuclei acid content, the 
lymphocytes are near normal in the presence of neoplasm without 
metastatic spread and are grossly abnormal when metastatic spread 
has occurred. Further, the presence of metastatic spread may be 
associated with a low blood lymphocyte count.
The evidence that the phytohaemagglutinin response is impaired 
in malignancy has been documented in the introduction, an 
indication of functional impairment of thymus dependent cells.
The present results show unequivocal elevation of the RNAP/dNAP 
ratio of the circulating lymphocytes in the presence of metastatic 
neoplasm. If it is the case that T-lymphocyte depletion accounts 
for these results this would have important implications for the 
effectiveness of immunosurveillance mechanisms.
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Miscellaneous group.
Diseases in the miscellaneous group were not analysed 
individually because of the limited numbers of patients with any 
one disease. However, the results recorded in full in Appendix ^  
do provide an essential background for interpretation of other 
studies. The results will be taken in descending order for the 
ratio RNAP/dNAP, the order listed in Table 18, allowing brief 
comment on each condition.
The lymphocyte nucleic acid content in acute leucaemia has not 
been extensively measured either previously or here, but the single 
value of 0,40 for the RHAp/dNAP ratio in the table is in keeping 
with the findings of Rigas et al, (1956). The range of RNAp/dNAP 
ratio found by Rigas and colleagues was 0,46 to 0,40 in four 
analyses in patients with acute leucaemia, values well above those 
anticipated in normal lymphocytes and appropriate to the 
morphologic appearance of the blast cells of the blood in acute 
leucaemia.
The average RNAP/DNAP ratio of the lymphocytes from the two 
patients with ulcerative colitis, 0,36, is above the average value 
for normal individuals. Whether this is an indication of 
abnormality in the lymphocytes is uncertain, and further study of 
this condition might reveal a significant abnormality. Similar 
comments apply to the results found in the very limited studies of 
macroglobulinaemia, sarcoidosis and Crohn*s disease. The only 
RNAP/DNAP results slightly above the mean for normal individuals
134
and lacking a known or suspected abnormality of immunity, is the 
single result from a patient with salicylate overdosage. Change 
in the blood lymphocytes induced by stress could account for this 
result since the overdosage was self-administered, and an increase 
in the size of the circulating lymphocytes may be associated with 
stress in man (Franlc and Dougherty, 1953)*
Interest in the results in Whipple's disease centre on the 
DNA measurements and these have been discussed. The values for 
the RNAP/dNAP ratio in patients with pemphigoid, colonic histio­
cytosis, acne, osteoporosis, osteomalacia, and one week after 
typhoid and paratyphoid immunisation, are close to the results in 
normals. This last observation is of interest since minor changes 
in the morphology of the blood lymphocytes have been reported 
following such immunisations (Crowther, Hamilton, Fairley and 
Sewell, 1969)* The changes appear to affect only a small 
proportion of the circulating lymphocytes, atypical cells 
constituting at most five per cent of the lymphoid cells in the 
study of Crowther et al.(1969)*
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Measurement of DNA and RNA in Human 
Peripheral Blood Lymphocytes
A .  C. A. .Glen*
A method is described, modified from a published technic, for obtaining lymphocytes 
from human peripheral blood. The cell preparations containing greater than 90%  
lymphocytes were analyzed for their DNA and RNA content, using a modified Schmidt- 
Thannhauser procedure. The peripheral blood lymphocytes of 40 normal adults were  
examined, and normal values established for the 2 compounds. The mean lymphocyte 
DNA was 0.73 p.g DNA phosphorus per million cells, and the mean lymphocyte RNA 
was 0.19 [ig RNA phosphorus per million cells. These values are consistent v/ith re­
sults published for human leukocytes. The ratio RNA phosphorus :DNA phosphorus is 
proposed as a reliable index of changes in the RNA content of the blood lymphocytes.
T ' h e  l y a e p i -i o c y t e  of the peripheral blood is a cell of considerable in­
terest. Its exact function is unknown, but it is closely involved in the 
mechanism of hom ograft rejection ( i ) ,  and in cellular immunity of the 
delayed hypersensitivity typo, and hence it appears implicated in the 
processes of autoimmune disease (/^). Htudy of the lymphocyte is compli­
cated by the considerable variation which occurs in the morphology of 
the cells. W introbe states ( a )  that the lymphocyte is generally small 
(10 g ) ,  but larger forms (10-20 jx) are common. Attemjots to be more 
precise in classification of the cells have met with difficulties. W iseman  
pointed out the considerable difference in size between fixed cells and 
those vitally  stained (4),  and decided on the degree of cytoplasmic  
basophilia as a more satisfactory means of classification. Other classifi­
cations have been used by Eeich and Reich (d), K risten son (6’), Hern- 
berg (Z, 8),  and Torelli e/; al, (#), but in each case the criteria have been 
subjective, and sometimes laborious, wdiere multiple cell measurements 
had to be taken. The present work describes the use of the measurement
F ro m  tlie D e p a r tm e n t  o f  B io c l ic m is lr y ,  the W catcrn  Tnfirmar.v, G la sg ow , Sco t lan d .
I  w ish  to  ex p ress  m y  g r a t i tu d e  to Dr. E .  U. H en d ry  fo r  p erm iss io n  an d  f a c i l i t i e s  to  u nd er­
take th is  work, to m y  co l le a g u e s  who g a v e  ad v ice  and  d on a ted  b lood , a n d  to  P r o fe s s o r  H .  N ,  
M unro fo r  g u id a n c e  a t  v a r io u s  s t a g e s  in  th e  work.
Tîecoived f o r  p u b l ic a t io n  Oct. 7, 1 9 6 6 ;  accep ted  fo r  p u b l ic a t io n  N o v .  28, 1966 .
* A d d ress  u n t i l  A lay 1, 1967  : D e p a r tm e n t  o f  N u t r i t io n  a n d  F o o d  S c ien c e ,  A la ssa ch u se tts  
I n s t i t u te  o f  T e c h n o lo g y ,  C a m b rid g e ,  M ass .  02139,
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of D N A  and R N A  in peripheral blood lyinphocyles as an objective  
description of the circulating lympliocytes. An additional I'cason for  
undertaking* these studies was that, although there have been m easure­
ments carried out by microdensitometry of the amount of D N A  in 
human blood cells relative to cells of othm* organs {10)  ^ and the absolute  
D N A  and R N A  content of human leukocytes has been determined by 
Davidson et al. {11), no values exist in the literature for the absolute  
levels of D N A  and R N A  in human lymphocytes carried out by chemical 
means. The establishment of a range of normal values for these com­
pounds was a necessary prelim in ary in the investigation of variations  
which might occur in disease, particularly those involving immune or 
autoimmune states.
-Materials and M eth o d s  
The Isolation of Lymphocytes from Peripheral Blood
T he m ethod  of Coulson and  Chalm ers {12) fo r  the s e p a ra t io n  of 
hum an  lym phocytes f ro m  p e r ip h e ra l  blood Avas modified in o rd e r  to in ­
c rease  the  p u r i ty  of the lym phocyte  yield and  the convenience of sam ple  
collection. T he  use  of e thy lened iam ine te traace tic  acid  (E D T A )  as the  
a n tico ag u lan t  aAmided the need  fo r  im m ediate  defibrination  of the  blood 
sam ple, a  d isa d v an tag e  of the  o rig ina l m ethod. D efibrina tion  is r e ­
ta ined , how ever, as a step  in the separa tion , since the fibrin clot selec­
tive ly  t r a p s  and  remoAms po lym orphonuc lea r  leukocytes. The p rocedu re  
was used  a f te r  the  bulk  of the red  cells h a d  been removed, a n d  the  
selection Avas th e re fo re  m ore  efficient. In the  m ethod, an  aqueous solution 
of ge la tin  p re p a re d  f ro m  lim e-processed hides Avas m ixed  Avith the  blood 
to accelera te  red-cell sed im enta tion . T his ge la tin  h a s  a  h igh  con ten t of 
calcium ion (8.0 mg./lOO gm. of the  solid), so th a t  an  increase  in  the 
am ount of E D T A  a n tico ag u lan t  Avas req u ired  fo r  the modified m ethod.
Reagents
1. Repelcote” 2% solution ( a v / v )  of d im cthy ld ich lorosilane  in 
carbon te trach lo rid e .
2. 0.11 M. ethylenccliamineteiraacetic aril 4 gm. of the  disodium 
salt p e r  10,0 ml. Avatcr, b ro u g h t  to p i t  7.4 Avilh 4N po tass ium  hydroxide,  
to give a solution of 40 mg. E D T A  per milliliter.
3. 0.10 3 /  calcium chloride  1.10  gm. anhydrous salt per 1 0 0  ml. 
in 0.05 M  sodium chloride (4.0 mg. calcium per m illiliter).
4. G e l a t i n A  3% solution ( a v / v )  in 0.15 ISl sodium chloride. The 
gelatin was No. 277 and No. 66003.' '^ The solution must be freshly pre­
pared.
^G elatin  and  G lue E e sea re l i  A s s o c ia t io n ,  W a rw ick  S t . ,  B ir m in g h a m  12, E n g la n d .
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5 . 0.15 M sodium chloride
G. 0.30 M sodium chloride
Method
A to ta l  of 20 nil. of blood w as collected from  a  vein and  ru n  into a  
])olystyi*onc tube conta in ing  1 ml. of the EDTA. solution. A f te r  m ixing, 
G,() ml. of the ge la tin  solution was added, and  the solution m ixed again . 
The d ilu ted  blood was then  t r a n s fe r r e d  to a  siliconized tube a n d  stood 
a t  a tem p era tu re  of 37° fo r  30 mim, d u r in g  Avhich tim e the m ix tu re  
separa ted  into 2 v isib ly  d is tinc t layers . T he  whole of the u p p e r  layer , 
freed from  the bulk  of the  red  cells, w as rem oved  to  a 50-ml. conical 
tlask fitted w ith  a stiiudng rod suitable  fo r  defibrination  (i.e., w ith  a 
wire paper  clip fixed on its  end). Calcium chloride solution (2 ml.) Avas 
added and defibrination  ca rr ied  out by  sw irling. A f te r  a])prox im ately  
If) mim, Avhen defibrination  Avas complete, 3 ml. of the E D T A  so lution 
Avas added  and  the suspens ion  rem oved to a cen tr ifu ge  tube. T he cells 
Avere then  spun doAvn by  c en tr ifu g a tio n  a t  350 g (1400 rp m  in a  head  of 
16'Cm. rad iu s )  fo r  10 m in. T he lym phocytes sed im ented  as a sm all 
button  tinged  Avith red, th e re  be ing  some red-cell con tam ina tion  a t  th is  
stage.
I t  Avas coiw enieut to m ake a  sm ear of the sed im ent by  sp re ad in g  a 
small sam ple on a g lass slide ; the  fixed and  s ta in ed  p re p a ra t io n  Avas 
then used  to  assess  the  con tam ina tion  Avith Avhite cells o th er  th an  
lym])liocytes. The red  cells AVore remoAuul by  a process of osmotic shock, 
lymphocytes being  re la tiv e ly  re s is ta n t  to hy])0tonic conditions. Ice- 
cold distilled Avater (2 ml.) Avas added  to the cell bu tton , the cells being  
suspended and le f t  fo r  exactly  15 sec. N orm al ton ic ity  Avas then  re s to re d  
by the addition of 2 nd. of ice-cold 0.30 31 sodium  chloride solution, and  
the cells m ain ta in ed  th e re a f te r  a t  4°. C en tr ifu g a tio n  a t  125 g (900 rp m  
in the 1 G-cm. head ) ag a in  gave a  cellu lar bu tton , th is  tim e gray-Avhite 
in color. The hem oglobin from  the lysed  re d  cells rem a ined  in  so lu tion  
and Avas rem oved by  P a s te u r  p ip e t  toge ther  Avith a  th in  lay e r  of r e d ­
cell ghosts overly ing  the  com pact button.
The lym phocytes Avere then suspended in 2.5 ml. of 0.15 31 so-5 am 
chloride solution. Some c lum ping of the cells Avas occasionally  observed. 
This Avas reduced by  the use of 0.15 31 saline con ta in ing  5 ml. of the  
EDTA solution p e r  100 ml. to  suspend  the cells. C lum ped cells w ere  
removed by alloAving them  to sedim ent to the bo ttom  of the  tube  on 
s tanding for 5 min. The suspended  cells Avere then  collected by  P a s te u r  
pipet, and  a  cell count Avas c a r r ie d  out by  add ing  0.1 ml, of the  cell 
suspension to 1.0 ml. of a  1.5% acetic-acid solution t in te d  Avith m ethy l 
violet, using  accura te  p ip e ts  fo r  the  dilution. T he cells w ere  counted in
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an in iprovcd N cu b au e r  counting  cham ber. U sna lly  abou t 12 million colls 
were obtained  fro m  20 ml. of blood, rep re se n tin g  a y ie ld  of 20% of the 
lym phocytes. A  m in im um  of 2 million cells Avas req u ired  fo r  reliable  
estim ation  of nucleic acid in the sam]>]e so th a t  a  10-ml. sam ple of 
p e r ip h e ra l  blood Avould in m ost cases giAm a  sa t is fa c to ry  y ield  of cells. 
R educed \mlum es of blood AAmre used on some occasions, Avith a p p ro p r i ­
a te ly  a d ju s te d  re a g e n t  Amlumes, bu t in genera l  a  20-ml. sam ple  Avas 
used. 3[ost cell p re p a ra t io n s  contained  a t  leas t  95% lym phocytes, the 
co n tam ina tin g  cells be ing  m ain ly  po lym orphonuc lea r  leukocytes, Avith 
occasional eosinophils. T he  fcAv cell suspensions Avith less than  90% 
p u r i ty  Avere re g a rd e d  as unsu itab le  fo r  chem ical ana lysis  a n d  Avere 
d iscarded .
The Separation of RNA and DNA
T h e  m e th o d  em p lo y ed  Avas e s se n t ia l ly  t h a t  o f  S c h m id t  a n d  T h a n n -  
h a u s e r  (13)  a s  m odified  b y  F le c k  a n d  3Tunro (14) ,  o m it t in g  e x t ra c t io n  
Avith l ip id  so]\m nts (75), a n d  u s in g  S c h n e id e r ’s m o d if ica tio n  fo r  e x t r a c ­
t io n  of D N A  (75). T h e  p ro c e d u re  m a k e s  use  o f  th e  h y d ro ly s is  of R N A  
in  d i lu te  a lka li ,  as  a  m o an s  of r e n d e r in g  i t  ac id  soluble , u n d e r  con d it io n s  
in  Avhich D N A  a n d  p r o te in  a r e  s tab le . R eac id if ica t io n  alloAvs s e p a ra t io n  
o f  the- ac id -so lub le  p o ly n u c leo tid e  d e iK e d  f ro m  h y d ro ly s is  o f  th e  RNA, 
f ro m  th e  ac id - in so lub le  re s id u e  D N A  a n d  p ro te in .  T h e  D N A  p ro te in  
f r a c t io n  m a y  th e n  be  t r e a t e d  Avith h o t  p e rc h lo r ic  ac id  to  e x t r a c t  th e  
DNA. C o n s id e ra b le  re d u c t io n  in  scale f ro m  th e  s t a n d a r d  p ro c e d u re s  
Avas r e q u i r e d  to  g ive  sufficient s e n s i t iv i ty  fo r  m e a s u re m e n t  o f  th e  sm all 
a m o u n ts  of  nucle ic  ac id  p r e s e n t  in  th e  sa m p le s  o f  ly m p h o cy te s .  3 fag-  
n es iu m  ch lo r id e  (0.05 31) Avas in c lu d ed  in  the  r e a g e n ts  u se d  f o r  nucle ic  
ac id  p re c ip i ta t io n ,  as  3 fg + +  fa c i l i ta te s  th e  p r e c ip i ta t io n  of r ibonuc le ic  
ac id  (77).
Reagents
1. 1,2N, and OMN, and 0.2N\ perchloric acid ( P C A) E a c h  m ad e  up  
in 0.05 31 m agnes iu m  chloidde.
2. 0.5N perchloric  acid (P G A )  in distilled^ w a te r
3. 0 .3N p o t a s s i u m  h y d r o x i d e
Procedure
All m an ip u la t io n s  Avere c a r r ie d  out a t  4° unless otherAvisc s ta ted . The 
sample, con ta in ing  a  knoAvn q u a n ti ty  of lym phocytes  betAvcen 2 X 1 0 ^  
and  20 X 10® cells, Avas p ip e t ted  into  a 4- X 0.5-in. cen tr ifuge  tube, 
usually  in 2.0 ml. of 0.15 31 sodium  chloride. To th is  Avas ad ded  one-half 
volume of 0.6N PCA, m aking  the  m ix tu re  0.2N in PC  A. T he suspension  
was le f t  f o r  10 min., then  cen tr ifu g ed  fo r  5 min, a t  500 g. T he superna-
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tant was discarded and the pellet resuspended iu 0.2N PCA. Centrifuga- 
lioii as before, followed by resiisponsion and recentrifugation, gave a 
}allot washed twice in PCA. E xcess of acid was carefully drained from  
the iiollet, which was then treated Avitli 0.5 ml. of 0.3N potassium hy­
droxide, and incubated at 37° for exactly I  hr.
.At (ho end of the  in cu b a tio n  p e r io d  the  so lu tio n  w as  cooled to 4°, a n d  
0.25 ml. of 1.2N P C A  ad d ed .  A fter th e  so lu tio n  h a d  s to o d  f o r  10 m in., 
contri Cugation a t  500 g  fo r  5 m in. Avas c a r r ie d  out, th e  s u p e r n a t a n t  b e in g  
t r a n s f e r r e d  to a g r a d u a te d  tube. T h e  p re c ip i ta te  Avas Avashed tAvice 
with 0.75-ml. volum es of 0.2N PCA, th e  Avashings b e in g  a d d e d  to  th e  
g ra d u a te d  tube. T h e  poo led  s u p e r n a t a n t  a n d  Avashings Avere m a d e  u p  
to a volum e of 2.5 ml. Avith 0.2N PCA, g iv in g  th e  R N A  f r a c t io n  in  0.2N 
I‘CA. I t  is ad v isa b le  to a s c e r ta in  t h a t  th e  2.5-ml. g r a d u a t io n  on th e  
tubes is accura te .
Idle Avashed precipitate Avhich contained the D N A  together Avith 
cellular protein Avas treated Avith 2.0 ml. of 0.5N P C A  and incubated at 
80° for 10 min., then cooled to 4°, allowed to stand for 10 min., and 
centrifuged for 5 min. at 500 g. A  1.5-ml. portion of the supernatant 
was removed and mixed Avith an equal volume of 0.5N P C A  to give the 
DNA fraction in 0.5N PCA. <
Measurement of RNA
31 easû re m e n t  of the  R N A  c o n ten t  o f  the  s e p a ra te d  R N A  f r a c t io n  Avas 
conveniently  c a r r ie d  o u t  b y  d e te rm in in g  th e  a b so rb a n c e  a t  260 m ^  of 
the acid-soluble m a te r ia l  o b ta in ed  b y  a lk a lin e  d ig es t io n  of th e  tissu e .  
A small am o u n t of p ro te in  m a y  be m a d e  soluble  b y  th e  a lka line- 
d igestion ' ])rocedure, a n d  th is  p o ly p e p t id e  Avill c o n tr ib u te  to  th e  a b ­
sorbance a t  260 mg,. A co r re c t io n  m a y  be m a d e  f o r  th is  e r ro r ,  p ro v id e d  
th a t  the specific ex tinc tion  o f  th e  c o n ta m in a t in g  m a te r ia l  is  knoAvn, as 
well as its  co n cen tra tio n .  As an  a l te rn a t iv e  to  p ro te in  a s sa y ,  a  c o r re c ­
tion for p ro te in  c o n ta m in a t io n  m a y  be m a d e  b y  a p p l ic a t io n  of a  2 Avave- 
haigih  co rrec tion  (14).  T h is  n e c e s s i ta te s  th e  p r e p a r a t i o n  of a  s am p le  of 
the tissue  RNA to  o b ta in  v a lu es  f o r  the  specific ex tin c tio n  coefficients a t  
2 selected AvaA'c len g th s ,  to g e th e r  Avith knoAAdedge of th e  specific e x ­
tinction coefficients o f  the  c o n ta m in a t in g  p o ly p e p tid e .  A  sam p le  of 
hum an lym phocy te  R N A  Avas o b ta in ed  b y  th e  m e th o d  of D ig iro la m o  
cl ctJ. (is), and  the  pu r if ied  p o ly p e p t id e  p r e p a r e d  folloAving th e  tech n ic  
of Flock a n d  3 ru n ro  (14).
Correction by Protein Estimation
Lymphocytes Avero isolated in quantity from human blood discarded 
from the hoart-lung machine, The polypeptide prepared from them had
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a m axim al ab so rp tio n  a t  275 npx, ami a m inim um  a t  255 mg,. The specific 
extinction coefficient 7^  ^ fo r  a  solution of the po lypeptide  in
0.2N P C A  conta in ing  1 g,g. p ro te in  per m illil i te r  Avas 0.00075 absorbance 
units . P ro te in  Avas m easu red  by the m ethod of LoAvry el al. (7.9), and 
th is  fac to r  Avas used  to co rrec t the extinction a t  260 mg, of the RNA f r a c ­
tion fo r  its  m easu red  p ro te in  contam ination. Bovine serum  album in 
Avas the refe rence  s ta n d a rd  (bovine se rum  album in F ra c t io n  37 from  
A rm our P h a rm aceu tica l  Com pany, E n g la n d ) .
Correction by 2 Wave Lengths
Purif ied  hum an  lym phocyte R N A  had, a f te r  a lkaline d igestion  and 
solution in 0.2N perch lo ric  acid, a  m olar  extinction coefficient Avith 
respect to phosp ho rus  (20) of 9200 a t  260 mg, with a 1-cm. l ig h t  pa th . 
T h is  solution h ad  a m axim um  a t  262 mg, and  a m inim um  a t  235 mg,. The 
ra t io  of the extinction a t  260 mg, to the ex tinction  a t  280 mg, Avas 1.3. 
U nhydro lyzed  R N A  h a d  a s im ila r spectrum  except th a t  the m axim um  
Avas a t  260 mg,. T here  Avas no detectable  p ro te in  con tam ination  of th is  
purified  R N A , b u t  since some m inor p ro te in  con tam ina tion  Avas to be 
expected in the frac t io n  obtained by  the modified S ch m id t-T hann hause r  
p rocedure  described  above, correction fac to rs  Avere calculated  as folloAvs.
T he correc ted  R N A  concentra tion , cR N A  {14),  of a  so lution is given 
by :
c R N A  ~  A - E ^ - B  - E^
w here and  a re  the absorbance  m easu rem en ts  of the solution m ade 
a t  2 wave leng ths  an d  X^ . A  a n d  B  a re  constan ts, depending  on the 
extinction coefficients of the p u re  R N A  and  of the  con tam ina tin g  p r o ­
tein. The selected Avave len g th s  Avere Xi — 260 m g  and  Xg =  232 mg. A 
and  B  a re  de rived  as follows :
A ~  ^-----------  B =  ------------- 1--------------
P 2ri-r2- î'i • ---------- To
J 2  ^]
Tj an d  7'2 a re  the  specific extinction coefficients of the lym phocyte  R N A  
a t  Xy an d  X^  ; these  values a re  0.296 a t  260 n ig  an d  0.182 a t  232 m g fo r  a 
solution in  0.2N perch lo ric  acid contain ing  1 gg. of R N A  p ho sp h o ru s  
p e r  m illiliter. PjfP  ^ is the ra t io  of the extinction coefficients of the p ro ­
tein con tam inan t a t  X; and  Xg ; a solution of the p u re  po lypep tide  in 
0.2N ]ierchloric acid gave the value for PJP^ of 0.471/2.241— i.e., 0.210. 
S u b s titu t io n  gives the  Amines of 3.876 fo r  A  and  0.812 fo r  B. T hus 
c R N A  =  (3.876 • 7 7 1  2 go ui(Ct) “  (0.812 - 7 '^ 2 3 2  m/t) gg- R N A  plio.splionis/iiil.
A  reagent blank obtained by carrying' a sample of saline through the 
Schmidt-Thannhauser separation gives small but significant extinction
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valiH.vs a I the 2 wave lengths used. Thus a reagent, blank is used with 
each hatch of analyses and appropriate correction made.
Mcasurûment of DNA
TIh' modified Schmidt-Thannhauser procedure described above Avas 
used jo obtain the D N A  fraction in O.fiN perchloric acid. iMeasurement 
of llio absorbance at 2G5 mg Avas used to estimate the D N A  content (75). 
The slandard for these measurements Avas highly polymerized calf 
Ibyimis DNA (Sigm a London Chemical Co.). The molar extinction co- 
C'licienl /C lion «vt Avas 9500 Avith respect to its phosi^horus content, the 
measurement being again in 0.5N PCiV, a 1-gg. p per milliliter of solu­
tion of the DN A  in 0.5N PC A  having an extinction at 265 m g of 0.308 
after the usual acid and alkali treatments of the separation procedure. 
Tlie wave length used represents the maximum for both the standard  
and the lymphocyte DNA. The separated DNik fraction Avas found to 
contain a small amount of dissolved protein so that a protein correction 
was again applied. This Asms carried out as described under the m eas­
urement of RNA, substituting the values applicable to the D N A  m eas­
urement (27).
Calf thymus standard, of concentration 1 gg. D N A  phosphorus per 
milliliter, had an extinction 2gs of 0.308 — n  and E^ 232 m/i of 
0.127 =  f 2 in 0.5N PCA. Values used for the protein contaminant Avere 
I \ / l \  =  0,224.
The corrected D N A  concentration, cDNA, was given by:
clAXA = ( 3 . 5 7 1 265 ni/t) — (0-802 ■ F I 232 in/t) gg- DNA pliosphoriis/nil.
Again corrections to the extinction values for reagent blank Avere made. 
The method of Ceriotti {22) Avas also used for D N A  analysis in some 
exjieriments.
Results
E x p erim en ts  Avere carried o u t  to assess  the reliability of the methods 
enqiloyed for the analysis of the nucleic-acid content of lymphocytes.
A so lution Avas p r e p a r e d  c o n ta in in g  DN A, RNA, a n d  p r o te in  in  
am ounts s im ila r  to those  e n c o u n te re d  in  th e  a n a ly s is  o f  ly m p h o cy te  
p rep a ra tio n s .  T h e  m a te r ia ls  u se d  Avere h ig h ly  p o ly m e r iz e d  ca lf  th y m u s  
I )X A, y eas t  RNiA ( f ro m  P a b s t  L a b o ra to r ie s ,  a n d  p u r if ied  by  th e  m e th o d  
of Zytko el al. (23) )  a n d  bov ine  s e ru m  a lbum in . T h e  p h o s p h o ru s  co n ten t  
of the s ta n d a rd  D N A  a n d  R N A  so lu tions  Avas d e te rm in e d  in  t r ip l ic a te  
(7n) and  the re su l ts  c o m p a re d  Avith th o se  o b ta in e d  b y  the  m odified  
S eb m id t-T h an n h au se r  p ro c e d u re ,  m e a s u r in g  b o th  D N A  a n d  R N A  b y  
1 \ absorbance. Tavo Avave le n g th  p ro te in  c o r re c t io n s  Avcre a p p l ie d  
using values a p p r o p r ia t e  f o r  th ese  m a te r ia ls .  D N A  Avas a lso  m e a s u re d
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by the Ceriotti {22) procedure. The royults obtained are shown in 
Table 1. Adequate reproducibility is rcllectcd in the low standard  
deviations of the recoveries. The Ceriotti method, with a mean re­
covery of 82%, was less satisfactory than U V  absorbance, with 100% 
recovery, for the measurement of DNA. U V  absorbance measurements 
of R N A  gave an 86% recovery.
When the Ceriotti and UV methods for D N A  were compared using  
lymphocyte preparations, a correlation coefficient of 0.97 was obtained 
(F ig . 1). The relationship between the 2 methods was such that m eas­
urement of D N A  phosphorus in micrograms by the Ceriotti method  
equaled 0.94 ^g. D N A  phosphorus by U V  +  0.004. Thus, the Ceriotti 
reaction gave consistently lower, but still well-correlated results when 
compared with measurement by U V  absorbance.
Cl.
Ô) 1*0 -
3 02*010
F i g ,  1 .  C er io tt i  m eth od  
( y  a x i s )  a n d  th a t  o f  
u ltra v io le t  ab so rb an ce  a t  
26 5  ( x  a x i s )  f o r  e s t i ­
m a t in g  D N A  in  22 sa m ­
p le s  f r o m  ly m p h o c y te s  
(r  — 0 .9 7 ;  y  =  0 .94  x  
4* 0 .0 0 4 ) .
yU g.D N A  Phosphorus lU V )
T a b l e  1 .  E e c o v e r y  E x p e r i m e n t s  w i t h  Co m p a r is o n  o p  M e t h o d s
i l e t h o â  of  
a na l ys i s No ,  of  an al y s e s
M e a n  %  re c o v e r y  
a n d  S . D .
O b s e r v e d  rafigo  
of  r e c o v e r y  ( % )
D N A  b y  C er io tt i .14 82,0 ±  9.4 6 5 -9 8
D N A  b y  U V  a b so rb an ce 18 100.4  db 4.7 9 3 -1 1 1
R N A  b y  U V  a b sorb an ce 19 86.4 ±  4.5 7 5 -1 0 0
A n a ly se s  w ere m ad e  on s ta n d a r d  so lu t ion s  o f  D N A ,  R N A  an d  prote in ,  carried  ou t  to assess  
the  recoveries  o b ta in a b le  b y  the  m eth o d s  o f  nuc le ic -ac id  m ea su rem en t  w hen  com p ared  w ith  
p hosphorus e s t im a t io n  o f  th e  pu re  so lu t ion s  tak en  as  100 % ,
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The extinction at 2G0 niyx a tneasurc of R N A  may be subject to 
error owing to the presence of protein {14).  Two methods of correction  
for the error m ay be used: either direct protein estimation with sub­
traction of an appropriate amount (see above) from the U V  absorb­
ance, or correction by measurement at 2 wave lengths in the ultraviolet 
spectrum. There is close agreement between the 2 methods (F ig . 2), 
with a correlation coefficient of 0.96.
IMeasurement of U N A  and R N A  by UV  absorbance, using the 2 w ave­
length corrections for protein in each case, were found to be'the most  
convenient and reproducible methods, and were selected for all subse­
quent experiments.
The reproducibility of the entire procedure was examined by com­
paring lymphocyte U N A  and R N A  values derived from duplicate 
samples of blood obtained from 5 individuals. The  mean variation for  
the D N A  measurements was ±  6.0% and for R N A  measurements 
4: 8.8%. When the ratio R N A  phosphorus/D NA phosphorus was calcu­
lated from these results, the mean variation fell to ±  3.8%. These 
fmdings express in part the error of cell counting. The R N A P /D N A P  
ratio of the lymphocytes does not include this error, so the ratio is the 
most reproducible of the estimates.
Samples from 1 individual, containing a range of cell numbers from  
1.43 million to 14.3 million lymphocytes, were analyzed. The individual 
measurements of D N A  and R N A  gave linear results over this range, 
and the graph of estimated cells against their nucleic acid content 
passed through the origin.
The nucleic-acid content of the peripheral blood lymphocytes of 40 
healthy individuals, 20 male and 20 female, was examined. The age 
range was 18-66, with a mean of 29, for the males, and 18-77, with a 
mean of 40, for the females. The results of the D N A  and R N A  analyses 
arc summarized in Table 2. There were no signihcant differences be­
tween males and fem ales in DNA, RNA, or in R N A /D N A  ratio. The 
mean value of the lymphocyte D N A  in the male subjects was 0.74 /^g. 
DNA phosphorus per million cells, and in the females 0.72 ^g. D N A  
phosphorus per million cells. The R N A  results were 0.19 ^g. and 0.20 
gg. R N A  phosphorus per million cells for the males and females, re­
spectively.
The peripheral blood lymphocytes were analyzed at intervals over a 
period of a year in 1 man (F ig . 3). During this period the DNAP/10®  
cells result varied from  1.05 gg, to 0.62 gg., and the RNAP/10® 
cells from 0.27 gg. to 0.13 gg . The variation in these 2 measurements 
tended to be coincident, while the calculated ratio R N A P /D N A P  of the 
lymphocytes showed less variation (0.20-0.30) than the individual R N A
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and D N A  valuoa, particularly when the ostiniation.s were repeated after  
an interval of a few days. These 2 lindings supported the view that 
much of the variability of the estimation was the result of errors in cell
counting.
Discussion
The modified cell-scparation procedure has been fully desci-ibcd, and 
only details will be discussed. The first is the choice of gelatin that is 
used to accelerate coll sedimentation ildie critical properties for this, 
step are not known, and it is only possible to describe the characteristics 
of a gelatin (No. 66003) which has proved satisfactory in pi-acticc. The 
staled properties of the gelatin were : source, limed hide; bloom jelly 
strength at 6.67%, 225 g; viscosity at 40° and 6,67%, 6.6 centistokes; 
moisture content, approximately 14%. The gelatin was of recent manu­
facture, and similar to that used by Coulson and Chalmers (7.2). An 
important detail of the modified })rocednre is that sufficient time must 
be allowed after defibrination to allow the fibrin strands to trap poly­
morphonuclear leukocytes. The recommended period is 15 min., but this
yug. RNA Phosphorus/m l. 
(T w o-W avelength  Procedure)
F i g .  2 .  M cjisurcincnt o f  
ly i i ip h ocytc  B N  A By ul- 
{;raviolct ab sorp tion  s iiow ­
ing  com parison  o f  2 m eth ­
ods o f  correction  fo r  
p rote in  error. B N  A  piios-  
pliorus resu lts  corrected  
by m easu rem en t  o f  p r o ­
te in  in 10 samjBes are  
shown on y  a x is ;  and  on  
X axis ,  sam e sam ples  cor­
rected  b y  2 w av e - le n g th s  
procedure (r  0 .96 ;  y
=  0 .08 X +  0 .0 1 ) .
T a b l e  2 .  T h e  D N A  a n d  B-NA C o n t e n t  o f  N o r m a l  H u m a n  L y m p h o c y t e s
D X A P  
( fiff. /l 00 cel ls)
R N A P  
(/iff./10  ^ cel ls)
Pa l i o
R N A P / D N A P
O bserved ran ge 0 .5 5 -1 .0 5 0 .1 0 -0 .3 5 0 .1 1 -0 .3 6
Mean 0.73 0.10 0.26
S tan d a rd  d ev ia t io n 0.12 0.06 0.06
Coefficient o f  v ar ia t ion 16% 32% 24%
A n a ly s e s  w ere m ad e  o f  the  p er ip h era l  blood lym p h o c y te s  o f  40 norm al in d iv id u a ls  (20  adult  
m ales and  20 a d u lt  f e m a le s ) .  B N  A and  D N A  are expressed  as m icrog ram s o f  D N A  or B N A  
phosphorus per m i l l io n  cells.
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should be increased if defibrination Is slow, to maintain the purity of 
the lymphocytes The viability of the cells as tested by trypan blue is 
close to 100%. The rigorous conditions for red-cell lysis were sa tis­
factory for chemical work, but may rc(]uire modification it’ cell culture is 
contemplated.
It is clear, particularly from Kig. o, that, an individual estimate of 
D N A  or EN A  expressed per million cells is not a reliable measure. 
Cell counting* is the principal source of variation, and since this error 
is dependent on the square root of the number of cells counted, it could 
be reduced by repeated counting. The analytical methods show relia­
bility adequate to give results within 5% (Table 1), and provided  
that accurate cell counting is available, reliable measurements of D N A
F ig .  3 .  B N A  pnoy- 
phorus p er  1 0 “ cells, B N A  
pliosphorus p er  10 “ cells, 
nnd ratio  B N A P / D N A P  
of b lood  l y m p h o c y t e s  
measured in  1 in d iv id u a l  
(m a le )  a t  in t e r v a ls  over  
1 year. A v e r a g e  norm a l  
values are i n d i c a t e d ,  
show ing  2 s tan d a rd  d e v i ­
ation l im its .
10
8
o D N A
E
o
R N A
R N A P
D N A P
M o n t h s
jthosphorus or E N A  phosphorus per 10*^  cells may be carried out in 
1 sample. However, in the present study it was considered important 
that the isolated cells should be treated with cold perchloric acid as 
soon as possible after their removal from the peripheral blood, thus 
limiting degradation of nucleic acid, particularly of the more labile 
UNA. Any nucleic-acid degradation would give consistently low values 
for the mean cell content, while the error of cell counting is a random  
one. The actual estimates of D N A  phosphorus per million cells in this 
study were distributed normally about the mean.
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Tho value of OJd /xg. DNA ])hosp]iorus per iniiliou lyuqdioeytes re­
ported here (O.Td ])g. DNA phosphorus per average coll) is close to that 
found by Davidson el al. (0.70 /xg. DNA phosphorus per million cells) 
in their measurements on human leukocyte preparations ( i l)^  and 
again slightly greater than the value of 0.09 ^g. D N A  phosphorus per 
million cells obtained by i\felais and i\iandel {24)  for human leukocytes. 
Although the measurements of Davidson el al. {11) and those described 
here Avcre carried out by different methods, it ap})cars that the lympho­
cyte and the polymorphonuclear leukocyte of peripheral blood cont,ain 
similar amounts of DNx\. This conclusion is supported by TTalc and 
Wilson {25),  who found, using microdensitometry, that the amount of 
Feulgcn-stained material (D N A ) in the mature polymorph is the same 
as in the small lymphocyte, and that the leukocyte of the peripheral 
blood is practically exclusively diploid {10).  Provided the D N A  content 
of the lymphocyte is constant, variation in the B N A  content of the cell 
m ayb e  assessed by measuring the B N A P /D N A P  ratio of cell prepara­
tions, thus eliminating cell-counting error.
The-criticism may be leveled that the gclatin-sedimentation method 
of lymphocyte purification m ay be selective, and qiroduce cell sus­
pensions of a particular D N A  value. This is unlikely since an inde­
pendent separation method based on cell flotation on silicone oil {25) 
gives values for the measurement of D N A  phosphorus and B N A  phos­
phorus of the lymphocyte in 15 normal individuals of 0.75 ^g. ±  0.09 
and 0.22 /xg. 0.05 per million colls. In a series of 40 lymphocyte sus­
pensions prepared by gelatin sedimentation from pathologic blood 
specimens, and containing an increased proportion of large lympho­
cytes, the mean DNA phosphorus content Avas 0.74 /xg. ±  0.12 per million 
cells {25).  The case for the constancy of blood l>mipliocyte D N A  is a 
strong one, and hence the ratio B N A P /D N A P  m ay be considered an 
accurate.reflection of the mean cell BN A . The question of Avhother the 
mature blood leukocyte contains less DNA than other diploid somatic  
{27)  cells does not alter this conclusion.
T h e  o b se rv e d  r a n g e  of B N A  p h o sp h o ru s ,  0.10-0.35 (m e an  0.19) ^g . 
p e r  m illion  ly m p h o cy te s ,  Avhen ca lcu la ted  as  B N A P /D N A P  r a t io  gave  
a  m e a n  v a lu e  of 0.26 ±  0.06 fo r  the  40 n o rm a l  in d iv id u a ls  te s ted .  T hose  
m ean  v a lu es  a r e  loAvcr th a n  th o se  o b ta in e d  in th e  leukocy te  b y  Davddson 
et al. {11)^ w ho fo u n d  a r a n g e  fo r  the  B N A  p h o s p h o ru s  of 0.11-0.31'/xg., 
Avith a m e a n  of 0.24 ^ g .  p e r  m illion cells, Avhich g av e  a  Aidue fo r  the 
B N A P /D N A P  r a t io  of 0.35 ±: 0.16. A lth o u g h  the  m e a s u re m e n ts  of 
D a v id so n  ei al. Avere c a r r ie d  ou t on cell p r e p a r a t i o n s  c o n ta in in g  bolh 
. ly m p h o cy tes  a n d  p o ly m o rp h s ,  a n d  could  be ex p ec ted  to g ive  d if fe ren t 
re su l ts ,  th e  a n a ly t ic a l  m e th o d s  u se d  a r e  a lso  im p o r ta n t .  D a v id so n  et al.
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(11) e s tiiualcd  RNA by nieasiiring the tu ta i })]iosphorns con (eat of tiic 
Scliiu id t-T lia iiahauser BN A  frac tion . Tlierc is evidence th a t  this f r a c ­
tion conta ins significant an ionnts of organic  phosphorus  com pounds 
o ther than  ribonucleotides, w ith  differences of degree am ong tissues. 
Davidson and  Smellie (AV) investiga ted  tliis ])oint, a lthough not spe ­
cifically in leukocytes, and  found th a t  20-25% of the pho sphorus  in the 
frac tion  from  r a t  liver was o ther  than  ribonucleotide phosphorus , while 
with rabb it  spleen (29)  the figure w as 10-15%. In com paring  our resu lts  
with those of D avidson  et al, ( l l ) ,  i t  should also be noted th a t  the m e th ­
od described here  fo r  the analysis  of B N A  gives 86% recovery. I f  an 
allowance is m ade fo r  the loss th an  100% i-ecovcry in the p re sen t  u l t r a ­
violet m easu rem en ts  (add  14% ) and  the e r ro r  due to the presence of 
nonribonucleotide phospho ru s  in the m easu rem en ts  of D avidson el al. 
(sub trac t  12% ), the content of B N A  phosphorus  is s im ila r  in leuko­
cytes and  no rm al lym phocytes, being close to 0.21 ju,g. p e r  m illion cells 
in each case. T h is  is in keeping  Avith the observation  th a t  cell sam ples 
rejected from  th is  scries because of g re a te r  th an  10% con tam ination  
Avith po lym orphonuclear leukocytes, Avhcn analyzed, gave resu lts  Avhicli 
fell Avithin the  n o rm al ran g e  fo r  lym phocytes. W h en  the corrections 
are applied to the B N A  Amines and  the B N A P /D N A P  ra t io  calculated 
from  them, the resu lts ' a re  0.29 and  0.30 fo r  the p re sen t  observations 
and those of D avidson  et éd., respectively . These a re  low values fo r  the  
B N A /D N A  ra t io  Avhen com pared  Avith o ther  cells; s im ila r  values have 
been reported  only f ro m  leukocytes and  thym us and  lym phoid tissue  
in animals (30).
Bepeated  m easu rem en t of the B N A P /D N A P  ra t io  in an  ind iv idual 
(Fig. 3) shoAvs th a t  th is  m easu re  is subject to varia tion . T h a t  these 
varia tions a re  rea l and  n o t analy tica l e r ro rs  is confirmed by  the r e ­
producibility of the  re su l ts  Avhen close in time. V a r ia t io n  in the ra t io  
would be b rough t abou t by  a  change in the p ro p o r t io n  of cell types 
circulating, or by syn thesis  of B N A  by the cells of the blood. B o th  these 
])ossibilities m ay  occur, since GoAvans (31)  has d em on s tra ted  th a t  ly m ­
phocytes recii’culate betAveen the  blood and  lym phatic  tissues, and  evi­
dence of synthesis of B N A  in blood lym phocytes has been re p o r te d  by 
Torelli et al. (9)  and  by  Cooper and  B ubin  (32)  and  by o thers  (33).  
Blood lymphocytes respond  in v itro  to a  v a r ie ty  of s tim uli by  increas ing  
ill size (34, 35) and  basophilia . Synthesis  of B N A  is e s tab lished  as p a r t  
of this t ran sfo rm a tion  (36, 37) ,  Avhich a p p ea rs  to p a ra lle l  the in-vivo 
changes in the blood of ind iv idua ls  exposed to d ip h th e r ia  toxoid  an tigen  
reported by P a r i s e r  et al. (38).
Jlow far the B N A P /D N A P  ratio of blood lymphocytes represents a 
measure of their biologic activity remains uncertain, nonetheless tfiç
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ratio doos represent a quantitalivo assessm ent of the nature of the 
■lymphocytes circulating in the blood.
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Rheum atoid factor and anti nuclear factors present 
in the sera o f  a high proportion o f patients witli 
rheumatoid arthritis have many o f  the characteristics 
o f  autoanlibodics (G lynn and H oi boro w, 1965). 
These serum autoanlibodics do not appear to be 
primary in the pathogenesis o f  the disease (Harris 
and Vaughan, 1961) although rheum atoid factor 
m ay sustain joint inflammation (R estifo, Lussicr, 
Raw son, Rockey, and H ollander, 1965). It is 
possible that cell-bound im m unity or delayed hyper­
sensitivity may be the im portant m echanism  in the 
disease process (D oniach  and R oitt, 1962) which  
would implicate sensitized lym phocytes as the 
effectors o f  tissue dam age (H olborow , 1967). W e 
have therefore studied the lym phocytes o f  peripheral 
blood in rheum atoid patients. The D N A  and R N A  
content o f  suspensions o f  isolated cells was measured; 
the D N A  to establish cell numbers, and R N A  co n ­
tent as an index o f their protein synthetic activity.
Material and Methods
Patients
A  total of 35 patients with rheumatoid arthritis was 
studied. Of these 24 had definite rheumatoid arthritis 
by the American Rheumatism Association criteria (Ropes, 
1959); 21 of this group were female, and their mean age 
was 55 years (range 25 to 78), The remaining eleven 
patients had probable rheumatoid arthritis; ten were 
female, and their mean age was 47 years (range 25 to 70). 
Forty healthy individuals, mostly hospital staff, served 
as controls ; twenty controls were female, and their mean 
age was 35 years (range 18 to 77).
Estimation of DNA and RNA
The method for analysis o f the D N A  and R N A  content 
of peripheral blood lymphocytes has been described 
elsewhere (Glen, 1967). It was carried out in two stages.
(1) To separate the lymphocytes from the other
P re s e n t A p p o in tm e n ts :
♦ S e n io r  R e g is tra r ,  D e p a r tm e n t  o f  B io c h e m is try ,  V ic t o r ia  In f i r m a r y ,  
G la s g o w .
t C . I . B . A . ,  C l in ic a l  R e s e a rc h  F e l lo w .
blood cells, 20 ml. venous blood were withdrawn from 
each patient and the lymphocytes separated by a modifi­
cation of the method of Coulson and Chalmers (1964) 
which utilizes a gelatin solution to accelerate cell sedi­
mentation. Red cells were removed by osmotic shock, 
and the lymphocytes were obtained with less than 10 per 
cent, contamination with other cells, usually polymor­
phonuclear leucocytes; a smear from each sample being 
checked for purity before analysis.
(2) Measured numbers o f cells, always greater than 
3 X 10''’ were then submitted to a modified Schmidt 
Thannhauscr separation (Fleck and Munro, 1962), and 
the separated D N A  and RNA fractions o f the lympho­
cytes analysed by ultraviolet absorbtiometry. The 
results obtained gave the D N A  and RNA  content o f the 
peripheral blood lymphocytes in each patient expressed 
as micrograms (ju-g.) D N A  phosphorus (DNAP) or 
RN A phosphorus (RNAP) per million cells.
A previous report (Glen, 1967) showed that the above 
analytical method was reproducible within rt 5 per cent. 
When the error introduced by cell counting was 
eliminated by expressing the results as the ratio ■ o f  
RNAP/DNAP, the mean variation in duplicate was 
reduced to ±  3.8 per cent.
Results
D N A
The results are summarized in Fig. 1 and Tables 
I and II (opposite).
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R N A P / D N A P  
1: S .D .
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R N A P N o r m a l  v. D e f in i te  - f  P r o b a b le  R A 1 7 3 1 7 *5 < 0 * 0 0 1
N o r m a l  v. D e f in i te  R A 1 6 2 2 4 * 7 < 0 * 0 0 1
N o r m a l  r .  P ro b a b le  R A 1 4 9 2 - 5 > 0 * 0 5
P r o b a b le  v. D e f in i te  R A 1 33 2 * 9 > 0 - 0 5
R N A P / D N A P  R a t io N o r m a l  r .  D e f in i te  +  P r o b a b le  R A 1 73 3 1 - 2 < 0 - 0 0 1
N o r m a l  v. D e f in i te  R A 1 62 4 3 * 0 < 0 * 0 0 1
N o r m a l  v. P r o b a b le  R A 1 49 2 - 8 > 0 - 0 5
P ro b a b le  r .  D e f in i te  R A 1 33 1 1 -9 5 < 0 * 0 1
N o  significant diflerence w as found between  
the D N A  phosphorus content o f  the circulating 
lym phocytes from  patients with rheumatoid  
arthritis and norm al individuals. The mean  
for the definite rheum atoid arthritis group was 
identical with that for the norm al series, 0 -73  /ig, 
D N A P  per 10® cells; the lym phocytes from the 
probable rheum atoid group had a higher m ean D N A  
phosphorus content, 0 -7 6  /ig. D N A P  per 10® cells, 
but this difference, was not significant. N o  signifi­
cant difference in the D N A  phosphorus content 
of the lym phocytes was noted between males and  
females in either the rheum atoid patients or the  
control subjects.
RNA
The results are summarized in Fig. 2 and Tables I 
and II. The mean R N A  phosphorus content o f  the  
circulating lym phocytes in  definite rheum atoid
arthritis, 0*27 /xg. R N A P  per 10® cells, was signifi­
cantly difièrent from the control group, 0*19 /^g. 
R N A P  per 10® cells (P <  0*001), The mean R N A  
phosphorus content o f  the lym phocytes o f  patients 
with probable rheum atoid arthritis was 0*23 j^ g. 
per 10® cells, and analysis o f variance o f the results 
showed no significant difference from  the control 
values.
R N A P /D N A P  Ratio
This was calculated for each patient and control 
from  the results o f  the R N A P  and D N A P  analyses. 
The R N A P /D N A P  ratios o f the lym phocytes in 
patients and controls are show n in Fig. 3 and  
summarized in Tables I and II. The m eans for the 
ratios in the three groups were: 0 30 for patients 
with probable rheum atoid arthritis, 0* 37 for patients 
with definite rheum atoid arthritis, and 0*26 for  
norm al subjects. The definite rheum atoid group
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was significantly difiercnt from  the normal (P < 
0-001). T he probable rheum atoid group was not 
significantly difiercnt from the normal, but dificrcd 
significantly from , the definite rheum atoid group  
(P  <  0-01).
It was possible to match for age and sex, ten 
patients with definite rheum atoid arthritis and ten 
controls. Pairings were carried out by random  
selection when m ore than one match was available. 
The lym phocyte R N A P /D N A P  ratio was again  
dilTcrent in the matched groups; the mean ratio for 
patients with definite rheum atoid arthritis was 
0*37 d: 0*04 and for norm al subjects 0*26 -± 0.03 
P  <  0*001).
Mo close correlation was found between the 
R N A P /D N A P  ratio o f  the lym phocytes and the 
clinical or laboratory features o f  rheumatoid arthri­
tis, although, as shown, above, clear difierenccs were 
noted between the patients with probable and 
definite rheum atoid arthritis when considered as 
groups.
Discussion
The results o f analyses o f the D N A  phosphorus 
(D N A P ) content per 10® cells o f  the b lood  lym pho­
cytes in rheum atoid arthritis and in norm al indi­
viduals are close to the expected diploid am ount for 
m an (Leslie, 1960). D N A  phosphorus is thus a 
good  index o f  cellularity, and hence the mean R N A  
o f  the lym phocytes may be expressed as the R N A  
p hosphorus/D N A  phosphorus (R N A P /D N A P ) ratio 
o f the cells.
The interpretation o f  the rise in the average R N A  
content o f  the blood lym phocytes in rheum atoid  
arthritis is com plicated by the diversity o f the blood  
lym phocyte both in origin and in m orphology.
B lood  lym phocytes arc in part newly-form ed cells 
derived from bone marrow or spleen (large and  
medium-sized cells) and part recirculating lym pho­
cytes (small lym phocytes) which enter the tissues 
from the blood stream, percolate through to the 
lymphatics passing through lymph nodes, and re­
enter the blood stream by way o f  the major lym phatic 
trunks (G ow ans, 1959). Som e o f  these small 
lym phocytes are know n to have a prolonged life 
span, recirculating from blood to lymph repeatedly 
over a number o f years (Buckton, Jacobs, Court 
Brown, and D oll, 1962). T he lym phocytes o f  the 
thoracic duct which com prise the bulk o f  the 
recirculating cells were studied in anim als by 
Everett, Calfrey, and R ieke (1964), w ho observed  
that exposure o f the anim al to antigen produced an  
increase in the size and the protein synthetic rate o f  
the small lym phocytes entering the circulation. 
These alterations m ust also im ply an increase in the 
R N A P /D N A P  ratio o f  the lym phocytes. Thus a
rise in the mean R N A  content o f  the peripheral 
blood lym phocytes can occur in several ways. 
Firstly, by an increase in the numbers o f  circu­
lating large lym phocytes (either absolute or relative), 
or secondly, by an increase in the R N A  content o f  
the individual cells, either large lym phocytes, or the 
smaller lym phocytes, or both.
It is likely that increased im m unological 
activity will result in an increased production o f  
newly-formed and hence large lym phocytes. W ardle 
and At tan (1967) observed hyperplasia o f lym phoid  
elem ents in the bone marrow o f  patients with  
rheum atoid arthritis, Everett and others (1964), in 
their studies o f  the effect o f  antigens on the lym pho­
cytes, observed an increase in the size o f  the long- 
lived lym phocytes and called the enlarged small 
lym phocytes “activated cells” . It is possible that, 
in rheumatoid arthritis, in the presence o f increased  
im m unological reaction, a proportion o f  the lym pho­
cytes carry increased am ounts o f  R N A  and are 
akin to Everett’s activated cells.
It is well established that small lym phocytes 
respond in vitro to a series o f agents, either specific, 
such as tubercujin purified protein derivative and 
pertussis vaccine, or non-specific, such as phyto- 
hacm agglutinin (Hirschhorn, Bach, K olodny, Fir- 
schcin, and Hashcm, 1963). This transform ation  
response is characterized by an increase in several 
features o f  the cell, including size, rates o f  nucleic 
acid synthesis, and R N A  content. A parallel has 
been drawn between the behaviour o f  the cells in 
vivo and their response in vitro, and this is o f  special 
interest in rheum atoid arthritis. Lym phocytes will 
transform in vitro when exposed to antiscra to 
y-globulin (Sell and C ell, 1965). A similar response 
in vivo to rheumatoid factor, circulating antibody to 
y-globulin, could be an explanation for increased 
amounts o f  R N A  in the circulating lym phocytes in 
rheumatoid arthritis.
The possibility that drug treatment o f  patients 
with rheumatoid arthritis has influenced the R N A P / 
D N A P  ratio o f  .the lym phocytes in this series has 
been considered. A ll o f  the patients investigated  
were taking salicylates or steroids or both. High  
lym phocyte R N A P /D N A P  ratios occurred in the 
patients studied irrespective o f  these categories. It 
is known that the im m ediate effect o f steroids is to  
reduce the number o f small lym phocytes, however 
the effect o f  prolonged therapy tends towards 
recovery o f the pre-treatment state (G len, Cooper, 
Jacob, Boak, Murray, and M unro, 1967). In the 
present series there was no significant difference in 
the R N A P /D N A P  ratios o f  those receiving steroids 
and the rest.
A lthough the precise cause o f  the change in the 
lym phocyte R N A P /D N A P  ratio Iras not been
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defined, the data show  that the ratio is frequently rheumatoid artiiritis, according to the American
increased in the blood lym phocytes o f patients with Rheumatism A ssociation diagnostic criteria. Similar
rheumatoid arthritis. H ow  this observation may measurements were made in forty healthy individuals, 
be linked to the pathogenesis o f the disease remains A significant increase in the R N A  content o f  the
an open question; however the dem onstration by lymphocytes in patients with definite rheum atoid
Birbeck and Hall (1967) o f  the transformation in arthritis when com pared with the controls was
vivo o f large basophilic lym phocytes (released ,by a demonstrated. Possible reasons for this difference
lymph node on antigenic stim ulation) into plasm a are discussed in relation to the known reactions o f
cells makes it very likely that lym phocytes are the lym phocyte to im m unological stimuli and to
indeed the effectors o f cell-bound immunity. drug treatment. It is concluded that the increased
lymphocyte R N A  content found in patients with 
rheumatoid arthritis is evidence o f  the participation  
Summary o f  the lym phocyte in the im m unological derange-
The average cell D N A  and R N A  was measured ments o f  the disease, and that the R N A /D N A  ratio
in lymphocytes obtained from  the peripheral blood o f  the lym phocyte may be a useful means o f  measur-
o f  24 patients with definite and eleven with probable ing im m unological activity.
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Lc teneur des lymphocytes en AON el en ARN duns la 
polyardiritc rhuniatoïdc
R É S U M É
On détermina le taux moyen d’A D N  et d’ARN dans 
les lymphocytes provenant du sang pcriplicriquc de 35 
malades atteints de polyarthrite rhumatoïde; chez 24 
d ’entre eux la maladie était “dcfinie” et chez 11 “ prob­
able”, selon les critères diagnostiques de VAmerican 
Rheumatism Association. On fit la même chose chez 40 
sujets sains. On mit en évidence une augmentation 
appréciable du taux lymphocytairc d’ARN chez les 
malades atteints de polyarthrite rhumatoïde “définie” 
par rapport aux témoins. On discute les raisons probables 
de cette dificrcnce à propos des réactions bien connues 
du lymphocyte à l’égard des stimulants immunologiqucs 
et des produits médicamenteux. On conclut que la 
teneur en A R N  augmentée des lymphocytes, trouvée 
chez des malades atteints de polyarthrite rhumatoïde, 
constitue une preuve de la participation du lymphocyte 
dans le dérangement morbide et que la raison AR N /A D N  
du lymphocyte peut être utile pour mesurer l’activité 
immunologique.
Las diras linfocitarias de AON y de ARN en la poH- 
artritis rcumatoidc
SüMARIO
Sc dctcrminaron las cifras médias de ADN  y de ARN  
en linfocitos de las sangrc péri 1er ica de 35 cnfermos con 
poHartrilis reumatoide, que fiié “dcfinida” en 24 casosy  
“ probable” en 11 casos, scgi'in los critcrios diagnôsticos 
de la American Rheumatism Association. Sc hizo lo 
mismo en 40 sujet os sanos. Se evidcnciô un aumcnto 
aprcciablc de las cifras linfocitarias de ARN en enfermes 
con poliartritis reumatoide “definida” en comparadôn 
con los tcstigos. Sc discutcii las causas probables de esta 
difcrcncia en rclaciôn con las reaccioncs conocldas del 
linfocito hacia estimulos inmunolôgicos y productos 
medicamenlosos. Sc concluyc que las cifras aumentadas 
de ARN en leucocitos, encontradas en cnfermos con 
poliartritis reumatoide, ofreccn una prucba de la parti- 
cipaciôn del linfocito en el dcsarreglo morboso y que la 
razôn A R N /A DN  del linfocito puede utilizarse para 
medir la actividad inmunolôgica.
^ SonJcrdruck nus • R eprint from  • Tire* a part 1  ^  ^ 1
 ^ M o d e r n  G a s t r o e n t e r o lo g y
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23. Immunological Defect as the Cause of Whipple’s Disease 
and Colonic Histiocytosis
A. Ferguson, J. D. Maxwell, R. C. Imrte and A. C. A. Glen
In Whipple’s disease, abnormal macrophages and many bacilli are present in the
intestinal mucosa. A variety of organisms have been cultured, suggesting that this disease 
is due to a host abnormality rather than to a specific infection. In colonic histiocytosis 
many macrophages are present, but do not contain bacilli. Both disease states could result
from an abnormal cellular response to foreign material. To test this hypothesis the
immunological functions of 4 patients have been studied.
All 4 patients were in complete remission and on no treatment. Case 1 (Whipples) had 
apparently been cured by a course of chloramphenicol 1 year earlier. Case 2 (Whipples) 
had been well since a course of tetracycline 3 years before. In cases 3 and 4 the diagnosis 
of colonic histiocytosis had been made on the basis of a history of chronic intermittent 
diarrhoea, and rectal biopsy containing many PAS-positive macrophages, •
M e t h o d s
D N A  and RNA were assayed in peripheral blood lymphocytes using a modilication of 
the Schmidt-Thannhauser procedure and ultra-violet absorbtinietry (1). The uptake of 
'^‘C labelled thymidine was used as a measure of lymphocyte transformation in response 
to varying concentrations of phytohaemagglutinin (PHA) (2). Mueller, Tormay and 
I m r i e  have reported preliminary studies on a human serum fraction which will further 
stimulate the D N A  synthesis produced by PHA. The effect of this material on PHA- 
stiniulated lymphocytes was studied in 3 cases.
,
R esu l t s
Screening tests revealed normal number and morphology of the circulating white blood 
cells. Several normal antibodies .were detected. There were no autoantibodies. Serum 
immunoglobulin-M was low in case 2.
The results of studies on lymphocytes are summarised in Tables 1, 2 and 3,
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Table 1. N ucleic acid content of peripheral blood lymphocytes.
D N A P  
(pg/10® lymphocytes)
R N A P  
(pg/10® lymphocytes)
Norm al human
lymphocytes
Mean 0.73 0.19
Standard deviation 0.12 0.06
Case 2 0.54 0.11
Case 3 0.45 0.10
Case 4 0.68 0.21
Table 2, Maximum lym phocyte response to P H A  (percentage o f control),
Control lOOVn
Case 1 52%
Case 2 54%
Case 3 47®/o
Case 4 102%
Table 3. E ffect o f scrum fraction on P H A  stimulated lymphocytes 
(percentage o f response to PFIA alone).
PH A  PFIA +  extract
. Control 1 0 0 - —> 135%
Case 2 100 94®/o
Case 3 100 310%
Case 4 100 > 251%
D iscu ss io n
The R N A  content of cells reflects their protein synthetic activity. In auto-immune 
diseases there is*an increase in the RNA content of circulating lymphocytes; with im­
munosuppressive therapy the lymphocyte R N A  content falls. The low R N A  in cases 2 
and 3 suggests that the immunological activity of these cells is low. The low mean 
lymphocyte D N A  may indicate that, in these patients, a significantly reduced proportion 
of lymphocytes are actively synthesising DNA, hence containing more than the diploid 
amount of DNA.
Lymphocyte transformation in response to PHA probably reflects the immunological 
capacity of the cells; a low response was found in 3 patients. Normally the serum 
fraction will increase D N A  synthesis by up to tOOYo. In case 2 there was no increase in 
response. In cases 3 and 4 the response was more than doubled. This suggests either that
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P H A  had exerted a submaximal clfcct, or that the amount o f  the factor in the patients’ 
cells was low.
These results could be due to generalised, mild lymphocyte abnormality. Alternatively,  
as the circulating lymphocytes arc of heterogeneous origin, they m ay indicate a smaller 
number of  lymphocytes w ith grossly impaired function —  perhaps those associated with  
the gastrointestinal tract. W hipple’s disease and colonic histiocytosis m ay form part o f  
the spectrum of disease states which result from impaired cell-mediated immune responses.
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THE NUCLEIC A C ID  CONTENT OF LYMPHOCYTES 
IN THYROTOXICOSIS
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S U M M A R Y
In LATS positive thyrotoxic patients the blood lymphocyte RNA content was 
significantly greater than normal, but not significantly different from normal in 
LATS negative thyrotoxicosis patients. Changes occurred in the RNA content of 
the lymphocytes following treatment whether by radioactive iodine or carbimazole.
' I N T R O D U C T I O N
The blood of a proportion of patients with thyrotoxicosis (Graves’ disease) contains a 
circulating immunoglobulin (IgG) the long acting thyroid stimulator, LATS (McKenzie,
1967). Blood lymphocytes have been identified as one site of IgG production (Turner & 
Forbes, 1966), and McKenzie (1967) showed that lymphocytes from thyrotoxic patients 
produced LATS when stimulated in vitro by phytohaemagglutinin. It is therefore relevant 
to reconsider the hatime of the lymphocytes in thyrotoxicosis. Hern berg (1954) has reported 
that the size of the blood lymphocytes was increased in thyrotoxicosis and returned to 
within normal limits when the patients were euthyroid after partial thyroidectomy. The 
measurement of the D NA and RNA content of the peripheral blood lymphocyte (Glen,
1967) provides an objective method of assessing the nature of the circulating lymphocytes; 
in some conditions, for example rheumatoid arthritis, there is a relationship between the 
RNA content of blood lymphocytes and the severity of the disease (Glen & Jasani, 1968).
On the assumption that thyrotoxicosis is in part an immunological disease, wc thought it 
of interest to measure the RNA content of the blood lymphocyte and to compare measure­
ments before and after carbimazole and radioactive iodine treatment. In addition, since the 
presence of the immunoglobulin LATS might be an index of the degree of the immuno-
Correspondence: Dr J. F. B. Smith, University Department of Medicine, Glasgow Royal Infirmary, 
Glasgow, C.4.
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logical disturbance, we compared lymphocytes from blood positive for LATS with cells 
from blood negative for LATS.
PATIENTS A N D  M E T H O D S
Methods. Blood samples from thirty-six patients, twenty-eight women and eight men 
(age range 22-70 years, mean age 49 years) were studied. The clinical thyrotoxicosis was 
confirmed with radioiodine studies, serum protein bound iodine estimations and serum tri­
iodothyronine resin sponge tests. Blood from healthy control subjects was taken from twenty 
adults, eleven men and nine women (age range 18-63 years, mean age 30 years).
The LATS activity of sera from the thyroid patients was measured using the bioassay of 
Kriss in which test and control sera (0-5 ml) are injected intraperiloneally into white male 
Swiss mice whose thyroid iodine is labelled and the thyroid stimulation monitored by 
measuring the increase in blood radioactivity at 24 hr (Kriss, Pleshakov & Chien, 1964). 
The net increase in blood radioactivity which represents the discharge of iodine from the 
gland is expressed as counts/min per O-I ml of blood and the results are recorded as a per­
centage increase for each sera. A blood radioactivity of 150% of that before administration 
of sera was taken as a LATS positive response.
The method for analysis of the D N A  and RNA content of the blood lymphocyte has been 
described previously (Glen, 1967); there are two stages, separation of lymphocytes from 
blood, and chemical analysis of D N A  and RNA.
20 ml of venous blood were withdrawn from each patient with EDTA as anticoagulant 
and the lymphocytes separated using a modification of the gelatin sedimentation procedure 
of Coulson & Chalmers (1964). The technique used was as described by Glen except that a 
suggestion by Cooper (1967) has been adopted in these experiments which has improved the 
reliability of the lymphocyte separation by eliminating polymorphonuclear leucocyte 
contamination of thé isolated cells. In this modification, the cell suspension was allowed to 
soak into cotton wool at 37^’C for 15 min and is thereafter expressed by gentle pressure. 
Red cells were removed by osmotic shock and a final cell suspension obtained which con­
tained at least 97% lymphocytes. Measured numbers of cells always greater than 4 x lO*’ 
were submitted to a modified Schmidt-Thannhauser separation, and the separated D N A  and 
RNA fractions analysed by UV absorptiometry making appropriate correction for the 
presence of protein (Fleck & Munro, 1962). The results were expressed as pg D N A  phos­
phorus (DNAP) per lO*’ cells and R N A  phosphorus (RNAP) per 10^  cells. It is an advantage 
to use the RNAP/DNAP ratio of the cells rather than RNAP content expressed per million 
cells since this eliminates cell counting error. The RNAP/DNAP ratio is a valid index of 
cell R N A  provided the D N A  content of the lymphocyte is constant. It has previously been 
shown that the lymphocyte RNAP/DNAP can be measured with an error of within ±5 % 
when duplicate blood samples are analysed.
Patients studied. Ten patients were treated with carbimazole and the nucleic acid measure­
ments were carried out before and after control of the thyrotoxicosis but during maintenance 
treatment with carbimazole 15-20 mg daily, an average of 4 months (range 2-6 months) 
after starting drugs. Twenty-one patients were treated with radioactive iodine and nucleic 
acid measurements were carried out on the lymphocytes before and after control of thyro­
toxicosis, 4 months (range 2-6 months) from the time of the dose. Of the remaining five 
patients, three patients underwent partial thyroidectomy and two patients did not return.
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RESULTS
The mean of the DNA values of the blood lymphocytes in the twenty normal individuals 
was 0*732 /ig DNAP per 10^  cells (SD = 0*114) and from the thirty-six thyrotoxic patients 
before treatment it was 0*740 //g (SD = 0* 117). These data are shown in Fig. 1. Treatment of 
thyrotoxicosis did not affect the D N A  values so that the RNAP/DNAP ratio was considered 
a valid index of mean RNA content of the lymphocytes and this applied irrespective of the 
treatment regimes.
Table 1 shows the RNAP/DNAP ratios of lymphocytes from thyrotoxic patients before 
and after treatment with either carbimazole or radioactive iodine and these data are
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F ig . 1. The blood lymphocyte D N A  content in normal and thyrotoxic patients. The mean 
values were not significantly different (NS) by /-test.
compared to those from normal individuals which are also shown in the Table. The results 
from the group of ten patients treated with carbimazole are higher than normals but only 
after drug treatment are the differences significant (P<0*02). This applies when the mean, 
after treatment, is compared to that before treatment or with normal people. When the 
RNAP/DNAP ratio data from patients treated with radio-iodine therapy is similarly 
examined there is a difference between means after therapy compared to that of normal 
people. In contrast, however, there is not a significant difference between the mean lympho­
cyte RNAP/DNAP before and after therapy, but the pre-treatment values are relatively high 
(mean = 0*323).
Fig. 2 shows the lymphocyte RNAP/DNAP ratios from the patients whose sera was 
negative in the LATS bioassay (twenty-two) and these from patients positive in the LATS
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T a b lk  j . Blood lymphocyte RNAP/DNAP ratios in untreated (thyrotoxic) and treated (euthyroid) 
patients with the results in normal individuals for comparison
Before treatment 
(thyrotoxic)
After treatment 
(euthyroid)
Comparison of prc- 
and post-treatment 
means by /-test
Treated by carbimazole Mean =  0-308 (10) 
SD =  0-053
*Mean =  0-365 (10) 
SD =  0-050
/ =  2-55 
P <0-02  
Significant
Radioactive iodine Mean =  0-323 (21) 
SD =  0-068
'“Mean =  0-352 (19) 
SD =  0-048
/ =  1-60 
P <0-20  
Not significant
Normal individual 
untreated
Mean =  0-296 (20) 
SD =  0036 '
* Values denoted by the asterisk are significantly different from the results in the normal untreated 
control subjects.
The results of comparison of the lymphocyte RNAP/DNAP ratio in pre-treatment thyrotoxic and 
post-treatment euthyroid patients are tabulated, showing the mean values and the standard devia­
tion with the number of individuals in parentheses. The results of a comparison of mean values by 
Student’s /-test are listed.
Lymphocyte RNAP/DNAP ratio
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bioassay (twelve); Ihc normal data are shown for comparison. The mean ratio values from 
those with LATS negative sera was 0*302 and from those with LATS positive it was 0*326. 
Intercomparisons were made and it was found that the mean lymphocyte ratio RNAP/ 
DNAP from LATS positive blood was higher (mean 0*326) than that from normal blood 
(mean 0*295), with a P value of <0*05.
The mean lymphocyte count in the peripheral blood of nineteen of the patients with 
untreated thyrotoxicosis was 2250 cells/mm^  with a range of from 1060 to 4600 lymphocytes/ 
mm^. Two patients had a total white cell count of 4000 or less/mm'^  with a relative lympho­
cytosis. Peripheral blood lymphocyte counts following treatment are incomplete but it 
appears from limited data that the lymphocyte count increases following radioiodine therapy 
and decreases in patients treated with carbimazole. This aspect of the study is being further 
pursued.
DISCUSSION
The results of the lymphocyte RNAP/DNAP ratio determinations do not show a large differ­
ence when thyrotoxic blood lymphocytes are compared with normal lymphocytes; however, 
the lymphocytes from blood positive for LATS had a higher RNA content than that present 
in the normal lymphocytes. An elevated RNAP/DNAP ratio of the lymphocytes is found 
when there is an absolute increase in the number of the larger cells or when the increase is 
relative due to a reduction in the number of small lymphocytes. The former is the case when 
there is increased immunological activity as for example in response to viral infection 
(Lesiewska, 1967; Pariser, Zucker & Meyer, 1952; Zucker-Franklin, 1969; Crowther, 
Fairley & Sewell, 1969).
In untreated thyrotoxicosis the lymphocyte RNAP/DNAP ratio is significantly higher 
than normal only in patients with a positive LATS bioassay and this, in the presence of 
normal blood lymphocyte counts, would be consistent with an increase of immunological 
activity. The data also suggest that immunological activity may be intensified by radio­
active iodine therapy, possibly as a result of antigen release by radiation damage to the 
thyroid gland.
The interpretation of data from drug-treated patients is difficult. Whether the significant 
increase in the mean lymphocyte RNA content, apparently produced by carbimazole 
treatment, indicates a special extra thyroidal effect of the drug in lymphocytes, requires 
further study.
It is of interest that thymic lymphoid follicle formation is present in adults with thyro­
toxicosis (Gunn, Michie & Irvine, 1964) and that there is a reduction in thymic size in 
patients on anti-thyroid drugs (Michie et at., 1967). Our data would suggest that the anti­
thyroid drugs also have a measurable effect on blood lymphocytes. We would interpret the 
data as indicating a reduction in thymic dependent lymphocytes resulting in an increase in 
the proportion of large lymphocytes in the blood. This has the implication that immuno­
suppression may be one of the actions of carbimazole.
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S U M M A R Y
Cellular and humoral immune responses have been measured in patients with 
Sjogren’s syndrome with, and without, rheumatoid arthritis, patients with sero­
positive and sero-negative rheumatoid arthritis, and a control group of patients. 
Several patients with sero-positive rheumatoid arthritis and patients with 
Sjogren’s syndrome complicated by rheumatoid arthritis failed to respond to 2-4 
Dinitrochlorobenzene, and exhibited poor secondary responses to tetanus toxoid. 
Mantoux responses, however, were diminished only in patients with the sicca 
syndrome. Estimation of RNA/DNA ratios of peripheral blood lymphocytes 
showed increased ratios in those groups of patients responding poorly to DNCB 
and tetanus toxoid. As the lymphocyte RNA/DNA ratio is correlated to mean 
lymphocyte diameter, this means that patients with elevated ratios have an absolute, 
or relative, increase in the number of large lymphocytes circulating in the peripheral 
blood. It is suggested that failure to respond to DNCB may be due to a deficiency 
of uncommitted small lymphocytes.
I N T R O D U C T I O N
Both rheumatoid arthritis and Sjogren’s syndrome, which is frequently associated with 
rheumatoid arthritis (Bloch, Buchanan, Wohl and Bunim, 1965), are characterized by 
lymphoid infiltrates in affected tissues, dysproteinaemia, and a multiplicity of serum 
autoantibodies (Bloch et a i , 1965; Anderson, Buchanan & Goudie, 1967; Whaley & 
Buchanan, 1969). In addition, generalized lymphadenophy and splenomegaly may occur 
in both diseases (Bloch et al., 1965; Robertson et al., 1968). In Sjogren’s syndrome without 
rheumatoid arthritis it is now well established that extra-salivary lymphoid abnormalities 
including ‘pseudolymphoma’, lymphoma and Waldenstrom’s macroglobulinaemia may 
occur (Talal & Bunim, 1964; Talal, Sokoloff & Barth, 1967). In rheumatoid arthritis there is 
statistical evidence to suggest an increased prevalence of lymphosarcoma (Lea, 1964).
Correspondence: Dr K. Whaley, The University Department of Pathology, Western Infirmary, 
Glasgow, W .l, Scotland.
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Abnormalities of the thymus including germinal centre formation have been reported in 
patients with rheumatoid arthritis (MacSween, Anderson & Milne, 1967), but to date, to 
our knowledge, no such changes have been found in Sjogren’s syndrome, although only a 
few cases have been examined (Bloch et aL, 1965).
Results of immunization studies in rheumatoid arthritis have yielded conflicting results. 
Normal antibody responses have been found to heterologous blood groups in patients with 
rheumatoid arthritis (Creger et a i , 1951). Meiselas et al. (1961) demonstrated hyper­
responsiveness to Brucella abortus whereas normal responses were found by another group 
of workers (Shearn, Epstein & Engleman, 1963). Results of immunization with tetanus 
toxoid have produced even more conflicting results; Greenwood & Barr (1960) showed 
higher antitoxin titres than controls, Vaughan & Butler (1962) detected no differences in 
antibody response, while Barr et a i , (1964) noted a significant number of rheumatoid 
patients having subnormal responses to tetanus toxoid. Normal antibody responses to 
pneumococcal polysaccharide have been observed (Larson & Tomlinson, 1953).
In view of the obvious anatomical and functional abnormalities of the immune system in 
Sjogren’s syndrome and rheumatoid arthritis, it was decided to investigate both cellular and 
humoral immune responses in these conditions.
MATERIALS A N D  M E T H O D S
Patients studied
Five clinical groups of patients were studied; control subjects who suffered from osteo­
arthrosis, disc degeneration or non-articular rheumatism, patients with sero-positive 
rheumatoid arthritis, patients with sero-negative rheumatoid arthritis, patients with rheu­
matoid arthritis and Sjogren’s syndrome, and patients with the sicca syndrome. All the 
patients studied were females, and none were taking corticosteroid or immunosuppressive 
therapy. Sjogren’s syndrome was diagnosed using the criteria of Bloch et al. (1965). Patients 
having Sjogren’s syndrome without an associated connective tissue disease were said to 
have the sicca syndrome. Keratoconjunctivitis sicca and xerostomia were diagnosed as 
previously described (Williamson et a i , 1967; Whaley et a i , 1969). Rheumatoid arthritis 
was diagnosed using the diagnostic criteria of the American Rheumatism Association 
(Ropes et al., 1958). The patients included fell into the ‘probable’, ‘definite’, or ‘classical’ 
categories.
Clinical details included the age of the patient, disease duration, functional grade and 
X-ray stage (Steinbroker, Traeger & Batterman, 1949), articular index (Ritchie et a i , 1968), 
and the presence or absence of granulomatous nodules, lymphadenopathy and splenomegaly 
Laboratory details included haemoglobin concentration (g/100 ml), white cell and platelet 
counts (per cu mm), erythrocyte sedimentation rate (ESR m m  in 1st hour-Westergren) 
and serum albumin and globulin concentrations (g/100 ml).
Examination for rheumatoid factor was performed by the latex agglutination technique 
(Hyland Laboratories), at a 1/20 serum dilution. Positive sera were then tested by the 
sensitized sheep cell agglutination test at a titre of 1/32 and then in doubling dilutions until 
an end point was reached (ZiflT et a i , 1956). Anti nuclear factor was detected by the technique 
of Beck (1961). Sera was screened at a dilution of 1/16 and positive sera were titrated in 
quadrupling dilutions until an end point of nuclear staining was reached,
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Cellular immune responses
Chemical contact sensitization with DNCB was performed by applying 2000 pg of 
DNCB in O-I ml of acetone to an area of approximately 3 cm diameter on the volar aspect 
of the upper forearm. The area was covered for 7 days and challenge doses of 25, 50 and 
100 pg of DNCB in 0-1 ml of acetone were applied to the opposite forearm after 14 days to 
see whether sensitization had occurred. The results were read— 2-4 days later when signs of 
delayed hypersensitivity, viz. erythema, induration and vésiculation, were recorded.
Old tuberculin, 0-1 ml of 1/10,000 dilution, was given intradermally, and the response 
read after 48 hr. An area of induration of 5 m m  or more was regarded as positive. Patients 
not responding to this dose were subsequently challenged with 0*1 ml of 1/1000 dilution, and 
if still negative 0-1 ml of 1/100 dilution. Patients not responding to 0-1 ml of 1/100 dilution 
were said to be Mantoux negative.
Humoral immune responses
Patients received two subcutaneous injections of 1 ml (about nine L.F. ) of the same 
batch of tetanus toxoid with an interval of 6 weeks between injections. The tetanus toxoid 
(Burroughs Wellcome) was stored in a refrigerator at 2^ 'C until used. Blood samples were 
taken before the first injection, and 14 days following the second injection. Tetanus 
antitoxin concentrations were determined in mice by the method of Glenny & Stevens 
(1938), the result being expressed as units of tetanus antitoxin per ml of blood. None of the 
patients had received tetanus toxoid prior to the study.
Isohaemagglutinin litres were estimated using standard 2% suspensions of human 
group Aj, A 2 and B erythrocytes and doubling dilutions of serum. The degree of ag­
glutination titre was read after 60 min at room temperature. Control sera of known iso­
haemagglutinin titre were always included (Dacie & Lewis, 1968). The number of pregnancies 
in patients was similar in all groups. Four patients with sero-positive rheumatoid arthritis 
had had blood transfusions, none of which had been associated with transfusion reactions.
Lym phocyte studies
Lym phocyte separation technique. Pure suspensions of peripheral blood lymphocytes were 
obtained by two different methods: (1) a modification of the method of Coulson & Chalmers 
(1964) using EDTA as anticoagulant and separating the red cells from the leucocyte-rich 
fraction by adding 6  ml of 3% gelatin in 0*15 M  saline to 20 ml of blood and allowing the 
tube to stand for 30 min at 37°C. The leucocyte-rich plasma was then defibrinated by stirring 
for approximately 15 min, thus also removing the majority of polymorphonuclear leucocytes;
(2) a second method, identical to the first, except that cotton wool was added to the de­
fibrinated suspension to reduce still further polymorphonuclear leucocyte contamination of 
the lymphocyte preparations. Only the lymphocyte suspensions from patients with the 
sicca syndrome were purified by this method.
Residual red cells were then removed from the lymphocyte preparations by osmotic 
shock, and following centrifugation at 125 g the supernatant containing free haemoglobin 
and red cell ghosts was pipetted off, leaving a button of lymphocytes over 95% pure. The 
cells were resuspended in 2-5 ml of 0*15 m  saline and a cell count performed. Approximately 
12 million lymphocytes were obtained from each 20 ml blood sample.
Estimation o f  the size o f  peripheral blood lymphocytes. The mean size of 100 lymphocytes 
on peripheral blood smears stained with Leishman’s stain was obtained using a Watson
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image-shearing eyepiece. Smears were examined without knowledge of lymphocyte RNA/ 
DNA ratios.
Estimation o f  R N A jD N A  ratio o f  lymphocytes. At least 2 million cells were necessary to 
estimate the cellular RNA and D N A  content. RNA/DNA ratios were measured using the 
technique of Glen (1967). The RNA content of the separated RNA fraction was determined 
by measuring the absorbance at 260 m p and then correcting for protein contamination 
(Fleck & Munro, 1962). D N A  concentrations were measured by estimating the absorbance 
at 265 m p (Davidson, 1957), using highly polymerized calf thymus D N A  (Sigma London 
Chemical Co.) as a standard.
Statistical methods
Results of DNCB and Mantoux tests and tetanus immunization were analysed using the 
chi square test, with Yates’ correction for small numbers where necessary. Isohaemag­
glutinin titres were analysed using the Student’s /-test.
RESULTS
Sensitization by D N C B
Three challenge doses of DNCB 25, 50 and 100 pg were used to attempt to increase the 
sensitivity of the test by revealing greater differences between the test groups and the 
controls at the lower doses. However, this was not observed, and so all patients responding 
to 100 pg DNCB were said to have been sensitized.
Table 1 shows the clinical features of the patients tested and the results of exposure to 
DNCB. Twenty-two of twenty-four (91-7%) control subjects were sensitized to DNCB. 
This is approximately the number one would expect to become sensitized in a normal 
population (Waldorf al., 1966), Normal responses to DNCB were observed in patients 
with the sicca syndrome (nineteen of twenty-four; 79*7%) and sero-negative rheumatoid 
arthritis (eleven of twelve 91*7%). Reduced numbers of patients sensitized to DNCB were 
found in sero-positive rheumatoid arthritics (ten of seventeen; 58*8%; P<0*05) and 
rheumatoid arthritics with Sjogren’s syndrome (eight of sixteen; 50%; E<0*005). The 
results noted in sero-positive and sero-negative rheumatoid arthritics did not differ signifi­
cantly from each other, probably because too few patients with sero-negative rheumatoid 
arthritis have been examined.
T a b l e  1. Results of DNCB sensitization
No. DNCB positive
Clinical group Number Age (yrs) 25 gg 50 pg 100 //g
Controls 24 59*3 ±  8*1 16 (66*7%) 17 (70*8%) 22 (91*7%)
Sero-positive RA 17 55*3 ±  9-1 5 (29*4%) 6 (35*3%) 10 (58*8%)
Sero-negative RA 12 46*4+ 13*2 7 (58*3%) 8 (66*7%) 11 (91*7%)
RA +  Sjogren’s 16 57*1 +  10*7 3 (18*8%) 5(31*3%) 8 (50*0%)
syndrome
Sicca syndrome 24 63*8±10*8 10(41*7%) 15 (62*5%) 19 (79*2%)
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T a b l e  2. Results of Mantoux tests
Mantoux positive
Clinical group Number Age (yrs) 1/10,000 1/1,000 1/100
Controls 26 59*9± 8*5 4 (15*4%) 11 (42*3%) 21 (80*8%)
Sero-positive RA 32 54*8 ±  8*7 4 (12*5%) 11 (34*4%) 22 (68*8%)
Sero-negative RA 21 51*0+13*7 3 (14*3%) 5 (23*8%) 13 (61-9%)
RA +Sjogren’s 19 55*7+10*4 1 (53% ) 2 (10*5%) 11 (57*9%)
syndrome f  <0*05
Sicca syndrome 24 63*8 ±10*8 2 (8*3%) 6 (25%) 11 (45*0%)
F < 0 0 5
All attempt to correlate DNCB unresponsiveness with clinical and laboratory indices 
revealed that the sero-positive rheumatoid arthritic patients had a significantly lower serum 
albumin level (f <0 01) and a higher mean articular index <0-025) than sensitized patients 
No correlations were seen in the other clinical groups.
M antoux tests
The mean age and sex distribution of patients Mantoux tested are shown in Table 2. 
Although all four test groups contained fewer Mantoux positive individuals than the control 
group at all three dilutions, only the groups of patients with rheumatoid arthritis and 
Sjogren’s syndrome, when tested with the 1/1,000 dilution (f <0 05), and patients with the 
sicca syndrome, when tested with the I/lOO dilution (E<0*05), had significantly reduced 
Mantoux responses. Patients with sero-positive rheumatoid arthritis who were Mantoux 
negative had a significantly higher mean erythrocyte sedimentation rate (P<0*025) than 
those who were Mantoux positive, and patients with sero-negative rheumatoid arthritis who 
were Mantoux positive had a significantly lower mean serum albumin (P<0*01) and a 
significantly higher mean erythrocyte sedimentation rate (P< 0*005).
No relationship between the responses to DNCB and Mantoux testing were observed in 
any of the clinical groups (Table 3).
T a b l e  3. Comparison of results of DNCB skin sensitization and Mantoux tests
Clinical group
DNCB positive DNCB negative
Mantoux Mantoux Mantoux Mantoux
positive negative positive negative
Controls
24
Sicca Syndrome 24 
RA+Sjogren’s syndrome 
16
Sero-positive RA 
17
Sero-negative RA 
12
17 (77*3%) 
10 (52*6%) 
6 (75*0%)
5 (22*7%) 
9 (47*4%) 
2 (25*0%)
2 (50*0%) 
1 (20*0%) 
5 (62*5%)
0 (50*0%) 
4 (80*0%) 
3 (37*5%)
8(80*0%) 2(20*0%) 5(71*4%) 2(28*6%)
5 (45*4%) 6 (54*5%) 1 (100%) 0 (0%)
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Lymphocyte R N A jD N A  ratios
The results of the nucleic acid estimations in normal subjects, using the two techniques 
for obtaining pure lymphocyte suspensions, showed a small but insignificant variation (Fig. 
1). However, it was decided to compare the mean lymphocyte RNA/DNA ratio in each 
group of patients to the values noted in control patients using the same method of purifying 
suspensions of lymphocytes.
The distribution of RNA/DNA ratios is shown in Fig. 1. The mean ratios for patients 
with the sieca syndrome (0-330 + S.D. 0-098) and sero-negative rheumatoid arthritis (0-293 
+ S.D. 0-033) do not differ significantly from those found in normal subjects. Significantly
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raised values were however noted in sero-positive rheumatoid arthritics (0-364 + S.D. 0-054; 
f <0-001), and rheumatoid arthritics with Sjogren’s syndrome (0-366 + S.D. 0-060; E < 0-001). 
The difference between the RNA/DNA ratios in patients with sero-positive rheumatoid 
arthritis is higher than that found in sero-negative individuals (P<0-01).
Relationship between R N A jD N A  ratio o f  peripheral blood lymphocytes and lymphocyte size
A correlation was found (/• — 0-76) between the mean diameter of lymphocytes in the 
peripheral blood, and the RNA/DNA ratio of the patient’s peripheral blood lymphocytes 
(Fig. 2). This suggests that patients with sero-positive rheumatoid arthritis, or rheumatoid 
arthritics with Sjogren’s syndrome, who have elevated lymphocyte RNA/DNA ratios, either 
have increased numbers of large lymphocytes in their peripheral blood, or a reduction in the 
number of circulating small lymphocytes.
Response to tetanus immunization
The results of tetanus immunization are shown in Table 4. There is a wide range of 
values in normal subjects and also in the various disease groups. The anti-toxin responses to 
secondary immunization were reduced in six cases of rheumatoid arthritis complicated by
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Fig. 2. Relationship between lymphocyte R NA /D N A ratio, cell size and mean lymphocyte 
diameter. # ,  RA; o, Normal. P =  0 02, r =  0 76.
Sjogren’s syndrome, and eight cases of sero-positive rheumatoid arthritis. The lowest 
secondary response in the controls was between 0*02 units/ml and 0*05 units/ml and re­
sponses less than this we have arbitrarily considered subnormal. In those groups with 
sero-positive rheumatoid arthritis and those with Sjogren’s syndrome associated with 
rheumatoid arthritis, the number of poor responders was significantly greater than in the 
control group (f <0*001 for sero-positive rheumatoid arthritis, f <0*001 for patients with 
rheumatoid arthritis associated with Sjogren’s syndrome).
Isohaemagglutinin titres
Table 5 shows the distribution of isohaemagglutinin titres in the clinical groups studied 
Compared to the control groups, patients with the sicca syndrome <0*05), and sero­
positive rheumatoid arthritis (f <0*01) had significantly reduced levels of anti-A^ . Reduced 
levels of anti-A2 were found in patients with Sjogren’s syndrome (R<0*05) and sero­
positive rheumatoid arthritis (R<0*02). Normal levels of anti-B were found in all clinical 
groups.
DISCUSSION
In this study we have measured the cellular and humoral immune responses in patients with 
sicca syndrome, rheumatoid arthritis complicated by Sjogren’s syndrome, and rheumatoid 
arthritis alone. The delayed hypersensitivity response to the chemical contact sensitizing 
agent DNCB was found to be normal in patients with the sicca syndrome, and those with 
sero-negative rheumatoid arthritis. Patients with rheumatoid arthritis complicated by 
Sjogren’s syndrome, and sero-positive rheumatoid arthritics exhibited impaired responses. 
Skin sensitization with DNCB has been attempted previously in patients with Sjogren’s 
syndrome (Leventhal, Waldorf & Talal, 1967) and rheumatoid arthritis (Epstein & Jessar, 
1959; Leventhal et aL, 1967). Our results are similar to those of Talal’s group, but they also
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observed a markedly diminished ability for patients with the sicca syndrome to become 
sensitized. This may reflect differences in patient selection and disease severity, as his 
patients have a relatively high incidence of lymphoid neoplasms (Talal & Bunim, 1964; 
Talal et a!., 1967), and patients with the sicca syndrome having this complication have been 
shown frequently to have neuropathy, arteritis, lymphadenopathy, splenomegaly and 
hyperglobulinaemia (Talal et al., 1967), all of which are indications of severe disease. The 
observation that patients with the sicca syndrome complicated by ‘pseudo-lymphoma’ 
usually could not be sensitised to DNCB (Leventhal et aL, 1967) supports this suggestion. 
Epstein & Jessar (1959), when assessing contact-type delayed hypersensitivity in patients 
with rheumatoid arthritis, used two antigens, DNCB and paranitrosodimethyl aniline 
(NDMA). Their results demonstrate a significant reduction in the number of rheumatoid 
arthritics who could be sensitized to NDMA, a weaker sensitizer than DNCB, to which 
normal response were obtained. The normal responses to DNCB may have been because 
these authors did not differentiate between sero-positive and sero-negative patients (39% 
of the patients were sero-negative for rheumatoid factor), and our results show that sero­
negative rheumatoid arthritics respond normally to DNCB.
Why patients with sero-positive rheumatoid arthritis and rheumatoid arthritis with 
Sjogren’s syndrome should not respond to DNCB is difficult to explain. The finding of 
normal Mantoux responses shows that the memory cells are intact, and able to mount a 
delayed hypersensitivity reaction in response to antigenic challenge, which suggests that 
unresponsiveness to DNCB may be due to a defect on the afferent side of the immunological 
response. This could be due to failure of immunologically competent small lymphocytes to 
come in contact with the area of skin exposed to DNCB, or alternatively the small lympho­
cytes having been exposed to DNCB, may fail to proliferate on reaching the local lymph 
node. Alternatively, unresponsiveness may be due to a defect on the efferent side of the 
immunological response. Thus, elevation of the RNA/DNA ratios of peripheral blood 
lymphocytes which has been shown to be due to an increase in the mean lymphocyte 
diameter, suggests that patients having elevated ratios have either a circulating population 
of large lymphocytes, perhaps transformed in response to antigenic stimuli, and/or a 
decrease in the number of circulating small lymphocytes possibly due to sequestration 
peripherally in the synovium. The finding that the groups of patients responding poorly to 
DNCB were the same as those with elevated lymphocyte RNA/DNA ratios suggests that 
the inability to become sensitized to DNCB may be due to such mechanisms. Finally, it is 
known that macrophages in patients with rhematoid arthritis have diminished phagocytic 
ability, and are unable to process protein antigens properly. Furthermore, they also 
respond poorly to chemotactic agents (Holt, 1970). All these factors could possibly account 
for failure to respond to DNCB, and obviously merit further study.
Diminished secondary responses to tetanus toxoid immunization occurred in patients 
with sero-positive rheumatoid arthritis and rheumatoid arthritis complicated by Sjogren’s 
syndrome. The reason for this is not apparent, but it is of interest that Barr et aL (1964) 
noted similar responses in patients with autoimmune thyroiditis. Conceivably patients who 
have high titres of humoral autoantibody have a diminished capacity to produce other 
immunoglobulins just as they have diminished albumin synthesis. On the other hand high 
or normal antitoxin titres to tetanus and diphtheria toxoids have been reported in patients 
with alcoholic cirrhosis where hypoalbuminaemia and general protein deficiency are evident 
(Havens, Shaffer & Hopke, 1951; Havens, Myerson & Klatchko, 1957; Cherrick et aL,
730 K. Whaley et al.
1959; Buchanan eî al., 1962). Moreover, antibody production is known to be normal in 
states of malnutrition (Gelfand, 1971. Personal communication).
Anti-Aj isohaemagglutinin titres were reduced in patients with the sicca syndrome and in 
patients with sero-positive rheumatoid arthritis. Anti-A2 levels were reduced in patients 
with the sicca syndrome, rheumatoid arthritis with Sjogren’s syndrome, and sero-positive 
rheumatoid arthritis. Other workers have noted decreased titres of anti-A and anti-B 
isohaemagglutinins in rheumatoid arthritic sera (Rawson, Abelson & McCarty, 1961; 
Rawson & Abelson, 1964; Kornstad, Guldberg & Kornstad, 1970). As isohaemagglutinins 
are exclusively IgM immunoglobulins (Kunkel, 1960). it is possible that the immune system 
is exclusively producing IgM rheumatoid factor and the presence of normal isohaemag­
glutinin titres in sero-negative rheumatoid arthritics is in agreement with this suggestion.
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SECTION 4
The lymphocyte and renal transplantation
136
4*1 Introductory review
The immune basis of allograft rejection has been established 
beyond question and an extensive literature on this topic has 
accumulated (Brent and Medawar, 19675 Elves, 1966). Not 
unexpectedly in the light of present understanding of immune 
reactions, antibody as well as cell bound mechanisms have been 
considered responsible for the rejection process. An early 
observation by Gorer (l937)? the appearance of circulating iso­
agglutinins following tumour transplantation, stimulated the search 
for anti-graft antibodies and claims of the importance of humoral 
mechanisms in renal transplantation have been made (Stetson, 1963; 
Altman, 1963? Milgrom, Litvac, Kano and Witebsky, 1966). On the 
other hand the active role of the lymphocyte in the processes of 
rejection has been firmly established since transplantation immunity 
can be transferred by lymph node cells (Mitchison, 1954), spleen 
cells (Billingham, Brent and Medawar, 1954), and peripheral blood 
leucocytes (Billingham, Silvers and Wilson, 1962).
The apparently conflicting claims of the importance of humoral 
mechanisms and cell bound immunity in rejection phenomena are less 
at variance when it is appreciated that rejection of a graft may 
take more than one form. An understanding of the pathology of 
graft rejection has evolved and although based on experimental work 
in rats (Strober and Gowans, 1965) a.nd on studies of canine renal
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allografts (Porter, Joseph, Randall, Stolinski, Hoehn and Caine, 
1964, and others), reviewed by Porter (1967), the process is 
probably as follows*
Within a few hours of the host blood circulation being 
established in the graft, host lymphocytes are exposed to graft 
antigens either by traversing the graft itself or in the local 
lymph nodes. In either case these lymphocytes reach the local 
lymph node or the spleen and give rise to a dividing line of cells, 
the immunoblasts. Over the succeeding few days the progeny of the 
immunoblasts are released via efferent lymphatics and the blood 
stream to reach the graft. There, these so called immunocytes 
interact probably with the endothelium of peritubular capillaries 
and gradual invasion of renal parenchyma with progressive tissue 
damage ensues. This is the pathology of acute renal allograft 
rejection occurring ih the absence of immunosuppressive drugs, 
within two weeks of the time of transplant. It is principally 
a cell mediated process, A proportion of rejected kidney grafts 
show only a minor cellular infiltrate. In these cases vascular 
damage is more conspicuous and there may be fibrinoid necrosis of 
arteriolar walls with platelet thrombi in glomerular capillaries. 
Here the presence of immunoglobulins, IgG and IgM as well as 
components of complement in the lesions, make it likely that 
antigen-antibody complexing is important for this type of 
rejection and may well initiate the formation of platelet thrombi 
(Mowbray, I966). Although of necessity this description has
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derived from animal experiments, there is evidence that renal 
allografts in man are rejected by the same mechanisms (starzl,
1964? Porter, I967). The use of immunosuppressive drugs is 
considered to modify principally the time scale of these events 
although Mowbray (l970) considers that in patients on adequate 
doses of steroids and azathioprine^humoral mechanisms are more 
important than cell mediated effects in human renal allografts.
The nature of the mononuclear cells which invade the graft 
in rejection is of special interest. Porter (1967) has 
classified the cells and recognises three types. Firstly, large 
lymphoid cells with cytoplasm packed with RNA in the form of 
ribosome clusters, the larger of these cells are the immunoblasts, 
the smaller the immunocytes; secondly, macrophages characterised 
by evidence of pinocytosis, the presence of lysosomes and small 
vesicles; and lastly, plasma cells. Early in the course of 
graft rejection immunocytes and immunoblasts predominate while 
later a greater proportion of macrophages and plasma cells are 
found. Hall (I967) in a comprehensive series of experiments on 
sheep with skin allografts demonstrated that immunocytes were 
produced in the lymph node draining the site of the graft and 
appeared in efferent lymph. Since these cells drain via major 
lymphatic trunks and appear ultimately in the blood they may be 
detectable by chemical measurements on isolated blood mononuclear 
cells.
Recently a report has appeared of morphological abnormalities
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in the blood lymphocytes in man in response to renal allograft 
(Parker and Mowbray, 1971)# There are also reports of functional 
abnormalities of blood. Inhibition of leucocyte migration under 
standard conditions has been shown to be a measure of cell mediated 
hypersensitivity (Soborg and Bendixen, I967) and this method has 
revealed the presence of strong sensitization to kidney and 
histocompatibility antigens in renal allograft rejection (Smith, 
Eddleston, Dominguez, Evans, Bewick and Williams, 1969)# The 
phytohaemagglutinin response of the blood lymphocytes in patients 
with a renal allograft on immunosuppressive therapy is impaired 
and there may be some lessening of this impairment prior to an 
episode of kidney rejection (Tennenbaum, St, Pierre and Cerilli,
1968). Another author however has reported no change in the 
phytohaemagglutinin response prior to rejection (Joseph, I966), 
but it appears that spontaneous transformation of lymphocytes in 
culture is increased when the cells are obtained from a patient 
prior to a rejection episode (Tennenbaum, St, Pierre and Cerilli,
1968), The changes in spontaneous transformation are supported 
by the observations of an increase in the rate of ENA synthesis 
(Parker, Ellis, Cameron, Ogg and Mowbray, 1970) and of DNA synthesis 
(Hersh, Butler, Eossen and Morgan, 1970) in peripheral blood 
lymphocytes at times of rejection. Spontaneous transformation is 
believed to indicate a sensitization of the lymphocytes to antigen 
or antigens and the impaired phytohaemagglutinin response may have
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resulted from the effect of immunosuppression. This last 
suggestion is uncertain since in the published work the impaired 
response is not usually present early in the life of the graft at 
a time when the immunosuppresive drugs are used in greatest dose.
On the assumption that a renal allograft has been achieved 
with an adequate, but less than perfect tissue match, one of the 
main problems in the management of the recipient is the balancing 
of suppression of graft rejection processes with the danger of 
impairment of the patient's response to infection. This problem 
is magnified when rejection of the graft is suspected and immuno­
suppressive therapy has to be increased. Berenbaum (196?), in a 
review of the reports of the Kidney Transplant Registry, points 
out that difficulties associated with drug toxicity and infection 
account for about one third of graft failures and are also factors 
in most instances of death in the recipient. Immunosuppression 
is usually monitored by maintaining the white cell count within 
the 5jOOO to 10,000 cells per mm^ range. This method is at best 
empirical and there is a great need for a method which will allow 
better control of immunosuppression and give an early indication 
of impending graft rejection.
Both azathioprine and prednisone, the established immuno­
suppressive drugs used in renal transplantation in man, are 
inhibitors of nucleic acid synthesis in lymphocytes (Berenbaum, 
1967? Tormey, Pudenberg.and Kamin, 1967)5 and measurement ôf 
lymphocyte DNA and RNA content is therefore of potential value in
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monitoring the effect of these drugs. In this section a series 
of these measurements on the blood lymphocytes from nineteen 
patients with a renal allograft is presented with the double 
objective of observing the effect of immunosuppression on the 
chemical analyses and of testing the hypothesis that changes occur 
in the blood lymphocytes in rejection in advance of changes in 
renal function, the most reliable sign of impending rejection 
(Chisholm, Papadimitriou, Kulatilake and Shackman, I969)*
Thoracic duct drainage prior to renal transplantation has had 
a limited trial as an adjunct to immunosuppressive therapy (Murray, 
Wilson, Tilney, Merril, et al,, I968 ; Series, Remmers, Fish, et 
al,, 1970), In a separate study, the opportunity was taken to 
monitor the chemistry of the lymphocytes obtained from the thoracic 
duct in man as immunosuppressive drugs, azathioprine and prednisone 
were commenced. The serial measurements obtained should be 
helpful in the interpretation of results of the blood lymphocyte 
analyses in patients on this regime. The technique of thoracic 
duct fistula (Tilney and Murray, I968) with continuous drainage 
of the lymph and return of the cell free lymph to the patient 
intravenously, provides massive numbers of lymphocytes of the 
order of ten thousand million per day, free from contamination 
with other leucocytes. It was possible therefore to study the 
chemistry of human thoracic duct lymphocytes without the constraint 
of limited material.
Considerable controversy existed at the time of the study over
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the nature of the RNA species present in lymphocytes especially 
in the early stages of the response of the cell to phytohaem­
agglutinin. Although the bulk of RNA in lymphocytes is ribosomal 
RNA, two groups of workers (Cooper and Rubin, 1965? Kay, I966) 
considered that the RNA rapidly synthesised in response to 
phytohaemagglutinin was not principally ribosomal or ribosomal 
precursor RNA. There is now much more information about the 
process of biosynthesis of RNA and the molecular species involved, 
a topic which has been reviewed by Burdon (197%). RNA destined 
to be ribosomal RNA is transcribed in the nucleolus from DNA as 
a high molecular weight material recognised experimentally by its 
sedimentation during high speed centrifugation as 45s RNA, This 
material is processed before it appears in the cytoplasm where it 
is found as two distinct molecular species, the l8s and 28s 
components of ribosomal RNA, Although it is now recognised that 
the lymphocytes, even when stimulated by phytohaemagglutinin, 
conform to the usual mammalian cell process for RNA maturation 
(Monjardino and MacGillivray, I968; Cooper and Kay, 1969) the 
earlier work of Cooper and Rubin (1965) was the stimulus to the 
investigation to be described.
Cooper and Rubin (1966) described a heterogeneous RNA, 
extractable from lymphocytes after short term, i.e. less than three 
hours, exposure to phytohaemagglutinin and recognisable as non- 
ribosomal RNA by pulse labeling and chase of the label with 
actinomycin D, The nature of such RNA was then unknown but its
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presence in cells stimulated by phytohaemagglutinin suggested that 
the rapidly labelled RNA might be a messenger RNA, Their work 
was restricted by limited material and non-lymphocyte RNA was 
required as a carrier in their RNA extraction procedures. The 
experiments described in this thesis provide an answer to the 
question of the nature of lymphocyte RNA in the resting and 
stimulated state.
4.2 Material and Methods 
Clinical material.
Serial measurements of blood lymphocytes in patients with a 
renal allograft.
This is a study of nineteen patients, recipients of twenty 
renal allografts, all but one carried out in the three years period 
up to the end of 1970. There were four live donors and sixteen 
cadaver donor kidneys in the series; the recipients were nine 
males and nine females, one male receiving a second graft. The 
mean age of the patients was thirty-one years with a range of from 
seventeen years to forty-six years. In addition, some results 
from a patient studied after this period were included since they 
illustrated a type of rejection noted in the main study, but less 
well documented. This patient was a female aged eighteen years
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who received a live donor renal allograft. Details of all these 
patients including an assessment of the tissue match according to 
the criteria of Botha (I969) are included in Appendix 1 0 .
Immunosuppression was maintained with azathioprine given as an 
initial dose of 3  mg per kg and then regulated according to the 
white cell count, and prednisone 2 0 0  mg per day, started at the 
time of the transplants and reduced daily in steps of 1 0  mg to a 
maintenance dose of from 1 0  mg to 3 0  mg per day. Definite clinical 
rejection episodes were diagnosed in the event of an increased 
serum creatinine and a decreased creatinine clearance present for 
twenty-four to forty—eight hours. Other factors such as decreased 
urine volume and renal tenderness were inconsistent findings.
Such episodes were treated by an intravenous infusion of 1  g 
prednisolone given over a two hour period and repeated on the 
following day if necessary. Two patients received x-irradiation 
(150 rads) to the area of the allograft during rejection crises.
Samples of venous blood were taken from the patients, always 
between 8 . 3 0  a.m. and 1 0 . 3 0  a.m., for the lymphocyte analyses as 
well as the general monitoring of the patient by the usual series 
of tests. In the initial stage of the project, blood sampling 
for lymphocyte analyses was infrequent and for this reason and 
because of early graft failure in some cases, less than five blood 
samples were obtained during the life of each of four grafts.
In the remaining fourteen allografts 289 lymphocyte analyses were 
undertaken during I4I graft months, i.e. each patient had
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on average an analysis every two weeks. In practice, the blood 
sampling was more frequent early in the life of the graft when the 
immunosuppressive therapy was being adjusted and it became apparent 
that sampling twice per week would be advantageous.
Studies on thoracic duct lymphocytes; serial measurements of the 
lymphocyte RNAP/DNAP ratio and analysis of the nature of 
lymphocyte RNA,
The four subjects in this study were patients maintained by 
intermittent haemodialysis prior to receiving allografts in the 
transplantation unit of the Peter Bent Brigham Hospital. The 
regimen before renal transplantation was not the conventional one 
and suppression of the immune response was carried out as follows: 
thoracic duct lymphocytes were drained continuously from a fistula 
beginning five days (in one patient nine days) before transplantation; 
azathioprine (2.5 mg daily per kilogram of body weight) was given 
starting forty-eight hours before operation, and prednisone 
(1.5 mg daily per kilogram of body weight) twenty-four hours before 
kidney transplantation. These drugs were continued for the life­
time of the allograft, dosages being adjusted as dictated by the 
patient's clinical state. The lymph was allowed to flow freely 
and was collected in sterile citrate-phosphate-dextrose bags 
(Penwal Laboratories); the cells were separated from the lymph by
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centrifugation at I50 gav. The cells were retained and the 
supernatant lymph fluid returned to the patient intravenously.
Methods.
Serial analyses of blood lymphocyte DNAP, SNAP and RNAP/PNAP 
ratio were carried out by the gelatin and cotton wool cell 
separation technique (Section 2.3) followed by the standard 
chemical technique (Section 2.8). The cytological methods used 
were those described in Section 2.5.
In the serial measurements of the DNA and RNA content of 
thoracic duct lymphocytes a much simplified cell separation 
procedure was adopted which produced excellent lymphocyte 
preparations. Prior to estimation of the nucleic acid content 
of these lymphocytes, they were freed of red cells by osmotic 
shock, fifteen seconds in ice cold distilled water, and analysed 
either freshly harvested or after short term storage at -4 0C 
(Section 2.I5 ).
Tissue typing.
The tissue typing procedures were carried out in the Glasgow 
Royal Infirmary following the microdrop technique of Terasaki and 
McLelland (1964) and assaying for leucocyte antigens. The results
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are listed according to the tissue match using the classification 
of Botha (1969)#
Short term lymphocyte cultures.
Thoracic duct lymphocytes were obtained from anephric patients 
just prior to renal transplantation whose blood urea nitrogen 
levels were kept low by frequent haemodialysis. The lymph 
contained about 98^ 0 small lymphocytes with variable contamination 
with erythrocytes. lymph, collected in plastic citrate-phosphate— 
dextrose bags, was centrifuged at 4C at 600 gav for ten minutes and 
the cell button washed twice with Medium 199 (Grand Island 
Biological Go.). lymphocyte cultures were set up in Medium 199
a
with yfo autologous serum at a concentration of 20 x 10 lymphocytes 
per ml. PHA-P (Bifco), diluted according to specifications of the 
manufacturer, was used at a final concentration of 0 .3 ml per 
100 ml of suspension and the same volume of sterile saline was used 
in control tubes. Uridine was added to the cultures as will be 
detailed.
Isolation of nuclei.
Lymphocyte nuclei were isolated by a method similar to that of 
Pogo, Allfrey and Mirsky (1966). All procedures following
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harvesting of cells were carried out at OC to 4C unless stated 
otherwise. After the cell harvesting centrifugation O.OIM 
citric acid (29 ml per tube) was added to the cell button and the 
resulting suspension agitated using a snugly fitting teflon pestle. 
Suspensions were then centrifuged at 5OOO r,p,m, for five minutes 
in a Sorval RC2B centrifuge (3000 gav) and the citric acid 
treatment repeated. After a final wash with 10 ml of 0.34 M 
sucrose, a drop of the suspension was removed and stained with 
azure C to monitor the presence of clean lymphocyte nuclei. The 
nuclei were then collected by another centrifugation (3000 gav) 
and RNA extracted from them.
RNA extraction, fractionation and counting.
Lymphocyte nuclei or whole lymphocytes were homogenised with 
a teflon pestle in 10 ml to 12 ml of 0.3^ sodium dodecyl sulfate 
containing 0,14 M sodium chloride and 0,05 M sodium acetate 
(pH 5 ,1)* After a few strokes, an equal volume of "90^ phenol 
containing 0,1^ hydroxyquinoline was added and the mixture 
homogenised further. The suspension was immediately shaken at 
65c foi' ten minutes, shaken at room temperature for fifteen 
minutes, and centrifuged (17,000 gav) for fifteen minutes at 4C, 
The clear aqueous layer was then removed and the RNA precipitated 
with 2,5 volumes of ethanol containing 2^ potassium acetate,
RNA was reprecipitated once with ethanol. An aliquot of an
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aqueous solution of the RNA containing 100 pg RNA was layered on 
a 5 ml 10^ to 40^ linear sucrose density gradient, and centrifuged 
for fifteen to sixteen hours at 24,000 rev/min in the S¥ 50 head of 
the Beckman L2 ultra—centrifuge. Gradients were passed through 
the cell of a Gilford model 2000 recording spectrophotometer and 
collected in fractions of eight drops each. Each preparation 
produced about sixteen fractions. After addition of one drop of 
5M perchloric acid to each vial, the fractions were hydrolysed at 
80C for fifteen minutes, cooled, and scintillation solution (lO ml) 
added to each vial. The scintillation fluid was of the following 
composition: Xylene 500 ml, Bioxane 1500 ml, Ethylene glycol
monomethyl ether I5OO ml, PRO 35 g? POPOP 1.75 g? Napthalene 280 g. 
Uridine generally labelled, was the isotope used in the 
experiments and was obtained from New England Nuclear Corporation 
at a specific activity of 50/mM, Radioactivity was determined in 
a Beckman CPM 100 liquid scintillation system. Quench curves were 
prepared for the counting conditions used and a counting efficiency 
of between I4 and I8 per cent established throughout.
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RESULTS
4.3 Blood lymphocyte DNA content in patients with a renal allograft
The mean lymphocyte DNA content for all the observations in 
the seventeen patients studied was 0,824 pg DNA phosphorus per 10^ 
cells with a standard deviation of 0,l65* This was slightly 
higher than the mean DNA content of the lymphocytes found in 
normal untreated individuals, mean value 0 , 7 3 2  pg DNA phosphorus 
per 10^ cells, and this difference was significant by t-test at 
the five per cent level. There was a significant difference in 
variance for this comparison (P = 2,10, p ~ <  0.05 ) Eind the t-test
result was therefore confirmed by Welsh's test for 'd' which 
upheld the result (n^ = 20, n^ - 299? d - 2.11, 1.0, p = 0.05),
When the DNA values were examined after allocation of the 
patients to four clinical groups, as will be defined later, the 
results were as follows: no infection, no rejection, 0,824;
unequivocal infection,0.836; unequivocal rejection,0.805; 
excessive immunosuppression,0,856 pg DNA phosphorus per 10^ cells. 
There were no significant differences between the groups and it 
is therefore valid to regard any changes in the lymphocyte RNAP/ 
DNAP ratio between groups as evidence of alteration in lymphocyte 
ENA content.
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4#4 The blood lymphocyte RNAP/PNAP ratio in patients with a renal 
allograft in relation to the blood lymphocyte count
The results of two hundred and ninety-nine analyses of both 
the blood lymphocyte RNAP/PNAP ratio and the blood lymphocyte count 
are shown in Figure 13,
In normal individuals not receiving immunosuppressive therapy, 
the accepted values for the normal blood lymphocyte count is from 
1500 to 3500 cells per mm^. Figure 13 shows eighty-four samples 
with a lymphopenia of 1000 cells per mm^ or less. Ten samples 
showed a lymphocytosis with a lymphocyte count of 3500 cells per 
mm^ or greater.
It can be seen from Figure 13 that the blood lymphocytes from 
patients with a renal allograft and receiving immunosuppressive 
treatment can have RNAp/pNAP ratio results outwith the range found 
in normal individuals of 0.20 to O.4O. Strictly, the two standard 
deviation normal range is 0.22 to 0.37 (Section 3.4). The range 
0.20 to 0 .40 gives convenient values close to the three standard 
deviation limits of normal. On fifteen occasions the lymphocyte 
RNAP/DNAP ratio was low and on fifty-four occasions it was elevated 
when compared to the lymphocytes of normal untreated individuals. 
Examination of Figure 13 would suggest that a low lymphocyte RNAP/ 
DNAP ratio is associated with lymphopenia while a high lymphocyte 
RNAP/dNAP ratio may be associated with a normal or low lymphocyte 
count.
Blood lymphocyte R M P / D M P  ratio and lymphocyte count in patients 
with a renal transplant, all results.
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These results were obtained by serial analyses of the blood 
lymphocytes from nineteen patients with a renal allograft studied over 
a period of three years. The broken lines indicate limits set for the
recognition of lymphopenia (less than 1,000 lymphocytes per mm^) and an 
abnormal lymphocyte RFAP/DRAP ratio (outwith the range 0.20 to O.dO).
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4#5 The relationship between the results of the analyses of blood 
lymphocyte count and RNAP/PMP ratio and the clinical state 
in patients with a renal allograft
In order to arrive at a range of values for the lymphocyte 
analyses in immunosuppressed patients with good graft function and 
to show possible differences in the lymphocyte response to infection, 
rejection or excessive immunosuppression, four clinical states were 
defined,
(a ) No infection or rejection.
To qualify for this group, patients had to be free of clinical 
or laboratory evidence of generalised or local infection or graft 
rejection at the time of or within ten days of analysis. In 
addition, the creatinine clearance had to be at least 50 ml/min.
If the patient had more than one rejection episode in the past they 
were not included in this group,
(B) Unequivocal infection.
To be included in this group the patient had to exhibit 
clinical and laboratory evidence of viral, fungal or bacterial 
infection. The possibility of the presence of rejection excluded 
patients from this group.
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(c) Unequivocal rejection.
Inclusion in the group required that clinical suspicion of 
graft rejection, acute or chronic, should be confirmed by a 
substantial elevation of the plasma creatinine maintained for 
twenty—four hours, A substantial rise of plasma creatinine was 
defined as an increase of 0,5 mg per 100 ml when the plasma 
creatinine was under 2.0 mg per 100 ml, and a rise of 1,0 mg when 
the initial plasma creatinine was greater than 2 mg per 100 ml.
The presence of infection excluded patients* results from this 
group.
(D) Excessive immunosuppression.
Patients were included in this group if they had had a blood 
leucocyte count of less than 4OOO cells per mm^, and no evidence 
of rejection or significant infection, A leucocyte count of less 
than 4000 cells per mm^ is recognised as an early sign of excessive 
immunosuppressive therapy, especially of azathioprine.
The blood lymphocyte counts and the lymphocyte RNAP/UKAP 
ratios for these groups are summarised in Table 22, Thirty-seven 
results from six patients comprised Group A, Nineteen results 
from seven patients comprised Group B, Seventeen results from 
ten patients comprised Group C and nine results from three patients
Table 22
The results of blood lymphocyte counts and the lymphocyte R M p /  
DNAP ratio in four categories; A) no infection or rejection,
B) unequivocal infection, C) unequivocal rejection, D) excessive 
immunosuppression, all in patients with a renal allograft.
Category
A
No infection, 
no rejection
B
Unequivocal infection
Number
37
19
Blood lymphocyte count Lymphocyte RNAP/
cells per ram'
Mean 2224 
SD 1056
Mean 1792 
SD 1028
DNAP ratio
Mean 0.300 
SD 0.047
Mean 0.354 
SD 0.066
Unequivocal rejection 17
Mean
SD
888
536
Mean 0.422
SD 0,063
D
Excessive
Immunosuppression
Mean
SD
632
403
Mean 0.253 
SD 0,071
The categories A, B, 0 and D are defined in Section 4.5 of the
text
Table 22 (cont*d)
Analysis by P-test
Comparison 
Blood lymphocyte count
Degrees of 
freedom F Probability
A V  B 36, 18 1.05 N.S.
A V  C 36, 16 3.88 < 0.001
A v D 36, 8 6.86 <0.001
B V  G 1 8, 16 3.68 < 0.01
1 e h a p/d m p
A V  B 36, 18 1.97 È.8.
A V  C 36, 16 1 .80 N.S.
A V  D 36, 8 2 ,2 9 N.S.
B V  C 1 8, 16 1.Q9 N.S.
A = No infection, no rejection 
B = Unequivocal infection 
C = Unequivocal rejection 
D " Excessive immunosuppression
Table 22A
Analysis of the mean values of the results from Table 22. 
Where there is significant difference in variance the d-test 
has been used in place of the t-test.
Comparison 
Blood lymphocyte count
Degrees of 
freedom Probability
A V B 54 1.13 — <0 .30 > 0.20
A V C 36, 16 3.76 6 .15,0.6
■X*
< 0 .01
A V D 36, 8 3.80 6 .16,0 .6 < 0.01
B V 0 18, 16 3.52 3 .36,0.6
*
< 0 .01
» RNAP/DNAP
*<0.001A V B 54 3.54 —*
A V C 52 8.15 -
*
<0
*<0.001
A V D 44 2.42 .02 >0.01
B V 0 34 3.23
#
<0 .01 >0.001
*
Differences are significant.
Probability values are calculated from the statistic d where 
differences in variance have required this to be used.
A " No infection, no rejection 
B = Unequivocal infection 
C = Unequivocal rejection 
D = Excessive immunosuppression
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were included in Group D.
Results from patients with neither rejection nor infection are 
taken as the normal group in this study of renal allografts. The 
results are very similar to published values for the blood 
lymphocyte count and the observed lymphocyte R M P / dM P  ratio in 
normal untreated individuals, although a tendency to slight 
lymphopenia is noted in patients with treated allografts. Serial 
analyses from individual patients show a striking stability of the 
RNAP/m AP ratio in patients included in this group. This is 
illustrated by the results obtained in patient BL displayed in 
Figure 15.
Blood lymphocyte counts in the four clinical states.
A useful intercomparison may be made between the four clinical 
states defined above, applying Student's t-test to the mean value 
for each group (Table 22). In the presence of infection the mean 
blood lymphocyte count is lower than when there is no infection, 
but this has not been shown to have statistical significance,
When unequivocal rejection is present there is a statistically 
significant lymphopenia (p = ^O.OOl). Wot unexpectedly since 
leucopenia defines the group, lymphopenia was present in the 
Group D patients (excessive immunosuppression),
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Blood lymphocyte M A p /DWAP ratio in the four clinical groups.
The lymphocyte RWAP/b NAP ratio results for the patients are 
listed in Table 22. Group B (infection group) and Group C 
(rejection group) each showed a significantly greater mean value 
for the lymphocyte RWAP/b WAP ratio than Group A (no infection or 
rejection), p = 0.001 in each case. Although the degree of
elevation of the mean lymphocyte RWAP/bWAP ratio was significantly 
greater in the presence of rejection than in the infection group 
(p = *<-0.0l), there is considerable overlap of observed values for 
the ratio in these two groups. The findings of a reduction in 
the lymphocyte RWAp /bWAP ratio in the presence of over-immuno­
suppression (Group B) is of relevance later in differentiation of 
the causes of lymphopenia.
When the value of the lymphocyte RWAp/bNAP ratio and the blood 
lymphocyte count are considered together in the same four clinical 
groups a clearer pattern emerges as may be seen from examination of 
Figure 14. This shows the individual values for the relationship 
between the blood lymphocyte count and the lymphocyte RWAP/b NAP 
ratio separately plotted for each of the four groups. These 
results are now summarised.
When neither infection or rejection are present (Group A) the 
blood lymphocyte count is variable, only occasionally low. The 
lymphocyte RWAP/BWAP ratio is not elevated above 0.40 in these 
patients, rather it may be occasionally low and then usually in
Blood iympiiocyte RWAP/jDJMAB ratio and lymphocyte count in patients 
with a renal allograft grouped according to clinical state*
N O  I N F E C T I O N ,  N O  R E J E C T I O N I N F E C T I O N
0.2 0.3 0.4
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g
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The results plotted are from individuals allotted to the categories 
A - no infection, no rejection; B - unequivocal infection; 0 » 
unequivocal rejection; D ~ excessive immunosuppression* These
categories are defined in Section 4*5*
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association with a low blood lymphocyte count* When infection is 
present (Group B) a low blood lymphocyte count tends to be 
associated with a low lymphocyte RWAP/d WAP ratio and a high 
lymphocyte count with a normal or high lymphocyte RNAP/PWAP ratio*
In contrast with this are the results from patients with unequivocal 
rejection (Group C). Here the usual values are a low blood 
lymphocyte count, less than 1000 per mm^, and an elevated 
lymphocyte RHAP/b NAP ratio usually greater than 0*40* In the 
presence of excessive immunosuppression as evidenced by a general 
leucopenia (Group B), it appears that a very low lymphocyte RlTAp/ 
BHAP ratio may be present when the blood lymphocyte count is also 
very low*
4.6 The value of the lymphocyte analyses in the diagnosis of rejection
In the previous section it was shown that a low blood 
lymphocyte count and an elevated lymphocyte RMP/BNAP ratio are 
common features of rejection* If the changes in the blood 
lymphocytes found in unequivocal rejection are to have diagnostic 
value, the incidence of misleading results must be shown to be low. 
Possible false negative results are considered first* There were 
two normal results from the same patient for both the blood 
lymphocyte count and the lymphocyte RHAP/b M P  ratio in the seventeen
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analyses during unequivocal rejection (Figure 14). During a 
further three rejection episodes each involving different patients 
there was a lymphopenia but with a lymphocyte RHA/dWA ratio within 
the upper normal limit of O.4O. These last results were however 
one, three and fourteen days after treatment of rejection with 1 g 
of prednisolone, so there remained only two results with a 
lymphocyte count of more than 1000 per mm^ and a lymphocyte RNAP/ 
DNAP ratio of less than O.4O during untreated unequivocal rejection 
out of a total of fourteen. Thus, a low incidence, i.e. 14 per 
cent of false negative results in untreated unequivocal rejection 
has been found in the three year study period. Special features 
of the rejection in the patient who had these normal results will 
be discussed later together with results of an additional patient, 
obtained after the three year study was complete but included since 
this patient also showed normal lymphocyte chemistry at a time of 
unequivocal rejection.
Table 23 details all the instances when results were obtained 
for the lymphocyte analyses which suggested rejection. Over the 
period of study, such results, i.e. those which showed a low blood 
lymphocyte count less than 1000 cells per mm^ and a lymphocyte 
RNAP/dNAP ratio of more than 0*40, were found during thirteen 
distinct periods in ten patients. Nine of these patients did have 
a clinical rejection episode* Of the individual nineteen abnormal 
results, rejection followed in fourteen with an average interval of 
twenty-three days. The interval between finding the abnormal
Table ^3
The relation in time oi‘ results for the lymphocyte analyses which 
suggested rejection, i.e. a blood lymphocyte count of 1000 cells per 
mm^ or less and a RNAP/DJ&IAP ratio greater than 0*40, and previous or 
subsequent rejection in patients with a renal allograft.
■ Patient Days since transplant
Blood 
cells per
lymphocyte 
mm^ ! RNAP/DNAP
Days since 
previous 
rejection
Days to 
next 
rejection
AP 7 560 0 .5 0 1 1
AP (20 410 0.44 ; 12 0
AP 864 0 .4 3 15 0
HJ3 (21 900 0.60 8 7
HB (30 570 : 0 .4 2 2 0
CG 27 950 0 .4 2 12 4
CM (68 860 0 .4 3 64 44
CM (96 1000 0 .4 3 , 92 16
CM 170 700 0 .4 5 68 28
CM 240 980 0 .5 0 41 0
JM 426 940 0 .4 1 0 26
MS 125 660 0 .44 12 29
RM 188 658 0 .5 2 184 1
JM 70 860 0 .4 2 0 0
JO 243 900 0 .4 4 0 3
MC ( 96 860 0 .4 9 67 129
MC (195 864 0 .4 5 166 30
MC (218 708 0 .5 1 189 7
MC (225 714 0 .46 196 1
Results bracketed together are regarded as belonging to a single 
episode.
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result and the clinical rejection episode (listed in Table 23) was 
variable, in one case the lymphocyte abnormality appeared one 
hundred and twenty-nine days in advance of rejection and was shown 
still to be present thirty, seven and one day before gradual 
function impairment of the graft was apparent and treatment 
initiated. Serial results from this patient who was latterly 
considered to be suffering from chronic rejection are shown in 
Figure 16. The remaining five abnormal results were not followed 
by a recognisable rejection episode. Two of those may be 
discounted since the results were obtained one and two days after 
treatment of a previous rejection with 1 g prednisolone. The 
incidence of false positive results in the diagnosis of rejection 
was thus three in nineteen, or 16 per cent.
It is appropriate to present now the results of serial analyses 
of the lymphocyte in patients with a renal allograft in order to 
illustrate the different lymphocyte responses encountered.
Although many measurements were made in these patients only the 
lymphocyte count, the lymphocyte RWAP/OTAP and the plasma creatinine 
together with the immunosuppressive therapy are included in the 
figures.
Figure 15 shows the results from a patient (BL) who had an 
excellent result from transplantation with no major rejection 
episodes. The limits of variation of the lymphocyte RNAP/PNAP are 
small. This is in contrast to Figure 16 which has been referred 
to earlier, illustrating chronic rejection. Here the lymphocyte
Serial analyses in renal transplantation; studies on a patient
with an excellent clinical result#
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Fiffure l6
Serial analyses in renal transplantation; stnaies on a patient
with Glaronlc rejection.
C H R O N I C
R E J E C T I O N4
0
6000 R N A / D N A  R A T I O
z 4000
W 2000
L Y M P H O C Y T E  C O U N T
R A T I  O 
0-6
0-4
0-2
la PREONISOIONE 10 PREDNISOLONE
V-
100 200 
DAYS S I N C E  T R A N S P L A N T A T I O N
P R E D N I S O N E
A Z A T H I O P R I N E
TH© blood lymphocyte analyses, plasma creatinine and details of the 
immunosuppressive therapy are plotted for a patient (MM) who developed 
chronic rejection. The lymphocyte HNAP/hMP ratio was elevated and 
remained elevated over luu days before renal function deteriorated and 
a chronic rejection state recognised.
Figure 17
Serial analyses in renal transplantationj studies on a patient
with acute rejection.
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The blood lymphocyte analyses, plasma creatinine and details 
of the immunosuppressive therapy are plotted for a patient (HB) 
who developed an acute rejection episode, recognised by changes 
in renal function on day 28. The lymphocyte RHAP/b NAP ratio was 
elevated and a lymphopenia present seven days in advance of 
changes in renal function.
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4
REJECTION
Ë
0
6 0 0 0
ES R N A / D N A  R A T I O4 0 0 0
à 2000
■J
LYMPHOCYTE COUNT
R A T IO  
0 6
0 * 4
0*2
1g PREDNISOVONE Ig PREDNISOLONE
50mg DAILY PREDNISONE
Ipomq DAILY
A Z A T H I O P R I N E
TO 30 40 50 60
DAYS SINCE T R A N S P LA N T A TIO N
The blood lymphocyte analyses, plasma creatinine and details ot the 
immunosuppressive therapy are plotted tor a patient (CD) who developed 
renal graft rejection on day 32 and failed to respond to the usual 
measures to reverse the rejection. The lymphocyte RNAP/DNA-P results 
remained normal during this period. These were atypical findings.
159
abnormality was apparent early in the life of the graft and when 
the transplanted kidney was finally removed after just over one 
year in the recipient there were almost no recognisable tubules or 
glomeruli present on microscopic examination of the allograft tissue, 
An example of the results of serial monitoring of the blood 
lymphocytes during a period of acute reversible rejection is shown 
in Figure 17* In this illustration lymphopenia with a markedly 
elevated lymphocyte OTAP/dNAP ratio was present at least seven days 
in advance of the decision to treat for acute rejection. The 
normal lymphocyte RNAP/MAP ratio just at the time of rejection was 
the only atypical feature of the results illustrated and was not 
found in other studies. The earliest rise in the plasma creatinine 
on which the decision to increase the immunosuppression was based, 
occurred five days after the changes in the lymphocytes were 
established. Four such examples, in different patients, of prior 
abnormality of the blood lymphocytes, have been adequately 
documented, thus in patients HB, CMcH, RMcK and MTJIoG the lymphocyte 
abnormality was present seven, forty-four, one, and one hundred and 
twenty-nine days in advance of the change in renal function. The 
last illustration of serial analyses shows a sequence of events 
which was much less common than events illustrated in Figures 15 and 
17, and was seen in two patients only. In both these patients 
there was early reduction of immunosuppression because of 
sensitivity of the patient to azathioprine or to the azathioprine 
and prednisone combination. About two weeks after the reduction
16o
of azathioprine therapy to a low level there was evidence of 
rejection which was not resolved hy the usual measures. The 
lymphocyte RNAP/dHAP remained below 0,40 throughout the period. 
In one of the two patients the donor kidney had to be removed on 
day forty-six and in the second (illustration in Figure 18) the 
creatinine clearance fell to 10 ml per minute with a plasma 
creatinine of greater than 4 mg per 100 ml.
4.7 Lymphopenia in patients with a renal transplant and on immuno­
suppressive therapy and its importance in the differentiation 
of over-suppression and rejection
Lymphopenia was a more frequent observation than leucopenia 
in this study. Of the eighty-four samples with a lymphocyte count 
of less than 1000 cells per mm^ twenty-one had a severe 
lymphopenia with a count of less than 500 lymphocytes per mm^. 
Leucopenia, defined as a blood white cell count of less than 4000 
cells per mm^, in contradistinction to lymphopenia, was present in 
only eleven samples in the study and only three times was severe 
lymphopenia and leucopenia present together. This dissociation of 
a low lymphocyte count and a low total leucocyte count is 
illustrated by white cell counts in the samples with severe 
lymphopenia. The mean white cell count of these lymphopénie
3
bloods was 6516 cells per mm .
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The mean blood lymphocyte RNAP/dNAP value from patients 
showing excessive immunosuppression recognised by a leucopenia 
is listed in Table 22, and the individual results displayed in 
Figure 14* Hhen lymphocytes specifically are reduced in number, 
and there is no rejection, the mean lymphocyte RFAP/dNAP is very 
low at 0.197 (SD 0,054)9 indeed lower than the value of 0,253  
found in a general leucopenia. This difference of the means is
just significant (p == <0*05), The observed range of values for
the RNAP/DNAP ratio in severe lymphopenia without rejection is 
0,12 to 0.279 and when patients with less severe lymphopenia are 
considered, i.e. those with a blood lymphocyte count up to 
1000 cells per mm^, the ra,nge of observed values for the 
lymphocyte RNAP/dNAP ratio extends upwards to 0.37. This value 
for the lymphocyte RNAP/bNAP ratio is lower than that considered 
appropriate for the diagnosis of graft rejection and it appears 
therefore that a lymphocyte RHAP/DNAP ratio of less than 0,40 
distinguishes the lymphopenia which may be the result of immuno­
suppressive drug action from the lymphopenia associated with 
rejection.
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4.8 The nature of the blood lymphocyte in patients with a renal
The nature of the blood lymphocytes in patients with a renal 
allograft was investigated by examination of their morphology on a 
stained slide. Three observers were asked to classify the 
lymphocytes as either large, medium, or small allocating as few 
cells as possible to the intermediate grading. Small lymphocytes 
were defined as mononuclear cells which approximated to the size of 
the red cells, and had a nucleus which occupied more than half of 
the cell diameter. The observers carried out their examination 
independent of each other and of the chemical measurements.
Fifteen blood samples were examined in this way and Figure 19 shows 
the results of the correlation between the lymphocyte RNAP/OTAP 
ratio and the percentage of blood lymphocytes classified as small 
lymphocytes, determined as the mean value for the three observers.
The coefficient of linear correlation for the comparison was 0,69, 
and this was significant at the one per cent level (t - 3*44)•
When the observed values of percentage of small lymphocytes for 
each individual observer was correlated with the cell chemistry, 
the correlation coefficients, 0,68, 0,66 and 0.43, were poorer than 
that derived from mean observations. The t values were respectively 
3.34, 3.19, 1.72 and only the first two were significant, p =<0,01 
in both cases. Figure 19 shows the considerable observer
Figure 19
Correlation of the blood lymphocyte RHAP/MAP ratio and the 
percentage of small lymphocytes determined on a stained blood film,
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The percentage of small lymphocytes was calculated as the mean of 
three independent observations and the observed range indicated by 
horizontal lines through the mean values. The coefficient of linear 
correlation for the percentage small lymphocytes and the lymphocyte 
RNAP/DRAP ratio was O.6 9.
163
variation in the individual values. As was anticipated, a high 
lymphocyte HHAP/DHAP ratio was associated with a low percentage of 
small lymphocytes. An attempted correlation of the lymphocyte 
chemistry and the percentage of large lymphocytes was less 
successful than that reported above.
4o9 The relationship between the donor kidney match and the RWAP/
DllAP ratio of the blood lymphocytes
Botha (1969) has examined methods of classifying the degree 
of tissue match between donor and recipient in human allografts 
and listed six main categories. These categories are best listed 
in a table (Table 24). It can be seen from the table that Grade A 
is perfect matching by present techniques and Grades B, G, D, E and 
F are in order of decreasing compatibility judged mainly by the 
presence of antigens in the donor leucocytes, not present in cells 
of the recipient.
The grade of match of the allograft for each of the patients 
according to the Botha system are included in Appendix 10. These 
data allowed comparison of the blood lymphocytes RHAP/hNAP ratio 
for patients of differing grades of tissue match. Certain 
precautions were required in the preparation of the data. The 
average of the values recorded for the lymphocyte RNAP/dNAP in
Table 2h
Grades of tissue match, in human allografts (Botha, 19^9)
Grade of Number of leucocyte antigens
Match Donor + Donor -
Recipient - Recipient +
A G O
B 0 1 or more
C + 1 0
C 1 1 or 2
G “ 1 3 or more
D 2 0 or more
B 3 0 or more
F recipient has preformed antibodies
to donor leucocytes*
Table 25
The relation between the donor kidney match, rejection and the 
lymphocyte RNAP/BMP ratio.
Tissue
match Patient
Duration 
of graft 
months
Rejection
episodes
Creatinine 'Mean monthly 
clearance RNAP/DNAP 
at 1/1/71 : 
ml/min individual
lymphocyte 
ratio
group
A
MC
MS
14
9
0
2u
86
60
0.36
0.35
0.36
B BL 19 0 93 0.30 0.30
HB 3 lu ip 60 0.34
CG 3 3u 64 0.33
G JM 13 0 37 0.28 0.33
JÜ 11 2p 111  ^ 0.37
AP 3 lu 78 0.34
RF 8 Ip 96 0.32
D MM
CM
8
10
2u
2u
lrreversibie[ 0.43 
rejection j
77 1 0.36
0.37
JL 1 lu Irreversible
rejection
1 0.36
E SM < 1 lu Infection 0.25 0.33
. RM 13 lu 26 0.34
Tissue match is according to Botha (1970). The rejection episodes 
are classed as unequivocal (u) and probable (p) as defined in the text. 
The mean lymphocyte BNAP/MAP ratios for each patient are calculated as 
follows. Individual analyses are grouped monthly and the average 
monthly ratio calculated. The mean ratio tabulated is the average of 
these monthly ratios.
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each patient was calculated month by month and the mean of these 
monthly ratios included as part of Table 25* This method of 
calculation reduced the bias which might arise when analyses were 
repeated frequently at times of possible rejection. Unequivocal 
rejection recorded in the table is defined in Section 4*5 and 
probable rejection when the rise in plasma creatinine although 
sustained, does not meet the criteria of a substantial rise laid 
down.
There is no simple relationship between the tissue match and 
the mean lymphocyte RNAP/d UAP ratio and it appears likely that the 
lymphocyte RUAP/MAP ratio has been influenced by factors other 
than the tissue match. The highest mean ratio occurred in a 
patient with a D match who developed an irreversible rejection, the 
lowest ratio 0.25 was in a patient with a D match who died of over- 
immunosuppression and infection. Three patients, one from each of 
Group A, B and C had no rejection episodes during the period of 
study, but their mean lymphocyte RNAP/d NAP ratio values were 0.36,
0.30 and 0.28 respectively. The first of these patients had 
repeated surgery for recurrent ureteric fistulae.
4.10 The nucleic acid content of human thoracic duct lymphocytes
Table 26 shows the nucleic acid content of lymphocytes obtained
Table 26
The nucleic acid content of human thoracic duct lymphocytes obtained 
from the initial drainage of a thoracic duct fistulae prior to renal 
transplantation.
patient
Number of 
samples
Jig M A P  per 
10^ cells
Jig RNAP per 
1q 6 cells
RNAP/DNAP
ratio
1 2 0.91 0.20 0.22
2 2 0.65 0.18 0.28
3 2 0.63 0.11 0.17
4 2 0.64 0.14 0.22
Mean value 10 0.72 0.16 *0.22 
SD 0.045
■X-
Comparison of the mean value for the thoracic duct lymphocyte RNAP/MAP 
ratio with the values for seventy-four estimations of blood lymphocyte 
RNAP/DNAP ratio in normal individuals show a significantly lower ratio 
in thoracic duct lymphocytes (t « 3*14 P ™ cO.Ol). The variance of 
these two groups was not significantly different (P = 1.49, P ” >0.05)*
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early in the thoracic duct drainage of four patients before immuno­
suppressant drugs were administered. The mean M A  content, 0.72 jig 
DHAP per 10^ cells, was similar to that found in normal blood 
lymphocytes by the same chemical methodology (Section 3.4). The 
mean value for the R M  content, 0.16 fig RNAP per 10^ cells and the 
RNAP/dNAP ratio 0.22, was lower than that found in blood lymphocytes 
and was significantly lower when compared by t-test with the seventy- 
four results for normal individuals by all methods (p = <0.0l).
4.11 The effect of immunosuppressant drugs, azathioprine and prednisone 
on the RNAP/MAP ratio of human thoracic duct lymphocytes
In this study serial measurements were made in four patients 
of the RNAP/MAP ratio of lymphocytes isolated from the thoracic 
duct at a time of institution of immunosuppressive therapy and also 
for a period after renal transplantation. Table 27 summarises the 
results of these determinations and serial results in one patient, 
typical of all four, are illustrated in Figure 20, The figure 
shows an unmistakable rise in the RNAP/DNAP ratio of the thoracic 
duct lymphocytes as azathioprine and then prednisone therapy are 
commenced. The tendency for the lymphocyte chemistry to return to 
normal on continual therapy is also illustrated. Statistical 
analysis of the results for all four patients (Table 27) shows that
Effect of immunosuppressive therapy on thoracic:duct lymphocyte 
RNAP/m a p  ratio.
The tabulated results are the RNAP/dNAP ratios of samples of 
lymphocytes from the thoracic duct obtained - a) prior to renal trans­
plant and immunosuppressive treatment; b) during the 24 hours which 
followed initiation of azathioprine treatment; o) during the 24 hours 
which followed initiation of prednisone treatment, azathioprine continued; 
d) after the transplant operation, with continued immunosuppression.
patient
24”hour period 
pre-treatment of
period
24-hour period 
following 
initiation of 
azathioprine azathioprine
therapy
Po st^transplant 
period
therapy
(a) (%) (c) (a)
i 0 .2 2 0 .2 9 0.37 0.27
(mean of 2 ) (1 analysis) (1 analysis) (mean of 2 )
2 0.28 0 .2b 0.33 0.27
(moan of 2 ) (mean of 8 ) (mean of 3 ) (mean of 6 )
3 0 .2 0 0.23 0 .3 0 0.33
(mean of 5) (mean of 6 ) (mean of 4 ) (mean of 3 )
4 0 .2 4 0.30 0.29 Spontaneous early
(mean of 4) (mean of 3) (mean of 2) closure of
Mean result 
for four 0 .235 0.275 0.323
thoracic duct 
fistula
0 .2 9 0
patients 3 ,9 , 0.033 SD 0.030 LSD.0.035 SD 0.035
Comparison with pre­ Significant 5Significant Significant
treatment values by difference difference difference
Student’s t-test p «<0.01 p s> <0.001 p «-«4 0 .05
Variances were not significantly different by F-test.
F ig u r e  20
Serial analyses on Jauman thoracic duct lymphocytes.
Daily output of 
TD,Lymphocytes X10®
20 -,
10 -
T.D. Fistula
Lymphocyte
0 * 4  —I
0  3  -
0 2 -
01  —
DNS
Renal Transplantation
■x-_  X.
P a tien t  2
Prednisone 100 mg.dallyi
loprine
11 20
The figure shows the daily output of thoracic duct lymphocytes from 
a thoracic duct fistula established as an immunosuppressive measure nine 
days before renal transplantation. Serial determinations of the 
thoracic duct lymphocyte RîTAP/d nAF ratio were made before immuno­
suppression, as azathioprine was commenced and then prednisone therapy 
was instituted. Measurements are also shown nineteen days after the
transplant operation.
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immunosuppressive therapy was associated with a significant 
increase in the RliAP/DNAP of the thoracic duct lymphocytes over the 
pre-treatment levels. The increase avera,ged 17 per cent with 
azathioprine and 37 per cent with combined prednisone and 
azathioprine therapy in the twenty-four hour period following the 
start of treatment. Some individual measurements of RNAp/dNAP 
were considerably higher than this, as much as 105 per cent over 
the pre-treatment level when patient 3 was first given prednisone 
(0.20 to 0,4 1)# A constant finding illustrated in Figure 20 was 
the progressive fall in the output of thoracic duct lymphocytes 
with continued drainage. However, there was no consistent change 
in RNAP/dHAP when early and late stages of the pre-treatment period 
were studied. Following transplantation the RHAP/PHAP was 
followed in two of the four subjects. In patient 2, the RNAP/
HMAP value had fallen to, the pre—treatment level sixteen days after 
transplantation, while in patient 3 the value was still elevated 
thirty days after the transplant. The latter patient showed signs 
of rejecting the graft*
4 .1 2  The nature of lymphocyte R M
The ribonucleic acid of whole lymphocytes.
Lymphocytes obtained from the thoracic duct of a patient on
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intermittent haemodialysis were set up in culture using Medium 199 
at a concentration of twenty million lymphocytes per ml. After 
addition of phytohaemagglutinin (PHA.) to one half of the cells and 
saline to the other as control, the suspensions were immediately 
distributed among ten culture tubes, five PHA and five control, each 
containing 250 x 10^ lymphocytes. The tubes were closed and 
incubated for eighty minutes at 370. For the final two, five, ten, 
twenty and thirty minutes of the incubation labelled Uridine was 
added to each tube as Uridine 4 per ml. At the end of the 
eighty minutes incubation all cultures were harvested and the ENA 
extracted from whole lymphocytes. The extracted RUA was analysed 
by sucrose gradient centrifugation as described^,measTxring optical 
density and radioactivity of the fractions separated by the gradient.
The results of the analysis of whole lymphocyte RMA are 
presented in Figure 21. Optical density measurements for control 
and phytohaemagglutinin stimulated culture were very similar and 
for simplicity only one line is plotted in the figures. Previous 
experience with this type of gradient allows recognition of the 
three optical density peaks in the positions anticipated for 4s, 
l8s and 28s ENA. This would indicate that the usual mammalian 
cell ENA components are present in human thoracic duct lymphocytes, 
namely transfer ENA and the two components of ribosomal ENA.
The kinetics of Uridine labelling in ENA is illustrated by the 
radioactivity measurements in Figure 21, Within two minutes of 
exposure of lymphocytes to the labelled ENA precursor, radioactive
21
Labeling kinetics of whole lymphocyte RNA with and without phyto- 
haeinagglutinin (PHA ) • Continued as Figure 21A overleaf.
FRACTION
 0  D. 2 6 0
 PHA
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0 , 4 2 MIN
0 . 3
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0 . 3
0.2
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0.4
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0.2
Q
\_
Thoracic duct lynphocytes
were set up in a series of
cultures and incubated as
described in the text. Half
were controls and half were
incubated with PHA for 8o
minutes, l'or the final 2, 5»
10 (and in Figure 21A ) 20 and
30 minutes of the incubation 
3
Undine-H was present at a 
concentration of 4 /lo/ml. At 
the end of 80 minutes the 
cultures were harvested and the 
RNA of the lymphocytes analysed 
hy density gradient centrifug­
ation, The distribution of 
the RNA on the gradient was 
analysed by ultra-violet 
absorption at 260 nm (continuous 
line) and by radioactivity
(counts per minute; shown as interrupted lines.
Figure 21A
Labeling Jcxnetios ot whole lymphocyte R M  continued,
20  MIN0 .4
0 .3
0.2
3 0  MIN
0.5
0 . 4
0,3
0.2
TOP FRACTION
Legend as for Figure 21 « Optical density denoted by continuous 
line is calibrated on the left and radioactivity, the broken lines, is 
calibrated in counts per minute on the right# The heavy molecular 
weight RNA species appear in the fractions to the right in the diagrams#
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OTA of low sedimentation coefficient (4s to 6s) was present and
phytohaemagglutinin had stimulated its synthesis by more than one
hundred per cent over the control. Labelling in the 4s to 6s
fraction increased, and by five minutes after addition of the
isotope was almost twice the two minute value, No further increase
in labelling of this fraction occurred during the remaining twenty-
five minutes exposure to isotope. Until ten minutes after the
3addition of Uridine H no significant labelling occurred in the 
40s to 50s OTA region, i.e, the part of the gradient occupied by 
newly synthesised ribosomal RNA in the form of heavy molecular 
weight ribosomal precursor RNA, The peaks of radioactivity in the 
40s to 50s region thereafter increased at all intervals up to 
thirty minutes, and the extent of labelling of RNA was always 
greater in the phytohaemagglutinin tubes than in the control tubes. 
This 50s RNA was not however present in sufficient quantity to 
give an optical density peak.
In a separate experiment twco lymphocyte cultures were set up 
as before and incubated for a total of one hundred and thirty-five 
minutes with and without phytohaemagglutinin. After an incubation 
period of one hundred and five minutes Uridine was added, 4 pio 
per ml, and incubation continued up to the one hundred and thirty- 
five minutes total incubation time. The cultures were then 
harvested, this time the lymphocyte nuclei were isolated and the 
nuclear RNA extracted, fractionated and counted. The results 
showing the optical density pattern and the radioactive counts for
if'igure 82
Density gradient separation of RÎTA from lymphocyte nuclei with and 
without PHA.
0.8
O.D. 260 
--P H A  
—  CONTROL
0.6
d 0.4
0.2
20TOP 155 10
ro
O
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Human thoracic duct lymphocytes were incubated in cultures with and 
without PHA for a total of lj|) minutes. During the last minutes of 
the incubation the cellsyere exposed to Uridine-H at 4 jio per ml. The 
nuclei were isolated prior to extraction of their RNk and its analyses by 
gradient centrifugation. The continuous line is optical density at 
260 nm and the broken lines the radioactivity for PHA and control samples. 
High molecular weight RHA is found in mantiona +.n -hkio -nn 0<n+ 4 y,
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nuclear RNA from phytohaemagglutinin and control cultures appear 
in Figure 22,
It may he seen that although the three major RNA species 
are represented in the optical density peaks the low molecular 
weight 4s component is less abundant in the extract of nuclei than 
in the previous whole cell RNA extract. High molecular weight 
RNA is present in nuclei, recognisable by the incorporation of 
Uridine in the area of high molecular weight material to the 
right of the 28s optical density peak. This radioactivity was 
again more marked in the phytohaemagglutinin stimulated cultures.
In further experiments reported elsewhere (Jacob, Cooper,
Gleh and Munro, 1969) the high molecular weight and rapidly 
synthesised RNA is seen to be precursor to ribosomal RNA since on 
exposure of a culture to excess of unlabelled Uridine and to 
Actinomycin D which inhibits RNA synthesis, with continuation of 
the incubation for one hour, label is lost from the high molecular 
weight region and appears mainly in the 28s region, i.e. the 
region of ribosomal RNA.
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4.13 Discussion
Blood lymphocyte analyses in renal transplantation.
lymphocyte I)NA content,
The evidence that the mean DBA content (DNAP content) of the 
lymphocyte is slightly greater in patients who have a renal allo­
graft than in normal individuals does not affect comparisons of 
the lymphocyte RHAP/dBAP ratios reported since there were no 
differences in the mean DNAP content of the lymphocytes between 
the various clinical groups. This observation does however 
support the view that in the presence of a substantial immuno­
logical stimulus the proportion of lymphocytes which have 
synthesised or are synthesising OTA prior to cell division is 
increased. This has been discussed earlier in Section 3.26.
Lymphocyte RNAP/dNAP ratio.
Certain types of grafted tissue, for example skin allografts 
in rabbits, appear to be rejected principally by a cell mediated 
reaction, that is an infiltration of large lymphoid cells which 
results in damage and destruction of the cells of the graft. The 
proliferation of lymph node cells in areas later identified as
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paracortical areas of the nodes (Soothorneand MacGregor, 1955) 
suggests that T-lyraphocytes respond to the stimulus of the graft, 
but other cells are also involved. Detailed studies of the lymph 
nodes in rabbits with skin grafts show an increase in a variety of 
cells including lymphoblasts, plasma cells, plasma cell precursors 
as well as lymphocytes (Andre, Schwarts, Mitus and Damashek, 1962A), 
The presence of plasma cells would indicate that antibody as well 
as cell mediated processes are involved in rejection.
Some evidence that there are abnormal mononuclear cells 
present in the blood at times of graft rejection has been introduced 
and the work reported in this thesis has confirmed in man that a 
significant abnormality in the circulating mononuclear cells is 
frequently present when a renal graft is being rejected. Previous 
studies of skin allografts have shown that the lymphoid cells 
which invade the graft are metabolically active with prominent 
nucleoli, and abundant free ribosomes in their cytoplasm (Wiener, 
Spiro and Russell, I964). Histochemically they have a high RNA 
content (Scothorne and Tough, 1952). The levels of RNAP/dNAP 
ratio observed in the blood lymphocytes during allograft rejection 
were sometimes greater than O.5O 9 equalling the highest levels 
reached in any condition. Only in neoplastic disease with 
secondary métastasés were similar levels reached, notable since 
graft rejection and the response to neoplastic disease have common
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features, both involving cellular immune reactions (Meuwissen, 
Stutman and Good, 1969),
It is evident from reviews of renal allograft rejection in 
man that the rejection process in patients on standard immuno­
suppression can take several forms, and Porter (I967) has defined 
these as follows:
1. Acute and immediate
This occurs when there is a major blood group incompatibility 
between host and donor or when the donor is presensitiaed.
Rejection usually takes place within minutes of transplantation 
and there is red cell sludging in the glomeruli.
2. Acute and early
Rejection occurs two to ten days after transplantation and is 
characterised by dense cellular infiltration and rupture of the 
peritubular capillaries. This is largely cell mediated and renal 
shutdown follows tubular necrosis.
3. Acute and later
In the period from eleven days onward rejection occurs and is 
characterised by coating of arteries, arterioles and glomerular 
capillaries with immunoglobulins and complement. Platelet 
aggregates are seen in glomerular capillaries with thrombi in 
larger vessels. Cellular infiltrate may or may not be a feature. 
Acute renal shutdown seems to be due to the glomerular platelet 
aggregates.
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4o Insidious and late
This type of rejection is characterised hy subendothelial 
accumulations of IgM and complement on the glomerular capillary 
basement membranes with slow impairment of renal function*
The information on the timing of rejection recorded in Table 23 
reveals that the majority of rejection episodes included in the 
present study would qualify as Porter's class 3 rejections.
There is a single episode occuring on day seven and falling within 
the time schedule for an acute early cell mediated rejection.
The possibility that some rejections were 'insidious and late* 
cannot be ruled out on the basis of day of onset alone.
If, as seems likely, the majority of the rejection episodes 
were of the type three variety a difficulty arises in determining 
the degree of cell mediated reaction to the graft and the extent 
that platelet aggregation and vascular damage has contributed to 
the rejection. This is important since platelet aggregation is 
thought to be initiated by antigen-antibody ooraplexing in the 
glomeruli and small vessels of the graft and therefore results from 
an antibody response. It is appropriate here to consider the 
evidence already introduced that the 'acute and later' rejection 
episodes in treated human renal allografts are triggered either by 
a cellular or an antibody response.
Extensive studies with many species of animal^reviewed for
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example by Moller and Moller (1967), have shown that humoral 
antibodies can by themselves be responsible for rejection of 
grafts which have a high sensitivity to antibodies, mainly cells 
belonging to the lymphatic system, 19s antibodies are more potent 
than 7s antibodies in this respect. On the other hand repeated 
experiments based on transfer of sensitised lymphoid cells have 
shown that cells can evoke rejection of transplanted tissues in 
situations where serum antibodies are ineffective (Mitchison,
1 9 5 4 5  Billingham, Brent and Medawar, 1 9 5 4 ) .
Mowbray (1966) considers that the dose levels of azathioprine 
which can be used in human renal transplant patients are 
insufficient to prevent an antibody response to graft antigens and 
he believes that antigen-antibody complexing initiates platelet 
aggregation in small vessels of the graft and hence the rejection 
episode. Rejection episodes are treated with prednisone (or 
prednisolone) and this may be effective since both steroids and 
6-meroaptopurine have been shown to prevent immune complex induced 
platelet aggregation (Mowbray, I966), Gell mediated graft 
rejection in Mowbray's view is rare in treated human renal allo­
grafts, Biopsy of the renal graft in patients on immunosuppression 
during acute rejection occuring more than eleven days after trans­
plantation frequently shows changes in the vasculature with 
platelet thrombi and the later consequence^fibrinoid necrosis in 
arteriolar walls, but a cellular infiltrate of lymphoid cells is 
also nearly always present despite the suppressing action of 
azathioprine (Porter, I967).
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Hurd and Ziff (1968) have shown in animal work that the effect 
of 6-meroaptopurine, the active metabolite of azathioprine, is to 
decrease the number of monocytes and large proliferating lymphocytes 
in the blood concurrently with the decrease in mononuclear cells in 
inflammatory sites. In an independent study of the in vivo 
action of azathioprine it was shown that rejection of skin grafts 
in rabbits occurs when the drug fails to prevent the proliferation 
of large mononuclear cells in the lymphoid tissue (Andre^, Schwartz, 
Mitus and Damashek, 1962B). One obvious interpretation of the 
elevation in lymphocyte RNAP/dNAP ratio observed frequently in the 
patients rejecting their grafts is that immunocytes or immunoblasts 
on route for the allograft are present in peripheral blood and are 
contributing to the mean RNA content of the isolated cells. This 
would imply that the cell mediated reaction is important in the 
majority of the rejection episodes.
Parker and Mowbray (1971) have published a detailed 
investigation of the uptake of labelled Uridine in tissue culture 
by peripheral blood mononuclear cells from patients with renal 
allografts. They used the same type of gelatin sedimentation 
method for isolation of the blood mononuclear cells as the present 
study (Coulson and Chalmers, 1967) and their finding of increased 
intensity of RNA synthesis in the blood mononuclear cells prior to 
and following rejection would appear to corroborate the lymphocyte 
RNAP/DNAP ratio results. However, Parker and Mowbray attribute 
the increase RNA synthesis to the contribution from large atypical
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cells present in the blood at the time of rejection. These cells 
on the basis of histochemistry, light and electron microscopy are 
considered to be myeloid rather than lymphoid cells and have been 
tentatively identified as promyelocytes.
The data on the absolute count and histochemistry of the 
atypical cells in the blood have been further detailed by Parker 
(1969)5 the maximum count observed was 6 0  per ml of defibrinated 
blood, that is on an estimated lymphocyte count of 1 0 0 0  per mm^, 
six per cent of the blood mononuclear cells, A simple calculation 
shows that a tenfold increase in the RNA. content of six per cent of 
the cells would be required to raise the mean RNAP/dNAP ratio of 
the mononuclear cells from the normal 0 , 3 0  to O.46 a value 
commonly found in rejection in the present study. The atypical 
promyelocytes observed by Parker and Mowbray and noted in the 
course of the present study do not have strikingly basophilic 
cytoplasm and although the nuclei are sites of rapid RNA turnover 
it is held that cells other than these are responsible for the 
increased RNAP/dNAP ratio in the blood mononuclear cells at the 
time of rejection. It is still of course uncertain what is 
implied by an elevated lymphocyte RNAP/dNAP ratio in terms of 
cellular or antibody mediated rejection, but a possible suggestion 
is that an elevated ratio signifies a more intense cellular immune 
response. The increase in spontaneous transformation of lymphocyte 
in vitro at times of rejection documented earlier would support this 
interpretation.
177
The results presented here propose the simultaneous 
determination of the blood lymphocyte count and the mean lymphocyte 
RNAP/dNAP ratio as a method of monitoring the effectiveness of 
immunosuppression in patients with a renal allograft. The method 
may distinguish graft rejection from excessive immunosuppression 
although both are associated with a low lymphocyte count. Lympho­
penia may be present in both infection and rejection in patients 
on standard immunosuppressive therapy, but only in rejection is the 
combination of lymphopenia with an elevated lymphocyte RNAp/DNAP 
ratio found. In contrast, lymphopenia in the presence of 
infection may be associated with a distinctly low lymphocyte RNAP/ 
DNAP ratio and presumably there may then be excessive immuno­
suppression. This difference between infection and rejection 
would appear to be the result of the more intense cellular response 
produced by the presence of the renal graft. Comparison of the 
results for infection and rejection in Figure 15B and I5C will 
clarify this point and show the necessity of measuring the 
lymphocyte count and RNAp/DNAP ratio together.
The conclusion that the mean lymphocyte RNAP/DNAP ratio is 
significantly reduced in excessive immunosuppression has not, to 
the author's knowledge, been previously reported. The belief that 
these findings reflect the high proportion of small lymphocytes 
circulating in the blood is bourne out by the study of the 
relationship between the lymphocyte RNAP/d NAP ratio and the 
percentage of small lymphocytes on a stained peripheral blood smear.
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From these findings, and since lymphopenia is usually present, it 
appears that in patients suffering from excessive immunosuppression 
there is a dearth of the large lymphocytes.
It is difficult to understand why lymphopenia should be a 
feature of graft rejection. Although in classical acute and early 
rejection of a renal graft the donor kidney is infiltrated with a 
large number of lymphocytes (Porter, 1967)5 these can hardly be 
sufficiently numerous to deplete the entire lymphoid system of cells. 
Hall (1967) and Prendergast (1964) consider that the mononuclear 
cells entering a graft represent a random selection from the 
mononuclear population of the blood. It is likely that immuno­
suppressive therapy reduces the turnover of lymphoid cells and the 
rate at which replacement cells reach the blood. Experimental 
verification of this has been produced by Hiud and Ziff (I968) and 
it may be that cells leaving the blood and entering kidney tissue 
during rejection are only slowly replaced and a lymphopenia 
develops. When there is lymphopenia and a high mean RWAP/OTAP 
ratio,the cells present must show a greater than normal proportion 
of large lymphocytes and since there is a low blood lymphocyte 
count it would appear that the blood is depleted of small lymphocytes 
during rejection. Because of the known reactivity of the lymphoid 
system during rejection it may be wrong to consider this state as 
a general depletion, and perhaps the immunocompetent small lymphocytes 
are instead deployed as 'graft rejection cells' to use the term of 
Wiener and colleagues (I964), It would be logical to consider this
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a T“lymphocyte depletion.
The value of an elevation in the lymphocyte RNAP/dM P  ratio in 
predicting graft rejection in a patient with a renal allograft is 
only seen when there is an accompanying lymphopenia. When both 
the high lymphocyte RWAP/OTAP ratio and low count were found a 
rejection episode took place after a variable interval (averaging 
twenty-three days) in nine out of the ten patients who showed these 
results. In seven episodes the interval was less than ten days, 
more akin to a delayed hypersensitivity response although immuno­
suppression might be expected to influence this. All but one of 
the nine rejections were reversible acute rejection, the single 
exception was of the chronic irreversible type.
Rejection occurred in two patients while the lymphocytes 
remained unequivocally normal and it is striking that in both of 
these patients the usual measures to reverse the rejection were 
ineffective. One patient improved only temporarily on heparin 
therapy combined with intravenous prednisolone. In the other 
patient who came to nephrectomy the donor kidney showed 
considerable vascular damage with proliferation of the intima and 
occlusion by thrombosis. The infiltrate of round cells, although 
present, was not a striking feature of the histology. Despite 
attempts to demonstrate antibody to HLA antigens in these patients 
none have been demonstrated.
The results of serial analyses of the blood lymphocytes in 
patients with a renal allograft, some of which are illustrated in
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Figures 15 to 18, show several interesting features. Figure 15 
shows typical results from a patient who has had excellent function 
in the grafted kidney for over two years at the time of writing. 
After the initial few weeks of the life of the graft the ratio 
has remained between 0.25 and 0.35? very different from the results 
shown in the succeeding figure (Figure 16). In Figure 15 the 
period from day sixty to eighty is of interest since during this 
time the patient had a herpes zoster infection which ran a typical 
course. A small reduction in azathioprine dosage was the only 
measure taken. The figure shows a sharp increase in the blood 
lymphocyte count at first but only a minor rise in the lymphocyte 
RNAP/DNAP ratio occurred.
The results illustrated in Figure 16 from a patient who 
developed chronic rejection have been described earlier. They 
were unique in this study. Support for the view that the early 
and marked changes in the lymphocyte RNAP/DNAP ratio illustrated 
represent an immunological reaction came from parallel 
determinations of the immunoglobulin levels in the patient. 
Exceptionally high levels of IgM, tenfold increases over normal 
levels, were found from an early stage in the life of the graft. 
These results are not reported because of difficulties in 
obtaining satisfactory absolute values, but the levels were 
undoubtedly exceptionally high. Such high levels in association 
with rejection have been reported (Zuhlke, Deodhar, Nakamoto and 
Kolft, 1967). Stocker and his colleagues studied cytoxic
I8l
antibodies in patients with a renal allograft on immunosuppressive 
therapy and noted a high incidence of cytoxic antibody in the IgM 
fraction (Stocker, McKenzie and Morris, I969). But perhaps the 
important point for this study is that the high immunoglobulin 
levels and the abnormal lymphocyte RNAP/dMP ratios found in the 
patient were the only indication that all was not well until some 
weeks later when deterioration of renal function was established.
Figure 17, an illustration of acute reversible rejection with 
prior abnormality of lymphocyte chemistry was a sufficiently common 
finding to make lymphocyte analyses potentially a clinically 
helpful test but since patients were followed who show no 
significant lymphocyte changes during rejection (Figure 18) although 
less commonly in the experience to date, certain caution in 
interpretation is required. Chisholm et al. (1969) have examined 
the value of eight simple laboratory determinations in blood and 
urine in patients after renal transplantation. Although 
significant changes occurred in several of these in relation to 
graft rejection, their experience was that tests based on serum and 
urine creatinine determinations were the most reliable indications 
of rejection. Other measurements have been made, for example 
urine enzyme analyses (Ballantyne, Wood and Meffan, I968), but it 
is doubtful if they are superior to measurements of serum and 
urine creatinine, their predictive value is no better than the 
simpler measurements. In four individuals with adequate 
documentation in the present study the lymphocyte abnormality was
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present prior to the change in renal function, while in two 
patients with rejection there was no lymphocyte abnormality.
It is considered likely that the nature of the rejection process 
differs in these two groups.
The comparison of measurements on stained blood films with 
the chemistry of the lymphocytes isolated from the same blood 
shows an inverse relation between the percentage of small 
lymphocytes and the average ENA content expressed as the ratio 
RNAP/DNAP. This is useful confirmation that the method of cell 
isolation has not greatly distorted the distribution of cells. 
The variation of individual observers in the determination of 
percentage small lymphocytes is considerable and determination 
of the percentage of small lymphocytes on a blood film would 
require checking by independent observers for reliability. The 
measurement of cell volumes electronically, for example by the 
Coulter counter, is a possible alternative.
Although earlier studies could demonstrate no evident 
correlation between graft failure and the grade of tissue 
match, more recently when account is taken of undetermined 
loci in the HLA system the correlation of a good match and 
good prognosis for the graft has been established (Hors, 
Peingold, Pradelizi and Dausset, 1971). Failure to show a 
relationship between the lymphocyte RNAP/DNAP ratio and the 
compatibility of donor and recipient by HLA testing in groups of
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patients suggests that other factors such as immunosuppression 
have been more important in determining the ratio.
Human thoracic duct lymphocytes.
The nucleic acid content of human thoracic duct lymphocytes 
has not been recorded in the literature. The findings reported 
in Table 26 show a mean lymphocyte OTA content of 0.73 jug DNAP per 
10^ cells.
The thoracic duct lymphocytes have a RNAP/d NAP ratio which is
lower than the average ratio in normal blood lymphocytes. This
is as anticipated from the knowledge of the high proportion of
small lymphocytes in the thoracic duct lymph of various species
(Elves, 1966) ranging from seventy to ninety-five per cent in
different mammals.
Interpretation of the results shown in the section which
reports serial monitoring of the thoracic duct lymphocytes in
patients requires a knowledge of the effect of azathioprine and
prednisone on nucleic acid metabolism and on the lymphocyte
population as a whole,
Azathioprine inhibits synthesis of both DNA and RNA by the
action of its metabolite 6-mercaptopurine which forms 6-mercapto-
k
purine ribotide. This acts by mimicking inosinic acid and 
inhibiting the early reactions leading to the synthesis of
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inosinic acid, the so called end product inhibition of the synthesis 
of phosphoribosylamine, 6-mercaptopurine ribotide also interferes
with inter-conversions of the purine ribonucleotides (Berenbaum,
1967)* The net effect of azathioprine is to inhibit nucleic acid 
synthesis. It is unclear which of the two, DNA or RNA synthesis, 
is affected most but it is likely that where active cell division 
is minimal the effect would be greatest on RNA synthesis. Although 
the effect of azathioprine on human thoracic duct lymphocytes 
reported here is a minor one, the RNAP/dNAP ratio of the lymphocytes 
showed a significant increase as azathioprine was first administered. 
This change is difficult to understand unless azathioprine alters 
the distribution of small and large lymphocytes perhaps by 
inhibiting release of the recirculating small lymphocytes from 
lymph nodes or, as in the case with steroids, small lymphocytes are 
more susceptable to the effects of the drug than are large 
lymphocytes.
The increase in the thoracic duct lymphocyte RNAP/dNAP ratio, 
as prednisone is first given to the patients, is considered to be an 
expression of changes in the cell types in the thoracic duct lymph 
at this time, Dougherty, Berliner and Berliner (I96O) showed that 
hydrocortisone produces a preferential dissolution of the small 
lymphocyte, large lymphocytes being resistant to the steroid* It 
is clear from the literature that DNA as well as RNA synthesis is 
inhibited in vitro by moderate levels (30 jag per 100 ml) of 
prednisolone (Tormey, Fudenberg and Kamin, 1967)# Depending on
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the rate of inactivation of the drug this level may he within the 
tissue concentration produced by the therapeutic administration of 
1 g  prednisolone given intravenously over two hours, the technique 
used to treat acute rejection crises. It is relevant to the 
measurements carried out on patients on long term steroid therapy, 
for example some patients with rheumatoid arthritis, that an 
elevated lymphocyte RNAP/OTAP was not sustained on continued and 
more usual dose levels of prednisolone. Steroids do however 
depress lymphocyte function and cell mediated reactions of the 
delayed hypersensitivity type are depressed to a far greater extent 
by steroids than are antibody mediated reactions (Gabrielson and 
Good, 1967).
The nature of lymphocyte RNA.
The observations recorded in Section 4*12 on the nature of 
lymphocyte RNA require interpretation in the light of present 
understanding of the process of RNA biosynthesis reviewed recently 
by Burden (l97l). The rapid incorporation of labelled Uridine 
into material which sediments at 40s to 50s RNA (as was observed 
in lymphocytes) is typical of a cell synthesising ribosomal RNA, 
Although Cooper (1969) believes that lymphocytes may show an 
unusually rapid degradation of ribosomal RNA once it is formed, 
there is no reason to believe that the molecular species
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synthesised are unusual. Other authors (Monjardino and 
MaoGillivrey, 1968) have recorded increased uptake of labelled 
precursor into ribosomal RNA under the influence of phytohaem­
agglutinin and the label which is rapidly incorporated in the 
region of 4s RNA is now recognised as likely to be precursor to 
transfer RNA (Burdon, 1971)» RNA extracted from whole lymphocytes 
has a high percentage of the nucleotides, guanylio acid and 
cytidylic acid, the two being 65 per cent of the total nucleotides 
present (Kiss, Astaldi and Airo, 1967), These percentages are 
typical of mammalian ribosomal RNA#
It was pointed out by Monjardino and MacGillivray (I968) that 
the unusual feature of the lymphocyte is its ability to respond to 
stimuli which may be specific antigen or non-specific such as 
phytohaemagglutinin. The cells respond by increasing their 
synthesis of ribosomal RNA thereby becoming equipped for 
accelerated protein synthesis and are therefore ideally suited for 
proliferation in a cellular immune or antibody response.
188
SECTION 5
Concluding Discussion
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5«. 1 Concluding discussion
It is clear from what has been presented earlier that the 
average RWAP/d NAP ratio of the cells isolated by the gelatin 
technique is increased in certain diseases associated with immune 
reactions, a finding which supports and extends previous 
investigations of the nature of the blood lymphocytes during the 
immune response. Interest centres round two questions which have 
emerged during work, firstly what is the nature of the change 
which has produced the altered RNAP/PNAP ratio, and secondly is 
there a difference in degree of abnormality between immune 
reactions involving antibody production and immune reactions in 
which there is a cellular immune response.
The biochemical approach to the assessment of the lymphocytes, 
an advantage in producing an objective measurement of the cells, 
has meant that the morphology of the cells has been less 
intensively studied. Miller (1969) has listed the cell types 
likely to be present in the peripheral blood and of importance in 
immune reactions. Progenitor or stem cells are the first of these 
types and although these are increased following immune stimuli, 
they constitute less than one per cent of the mononuclear cells. 
Monocytes are of importance as mobile macrophages, participating 
in the cellular immune infiltrates of delayed hypersensitivity 
reactions, but they may be difficult to distinguish from the
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quantitatively more important lymphocytes. Small lymphocytes are
the most easily recognised of the circulating mononuclear cells
and the proportion of these cells in the blood has been shown to
fall when the RNAP/d NAP ratio of the gelatin isolated cells is
increased. The proportion of mononuclear cells other than small
lymphocytes must therefore increase in these circumstances and it
is appropriate to consider the extent of the changes observed.
In response to quite minor stimuli, for example the injection
of diptheria toxoid, pertussis antigen, or typhoid paratyphoid
antigen, Pariser et al, (1952) and Crowther et al, (1969) have
demonstrated up to six per cent of atypical mononuclear cells in
the peripheral blood, usually around the sixth day following the
stimulus. The present technique, RNAp/dNAP ratio determination,
has revealed substantial changes in the lymphocyte population in
rheumatoid arthritis, Sjogren's syndrome, lupus erythematosus,
neoplasm and during renal allograft rejection. The degree of
change is best illustrated by considering a simple numerical
example. If ten per cent of the lymphocytes double their R M
content, going from the normal RNAP/dM P  ratio of 0.30 to a ratio
of 0 ,6 0, then the mean lymphocyte RNAp/dHAP ratio changes only
from 0 .3 0 to 0.33, that is (90 x 0.30) 4- (lO x 0,60) _
100 "
It is similarly apparent that when the mean lymphocyte RPAP/PNAP
increases to 0,50 a ninefold increase in the RNA content would be
required in ten per cent of the cells. It seems likely then
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that more than ten per cent of the cells are altered when the mean 
lymphocyte M A P / M A P  ratio climbs to a high value and that a 
change in the proportion of large, medium and small lymphocytes 
in the blood accounts for this rather than the introduction of a 
small number of atypical cells. It is for this reason that the 
term * lymphocyte RNAP/MAP ratio' has been used throughout the 
study. In addition, the calculations throw some light on the 
sensitivity of the test and would suggest that changes in 
lymphocyte chemistry involving a small fraction of the cells could 
occur undetected.
One of the features which is apparent in a general view of 
the results is the association between reports of depressed blood 
lymphocyte response to phytohaemagglutinin in vitro and the 
observation of significant increase in the mean blood lymphocyte 
RNAP/PNAP ratio. This is the case in rheumatoid arthritis, 
Sjogren's syndrome and neoplasm, three out of the four conditions 
in which a substantial elevation in blood lymphocyte RNAP/PNAP 
ratio was found. Allograft rejection is left out here because of 
the complication of immunosuppression. In the fourth condition 
with an elevated blood lymphocyte RNAP/MAP ratio, lupus 
erythematosus, the phytohaemagglutinin response is said to be 
normal but there must be reservations about this finding since it 
depends on observations by a single group of investigators,
Patrucco et al, (1967)9 who also failed to show a significantly 
abnormal response in a smaller series of patients with rheumatoid
192
arthritis. If it is accepted that there may well he a correlation 
between an impaired phytohaemagglutinin response and an elevated 
lymphocyte RNAP/DNAP ratio, what does this imply? Davies (1969), 
in his review of the thymus and the cellular basis of immunity, is 
satisfied that the phytohaemagglutinin response is principally a 
function of thymus dependent cells, and it may be that the 
elevated lymphocyte R M P / dNAP ratio in three at least of the above 
conditions has arisen from depletion of thymic dependent cells.
The remaining lymphocytes would presumably be B-lymphocytes or 
perhaps T-lymphocytes already in the process of transformation and 
therefore not responsive to phytohaemagglutinin, For whatever 
reason it is clear that a considerable change in the lymphocyte 
population must occur to account for the high values of lymphocyte 
RNAP/dNAP ratio which have been observed.
Evidence that the thymus dependent T-lymphocytes are at least 
relatively depleted in rheumatoid arthritis has come from the 
detection of immunoglobulins bound to the surface of lymphocytes 
in rheumatoid arthritis. This technique outlined earlier 
(Papamiohail et al,, 1971) has shown that B-lymphocytes are a 
greater than normal proportion of the blood lymphocytes in the 
disease, Rhat this means in terms of the relative importance of 
antibody and cellular immunity is uncertain but it is reasonable 
to question whether alterations in the proportions of B— and T— 
lymphocytes in rheumatoid arthritis and perhaps in other conditions 
would reflect on the mean lymphocyte RffâP/DNAP ratio. The
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possibility that B-lymphocytes might have more RNA on average than 
T-lymphocytes remains open.
The second question, that of a difference in degree of change 
in the RNAP/d NAP ratio between cellular immune and antibody 
reactions, is inevitably linked to the first question, the nature 
of the change itself. Quite naturally one may not devise separate 
experimental tests of these responses in man and clues from the 
study of pathology are correspondingly more valuable.
The most reliabl;e example of a cellular immune response occurs 
in the study of renal transplant patients, A single natient (AP 
in Table 23) had a rejection which met Porter's strict criteria 
(1967) for an early acute, and therefore cellular rejection. In 
this patient the lymphocyte RNAP/dNAP ratio reached a high value, 
0,50? at the time of rejection. Other patients with a renal 
allograft had similar elevations of the ratio prior to rejection 
and probably illustrate cellular rejection, but since they do not 
meet Porter's criteria of acute and early rejection the data are 
less conclusive. Indirect evidence that many of these episodes 
are examples of cellular rejection has come from the two rejection 
episodes in which the lymphocyte RPAP/DBAP ratio remained normal. 
These suggest that two different types of rejection occur in 
patients on immunosuppressive therapy; the type with the evidence 
of metabolically active lymphocytes, that is the elevated RITAP/ 
DEAP ratio, may be associated with cell mediated rejection. If 
however an elevated ratio implies, depleted T—lymphocytes as was
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asserted earlier, then this depletion could have arisen from 
transformation of T-lymphocytes under the influence of graft 
antigens with subseouent accumulation of these cells in the graft.
Only minor changes are to be found in the lymphocyte RNAP/ 
DNAP ratio when the immune response results principally in 
antibody production. The study of infection was not ideal in 
this respect since the timing of the blood samples was not always 
optimum and the response not necessarily specifically directed to 
antibody production. It is notable that the lymphocyte RNAP/
DNAP ratio remained normal following typhoid paratyphoid 
immunisation, but more convincing was the observation that no 
significant elevation of the lymphocyte RNAP/DNAP ratio occurred 
in sicca syndrome. Here the main abnormality is in antibody 
production. It appears that antibody reactions do not produce 
sufficient change in the blood lymphocytes to alter their RNAP/ 
DNAP ratio.
It is perhaps useful to try to summarise this discussion in 
the form of a working hypothesis and the following is proposed:
An elevated blood lymphocyte RNAP/d NAP ratio arises in the 
course of a cell mediated immune reaction due to a transformation­
like response in the T-lymphocytes which are later gradually 
sequestered from the circulation. There is then a functional
impairment of T-lymphocytes due to lack of uncommitted cells and
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therefore a relative increase of B-lymphocytes in the blood.
The original aim of the work was to arrive at an objective 
means of assessment of the blood lymphocytes, and this has been 
achieved. The measurement of lymphocyte nucleic acids would be 
greatly increased in usefulness if it could be shown that a high 
lymphocyte RNAP/DNAP ratio distinguishes cellular immune reactions, 
but this point remains to be established. Increasing use of the 
immunofluorescent technique to identify B-lymphocytes would 
contribute here as would examination of the blood lymphocyte RMAP/ 
DNAP ratio in experimental cell mediated reactions.
If measurement of the lymphocyte RNAP/DNAP ratio is to be 
developed into a routine test, a speeding up and simplification 
of the analytical techniques would be desirable. The rapid 
isolation of lymphocytes by flotation on a Ficoll-Isopaque mixture 
would be an obvious choice for cell isolation (Bqyum, 1968) and an 
automated technique for determination of nucleic acid by fluorimetry 
described by Van Dyke and Szustkiewicz (1968) holds promise of a 
rapid assay procedure.
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Conclusions
6.1 The normal values in man for the lymphocyte nucleic acid 
content, using the most satisfactory cell separation technique, 
are as follows: DNA phosphorus, 0,60 to 1.00 pg per 10^ cells
RNA phosphorus, 0.16 to 0.30 p g  per 10^ cells
RNA?/DNAP ratio, 0.22 to 0.37.
6.2 The mean blood lymphocyte DNA phosphorus 0,74 pg per 10^ cells
was similar in normal individuals and in patient groups. The
value is close to the diploid amount for man. There were 
only minor exceptions to this rule, and in general it is 
valid to use the ratio RNAP/DNAP as a measure of the 
lymphocyte RNA content. This ratio is proposed as an 
objective assessment of the blood lymphocytes.
6.3 When groups of patients are considered the mean RNAp /dNAP 
ratio of the blood lymphocytes was shown to be significantly 
increased in patients with the following conditions; 
rheumatoid arthritis, Sjogren's syndrome, lupus erythematosus 
and neoplasm.
6.4 The mean blood lymphocyte RNAP/dNAP ratio was increased in 
patients with infection, thyrotoxicosis and sicca syndrome.
1 9 8
This increase was less substantial than in conditions listed 
under 6.3. A statistically valid difference from normal 
could be shown in relation to only one group of normal results 
in patients with infection, only when LATS negative patients 
were eliminated in the thyrotoxic group, and not at all in 
patients with sicca syndrome.
6.5 Patients with no known immunological abnormality had normal 
results for the lymphocyte RNAP/dNAP ratio.
6.6 Factors which might influence the lymphocyte RNAP/MAP ratio 
including severity of the disease, the blood lymphocyte count 
and therapy have been considered. In rheumatoid arthritis 
an elevated lymphocyte RNAP/dNAP ratio is most consistently 
related to severity of the disease.
6 .7 Patients with a renal allograft on immunosuppressive therapy 
have a mean blood lymphocyte RNAP/dNAP ratio which is similar 
to that found in normal untreated individuals provided the 
patients are not showing evidence of infection, over­
immunosuppression, or graft rejection,
6.8 The mean blood lymphocyte RNAP/DNAP ratio is frequently 
elevated in patients with a renal allograft when they show 
evidence of infection or graft rejection. These two may
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usually be distinguished by the lymphopenia associated with 
graft rejection. Similarly, a clinically important 
distinction between lymphopenia associated with graft 
rejection and lymphopenia arising from over-immunosuppression 
is made by measuring the lymphocyte RNAP/d NAP ratio; the 
ratio is low when there is excessive immunosuppression and 
elevated when there is rejection*
6.9 While the lymphocyte RNAP/DWAP ratio may become abnormal some 
days in advance of an acute rejection reversible with steroid 
therapy, rejection may also occur in the presence of a normal 
blood lymphocyte RNAP/d NAP ratio. The experience has been 
that these latter rejections do not respond well to steroid 
treatment.
6.10 There is evidence drawn from the entire study that the 
lymphocyte RNAP/dNAP ratio may be more markedly elevated when 
there is a cellular immune response than when there is an 
antibody response alone.
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Abbr evi at i ons
The recommendations of the Biochemical Journal (instructions 
to authors, 1969) have been used throughout the text. The less 
common abbreviations have been explained where they appear, and 
are also listed here for reference.
G Centigrade
DNA Deoxyribose nucleic acid
E Extinction coefficient
EDTA Ethylene-diaraine-tetra-acetic acid
E3H Erythrocyte sedimentation rate
gav Average centrifugal force in gravity units
LATS Long acting thyroid stimulator
LE Lupus erythematosus
PHA Phytohaemagglutinin
POPOP l,4-Di-(2-(5 phenyloxazolyl)) -benzene 
PPO 2 ,5"“Diphenyloxazole
PVP Polyvinyl Pyrrolidone
RNA Ribose nucleic acid
8 The Svedberg unit (10 sec.)
SD Standard deviation
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AlWNDIX 9
Individual results of the nucleic acid analyses in patients from the list 
of miscellaneous conditions. BNA is in jog DNA phosphorus per 10^ cells and 
KNA in pg jRNA phosphorus per 10 cells.
M A P  g RNAP m a p /m a p
Condition pg per 10 cells jug per 10 cells ratio
Acute leucaemia 0 ,66 0.26 0,40
Ulcerative colitis 0,66 0,25 0,38
Ulcerative colitis 0,62 0,20 0.33
Macroglohulinaeinia 0.65 0.23 0 ,36
Crohn's disease 0.63 0,24 0,38
Crohn's disease 0 ,44 0.13 0.29
Sarcoidosis 0.98 0.32 0.33
Salicylate poisoning 0.98 0,28 0,33
Whipple'8 disease 0 .62 0.22 0.36
Whipple's disease 0.54 0,11 0,20
Pemphigus 0;74 0.22 0.30
Colonic histiocytosis 0.13 0,30
Colonic histiocytosis 0,68 0.21 0.28
Post TAB immunisation 0.70 0.20 0.29
Post TAB immunisation 0,79 0.21 0.2?
Post TAB immunisation 1.01 0,29 0,29
Acne 0.80 0.23 0.29
APPENDIX 9 (continued)
Condition
DNAl" ^ HNAP ^ BNAP/DNAP
pg per 10 cells pg per 10 cells ratio
Osteoporosis 0.71 0.19 0.27
Osteomalacia 0.43 0.10 0.24
Light chain myeloma 0.57 0.13 0.22
Chronic lymphatic leucaemia 1.42 0.37 0.26
Chronic lymphatic leucaemia 0.72 0.14 0.19
Chronic lymphatic leucaemia 0 .72 0.15 0.20
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LYMPHOCYTE MONITORING BY BLOOD LYMPHOCYTE 
COUNTS AND R N A /D N A  DETERMINATION IN
PATIENTS WITH A RENAL ALLOGRAFT
A . C . A . G l e n , P. R. P. B e l l, J. D . B riggs, A . M. P a t o n ,
K . C . C a l m a n , an d a .  L. L inton
Department oj  Biochemistry, Victoria Infirmary, Glasgow, the University Department of 
Surgery, and the Renal  Unit, Western Infirmary, Glasgow, Scotland
SUM M ARY
Two hundred and n inety-nine analyses of both blood lym phocyte count and lym pho­
cyte ribonucleic acid/deoxyribonucleic acid (R N A /D N A ) ratio in 17 patients w ith a 
renal allograft are reported. In  the absence of infection, patients on standard im m uno­
suppressive regimes have normal results for the lym phocyte R N A /D N A  ratio, although  
they m ay have lym phopaenia. U nequivocal infection and rejection m ay usually be dis­
tinguished by the lym phopaenia associated w ith rejection, although in both  the lym pho­
cyte R N A /D N A  ratio is elevated. A clinically im portant distinction betw een lym pho­
paenia in rejection and lym phopaenia resulting from overim m unosuppression is made 
by measuring the lym phocyte R N A /D N A  ratio. The ratio is low in oversuppression  
and elevated in rejection. T lie combined measurem ents of lym phocyte R N A /D N A  ratio 
and lym phocyte count have a predictive value in more than one-half of the rejection  
episodes which show abnorm ality at least 5 days earlier than m easurem ents which de­
pend on renal function.
On the assum ption that a renal allograft has nosuppression and give an early indication of 
been achieved w ith an adequate, but less than im pending graft rejection.
perfect, tissue m atch, one of the m ain problem s L ym phocytes are closely im plicated in the pa­
in the m anagem ent of the recipient is the bal- thology of graft rejection and are readily acces-
ancing of suppression of graft rejection processes sible in blood. Both azathioprine and prednisone,
w ith the danger of im pairm ent of the patient's the established im m unosuppressive drugs used in
response to infection. This problem is magnified renal transplantation in man, are inhibitors of
'when rejection of the graft is suspected and im- nucleic acid synthesis {2, 33) ,  so that measure-
m unosuppressive therapy has to  be increased, m ent of lym phocyte D N A  and R N A  content is
Berenbaum  (3 ) ,  in a review of the reports of the of potential value in m onitoring the effect of
K idney T ransplant R egistry (7 /-7 d ) ,  points out these drugs. In addition, previous experience
that the difficulties associated with drug toxicity  with the lym phocyte nucleic acid determ ination
and infection account for about one-third of points to the mean blood lym phocyte R N A /
graft failures and are also factors, in m ost in- D N A  ratio as a reproducible m easurem ent (6')
stances, of death in the recipient (S, 6 ) .  correlated with the m ean Ijunpliocyte diam eter
Im m unosuppression is usually m onitored b y  (7) and related in theory and in practice to
m aintaining th e w hite cell count w ithin  the immunological activ ity  in man (5, 3S) . A range
5,000-10,000 cells/mm^ range. This m ethod is at for th e blood lym phocyte R N A /D N A  ratio in
best empirical and there is a great need for a normal persons has been established (6)  and
m ethod which will allow better control of im m u- confirmed in an independent laboratory (H .
^Address requests for reprints to: Dr. A. C. A. Sakai et ah, peisonal com m unication).
Glen, Biochemistry Department, Victoria Infir- There is already in the literature evidence of
mary, Glasgow, S.2., Scotland. functional abnorm ality of th e blood lym phocytes
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in relation to allograft rejection and im m uno­
suppression. Spontaneous transform ation of 
blood lym phocytes in vitro increases at a tim e of 
Immunological a ctiv ity  directed against th e graft 
and effective im m unosuppression im pairs the  
phytohaem agglutinin response {33).  Changes in 
recipient leucocyte m igration, using a standard  
technique, can be dem onstrated in relation to  
renal allograft rejection {3Î)  and an increase in 
the rate of R N A  {18) and D N A  synthesis {11) 
in peripheral blood lym phocytes has been dem ­
onstrated at tim es of rejection. B ecause of these 
changes in the behaviour of lym phocytes during 
periods of im m unological activ ity , a study of th e  
qualitative and quantitative changes in lym pho­
cytes following renal transplantation m ay pro­
vide a reliable m eans of m onitoring hnm unosup- 
pression and forecasting graft rejection. This 
paper presents the results of m onitoring blood  
lym phocyte count and R N A /D N A  ratio in a 
series of 17 patients following renal transplanta­
tion.
M ATERIALS A N D  M ETH O DS
Clinical material.  This stu d y of 17 patients, 
recipients of 18 renal allografts, was carried out 
in th e 3-year period up to  the end of 1970. 
There were 3 live donors and 16 cadaver donor 
kidneys in the series ; the recipients were 9 males 
and 8 fem ales, 1 m ale receiving a second graft. 
T he m ean age of the patients was 31 years, w ith  
a range of from  17 to 46 years.
Im m unosuppression w as m aintained w ith  aza­
thioprine given as an initial dose of 3 m g /k g  and  
then  regulated according to the w hite cell count. 
Prednisone, 200 m g /d a y , was started a t th e tim e  
of the transplants and reduced daily in steps of 
10 mg to a m aintenance dose of from  10 to  30 
m g/d ay . D efinite clinical rejection episodes were 
diagnosed in the event of an increased serum  
creatinine and a decreased creatinine clearance 
present for 24^48 hr. Other factors such as de­
creased urine volum e and renal tenderness were 
inconsistent findings. Such episodes were treated  
by an i.v. infusion of 1 g of prednisolone given  
over a 2-hr period and repeated on the following 
day if necessary. T w o patien ts received X -irra- 
diation (150 rads) during rejection crises.
Sam ples of venous blood were taken  from  th e  
patients, alw ays betw een 8 :3 0  and 10:30 A M , 
for the lym phocyte analyses as well as th e  gen­
eral m onitoring of the p atien t b y  the usual series
of tests. In  the initial stage of the project, 
blood sam pling for lym phocyte analysis was in­
frequent and, for this reason and because of early 
graft failure in som e cases, fewer than  5 blood  
sam ples were obtam ed during th e life of each of 
4 grafts. In  the remaining 14 allografts, 289 lym ­
phocyte analyses were undertaken during 141 
graft m onths, i.e., each patient had, on the aver­
age, an analysis every 2 weeks. In  practice, the  
blood sam pling was m ore frequent early in th e  
life of the graft when the im m unosuppressive 
therapy was being adjusted and it becam e ap­
parent that sam pling tw ice/w eek  would be ad­
vantageous.
Labor a tory  methods.  B lood sam ples from pa­
tients were analysed by  recording th e tota l w hite  
count b y  standard Coulter counter techniques 
and the differential w hite cell count, on a stained  
slide. L ym phocyte nucleic acid analysis was car­
ried out after lym phocyte isolation from blood  
by a m odification {6) of the Coulson and Chal­
mers gelatin sedim entation m ethod {18 ). An ad­
ditional step from the published technique {6) 
was included at the stage when the lym phocytes  
were in suspension and freed from  the bulk of 
the red cells. T his was to  m cubate the suspen­
sion with washed cotton wool for 15 min at 37 C. 
L ym phocytes were recovered from the wool 
thereafter by gentle pressure. This step im ­
proved the purity of the preparation and re­
duced polym orphonuclear cell contam ination to 
under 5%; residual red cells were rem oved by  
osm otic shock.
T he analyses of D N A  and R N A  in the lym ­
phocyte suspensions, using a m inim m n of 3 X 
10® cells, were carried out b y  a modified Schm idt 
Thannhauser {11) procedure described else­
where {6).
Although the lym phocyte D N A  and R N A  
content/10® cells w as noted, taking account of 
the lym phocyte count in th e cell suspension, th e  
results in this paper are recorded as th e mean  
lym phocyte R N A /D N A  ratio. T he ratio R N A /  
D N A  of th e cell is a valid index of its R N A  
content provided it can be shown that the m ean  
D N A  content of the cell is constant in th e popu­
lation under study and is not being influenced  
by active D N A  synthesis or polyploidy.
RESULTS
T he results of 299 analyses from patients are 
plotted in Figure 1. In  normal persons not re-
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Fiquhe 1. The relationship between blood lymphocyte count in cells per cubic millimeter 
and the lymphocyte R N A /D N A  ratio in patients with a renal allograft on immunosuppres­
sive therapy. The dotted lines show lim its of normal for the lymphocyte R N A /D N A  ratio 
in untreated persons without a graft. A blood lymphocyte count of 1,000 cells/mm'* or less 
defines a lymphopaenia.
reiving im m unosuppressive therapy, the ac- 
ce])ted \a lu e  for the normal blood lym phocyte  
count is from 1.500 to 3,500 cells/m iiP . Figure 1 
shows 84 samplc.s with a lym phopaenia of 1,000 
cells/m nr‘ or loss. Ten sam ples showed a lym ­
phocytosis with a lym phocyte count of 3,500 
cells/mm" or greater.
It can be seen also from Figure 1 th at th e  
blood lym phocytes from patients having a renal 
allograft and receiving im m unosuppressive 
treatm ent can have R N A /D N A  ratio results 
outside the range found in normal persons of 
0.20-0.40. On 15 occasions the lym phocyte  
R N A /D N A  ratio was low and on 54 it was 
elevated when compared to the lym phocytes of 
normal untreated persons. Exam ination of F ig ­
ure 1 would suggest th at a low lym phocyte  
R N A /D N .A  ratio is associated vdtli lym phopae­
nia while a high lym phocyte R N A /D N A  ratio 
m ay be associated w ith a norm al or low lym pho­
cyte count.
In order to arrive at a range of values for the  
lym phocyte analyses in  im m unosuppressed pa­
tients w ith good graft function and to show pos­
sible differences in th e lym phocyte response to  
infection, rejection, or excessive im m unosup­
pression, four clinical states were defined.
A. N o  injection or rejection.  To qualify for 
this group patients had to  be free of clinical or 
laboratory evidence of generalised or local infec­
tion or graft rejection, at the tim e of, or w ithin  
10 days of, analysis. In addition, th e creatinine 
clearance had to be at least 50 m l/m in . I f  the  
patients had more than one rejection episode in  
th e past they  were not included in this group.
B. Unequivocal  infection.  To be included in
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this group the patien t had to exhibit clinical and  
laboratory evidence of viral, fungal, or bacterial 
infection. T he possib ility  of the presence of 
rejection excluded patients from  this group.
C. Unequivocal  rejection.  Inclusion in this 
group required th at clinical suspicion of graft 
rejection, acute or chronic, should be confirmed  
by a substantial elevation of the plasm a creati­
nine m aintained for 24 hr. A  substantial rise of 
plasm a creatinine was defined as an increase of 
0.5 m g/100  ml when the plasm a creatinine was 
under 2.0 m g/100  ml, and a rise of 1.0 m g when  
the initial plasm a creatinine was greater than  2 
m g/100  m l. T he presence of infection excluded  
patients' results from  this group.
D.  Excessive immunosuppression.  P atien ts in 
this group had a blood leucocyte count of less 
than 4,000 cells/mnf*. E vidence of rejection or 
significant infection resulted in exclusion from  
the group .
T he blood lym phocyte counts and th e lym - 
lihocyte R N A /D N A  ratios for these groups are 
presented in Table 1. T hirty-seven  results from  
6 patients com prised group A, 19 results from  7 
patients com prised group B , 17 results from  10 
patients com prised group C, and 9 results from  
3 patients were included in group D .
Results from patients w ith neither rejection  
nor infection are taken as the norm al group in 
th is study of renal allografts. T he results are 
very similar to  published values for th e blood  
lym phocyte count and the lym phocyte R N A /  
D N A  ratio {6) in norm al untreated  persons, 
although a tendency to slight lym phopaenia is 
noted in patients w ith  treated  allografts. Serial 
analyses from  individual patien ts show  a striking  
stab ility  of the R N A /D N A  ratio in those pa­
tien ts included in th is group.
A  useful intercom parison m ay be m ade b e­
tw een the 4 clinical states defined previously, 
applying S tu dent’s t test to  th e m ean value for 
each group (T able 2 ) . T he blood lym p hocyte  
count results are considered first. In  the pres­
ence of infection, the m ean blood lym phocyte  
count is lower than  when infection is absent, but 
this has not been shown to have statistica l sig­
nificance. W hen unequivocal rejection is present, 
there is a statistica lly  significant lym phopaenia  
(P  <  0 .001). N o t unexpectedly, lym phopaenia  
was present in the group D  p atien ts (excessive  
im m unosuppression). On exam ination of the  
lym phocyte chem istry, group B (infection
T a u l k  1.  I n t e r c o m p a r i s o n  o f  t h e  r e s u l t s  o f  t h e  
b l o o d  l y m p h o c y t e  c o u n t  a n d  t h e  l y m p h o c y t e  
R N A /D N A  r a t i o  i n  t h e  f o u r  c a t e g o r i e s
Category
Blood 
lym phocyte 
count 
(mean cells/ 
m m : SD)
Lym phocyte 
RN A /D N A  
ratio  
(mean =fc SD)
A. N o in fection , no  re ­
jection
B. U nequivocal infection
C . U nequivocal rejection
D . Excessive im m u n o ­
suppression
2 ,2 2 4  ±  1 ,0 5 0  0 .3 0 0  ±  0 .0 4 7
1 ,7 9 2  ±  1 ,0 2 8  
888 ± 5 3 6  
623 ±  403
0 .3 5 1  ±  0 .0 0 0  
0 .4 2 2  ±  0 .0 6 3  
0 .2 5 3  ±  0 .0 7 1
T a ü l e  2 .  Analysis by Ltest.
M easurem ent Comparison P
Blood ly m p h o ­ N o infection, no rejection v e r­ NS
cy te  co u n t sus in fec tion
N o in fection , no rejection  v e r­
sus re jection
<0.001
N o infection , no rejection ver­
sus excessive im m u n o su p ­
pression
<0.001
In fec tion  versus rejection <0.01
L y m p h o cy te N o  infection , no rejection ver­ <0.001
R N A /D N A sus infection
n ilio N o infection, no rejection v e r­
sus rejection
<0.001
N o infection , no rejection v e r­
sus excessive im m u n o su p ­
pression
< 0 .02
In fec tion  versus rejection <0.01
group) and group C (rejection group) each 
showed a significantly greater m ean value for 
the lym phocyte R N A /D N A  ratio than  group A 
(no infection or rejection) {P  <  0.001 in each 
ca se ). T he degree of elevation of th e m ean lym ­
phocyte R N A /D N A  ratio was significantly  
greater in th e presence of rejection (P  <  0 .01). 
There is, how ever, considerable overlap of ob­
served values for th e ratio in groups B  and C 
(infection and rejection). T he finding of a re­
duction in the lym phocyte R N A /D N A  ratio in 
th e presence of over im m unosuppression is of rel­
evance later in relation to th e cause of lym pho­
paenia.
W hen the value of the lym phocyte R N A /  
D N A  ratio and th e blood lym phocyte count are 
considered together in th e sam e 4 groups a 
clearer pattern  emerges as m ay be seen from  
exam ination of Figure 2. T his shows th e individ­
ual values for th e relationship betw een th e blood  
lymi^hocyte count and the lym phocyte R N A /  
D N A  ratio separately p lotted  for each of the 4
438 TR A N SPLA N TA TIO N  
NO INFECTION, NO REJECTION
VoL 12, No.  6
INFECTION
t
• • • •
B
• •
0.3 0,3 0.4
RHA/nWA RATIO
0.1 O.a 0.3 0.4 0.0
AMA/DMA RATIO
REJECTION EXCESSIVE IMMUNOSUPPRESSION
I 4000
aooo-
looo
0.3 0.4 0.0o.a0.1
RM/TKA RATIO
0.3
RMA/MU RATIO
0.0
Kigtjre 2. The relationship between the blood lym phocyte count in cells per cubic m illi­
meter and the lym phocyte R N A /D N A  ratio in patients with a renal allograft and on im ­
munosuppressive therapy in four clinical categories: A, no infection, no rejection; B, 
unequivocal infection; C, unequivocal rejection; and D, excessive immunosuppression. These 
categories are defined in the text.
groups. T he results m ay be summarised as fo l­
lows.
W hen both infection and rejection are absent 
(group A) the blood lym phocyte count is varia­
ble, only occasionally low. T he lym phocyte  
R N A /D N A  ratio is not elevated above 0.40 in  
these patients; rather, it  m ay be occasionally  
low and then usually in association w ith a low  
blood lym phocyte count. W hen infection is pres­
ent (group B ) ,  a low  blood Ijrmphocyte count 
tends to be associated w ith a low lym phocyte  
R N A /D N A  ratio and a high lym phocyte count 
with a normal or high lym phocyte R N A /D N A  
ratio. In contrast w ith th is are th e results from
patien ts w ith unequivocal rejection (group C ). 
H ere th e usual values are a low  blood lym pho­
cyte count, less than 1,000/mm®, and an elevated  
lym phocyte R N A /D N A  ratio, usually greater 
th an  0.40. In  th e presence of excessive im m uno­
suppression, as evidenced b y  a  general leucopa- 
enia (group D ) ,  it  appears th at a very low  lym ­
p hocyte R N A /D N A  ratio m ay be present when  
the blood lym phocyte count is also very  low.
If the changes in th e blood lym phocytes found  
in unequivocal rejection are to  have diagnostic 
value, the incidence of m isleading results m ust 
be shown to  be low. Possible false negative re­
sults are considered first. T here were tw o normal
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results from th e sam e patient for both  the blood  
lym phocyte count and the lym p hocyte R N A /  
D N A  ratio in th e 17 analyses during unequivo­
cal rejection. D uring a further 3 rejection epi­
sodes, each involving different patients, there  
was a lym phopaenia but w ith  a lym phocyte  
R N A /D N A  ratio w ithin  th e upper norm al lim it 
of 0.40. T hese last results were, however, 1, 3, 
and 14 days after treatm ent of rejection w ith 1 
g of prednisolone, so there rem ained only 2 re­
sults w ith a lym phocyte count of m ore than  
1,000/mm® and a lym phocyte R N A /D N A  ratio  
of less than  0.40 during untreated unequivocal 
rejection out of a to ta l of 14. Special features of 
the rejection in the 1 patient who had these  
normal results are discussed later. T hus, a low  
incidence, i.e., 14% of false negative results in 
untreated unequivocal rejection, has been found.
Over the whole tim e of study, results were 
obtained during 12 d istinct periods in 10 pa­
tients who showed a low blood lym phocyte  
count and a lym phocyte R N A /D N A  ratio of 
more than 0.40 and therefore suggested the pos­
sibility of a subsequent rejection episode. N in e  
of these patients did h ave a clinical rejection  
episode. Of the individual 19 abnormal results, 
rejection followed in 14 w ith an  average interval 
of 23 days. T he interval betw een finding the 
abnormal result and the clinical rejection epi­
sode was variable; in  one case th e  lym phocyte  
abnorm ality appeared 129 days in advance of 
rejection and was shown still to  be present 30, 7, 
and 1 day before gradual functional im pairm ent 
of th e graft was apparent and treatm ent was 
initiated. T he remaining 5 abnormal results were 
not followed by  a recognisable rejection episode. 
T w o of these m ay be discounted since th e results 
were obtained 1 and 2 days after treatm ent of 
rejection with 1 g of prednisolone. T he incidence 
of false ]iositive results in th e diagnosis of rejec­
tion was thus 3 in 19, or 16%.
An exam ple of the results of serial m onitoring  
of the blood lym phocytes during a period of 
acute reversible rejection is show n in Figure 3. 
In th is illustration lym phopaenia w ith a m ark­
edly elevated lym phocyte R N A /D N A  ratio was 
present at least 7 days in advance of th e deci­
sion to  treat for acute rejection. T he earliest rise 
in the plasm a creatinine, on which the decision  
to increase th e im m unosuppression was based, 
occurred 5 days after th e changes in th e lym ­
phocytes were established. Four such exam ples.
in different patients, of prior abnorm ality of th e  
blood lym phocytes have been docum ented.
L ym phopaenia was a m ore frequent observa­
tion than leucopaenia in th is study. Of th e 84 
sam ples w ith a lym phocyte count of less than  
1,000 cells/mm®, 21 had a  severe lym phopaenia  
w ith a count of less than 500 lym phocytes/m m ®. 
Leucopaenia, defined as a blood w hite cell count 
of less than 4,000 cells/mm®, in contradistinction  
to lym phopaenia, was present in only 11 samples 
in th e study, and only 3 tim es were severe lym ­
phopaenia and leucopaenia present together. 
T hus, the average w hite cell count in the sam ­
ples w ith less than 500 lymphocytes/mm ® was 
6,516 cells/mm®.
T he mean blood lym phocyte R N A /D N A  
value from patients showing classical overim m u­
nosuppression by  virtue of a leucopaenia not 
associated w ith rejection is listed in Table 1, and  
the individual results are displayed in F igure 2, 
In the presence of severe lym phopaenia, and not 
associated with rejection, th e  m ean lym phocyte  
R N A /D N A  is lower a t 0.197 (SD  0.054) than  
the value of 0.253 found in leucopaenia. T his 
difference of the m eans is just significant (P  <  
0.05). M ore im portant is the observed range of 
values for th e ratio in severe lym phopaenia not 
associated with rejection, i.e., 0 .12-0.27. W hen  
patients with less severe lym phopaenia are con­
sidered, i.e., those w ith a blood lym phocyte  
count of less than 1,000 cells/mm®, the range of 
observed values for the R m p h ocyte R N A /D N A  
ratio extends upw ard to  0.37. T his value for the  
lym phocyte R N A /D N A  ratio is lower than that 
considered appropriate for the diagnosis of graft 
rejection and it appears, therefore, th a t a lym ­
phocyte R N A /D N A  ratio of less than 0.40 dis­
tinguishes the lym phopaenia which m ay be the  
result of im m unosuppressive drug action from  
the lym phopaenia associated with rejection.
M easurem ent of the mean D N A  content of 
the lym phocytes isolated from peripheral blood  
was not a main objective in the study, but a cell 
count was carried out to  check that in each case 
the yield of cells was sufficient for analysis. A  
series of values for the mean D N A  content of 
the cells was therefore obtained using m anual 
counting in Neubauer chambers as a reference. 
Individual values thus determ ined are inaccu­
rate, but average values of m ultiple sam ples 
have more validity. T he following values were 
found for the mean lym phocyte D N A  content in 
the various groups all expressed as /ig D N A
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Figure 3. The course of an acute rejection episode showing serial changes in plasma 
creatinine, blood lymphocyte count, lymphocyte R N A /D N A  ratio, and prednisone and 
azathioprine therapy. Treatment of rejection episodes with i.v. prednisolone in 1-g dose is 
indicated by an arrow.
phosphoru.s/10" cells: no infection, no rejection, 
0.824; unequivocal infection, 0.836; unequivocal 
rejection, 0.805; excessive immunosupi^ression 
(leucopaenia), 0.856; and severe lym phopaenia,
0.837. As there was no significant difference be­
tween the mean values for all groups it is valid  
to regard changes in the lym phocyte R N A /  
D N A  ratio between the groups as evidence of a 
difference in the mean lymi^hocyte R N A  con­
tent.
W hen the groups were combined, the mean  
lym phocyte D N A  content was 0.824 w ith  a 
standard deviation of 0.165 /rg of D N A  phos­
phorus/10" cells. This was slightly higher than  
the mean D N A  content of lym phocytes found in 
normal untreated persons, i.e., 0.732 jxg of D N A  
phosi)lmru.s/10" cells, a difference of the mean  
which was significant at the 5% level.
DISCUSSION
T he features of cell-m ediated graft rejection, 
notably the proliferation of blast cells in the  
lym ph node which drains th e area of the graft 
and the subsequent m igration of lym phoid cells 
to the graft to participate in its destruction, 
have been established experim entally { 1 ,1 0 ,  24) .  
I t  was anticipated from  th is experim ental work  
that atypical m ononuclear cells would be found  
in the peripheral blood as part of the im m uno­
logical response to  the graft, and this has been  
confirmed in man b y  the previously reported  
functional abnorm alities of the lym phocyte {11, 
18, 21, 22] as well as by the changes in the  
lym phocyte R N A /D N A  ratio in relation to  
renal allograft rejection reported here. T he diag­
nostic usefulness of the various tests showing 
alteration in the circulating blood lym phocytes
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in graft rejection is lim ited by the appearance of 
the so called hyperbasophilic m ononuclear cells 
in response to  a variety of stim uli including in­
jected antigen ( / ,  17),  virus {IS) ,  and bacterial 
{26) infection. T he present paper proposes the  
sim ultaneous determ ination of the blood lym ­
phocyte count and the m ean lym phocyte R N A /  
D N A  ratio as a m ethod of m onitoring the effec­
tiveness of im m unosuppression in patients with  
a renal allograft. T he m ethod distinguishes graft 
rejection from excessive im m unosuppression, 
even when the oversuppression is com plicated  
by infection.
Lym phopaenia m ay bo present in both infec­
tion and rejection in patients on standard im m u­
nosuppressive therapy. Only in rejection, how ­
ever, is the com bination of lym phopaenia w ith an 
ele \a ted  lym phocyte R N A /D N A  ratio found. In  
contrast, lym ]ihopacnia in the presence of infec­
tion m ay be associated with a d istinctly  low  
lym phocyte R N A /D N A  ratio. This difference 
between infection and rejection m ay be the re­
sult of the more intense cellular response pro­
duced by the presence of the renal graft. In  
som e infections in im m unosuppressed patients 
the lym phocyte R N A /D N A  ratio is increased  
but here there is no lym phopaenia. Comparison  
of the results for infection and rejection in F ig ­
ure 2, 13 and C, will clarify th is point and show  
the necessity of measuring the lym phocyte count 
and R N A /D N A  ratio together.
It is difficult to understand w hy lym phopaenia  
should be a feature of graft rejection. A lthough  
in classical acute rejection of a renal graft the  
donor kidney is infiltrated w ith a large number 
of hunphocytes {19) ,  these can hardly be suffi­
ciently numerous to deplete the entire lym phoid  
system  of cells. H all {10) and Prendergast {20)  
consider that the m ononuclear cells entering a 
graft represent a random selection from the  
mononuclear population of the blood. I t  is likely  
that immunosuiDpressi^m therapy reduces the  
turnover of lym phoid cells and the rate at 
which replacement cells reach the blood ; it m ay  
be that cells leaving the blood and entering kid­
ney tissue during rejection are only slowly re­
placed and a lym phopaenia develops.
The observation that the tym phocyte R N A /  
D N A  ratio, and, hence, the m ean lym phocyte  
R N A  content, is reduced when o \e r  immu no­
suppression is present is of interest since aza­
thioprine, a 6-m ercaptopurine analogue, and cor­
ticosteroids are believed to inhibit R N A  and
D N A  synthesis {2) .  liow ever , the effect on the  
mean lym phocyte R N A /D N A  ratio is more 
likely to be attributable to a change in cell pop­
ulation than to a direct action on the nucleic 
acid content of individual lym phocytes. A zathio­
prine is thought to interfere with the turnover  
of the large active mononuclear cells {12) ,  re­
ducing their numbers, and this would account 
for the lowered m ean lym phocyte R N A /D N A  
ratio in overim m unosuppressed patients. In a 
previous study of thoracic duct lym phocytes in 
man {9) ,  an increase in the mean cell R N A /D N A  
ratio was noted as azathioprine and prednisone 
were first adm inistered prior to transplantation. 
T he altered ratio was transient and drug treat­
ment alone is unlikely to be the explanation of 
fhe changes observed in the blood lym phocytes 
during rejection since m ost of the results ob­
tained were during m aintenance therapy w ith a 
m oderate drug dosage. Indeed, on successful 
treatm ent of rejection w ith 1 g of prednisolone, 
the lym phocyte abnorm ality is resolved (Fig. 3 ).
Porter (19)  has detailed the pathological 
changes which occur during rejection of a renal 
allograft in man. H e considers that rejection  
which occurs in the first 11 days after transplan­
tation, excluding im m ediate rejection, is largely  
a cell-mediated process and that, in later rejec­
tion, vascular changes and immunoglobulin dep­
osition w ith p latelet and fibrin throm bi are more 
prominent features of th e pathology. In  the  
study of unequivocal rejection reported here all 
but one of the episodes were acute or chronic 
rejections occurring 11 days or more after the  
date of the transplant. L ym phocyte abnorm ality  
was detected in m ost of these rejection episodes. 
The one patient who had persistently normal 
lym phocytes in the presence of unequivocal 
rejection did have predom inantly vascular 
changes in the donor kidney and cellular infil­
trate was slight. I t  is apparent, however, that 
the blood lym phocytes arc usually abnormal 
even when rejection is m ore than 11 days from  
transplantation. T he patien t who showed the  
longest period of abnorm ality prior to graft 
rejection developed an insidious progressive 
rejection which did not respond to treatm ent, 
and over a period of 2 m onths the creatinine 
clearance fell from 40 m l/m in  to less than 2 
m l/m in .
T he evidence that the mean D N A  content of 
the lym ]ffiocyte is slightly greater in patients  
who lia^'o a renal allograft than in normal per­
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sons does n ot affect com parisons o f th e  ly m p h o ­
cy te  R N A /D N A  ratios reported  s in ce  th ere  w as  
no difference in th e  m ean  D N A  con ten t of th e  
ly m p h o cy tes  b etw een  th e  various clin ical groups.
In  conclusion, th e usefu lness o f th is  m eth od  of 
lym%)hocyte m on itorin g  is in th e  d istin ction  
w hich m ay  be m ad e b etw een  g ra ft rejection  and  
overim m unosuppression  in  iym p h op aen ic  p a ­
tien ts. T h e  ab n orm ality  of th e  Ijnnp liocyte in  
rejection w as presen t 5 days or m ore before ev i­
dence of renal dam age becam e ap p aren t in  m ore  
than  on e-h a lf of th e  fu lly  d ocu m en ted  cases. T h e  
appearance of an e leva ted  ly m p h o cy te  R N A /  
D N A  ratio in associa tion  w ith  lym p h op aen ia  is 
therefore an in d ication  for close su p erv ision  of  
th e  p a tien t. N orm al ly m p h o cy te  counts and  
R N A /D N A  ratios do n o t gu aran tee th a t  p a ­
tien ts w ill be free of rejection , b u t do con trib ­
u te in form ation  on th e  degree of im m u n osu p ­
pression.
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DNA AND RNA MEASUREMENTS ON THORACIC 
DUCT LYMPHOCYTES OF PATIENTS UNDERGOING 
RENAL TRANSPLANTATION
A . C . A . G le n ^ , W . C . C ooper ,^ J . L . B oak ,^ J . E . M u r r a y ,^
AND H. N. M u n r o^
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SUMMARY
The ribonucleic acid (R N A ) and deoxyribonucleic acid (D N A ) 
content of thoracic duct lym phocytes was examined serially prior to  
and during immunosuppressive therapy in four patients receiving 
renal allografts. Before drug treatment, the mean values for the 
nucleic acid content of the thoracic duct lym phocytes were 0.72 pg of 
D N A  phosphorus/cell and 0.16 pg of R N A  phosphorus/cell. In all 
patients the mean R N A /D N A  ratio of the lym phocytes increased 
transiently as azathioprine or prednisone was administered. T he in­
creases, which averaged 17% with azathioprine and 37% with com­
bined prednisone and azathioprine in the 24 hr following initiation of 
the drugs, were statistically significant. In short-term tissue culture, 
the response of thoracic duct lym phocytes on exposure to phyto­
hemagglutinin was determined by nucleic acid measurement. Evidence 
is presented of an impaired transformation response of lym phocytes 
from patients being treated with azathioprine.
T h e  c ir c u la t in g  ly m p h o c y te  is  in v o lv e d  d ir e c t ly  in  s e v e r a l  b a s ic  im m u n o lo g i­
c a l r e a c t io n s , o n e  o f  w h ic h  is  th e  r e je c t io n  o f  a l lo g r a f t s  ( 7 ) .  W e  h a v e  m e a su r e d  
r ib o n u c le ic  a c id  (R N A )  a n d  d e o x y r ib o n u c le ic  a c id  ( D N A )  in  th o r a c ic  d u c t  
ly m p h o c y te s  (T D D )  o f  p a t ie n t s  u n d e r g o in g  r e n a l h o m o tr a n s p la n ta t io n  w ith  
tw o  g e n e r a l o b je c t iv e s  in  m in d :  to  a s se s s  th e  fu n c t io n a l  s ta tu s  o f  th e  T D D  
s e r ia l ly ,  d u r in g  t r e a tm e n t  o f  th e  p a t ie n t  w ith  im m u n o su p p r e ss iv e  d ru g s a n d  fo l-
 ^Send reprint requests to Dr. H. N . Munro, Department of Nutrition and Food Science, 
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
 ^Supported by Grant DA-49-193-Md-02560 from the United States Army.
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lowing renal transplantation, and to assess the in vitro responsiveness of the pa­
tien t’s lymphocytes to phytohemagglutinin (PH A ).
Plum an TD L, available to us as a result of thoracic duct drainage of patients 
undergoing renal transplantation, permitted us to use greater quantities of 
lymphocytes in these experiments than would be feasible with blood lympho­
cytes. Therefore, it  was possible to perform multiple experiments on lympho­
cytes from the same patient and, since the thoracic duct fistula was open during 
the initiation of immunosuppressive treatm ent, serial studies of lymphocytes 
were possible during this period. The TD L were 95-100% small lymphocytes, 
almost uncontaminated with other blood cell types ; thus, it was not necessary 
to remove contaminating leukocytes. A disadvantage of using TD L from trans­
plantation subjects who are anephric and are maintained by hemodialysis is 
th a t the lymphocytes so obtained cannot be considered normal in all respects ; 
th a t is, it is known th a t such lymphocytes may not transform  as readily as do 
lymphocytes from normal persons {15). However, these lymphocytes do re­
spond to mitogens and we have found no significant metabolic abnormalities in 
these cells.
Morphological studies of the TD L in individuals with increased immunologi­
cal activity, as evidenced by elevated y-globulin levels (17), show an increased 
frequency of cells with developed endoplasmic reticulum, and there appears to 
be a morphological spectrum of lymphocytes with increasing ribosome cluster­
ing and development of endoplasmic reticulum {18). Approximately 75% of 
lymphocyte RNA is ribosomal RNA, so th a t an increase in the average RNA 
content of lymphocytes essentially reflects a rise in ribosomal population. 
Changes in nuclear RNA are quantitatively insignificant. Thus, measurement 
of the mean RNA content of lymphocytes in the thoracic duct would quantitate 
the protein synthetic potential of these cells and, hence, to some extent, reflect 
their immunological activity. The relationship between immunological activity 
and the average RNA content of the lymphocytes is complex (d), but appears 
to follow, a t least in part, immunological changes. In  peripheral blood lympho­
cytes, the average DNA content of the lymphocyte has been shown to be con­
stant both in normal individuals and in those in whom immunological activity 
is increased {6), Therefore, the RN A /D N A  ratio of lymphocytes is a measure 
of their RNA content and is known to be elevated in conditions of increased 
immunological activity, e.g., rheumatoid arthritis {6), lupus erythematosis, 
Sjogren’s disease, and allograft rejection (Glen, unpublished data). Morpho­
logical changes, implying changes in the RN A /D N A  ratio of lymphocytes, are 
a well documented feature of the immune response {1, 10), so th a t a change in 
the ratio may have clinical application to patients receiving allografts whose 
lymphocytes are involved in rejection of the foreign tissue.
In this study, nucleic acid measurements have also been used to follow the re­
sponse of the patients’ lymphocytes in culture to stimulation by phytohemag­
glutinin. The use of lymphocyte R N A /D N A  ratio has practical advantage over 
enumeration of transformed lymphocyte as an index of cell response. This pro­
cedure permits assessment of alterations in the lymphocyte metabolic response 
to PHA in the patients on immunosuppressive therapy.
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MATERIALS AND METHODS
The four subjects in this study were patients maintained by interm ittent he­
modialysis prior to receiving allografts in the transplantation unit of the Peter 
Bent Brigham Hospital. The regimen before renal transplantation was directed 
a t  suppression of the immune response as follows: T D L  were drained contin­
uously from thoracic duct fistula beginning 5 days {in one patient, 9 days) 
before transplantation; azathioprine (2.5 mg da ily /kg  of body wt) was given, 
starting 48 hr before operation; and prednisone (1.5 mg daily /kg  of body wt) 
was given, 24 hr before kidney transplantation. These drugs were continued for 
the lifetime of the allograft, dosages being adjusted as dictated by the patients ' 
clinical status. Dosage schedules and other details of clinical management of 
the patients have been described (16). The lymph was allowed to flow freely 
and was collected in sterile bags with citrate as the anticoagulant (Fenwal 
Laboratories) ; the cells were separated from the lymph by centrifugation at 
150 {/.
Prior to estimation of D N A  and RNA, samples of lymphocytes were freed 
of red cells by osmotic shock and analysed using a modified Schmidt-Thann- 
hauser procedure ( / ,  5). The lymphocytes, usually 10 X 10" cells/tube, were 
analysed either when freshly harvested from the lymph or after shoi’t-term 
storage at —40 C in 0.01 m  sodium acetate buffer, pH  5.2. A decay curve was 
used to compensate for the small losses of nucleic acids during storage (am ount­
ing a t  most to 15% of the RN A  after 30 d a y s ) .
The same methods of measurement for D N A  and RNA were used to follow a 
series of short-term in vitro cultures of the T D L , which were analysed serially 
in duplicate. The cultures were set up with sterile precautions using saline- 
washed, nonosmotically shocked fresh lymphocytes in tissue culture medium 
199 (Grand Island Biological Co.). The lymphocyte concenti’ation was 1-3 X 
10" cells/ml. Penicillin (100 units /m l) and streptomycin (100 ,ug/ml) were 
added to the culture medium with 3% serum, usually the patient's  own, ob­
tained prior to any drug treatm ent. In  some experiments fetal calf serum was 
substituted for autologous scrum. When PH A  (Difco PH A -P , Difco L abora­
tories, Detroit, Alichigan) was used, 1.25 p] of the solution, reconstituted to the 
m anufacturer’s specifications, were added per milliliter of culture. The closed 
culture tubes were incubated at 37 C. Red cells ]) res cut in the cultures contrib­
uted an error of about 5% to the RNA assays; however, no con-cction was made 
for this since all the cultures had about the same degree of red cell contam ina­
tion.
RE8UITS
Composition of fresh T D L .  Table 1 shows the nucleic acid com})osition of 
lymphocytes obtained early in the thoracic duct drainage of four patients be­
fore immunosupiiressants were administered. The mean DNA content (0.72 pg 
of D N A  phosphorus/cell), the diploid amount for man (,9), was similar to tha t 
found in blood lymphocytes by the same analytical method (5). The mean 
values for the RN A  content (0.16 pg of RNA phos])horus/cell) and for the
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T.MtEE 1. DNA and RNA content of human TDL measured before drug treatment
P a tie n t N o .  o f
C e ll  c o n te n t  (p g /c e ll )
R N A / D N Asam ples D N A  p h o sp h o ru s R N A  p h o sp h o ru s
1 2 0.91 0.20 0.22
2 4 0.65 0.18 0.28
3 2 0.63 0.11 0.18
4 2 0.64 0.16 0.22
Mean TDL 10 0.72 0.16 0.22
Mean blood lymphocytes 40 0.73 ±  0.12'' 0.19 ±  0.06 0.26 ±  0.06
for comparison"
"This row of data was obtained from measurements on normal human blood lym pho­
cytes (6). The mean R N A /D N A  ratio, 0,26, is slightly higher than the mean ratio (0.22) of 
the four patients, but the diilerence between the means is not statistically  significant.
'' Mean SI).
T . \ h l e  2 .  E f f e c t  o f  i m m u n o s u p p r e s s i v e  t h e r a p y  o n  TDL R N A /D N A  r a t i o "
Patient
R atio at
Pretrcatm ent 
period (a)
24-hr period following 
initiation of azathioprine 
therapy (b)
24-hr period following  
in itiation  of prednisone 
therapy (c)
Posttransplant 
period (d)
1
2
3
4
Mean result for four 
patients
0.22 (mean of 2) 
0.28 (mean of 2) 
0.20 (mean of 5) 
0.24 (mean of 4)
0.235
0.29 (1 analysis) 
0.28 (mean of 8) 
0.23 (mean of 6) 
0.30 (mean of 3)
0,275
Significant difference 
P  <  0.01
0.37 (1 analysis) 
0.33 (m ean of 3) 
0.30 (mean of 4) 
0.29 (m ean of 2)
0.323
Significant difference 
P  <  0.001
0.27 (mean of 2) 
0.27 (mean of 6) 
0.33 (mean of 3)
Spontaneous early  
closure of thoracic 
d u ct fistula  
0.290
Significant difference 
P  <  0.05
C om parison w ith  pretrentm ent values by  
S tu d en t’s t test
" T h e tabulated  results arc the R N A / D N A  ratios of sam ples of lym ph ocytes from  th e  thoracic d uct obtained  (a) 
prior to renal transplant and im m unosuppressive treatm ent, (b) during th e  24 hr w hich follow ed in itia tion  of azath io­
prine treatm ent, (c) during th e  24 hr w hich follow ed in itiation  of prednisone treatm ent, w ith  azath ioprine con tinu ed , 
and (d) after th e  transplant operation, w ith  continued  im m unosuppression .
R N A /D N A  ratio (0.22), while louver than  those found in blood lymphocytes 
(5), were not significantly different by S tudent’s t test.
Table 2 summarizes the results of serial determination of the R N A /D N A  
ratio of T D L  at the time of institution of immunosuppressive therapy  and also 
for a period after renal transplantation. These results are also illustrated in 
Figures 1 and 2. Statistical analysis of the results for all four patients (Table 
2) shows th a t  immunosuppressive therapy increased the R N A /D N A  of the 
T D L  significantly over the pretreatm ent levels. The increase averaged 17% 
with azathioprine and 37% with combined prednisone and azathioprine the r­
apy in the 24-hr period following the s tart  of treatm ent. Some individual meas­
urements of the R N A /D N A  were considerably higher than  this, as much as 
105% over the p retreatm ent level when patient 3 was first given prednisone 
(Fig. 2; 0.20-0.41). A constant finding illustrated in Figures 1 and 2 was the 
progressive fall in the output of T D L  with continued drainage. However, there
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was no consistent change in the R N A /D N A  when early and late stages of the 
pretreatm ent period were studied. The progressive rise of the R N A /D N A  of 
the lymphocytes a t the initiation of immunosuppressive treatm ent is also evi­
dent. Following transplantation, the R N A /D N A  was followed in 2 of the 4 
subjects. In  patient 2 (Fig. 1), the R N A /D N A  value had fallen to the pre­
trea tm ent level 16 days after transplantation, while in patient 3 (Fig. 2), the 
value was still elevated 30 days after the transplant. The latter case showed 
signs of rejecting the graft.
Changes in T D L  during culture. The T D L  were also studied in short-term 
tissue culture, using cells obtained both during the prctreatm cnt period and 
after azathioprine trea tm ent (but before predisone was started). Parallel cul­
tures gave satisfactory duplication. The mean variation (difference between 
duplicate cultures expressed as percentage of the mean value) was 1.7% for 
D NA measurements and 3.5% for RN A  analyses. For the R N A /D N A , the 
mean variation was 4.4%. These values are close to the expected variation for 
the method of analysis (5).
The response of the T D L  to PH A  was examined before and after azathioprine 
therapy by comparing cultures grown with and without mitogen. A represen­
tative experiment is illustrated in Figure 3, and a comparison of the cultures 
a t 32 hr is drawn up in Table 3. Results a t 32 hr were selected for Table 3 since 
the RNA content of the cultures reached a plateau at about tha t time.
D a i l y  o u t p u t  o f  
T.D, L y m p h o c y t e s  X 1 0 ' P a t i e n t  2
,T.D. F i s t u l a
R e n a l  T r a n s p l a n t a t i o n
10 -
L y m p h o c y t e  
0 - 4  -1
0 - 3  -
0-2 - # .
P r e d n i s o n e  1 0 0  m g . d a i l y
^ A z a t h i o p r i n e  1 5 0  m g .  daily;
10 2 811 20 2 47 8 930
D a y s
F i c u i{K 1. Th(" dilily output and R N A /D N A  ratio of th(’ TDL of ])aliont 2 undergoing 
conlimions duet, drainagi', inununoHUppressivo therapy, iind reiuil IranKpUintation. This 
figure is representative of the four jiiitienls studied, with the exee))tion of ]iatient 3 (Fig. 2), 
whose final ratio was higher, ralh('r than lower, tlian her pi'ct rent ment ratio.
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D a i l y  o u t p u t  o f  
L y m p h o c y t e s  X  1 0 ® P a t i e n t  3
T D .
F i s t u l a
R e n a l  T r a n s p l a n t a t i o n
L y m p h o c y t e  R N A  
0 - 4 - ,
0  3 -
P r e d n i s o n e  l O O m g . d a l l y
0 1 -
3 41 2 5 2 7
D a y s
FiGUitH 2. The daily output and R N A /D N A  ratio of the TDL of patient 3 undergoing 
continuous duct drainage, immunosuppressive therapy, and renal transplantation.
DADl analyses. A consistent fall in the D N A  content of all the cultures oc­
curred with incubation, an illustration of the cell death and dissolution which 
take place in lymphocyte cultures. At 32 hr, the D N A  level had fallen to be­
tween 74 and 80% of the initial level.
R N A  analyses. N et accumulation of RNA, despite falling cell numbers in­
dicated by the DNA analysis, occurred during the culture of lymphocytes 
(PI'IA-stiraulated) obtained prior to azathioprine, in two of three patients. A t 
32 hr, the average RNA content of the cultures for the three patients was 10% 
above the starting level in the presence of PHA, and 30% below the starting 
level in the absence of PHA. In  contrast, for cultures of lymphocytes obtained 
after initiation of azathioprine treatment, the to ta l RN A  content of the cul­
tures had fallen slightly even with PH A  stimulus and had fallen more d ra ­
matically in the absence of PH A  (compare Fig. 3, A and B). At 32 hr, the 
average RNA content for the cultures after azathioprine was 58% of the s ta r t ­
ing level in the absence of PH A  and 89% of the starting level with PHA.
R A ^A /D N A  ratio. Figure 3, C and D  illustrates the change in the average 
lymphocyte R N A /D N A  ratio during culture of the cells obtained in one p a ­
tient, prior to and after azathioprine therapy. While the R N A /D N A  ratio of 
the cells cultured in the absence of mitogen apparently  fell more rapidly if the 
lymphocytes were from a patient on azathioprine treatm ent, more significant 
is the difference between the response to PH A  in the pre- and postazathioprine 
cultures. Analysis of the cultures a t  32 hr for three patients, comparing the 
PITA-stimulated culture with the corresponding control cultures, shows an
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NO  Fi IM UR AN  Fi
14.014.0
DNAP 2.0DNA Pi2.o;
10.010.0
— . f p/^/i 
*■ A/o PHA
8.08.0
JJLG
R NAP 6.06.0
RNAP
4.04.0
3.03.0
2.02.0
RaHo:
RNAP
DNAP
10 20 30 40 50 60 70 20 30 40 50 60 ro
HOURS IN CULTURE
F i g u r e  3. An assessment of short-term tissue culture of TDL b.y measurement of DNA  
phosphorus (D N A P ), RNA phosphorus (R N A P), and the R N A /D N A  ratio. A, D N A  and 
RNA measurements on cells obtained before the patient received azathioprine treatment, 
cultured in the presence of PHA ( • )  and in the absence of PHA (O)- B, D N A  and RNA  
on cultured cells obtained during azathioprine treatment. C, The R N A /D N A  ratio of the 
cells in culture, calculated from A. D , The R N A /D N A  ratio of the cells in culture, calcu­
lated from B.
T a b l e  3. The effect of azathioprine therapy on the PHA response of TDL"
Measurement^
Responses of patient not on immuno­
suppression
Responses of patient on 
azathioprine
Control culture Culture with PHA Control culture Culture w ith PHA
DNA content of cu l­
ture
UNA content of cu l­
t u r e
R N A /D N A  ratio o f  
cultured cells
81, 79, 64 (74) 
79, 73, 60 (71) 
98, 94, 84 (92)
76, 83, 78 (78)
117, 129, 85 
(110)
163, 158, 117 
(146)'=
74, 78, 88 (80) 
58, 54, 62 (58) 
79, 69, 94 (81)
90, 76, 75 (80)
87, 98, 83 (89)
97, 128, 98 
(108)<^
" Thoracic duct cells obtained from patients before immunosuppression and also after 
24 hr on azathioprine therapy were set up in tissue culture. Eight cultures were incubated 
for each patient. For the presuppression period, there were duplicate cultures w ith PHA  
added and duplicate controls w ithout PHA; sim ilarly, for the azathioprine period, there 
were two PHA-treated cultures and two controls. The cultures were incubated at 37 C 
for 32 hr and analysed for their DNA and RNA content. Results are expressed as the mean 
of duplicate cultures for each patient, together with the mean response for three patients 
in parentheses.
 ^ Preincubation content =  100.
Control versus PHA, significant difference by I test, P  <  0.05.
Control versus PHA, no significant difference by I te st, P  >  0.05.
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average difference of 54% (146-92) between the cultures obtained before aza­
thioprine trea tm ent and 27% (108-81) between those after azathioprine ad­
ministration. The t- tes t of the  H N A /D N A  analysis from three patients a t  32 
hr reveals a significant difference between the PH A  culture and the control 
culture when the cells were obtained prior to immunosuppressive therapy  (T a ­
ble 3). Culture prepared from cells obtained after azathioprine trea tm ent did 
not show this significant difference between control culture and PH A -stim ulated 
culture.
DISCUSSION
The response of the T D L  to the initiation of immunosuppressive therapy  by 
increase in the R N A /D N A  is regarded as an expression of changes in the cell 
types in thoracic duct lymph. Dougherty et al. {B) showed th a t  hydrocortisone 
produces preferential dissolution of the small lymphocyte, the large lympho­
cyte being relatively resistant to the steroid. A similar sensitivity of the  small 
lymphocyte to azathioprine, a derivative of 6-mercaptopurine, would explain 
the observed change in the R N A /D N A  ratio. The observed increase in the 
average R N A  content of the lymphocyte has application in the interpretation 
of change in the lymphocyte, whether in blood or lymph, in relation to the im ­
mune response. In  the clinical setting, misinterpretation of a rise in the lympho­
cyte R N A /D N A , as immunosuppressive drugs are instituted or increased, can 
be avoided. A rise in the lymphocyte R N A /D N A  ratio in the absence of any 
change in immunosuppression is likely to result from an immune response, the 
appearance of active “interm ediate” cells being a known accompaniment of 
immunological activity  (17). A similar increase in the R N A /D N A  ratio of the 
circulating lymphocyte may be expected to occur during the rejection of an 
allograft.
In  two patients, the lymphocyte was followed after transplantation. P a tien t 
3 (Fig. 2) showed evidence of graft rejection and her lymphocyte R N A /D N A  
remained elevated. I t  is likely th a t  the increased sensitivity of the patien t to 
strong donor histocompatibility antigens caused production and release into 
the circulation of a population of large, young lymphocytes; perhaps the en­
larged pyroninophilic cells were associated with rejection of allografts in gen­
eral (7) and with kidney allografts in particular {11). Six months following 
the allograft, pa tien t 3 was readm itted to the hospital w ith clinical signs of a 
rejection crisis. The dosages of azathioprine and prednisone were increased, and 
the rejection was aborted. Thus, serial determination of the lymphocyte R N A / 
D N A  may be of potential value in monitoring the immune status of patients 
who have received kidney allografts. This is being currently tested in a study 
of the blood lymphocyte R N A /D N A  as a gauge of impending renal allograft 
rejection.
The small lymphocyte of blood or lymph is not an “end stage” cell, as for­
merly believed, bu t can enlarge and s ta r t  dividing when appropriately s tim u­
lated (12). In  vitro stimulation of lymphocytes by PH A  and other mitogens 
has made it possible to study these cells as they differentiate into large blastoid 
cells which undergo mitosis. The degree of PITA response in vitro can be cor­
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related with the effectiveness of suppression of delayed hypersensitivity {8, 13), 
of which allograft rejection is one manifestation.
Our culture experiments were monitored by analysis of DNA and RNA 
content. The advantage of this method is th a t  change in cell number can be 
noted as well as changes in the nature of the cells present. Simple comparison 
of the R N A /D N A  ratio would suffer from the problem of the more usual meas­
urement, e.g., percentage of transform ation or tritiated thymidine incorpora­
tion, for which changes in cell number are unknown.
Prior to azathioprine therapy (Table 3), T D L  in tissue culture responded to 
PH A  by increasing their RN A  content, one of the parametei’s associated with 
lymphocyte transformation. Sell et al. (14) showed DNA synthesis to be a late 
event in lymphocyte culture, occurring 36-48 hr after addition of PH A  to 
lymphocytes. Our experiments show no net synthesis of D N A  in response to 
PH A ; rather, there is evidence of a reduction in cell numbers, but RNA syn­
thesis is evident from the statistically significant increases in the R N A /D N A  
in a comparison of control and PH A-stim ulated cultures.
The percentage of transformation of cultured T D L  used in the present ex­
periments, although not precisely measured morphologically, was known (by 
scanning of stained preparations) to be less than the maximal percentage ob­
tainable, which is about 80% of cultured normal blood lymphocytes 72 hr aftei' 
addition of PHA. Wo believe th a t  this less than  maximal value agrees with 
the known blunted response to PH A  of blood lymphocytes from uremic p a ­
tients (3).
Cultured T D L  th a t  had been exposed in vivo to azathioprine did not respond 
well to PH A ; their R N A /D N A  ratio increased only slightly, compared with 
th a t  of lymphocytes from the same patient before azathioprine was started 
(Fig. 3, C and D ). Hersh and Oppenheim (8) reported th a t  the in vitro response 
to PH A  of blood lymphocytes of patients receiving intermittent therapy with 
6-mercaptopurine was reduced from 71% before treatm ent to 1.5% during 
treatment. Percentage of transformation was used as the measurement. Ten- 
ncnbaum et al {15) made similar observations in patients under immunosup­
pression. Our results confirm these observations by an objective chemical meas­
urement and, further, draw attention to the changes in the nature of the cells 
in thoracic duct lymph which occur as immunosuppressive drugs are instituted,
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Synthesis of Ribonucleic Acid in Human Lymphocytes
s. T. JACOB, W. C. COOPER, A. C. A. GLEN,* and H. N. MUNRO Department of N utri­
tion and Food Science, Massachusetts institute of Technology, Cambridge, Massa­
chusetts
INTRODUCTION
The small lymphocyte o f  blood or lymph i s  an immunocompetent 
c e l l , ^  capable in vitro o f  s y n t h e s i s  o f  r ib onu c l e i c  ac id  (RNA) 
protein,'^ and deoxyr ibonuc le ic  ac id  (DNA),^ and o f  d i v i s i o n . ^
When s t imula ted  in vitro with the mitogen phytohemagglut inin (PHA), 
lymphocytes perfonrt the se  func t ions  in a grea t l y  a c c e l e r a t e d  fa s h ­
ion. At the end o f  72 hours o f  exposure to  PHA, us ua l l y  more than 
70% o f  human lymphocytes in cu l ture  have become l a r g e ,  b l a s t - l i k e  
forms known as transformed lymphocytes .  Although the mechanism 
of ac t i on  o f  PHA i s  unknown, i t  i s  assumed that  the earliest 
e f f e c t s  o f  t h i s  mitogen are the most important because they i n i t i ­
ate the sequence o f  i n t r a c e l l u l a r  events  whose u l t imate  expres s ion  
is the f u l l y  transformed lymphocyte.  Reported here are some ear l y  
e f f e c t s  o f  PHA on lymphocyte RNA metabol ism.
In these  exper iment s ,  the answer was sought to the fo l l owing  
quest ion:  “What are the s i z e  c l a s s e s  o f  RNA s t imula ted  very ear l y
(within two hours)  a f t e r  addi t ion  o f  PHA to lymphocyte cul tures?"  
Other reports  s u f f i c i e n t l y  d e t a i l e d  to permit  a t e n t a t i v e  answer 
to t h i s  ques t ion  have come from only two groups o f  w o r k e r s ^  
Careful a n a l y s i s  o f  the data from these  groups revea l s  the f o l l o w ­
ing points  o f  agreement between them: 1) The r e s t i n g  lymphocyte
synt hes izes  4 to 6 S-RNA and a much smal ler  proport ion o f  18 and
r-RNA). 2) Addit ion o f  PHA to lympho- 
in a t ime course pattern o f  RNA s y n t h e t i c  
s y n t h e s i s  o f  any given s i z e  s p e c i e s  o f  
time e lapsed a f t e r  add i t ion  o f  PHA. In .
28 S-RNA (ribosomal RNA: 
cytes in cu l ture  r e s u l t s  
a c t i v i t y  where increased  
RNA i s  a funct ion  o f  the
^Present Address^ Bioohemistry Department^ Victoria Infirma,-- 
GlasgcWy Scotland,
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sh o r t  i n t e r v a l s  ( l e s s  than three  hours)  a f t e r  add i t i on  o f  PHA to * 
c u l t u r e s ,  i nc orp ora t i on  o f  l a b e l e d  ur id i ne  i n t o  RNA occurs in two . 
c a t e g o r i e s  o f  RNA: 1) 4 to 6 S and p o l y d i s p e r s e  (about 6 to  35
S ) ,  both o f  which are s t a b l e  to a chase with act inomycin-D and 
cold  u r i d i n e .
Rubin, Cooper,  and Kay concluded t ha t  PHA f i r s t  enhances  
s y n t h e s i s  o f  nonribosomal RNA, which may e i t h e r  p o l y d i s p e rs e  or  
, may sediment  a t  4 to  6 S,  and tha t  PHA causes  inc reased  sy n th es i s  
o f  s i g n i f i c a n t  q u a n t i t i e s  o f  r-RNA only a f t e r  s i x - h o u r  ' incubat ion/  
The l a t t e r  c o n c l u s i o n ,  al though perhaps ge n e r a l l y  accepted a t  this  
t ime ,  i s  not  v a l id a t e d  by the  f i nd in g s  reported h e r e . The authors'  
r e s u l t s  i n d i c a t e  t h a t  w i th i n  90 minutes o f  i n c ub a t io n ,  PHA st imu­
l a t e s  the  s y n t h e s i s  o f  heavy (40 to 50 S) RNA, a s i g n i f i c a n t  por­
t i o n  o f  which i s  r-RNA p recursor .
MATERIALS AND METHODS 
Lymphocyte cultures
Thoracic  duct  lymphocytes were used from anephric  p a t i e n t s  
whose blood urea n i t rogen  l e v e l s  were kept low by f requent  hemo­
d i a l y s i s .  The lymph l e u c o c y t e  d i f f e r e n t i a l  count  was about 98% 
small  lymphocytes;  v a r ia b l e  lymph contaminat ion with ery throcy tes  
occurred but did not  a l t e r  the  r e s u l t s .  Lymph, c o l l e c t e d  in p l a s ­
t i c  c i t r a t e - p h o s p h a t e - d e x t r o s e  bags ,  was c e n tr i f u g e d  a t  4°C at  
600 £  f o r  10 minutes and the c e l l  button washed twice  with Medium 
199. Lymphocyte c u l t u r e s  were s e t  up in Medium 199 wi th 3% auto­
logous serum at  a co nc en tr a t io n  o f  20 x 10  ^ lymphocytes per ml.  
PHA-P ( D i f c o ) ,  d i l u t e d  according  to s p e c i f i c a t i o n s  o f  the manu­
f a c t u r e r ,  was used a t  a f i n a l  concentra t ion  o f  0 . 3  m l / 100 ml 
su sp ens io n ;  the  same volume o f  s t e r i l e  s a l i n e  was used in control  
t ub es .  Experiments are numbered 1, 2,  and 3 to  correspond with 
the f i g u r e s .  Other experimental  d e t a i l s  are descr ibed  in the  
f i g u r e  l eg e nd s .  Note t h a t  in Experiment 3,  RNA was e x tra c te d  
from whole lymphocytes ,  not  from n u c l e i .
Isolation of nuclei
All  procedures  f o l l o w i n g  harv es t ing  o f  c e l l s  were carr ied  
out  a t  0°C to  4°C un le s s  s t a t e d  o th erw i se .  This method i s  s imi lar  
to th a t  o f  Pogo et al A  A f t e r  the harves t ing  c e n t r i f u g a t i o n ,
"^ Data presented at this Conference by H,L, Cooper (Chapter 
50) makes it clear that his group now finds that PHA does stimulate 
synthesis of r~RHA at early intervals after addition of the mitogen
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c i t r i c  ac id  (0 .01  M; 29 ml / tube)  was added to the c e l l  button and 
the r e s u l t i n g  suspension a g i ta t e d  using a s n u g l y - f i t t i n g  motor-  
driven Tef lon p e s t l e  in the tubes .  Suspensions were then c e n t r i ­
fuged (3,000 £)  and the c i t r i c  ac id  treatment repeated.  Af t er  a 
f inal  wash with 10 ml o f  0 . 34  M sucrose ,  a drop o f  the suspension  
was removed and s ta ine d  with azure C to monitor the presence o f  
clean lymphocyte n u c l e i .  (This procedure a l so  removed a l l  e ry thro ­
c y t e s . )  The nucle i  were then c o l l e c t e d  by another c e n tr i f ug a t io n  
(3,000 £)  and RNA e x tr ac t ed  from them.
RNA extraction, fractionation, and counting
Lymphocyte nucl e i  or whole lymphocytes ( see  legend to Fig.  3) 
were homogenized with a Tef lon p e s t l e  in 10 to 12 ml o f  0.3% 
sodium dodecyl s u l f a t e  contain ing  0 .14  M sodium ch lor ide  and 0 .05  
M sodium ace ta te  (pH 5 . 1 ) .  Af ter  a few s t r o k e s ,  an equal volume 
of 90% phenol con ta in ing  0.1% hydroxyquinol ine was added and the  
mixture homogenized fur ther .  The suspension was immediately  
shaken at  65°C for  10 minutes ,  shaken a t  room temperature for  15 
minutes,  and cen tr i fuged (17,000 £)  f or  15 minutes at  4°C. The 
c lear  aqueous l ayer  was. then removed and the RNA p r e c i p i t a t e d  
with 2 .5  volumes o f  ethanol  containing  2% potassium a c e t a t e .  RNA 
was r ep re c i p i t a t ed  once with e t h a n o l . An a l iq uo t  o f  an aqueous 
so lu t ion  o f  the RNA containing  100 yg RNA (about 2 ÛD un i t s )  was 
layered on a 5 ml,  10 to 40% l i n e a r  sucrose  dens i ty  grad ien t ,  and 
centr i fuged for  15 to 15 hours a t  24,000 rev/min.  Gradients were 
passed through the c e l l  o f  a Gi l ford model 2,000 recording sp ec ­
trophotometer and c o l l e c t e d  in f r a c t i o n s  of  e i g h t  drops each.
Each preparation contained a t o ta l  o f  about 16 f r a c t i o n s .  Af t e r  
addit ion o f  one drop o f  5 N perch lor i c  acid to each v i a l ,  f r a c ­
t ions  were hydrolyzed a t  80°C fo r  15 minutes ,  co o l ed ,  and Bray's  
so lu t ion  (10 ml) added to each v i a l .  Rad ioac t iv i ty  was determined  
in a Beckman CPM-100 l iq u i d  s c i n t i l l a t i o n  system.
RESULTS
In comparison with control  c u l t u r e s ,  PHA in Experiment 1 
(Fig.  1) s t imulated  incorporat ion  o f  l abe l ed  uridine  in to  high 
molecular weight  (MW) RNA o f  lymphocyte nucle i  by a t  l e a s t  100%. 
The peak o f  r a d i o a c t i v i t y  in t h i s  experiment occurred a t  about  
40 S,  assuming a l i n e a r  gradien t .  In Fig.  2,  comparison o f  the  
heavy broken l i n e s  in parts  A ( contro l )  and B (PHA) shows tha t  
the s t imula tory  e f f e c t  o f  PHA occurred in 90 minutes ,  as compared 
with 135 minutes in Fig.  1. In Experiment 2,  the l a b e l i n g  peak 
occurred at  about 45 S in both PHA and control  pulse  tubes and
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Fig.  1 Sucrose Gradient Sedimentation of Pulse-Labeled RNA from 
Nuclei of Lymphocytes Incubated for a Total of 135 minutes 
with and without PHA. A suspension of 20 x 10® lympho­
cytes per ml was divided into equal (25 ml) portions, one 
of which was treated with PHA-P, and the other with ster­
ile saline. After an incubation period of 105 minutes, 
cultures were pulse labeled for an additional 30 minutes 
with uridine-5-T (4 pc/ml) (Nuclear Chicago Corporation; 
spec act 5 c/mM). Cultures were then harvested, nuclei 
isolated, and RNA extracted, fractionated, and counted. 
Solid line is OD26O oi lymphocyte nuclear RNA (ordinate 
at left) . Broken lines are counts/min for ,P11A and con­
trol nuclear RNA (ordinate at right).
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Fig, 2, Sucrose Gradient 
Sedimentation of Lymphocyte 
Nuclear IWA from Pulse- 
Chase Experiments, Data 
from two experiments (two 
patients) performed in the 
same manner have been com­
bined in this illustration. 
Suspensions of 20 x 10^lym­
phocytes/mi (25 mi/tube) were 
incubated with sterile saline 
(a) or witil PHA-P (d) for 90 
min, during the last 30 min 
of which uridine-II^ was also 
present (T /xc/ml). The pulse 
members of the pairs were j 
then harvested, nuclei iso- ! 
lated, and JÎNA extracted, 
fractionated, and counted. ' 
Actinomycin-D ( 10 /ig/ml) and' 
cold uridine ( o . l  m M ) were 
added to the chase members of 
the pairs, and incubation was 
continued for another hour b e ­
fore harvesting,. Solid lines 
are ODg^o of lymphocyte nuclear 
RNA (ordinates at left). Bro­
ken lines are counts/min of 
RNA of pulse and chase tubes 
(ordinates at right).
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the PHA p u l s e - l a b e l i n g  p r o f i l e  had a shoulder  a t  about 50 S which 
was not  pre sen t  in the contro l  tubes .  The in c r e a se  in e x t e n t  o f  
inco rp ora t ion  o f  l a b e l e d  ur id ine  i n t o  nuc l ea r  RNA in PHA cul tures  
was between 50 and 100% t h a t  o f  c on tr o l s  in  Fig .  2 ,  which shows 
average va lues  from two p a t i e n t s . Experiment 2 a l s o  demonstrates  
t h a t  the newly s y n t h e s i z e d  nucl ear  RNA i s  chased a f t e r  one hour 
to  reach a peak a t  28 S in both control  and PHA tubes .  However,  
i t  appears t h a t  a sm a l l e r  proport ion o f  the high MW la b e l e d  RNA 
in the PHA tubes  was chased to the 28 S region than was the  case  
in the contro l  t ub es .  In f a c t ,  the shape o f  the  chased RNA curve 
in the c o n t r o l s  (F ig .  2 ,  part  A) i s  roughly symmetrical  around 
the 28 S OD peak,  whereas the shape o f  the chased curve in the  
PHA tubes (F ig .  2 ,  par t  B) i s  markedly skewed to the r ig h t  o f  
28 S,  i n d i c a t i n g  t h a t  a l a rg e  port ion o f  the  40 to  50 S-RNA syn­
t h e s i z e d  in the presence  o f  PHA was ra ther  s t a b l e  a f t e r  a one-  
hour chase with act inomycin-D and co ld  u r i d i n e .  Thus,  s y n th e s i s  
o f  45 S r-RNA precursor  occurred in both contro l  and PHA tubes ,  
but in the  l a t t e r ,  a s i g n i f i c a n t  proport ion o f  the high MW RNA 
did not  have the chase  c h a r a c t e r i s t i c s  o f  r-RNA precursor .  I t  i s  
a l s o  apparent  from Fig.  2 t h a t  some o f  the t o t a l  r a d i o a c t i v i t y  in 
the PHA pu l se  tubes  (approximately  30%) was l o s t  during the  chase,  
and thus did not  appear in the chase t u b e s . This phenomenon did 
not  occur to any e x t e n t  in the contro l  experiment .  Therefore ,  a 
por t ion  o f  the  newly made, high MW RNA i s  more l a b i l e  in the  
presence  o f  PHA than in  i t s  absence .  I t  cannot be determined  
from the pre sen t  data whether  t h i s  l a b i l i t y  i s  a fun c t ion  o f  the 
presence o f  PHA per se, or whether i t  r ep resen t s  g r ea te r  l a b i l i t y  
o f  those  s p e c i e s  o f  high MW RNA s y n t h e s i z e d  in gr ea t er  quant i ty  
in the presence  o f  PHA.
Fig.  3 shows the k i n e t i c s  o f  uridine-H^ l a b e l i n g  o f  whole  
lymphocyte RNA ( se e  l egend to Fig.  3 f o r  experimental  d e t a i l s ) .  
Within two minutes '  exposure o f  lymphocytes to the l a be l e d  RNA 
pre cursor ,  r a d i o a c t i v e  4 to 6 S RNA was p r e s e n t ,  and PHA had 
s t i m u l a t e d  i t s  s y n t h e s i s  by more than 100% over  the c o n t r o l .  
Label ing in the  4 to  6 S f r a c t i o n  i n c r e a s e d ,  and by f i v e  minutes  
a f t e r  ad d i t i o n  o f  i s o t o p e  was almost  twice  the  two-minute value;  
no fu r th e r  in c r e a s e  in l a b e l i n g  o f  t h i s  f r a c t i o n  occurred during 
the remaining 25 minutes '  exposure to  i s o t o p e .  No s i g n i f i c a n t  
l a b e l i n g  occurred in the 40 to 50 S RNA region un t i l  10 minutes  
a f t e r  a d d i t i o n  o f  ur idine-H^.  The peaks o f  radi oa c t i  vi ty  in the  
40 to  50 S region then in c re as e d  a t  a l l  i n t e r v a l s  up to  30 min-  
u t e s , and the e x t e n t  o f  l a b e l i n g  o f  RNA was always g r ea t er  in the 
PHA tubes  than in the  contro l  tubes .
SYNTHESIS OF RIBONUCLEIC ACID 675
— 0  D 260 
- P I I A
— CONTROL
0  3
0 4
0 .3
0.2
0 1
to MIN
0.4
0 .3
0.28
§
0 4
0 3
/\ \
0.2
3 0  MIN
0 5
0 4
0  3
0 2
TOP FRACTION
F i g . 3* Labe ling-Kino tics o f  
R N A  in Lymphocytes With and 
Witiiout PIIA-P for 80 minutes. 
Lymphocyte cultures were set 
up as in Experiments 1 and 2 . 
After addition of PIIA-P or 
saline to equal portions,the 
lymphocyte suspensions were 
immediately distributed among 
10 culture tubes (five PHA; 
five control), each contain­
ing 250 X 106 lymphocytes/ml'. 
The tubes were closed and in­
cubated at 37°C. For the final 
2 f ^ f l 0 f 2 0 f  and 30 minutes, res­
pectively, (five parts of the 
figure, reading from top to 
bottom) of the 80-minute total 
incubation time of the five 
sets of t u b e s , uridine-II® (New 
England Nuclear Corporation; 
spec act 5 c/mM, generally- 
labeled) was added. Isotope 
was added in final concentra­
tion of 4 ^c/ml suspension.
At the end of 80 minutes all 
cultures were harvested and 
RNA was extracted from whole 
lymphocytes, RNA was fraction­
ated and counted as in experi­
ments 1 and 2.
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DISCUSSION
The data i n d i c a t e  t ha t  PHA s t i m ula te s  s y n t h e s i s  o f  both 
ribosomal and nonribosomal RNA wi th in  two hours a f t e r  addi t ion  
o f  the mitogen to  lymphocyte c u l t u r e s .  This f i nd ing  i s  contrary  
to the publ i shed reports  o f  the two groups who have worked in 
t h i s  s p e c i f i c  area.
The authors b e l i e v e  tha t  t h e i r  method o f  rapid e x tr a c t io n  
o f  RNA with hot  phenol from lymphocyte nucle i  ( the  cytoplasm  
having been sheared away, wi th a homogenizer) has permitted the 
obtainment o f  undegraded high MW RNA which more convent ional  
methods o f  lymphocyte proces s ing  and RNA e x tr a c t i o n  do not  obtain.  
Furthermore,  i t  was not  necessary  in these  experiments to r i sk  
int roduc t ion  o f  a r t i f a c t  by add i t ion  o f  extraneous RNA e i t h e r  as 
an OD marker or  as a c a r r i e r ;  the OD seen in the f i g ur es  i s  that  
o f  the lymphocyte RNA i t s e l f .
At l e a s t  three reasons expla in  the succes s  o f  the method 
used in the presen t  work to e x t r a c t  rap id ly -1abe l ed  undegraded 
high MW RNA from PHA-stimulated lymphocytes.  These are: 1) The
ra d io ac t iv e  high MW RNA o f  the nucle i  i s  not  d i l u t e d  by cy to p l a s ­
mic cold RNA, as occurs when RNA i s  ex t racted  from whole lympho­
c y t e s .  2) Cytoplasmic ri bonucl e a s e s , which might otherwise  
degrade the l abe l ed  RNA during the process o f  e x t r a c t i o n ,  are 
removed with the cytoplasm before  RNA e x tr a c t i o n  i s  begun. 3)
The r ap id i t y  with which tfie hot  phenol e x t r a c t i o n  i s  carr i ed  out 
l i m i t s  the breakdown o f  high MW RNA during sample manipulat ion.  
That the RNA e x t r ac te d  in the present  study i s  l a r g e l y  undegraded 
i s  ev ident  from F igs .  1 and 2; the r a d i o a c t i v i t y  a f t e r  pu l s e -  
l a b e l i n g  i s  at  peak values  in the 40 to 50 S region o f  the gradi­
e n t s ,  and f a l l s  away in the d i r e c t i o n  o f  lower S va lues .
Since  increased  s y n t h e s i s  o f  RNA and o f  prote in  i s  demon­
s t r a b l y  increased  in lymphocytes exposed to PHA f o r  only 15 min- 
ute s ,^  i t  i s  reasonable  to  assume tha t  a prompt incre ase  in syn­
t h e s i s  o f  a l l  macromolecules i s  necessary  to maximize c e l l u l a r  
RNA and prote in  s y n t h e t i c  a c t i v i t y .  Such macromolecules should 
inc lude  r-RNA 45 S precursor  and i t s  processed products ,  28 and 
18 S-RNA. However, the  18 S p a r t i c l e  probably moves i n t o  the 
cytoplasm immediately a f t e r  sy n t h e s i s  and c leavage  o f  45 S-RNA.^ 
Since  only the lymphocyte nuclear  RNA was e x tr a c te d  in Experiment  
2,  only the l a be l e d  28 S product ,  and l i t t l e  l a be l e d  18 S-RNA,
^as found a f t e r  a one-hour chase.
In cu l tures  incubated with or without  PHA fo r  80 minutes  
(F ig .  3 ) ,  k i n e t i c  s t u d i e s  showed uptake o f  uridine-H^ in to  4 to 6 
S-RNA and in to  40 to  50 S-RNA wi thin 2 and 20 m i n u t e s , r e s p e c t i v e l y ,
£^■(26 previous footnote.
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a f t e r  ad d i t i o n  o f  the i s o t o p e  to  the c u l t u r e s  (whole lymphocyte  
RNA e x t r a c t e d ) .  The emerging peak o f  4 to 6 S r a d i o a c t i v i t y  
increased  to a maximum by f i v e  minutes and the 40 to 50 S peak 
cont inued to  in c r e a s e  f o r  the remaining 20 minutes o f  exposure  
t o  i s o t o p e .  The low and high MW RNA peaks were a t  a l l  t imes  
higher  in the PHA than in the contro l  c u l t u r e s .
The rapid l a b e l i n g  o f  4 to 6 S-RNA r a i s e s  a ques t i o n  as to  
i t s  nature .  I t  does not  appear to be t r a n s f e r  RNA (t-RNA) f or  
the f o l l o w in g  reasons:  1) t-RNA i s  probably s y n t h e s i z e d  in the
nucleus  in  mammalian c e l l s  s t u d i e d . 7(9 The experiments  i n d i c a t e  
t h a t  the 4 to  6 S-RNA s y n t h e s i z e d  in lymphocytes ,  e i t h e r  r e s t i n g  
or in the presence  o f  PHA, has i t s  o r i g i n  in the  cytoplasm (com­
pare l a b e l i n g  pat t ern  o f  F ig s .  1 and 2 with tha t  o f  Fig .  3 ) .  2)
Sy n t h e s i s  o f  4 to 6 S-RNA occurs  in r e s t i n g  l y m p h o c y t e s 8 and 
PHA r ap i d ly  enhances the  s y n t h e s i s  o f  t h i s  RNA s p e c i e s .  Kay has 
r e c e n t l y  reported t ha t  g e l - f i 1t r a t i o n  a n a l y s i s  o f  t h i s  RNA s p e c i e s  
and the k i n e t i c s  o f  i t s  degradat ion by pan cre a t i c  ri bonucl ease  
su g ge s t  tha t  much o f  the  newly s y n t h e s i z e d  4. t o  6 S-RNA i s  not  
t-RNA.^
SUMMARY
RNA metabol ism was s t u d i e d  in human t h o r a c i c  duct  lymphocytes  
exposed in c u l t u r es  to  PHA f o r  two hours or l e s s .  A f t e r  incuba­
t i o n  with or wi thout  PHA and p u l s e - l a b e l i n g  with r a d i o a c t i v e  
u r i d i n e ,  nucl e i  o f  the  lymphocytes were i s o l a t e d  and t h e i r  RNA 
e x t r a c t e d  and f r a c t i o n a t e d .  PHA-incubated lymphocytes s y n t h e s i z e  
50 to  100% more 40 to  50 S-RNA than c o n t r o l s .  Much o f  t h i s  high 
MW newly s y n t h e s i z e d  nu c l ear  RNA appears to be ribosomal  RNA pre ­
c ur sor ,  s i n c e  i t  i s  chased to  a peak a t  28 S. Label ing k i n e t i c s  
o f  whole lymphocyte RNA in c e l l s  exposed for  80 minutes t o  PHA 
shows t h a t  uridine-H^ f i r s t  appears in 4 to  6 S-RNA a t  two min­
u t e s ,  and in 40 to  50 S-RNA a t  10 minutes a f t e r  ad d i t i o n  o f  l a b e l .
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DISCUSSION SESSION
JOHN KAY, Bethesda, Md.: I feel a little bit misquoted on the
subject of the 4 to 6 S-RNA. The 4 S-RNA that I was studying was 
located in the cytoplasm, I think, but that doesn’t mean that it 
wasn’t synthesized in the nucleus. Any labeling of 4 S-RNA which 
could occur in the cytoplasm would be labeling of the terminal 
trinucleotide of transfer RNA. I eliminated such a possibility 
by digestion of the RNA with venom phosphodiesterase, which didn't 
degrade the radioactive RNA. ' When I reported that a lot of 
labeled 4 S-RNA in the cytoplasm was not transfer RNA, I meant 
about one half of it was transfer RNA. The stimulation by PHA of 
the RNA which seemed to be transfer RNA was at least as big, if 
not bigger, than the stimulation of the RNA which could be dis­
tinguished from transfer RNA. What you call 45 S-RNA appears to 
be what we call polydisperse RNA. I would like to hear your evi­
dence that this is in fact 45 S-RNA, because only a very little 
of it seemed to chase into ribosomal RNA!
ARNOLD RUBIN, New York, N.Y.: It also should be made clear, Dr.
Cooper, whether you have any way of demonstrating that the 4 to 
6 S was net synthesis. This is the point that Dr, Kay is trying 
to bring out.
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W.C. COOPER; I didn't show the slides of the whole cell experi­
ments that we did because many of them were unsuccessful. We did 
have tremendous peaks of labeling in 4 to 6 S in short times in 
whole cells and we don't think this is all due to terminal addi­
tion, because we believe the absolute amount of it is just too 
vast to be explained by this mechanism. We don't know what this 
4 to 6 S is.
In answer to the question about the ribosome, in the control 
lymphocytes, the 45 S or the heavy RNA which peaked at 45 S, chased 
almost completely to 28 S after an hour of actinomycin and uridine. 
I thought that was clear on the slide. After PHA, which wasn't 
as good a chase and we presumed that this RNA which doesn't chase 
was heterodisperse.
HERBERT COOPER, Bethesda, Md.: The absence of a particular labeled
species from the nuclear extract doesn't mean that it's not made 
in the nucleus. This is exemplified by the fact that you don't 
find any labeled 18 S-RNA, after your chase in the nuclear extract 
and, yet, even the most skeptical of us will admit that 18 S-RNA 
is made in the nucleus. So the absence of the 4 S label from your 
extract would also imply the same. Another point would be that 
it does look from your pulse-labeling studies and subsequent chase 
that, in fact, you do have essentially the same pattern we have 
in the pulse, that is, a super-imposition of a relatively small 
45 S peak on a broad base of polydisperse material. The polydis­
perse material has been, to a good extent, lost following your 
chase. The 45 S material has gone into 28 S and as Dr. Kay pointed 
out; it does represent a rather small peak.
